<SEC-DOCUMENT>0000950123-25-001897.txt : 20250703
<SEC-HEADER>0000950123-25-001897.hdr.sgml : 20250703
<ACCEPTANCE-DATETIME>20250213065053
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000950123-25-001897
CONFORMED SUBMISSION TYPE:	DRS/A
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20250213
<PUBLIC-REL-DATE>20250703
DATE AS OF CHANGE:		20250213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ambiq Micro, Inc.
		CENTRAL INDEX KEY:			0001500412
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				271911389
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DRS/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	377-06209
		FILM NUMBER:		25617117

	BUSINESS ADDRESS:	
		STREET 1:		6500 RIVER PLACE BOULEVARD
		STREET 2:		BUILDING 7, SUITE 200
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78730
		BUSINESS PHONE:		(512) 879-2850

	MAIL ADDRESS:	
		STREET 1:		6500 RIVER PLACE BOULEVARD
		STREET 2:		BUILDING 7, SUITE 200
		CITY:			AUSTIN
		STATE:			TX
		ZIP:			78730
</SEC-HEADER>
<DOCUMENT>
<TYPE>DRS/A
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML><HEAD>
<TITLE>DRS/A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>As submitted confidentially to the Securities and Exchange Commission on
February&nbsp;13, 2025. This Amendment No.&nbsp;2 to the draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right"><B>Registration No.&nbsp;333-&#8195;&#8195;&#8195; </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES
AND EXCHANGE COMMISSION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Form <FONT
STYLE="white-space:nowrap">S-1</FONT> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><I>Under </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B><I>The
Securities Act of 1933 </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:22pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Exact
name of Registrant as specified in its charter) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>3674</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">27-1911389</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(State or other jurisdiction of<BR>incorporation or organization)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(Primary Standard Industrial<BR>Classification Code Number)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(I.R.S. Employer<BR>Identification Number)</B></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>6500 River Place Blvd., Building 7 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Suite 200 Austin, Texas 78730 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(512) 879-2850 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address,
including zip code, and telephone number, including area code, of Registrant&#146;s principal executive offices) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Fumihide Esaka
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Chief Executive Officer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>6500
River Place Blvd., Building 7 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Suite 200 Austin, Texas 78730 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>(512) 879-2850 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name,
address, including zip code, and telephone number, including area code, of agent for service) </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><I>Copies to:
</I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Christina T. Roupas</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Courtney M.W. Tygesson</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Michael Platt</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Anitha
Anne</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Cooley LLP</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>110
N. Wacker Drive, Suite 4200</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Chicago, IL 60606</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(312) 881-6500</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Alan F. Denenberg<BR>Emily Roberts</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Davis Polk&nbsp;&amp; Wardwell LLP</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>900 Middlefield Road</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Redwood City, CA 94063</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(650) 752-2000</B></P></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman"><B>Approximate date of commencement of proposed sale to the public</B>: As soon as practicable after this registration statement becomes
effective. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415
under the Securities Act, check the following box:&#8194;&#9744; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&#8194;&#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.&#8194;&#9744; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If this
Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering.&#8194;&#9744; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT
STYLE="white-space:nowrap">non-accelerated</FONT> filer, a smaller reporting company or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company,&#148; and
&#147;emerging growth company&#148; in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Large accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-accelerated</FONT> filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller reporting company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging growth company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&#8194;&#9744; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman"><B>The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the
Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with the provisions of Section&nbsp;8(a) of the Securities Act of 1933 or until the Registration
Statement shall become effective on such date as the Commission, acting pursuant to said Section&nbsp;8(a), may determine. </B></P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXPLANATORY NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While our financial statements and information for the nine months ended September 30, 2024 are otherwise required by Regulation <FONT
STYLE="white-space:nowrap">S-X</FONT> at the time of the submission of this registration statement, we are an &#147;emerging growth company&#148; (as defined in Section&nbsp;2(a) of the Securities Act) and reasonably believe that such financial
statements and information will not be required to be included in this registration statement at the time of effectiveness. Accordingly, pursuant to the applicable provisions of the Fixing America&#146;s Surface Transportation Act, we are omitting
unaudited financial statements as of and for the nine months ended September&nbsp;30, 2024. We intend to amend this registration statement to include all financial information required by Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> at the
date of such amendment before distributing a preliminary prospectus to investors. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <DIV STYLE="position:relative; overflow:visible; width:651pt; height:36pt; transform-origin:bottom left; transform: rotate(-90deg) translate(-100%, 100%) translateX(36pt);">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial Narrow"><FONT COLOR="#ff4338"><B>The information in this preliminary prospectus is not complete and may be changed. We may not sell these securities until the
registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or
sale is not permitted. </B></FONT></P></DIV><DIV STYLE="position:relative; overflow:visible; margin-left:54pt; margin-right:54pt; transform: translateY(-36pt);"> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ff4338"><B>PRELIMINARY PROSPECTUS </B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#ff4338"><B>(Subject to Completion, dated&#8195;&#8195;&#8195;&#8195;, 2025) </B></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>&#8195;&#8195;&#8195;Shares </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377490g61t49.jpg" ALT="LOGO" STYLE="width:3.13786in;height:0.930593in;">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMMON STOCK </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This is the
initial public offering of shares of common stock of Ambiq Micro, Inc. We are offering shares of our common stock. No public market currently exists for our shares. We anticipate that the initial public offering price will be between
$&#8195;&#8195;&#8195;and $&#8195;&#8195;&#8195;per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to apply to have our common stock listed
on&#8195;&#8195;&#8195;under the symbol &#147;AMBQ.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an
&#147;emerging growth company,&#148; as defined under the federal securities laws and are subject to reduced public company reporting requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Investing in our common stock involves risks. See &#147;<A HREF="#rom377490_2">Risk Factors</A>&#148; beginning on page&nbsp;15. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discounts and
commissions<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds to Ambiq Micro, Inc. before expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See &#147;Underwriting&#148; for a description of the compensation payable to the underwriters.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have granted the underwriters the right to purchase up to&#8195;&#8195;&#8195;additional shares of common stock from
us, solely to cover over-allotments, if any. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:12pt; font-family:Times New Roman"><B>Neither the Securities and Exchange Commission nor any state securities commission has
approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters expect to deliver the shares of common stock to purchasers on or about&#8195;, 2025. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:16pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:16pt">
<TD VALIGN="top" ALIGN="center"><B>BofA Securities</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>UBS Investment Bank</B></TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#8195;&#8195;&#8195;&#8195;, 2025 </P></DIV> <p STYLE="clear:both; font-size:1pt; height:0">&nbsp;</p>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_1">PROSPECTUS SUMMARY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_1a">THE OFFERING </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_1b">SUMMARY CONSOLIDATED FINANCIAL DATA </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_2">RISK FACTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_3">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_4">INDUSTRY AND MARKET DATA</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_5">USE OF PROCEEDS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_6">DIVIDEND POLICY</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_7">CAPITALIZATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_8">DILUTION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_9">MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
 OF OPERATIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_10">BUSINESS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">79</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_11">MANAGEMENT</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
</DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_12">EXECUTIVE COMPENSATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_13">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_14">PRINCIPAL STOCKHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_15">DESCRIPTION OF CAPITAL STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_16">SHARES ELIGIBLE FOR FUTURE SALE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_17">CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS OF OUR COMMON STOCK</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">129</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_18">UNDERWRITING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">133</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_19">LEGAL MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_20">EXPERTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_22">WHERE YOU CAN FIND ADDITIONAL INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">144</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#rom377490_23">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">F-1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  </div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we nor
the underwriters have authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses we have prepared. Neither we nor the underwriters take any
responsibility for, or can provide any assurance as to the reliability of, any other information that others may give you. We are not offering to sell, or seeking offers to buy, shares of our common stock in any jurisdiction where these offers and
sales are not permitted. The information in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or any sale of shares of our common stock. Our business, financial condition and
results of operations may have and are likely to have changed since that date. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Through and including&#8195;&#8195;&#8195;&#8195;, 2025
(the 25th day after the date of this prospectus), all dealers effecting transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This delivery requirement is in addition to the
obligation of dealers to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For investors outside the United States: Neither we nor the underwriters have done anything that would permit this offering or possession or
distribution of this prospectus or any free writing prospectus in connection with this offering in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into
possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of our common stock and the distribution of this prospectus outside of the United States. See the section titled
&#147;Underwriting&#148; for additional information </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_1"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights selected information that is presented in greater detail elsewhere in this prospectus. This summary does not
contain all of the information you should consider before investing in our common stock. You should read this entire prospectus carefully, including the sections titled &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of
Financial Condition and Results of Operations&#148; and our consolidated financial statements and the related notes included elsewhere in this prospectus, before making an investment decision. Please see &#147;Industry and Market Data&#148; for
information concerning certain market statistics included in this prospectus. This summary contains forward-looking statements that involve risks and uncertainties. Unless the context otherwise requires, the terms &#147;Ambiq,&#148; &#147;the
Company,&#148; &#147;we,&#148; &#147;us,&#148; and &#147;our&#148; in this prospectus refer to Ambiq Micro, Inc. and its consolidated subsidiaries. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Mission </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our mission is to enable
intelligence (artificial intelligence (AI) and beyond) everywhere by delivering the lowest power semiconductor solutions. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a pioneer and leading provider of <FONT STYLE="white-space:nowrap">ultra-low</FONT> power semiconductor solutions designed to address
the significant power consumption challenges of general purpose and AI compute &#150; especially at the edge. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our customers rely on
Ambiq to deliver AI compute closer to end users (edge environments) where power consumption challenges are the most severe. Our hardware plus software innovations deliver two to five times lower power consumption than traditional semiconductor
designs. Our products power over 260&nbsp;million devices today. We shipped more than 42&nbsp;million units in 2024, and we estimate that over 40% of them ran AI algorithms. We seek to drive growth in AI adoption at the edge in the personal devices,
medical/healthcare, industrial edge, and smart home and building markets and continue to set new standards in edge AI performance and power efficiency. Over time, we expect to integrate our <FONT STYLE="white-space:nowrap">ultra-low</FONT> power
technology into additional chip products that benefit from greater power efficiency, including high-performance compute applications such as AI data centers and automotive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">AI is perhaps the most disruptive and revolutionary technology trend of recent history, estimated to represent $23 trillion of global annual
spend by 2040, according to McKinsey. AI use cases continue to permeate our lives and improve our daily productivity by enabling us to interact with devices via voice and gestures, unlock our homes with facial recognition, track health accurately
and intelligently, and hold clear calls amidst loud background noise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, a majority of AI compute has been deployed in data centers
due to its large physical scale and the need for wall plug energy, as AI compute requires enormous and steady energy resources. At the edge, however, power limitations have been especially acute due to small device size and limited battery life. We
believe this greatly constrains the potential of AI to improve our daily, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">on-the-go</FONT></FONT> lives. Enabling AI at the edge &#150; where the action takes place &#150; with vastly
improved power efficiency will allow faster real-time decision-making due to data proximity, greater data privacy, higher energy efficiency from reduced network usage, and less dependence on constant costly connections to the cloud. We believe new
AI use cases will only be possible if edge devices are much more power efficient. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our proprietary
<FONT STYLE="white-space:nowrap">Sub-threshold</FONT> Power Optimized Technology (SPOT<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>) platform is designed to fundamentally and cost-effectively reduce power consumption of battery- and
wireline-powered devices alike. Depending on the application, devices incorporating SPOT demonstrate a two to five times reduction in power </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consumption compared to conventional integrated circuit designs. SPOT is a ground-breaking approach at the chip design level that incorporates <FONT STYLE="white-space:nowrap">sub-</FONT> and
near-threshold hardware without using expensive manufacturing processes. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We provide a full-stack solution encompassing tightly
integrated hardware and software. Our solutions include a diverse family of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">systems-on-chip</FONT></FONT> (SoCs) and the software required to enable
<FONT STYLE="white-space:nowrap">on-chip</FONT> AI processing, general compute, sensing, security, storage, wireless connectivity, and advanced graphics. Our SoC solutions deliver compute at a very small fraction of the power consumed by our
competitors&#146; products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our <FONT STYLE="white-space:nowrap">ultra-low</FONT> power SoCs serve a wide range of markets requiring <FONT
STYLE="white-space:nowrap">on-device</FONT> and real-time AI, including smartwatches and fitness trackers, augmented and virtual reality (AR/VR) glasses, smart rings, digital health monitors, security systems and access control, livestock tracking,
crop monitoring, and factory automation. These devices increasingly offer <FONT STYLE="white-space:nowrap">on-chip</FONT> <FONT STYLE="white-space:nowrap">AI-powered</FONT> features such as speech recognition, image and video processing, and
sensing, further straining power consumption, which our solutions are positioned to address. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As global demand for our SoC solutions
accelerates, our sales and marketing efforts are increasingly focused on our end customers in target geographies such as the United States, Europe, and Asia <FONT STYLE="white-space:nowrap">(ex-Mainland</FONT> China). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the years ended December&nbsp;31, 2024, and December&nbsp;31, 2023, we recognized revenue of $&#8195;&#8195;&#8195;&#8195;million and
$65.5&nbsp;million, respectively. Revenue from end customers in the United States, Europe, and Asia (outside of Mainland China) grew by &#8195;%, to $&#8195;&#8195;&#8195;&#8195;million in 2024 and achieved a gross margin of &#8195;%. We intend to
continue to focus on business outside of Mainland China. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Industry </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Growing Need for AI at the Edge </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Edge AI is expanding as machine learning outperforms traditional algorithms&#151;enabling tasks like speech recognition&#151;and meets customer
demand for cloud-independent solutions. Meanwhile, large language models (LLMs) in the cloud rely on quality edge inputs, which is evident in industrial automation, healthcare, and consumer devices. To fully realize AI&#146;s potential, computation
must move to the edge where data originates, enabling faster decisions, enhanced privacy, improved energy efficiency, and reduced cloud reliance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, realizing this vision requires overcoming a fundamental challenge: <B>power efficiency.</B> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Key Challenges of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Edge-to-Cloud</FONT></FONT> Data Processing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Today, advanced analytics and AI inference are often processed in the cloud due to the difficulty or impossibility of running them at the edge.
However, this approach has several drawbacks: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Latency.</I></B> The round trip to the cloud adds significant latency, preventing real-time behaviors and
feedback. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Connectivity.</I></B><I> </I>Wireless connectivity often consumes significant power and is limited to those
applications with reliable connections. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Security and Privacy. </I></B>Sending sensitive data to the cloud increases privacy breach risks.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Cost.</I></B> Cloud services represent a significant expense that usually scales with the amount of data
transferred to/from the cloud. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Key Challenges to AI Inferencing at the Edge </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Power Consumption. </I></B>Optimizing power consumption for all functions, from AI inferencing to wireless
connectivity to sensor management, is a fundamental challenge for edge devices. This challenge is significantly amplified as processing, performance, connectivity, and AI compute needs increase. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Real-Time Inferencing. </I></B>Most of today&#146;s AI models are designed to run in the cloud, processing
large batches of data. Edge AI is often called on to act on streams of data in real time, which requires a significant redesign of the data processing and inferencing algorithms. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Size. </I></B>Many edge devices are physically <FONT STYLE="white-space:nowrap">size-constrained,</FONT>
thereby limiting the capacity of the battery and battery life. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Integration. </I></B>Given device size constraints, vendors increasingly opt for highly integrated SoCs to
drive their devices instead of complex designs with many discrete chips having relatively narrow functionalities. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Privacy and Security. </I></B>While bringing AI to the edge improves system security and reduces the attack
surface, it creates high-security expectations for small edge devices with minimal compute resources. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Resource Constrained AI Model Development. </I></B>Most AI models today are built for the cloud, where
compute performance, memory, and power are readily available. Building <FONT STYLE="white-space:nowrap">&#147;right-sized&#148;</FONT> models that execute efficiently on the edge is extremely challenging. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our <FONT STYLE="white-space:nowrap">ultra-low</FONT> power SoC solutions are designed to fundamentally address our end customers&#146; needs
for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">ultra-low-power</FONT></FONT> consumption for all functions, better connectivity, and increased AI compute (especially at the edge). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Technology </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SPOT<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> is our proprietary <FONT STYLE="white-space:nowrap">ultra-low</FONT> power chip design platform created to solve this severe power consumption problem. SPOT consists of a set of chip design
techniques that allow standard transistors to operate in an <FONT STYLE="white-space:nowrap">ultra-low</FONT> power mode called <FONT STYLE="white-space:nowrap">&#147;sub-threshold&#148;</FONT> and &#147;near-threshold&#148;. When combined with
other <FONT STYLE="white-space:nowrap">low-power</FONT> chip architecture techniques, SPOT enables our SoCs to deliver two to five times lower power consumption than leading alternative solutions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By significantly reducing the power required for sensing, communication, security, and AI compute, customers are given flexibility on how best
to deploy the vastly improved energy budgets of their products. They can use this flexibility to run larger AI models faster, add more sensors, reduce battery size, and/or extend battery life. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Specifically, we have developed wide-ranging chip architectures, intellectual property (IP) building blocks, and integrated circuit (IC)
design methodologies for digital circuits, analog circuits, and embedded memories &#150; accumulating significant expertise and IP related to product design, validation, and production testing. Our proven expertise in, and experience with, <FONT
STYLE="white-space:nowrap">ultra-low</FONT> power design provides us with a substantial competitive advantage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we have
developed a wide range of chip architecture techniques that are designed to enable even lower power than <FONT STYLE="white-space:nowrap">sub-threshold</FONT> and near-threshold operation alone. Many of these chip design techniques are protected by
IP rights, including patents and trade secrets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While many <FONT STYLE="white-space:nowrap">high-end</FONT> processor chip companies can
increase performance or decrease power consumption with advanced process technology nodes, these expensive manufacturing processes are typically not cost-effective for edge devices. With our SPOT platform, we are able to manufacture our products at
much more </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cost-effective process technology nodes. Furthermore, reliance on advanced process technology nodes and Moore&#146;s Law to solve the power problem is particularly limiting as Moore&#146;s Law is
viewed by many as dead or broken. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a more detailed description of our technology, see &#147;Business&#151;Our Technology&#148;.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Products </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our SPOT platform
serves as the foundation for a series of SoCs for edge AI devices that deliver <FONT STYLE="white-space:nowrap">ultra-low</FONT> power for AI computations, general purpose computations, sensing, communications, power conversion, and more. These SoCs
are paired with a full-stack software solution that is designed to enable efficient resource-constrained AI application development and a fast <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">time-to-market.</FONT></FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>SoC Products for Edge AI </I></B></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our portfolio includes two flagship SoC product families, both with rich sets of peripherals: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Apollo: </I></B>The Apollo family of products pair rich peripheral sets with host processors capable of
software-based AI computations (e.g., Apollo3 and Apollo4 families) or vector-accelerated AI computations (e.g., Apollo5 family). For most edge AI use cases, we believe the combination of the Apollo products with our full stack software solution
provides the optimal power, performance, feature, and cost <FONT STYLE="white-space:nowrap">trade-off.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Atomiq: </I></B>The first Atomiq family product is currently in development. This novel product targets AI
applications requiring demanding edge AI compute requirements and is thus expected to provide the highest performance and lowest power ever delivered by our products. Atomiq is expected to feature a full neural processing unit (NPU) for
high-performance AI acceleration along with new memory innovations &#150; all with the goal of achieving minimum power and maximum performance on AI model execution at the edge. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Software Products for Edge AI </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To
truly unlock edge AI use cases, our <FONT STYLE="white-space:nowrap">ultra-low</FONT> power SoCs must be paired with carefully optimized proprietary software. To make edge AI application development easier for our customers, Ambiq provides a series
of core software products: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>General enablement firmware: </I></B>Our AmbiqSuite Software Development Kit (SDK) provides <FONT
STYLE="white-space:nowrap">low-level</FONT> firmware and drivers required to operate our SoCs efficiently. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Feature enablement software: </I></B>On top of AmbiqSuite SDK, we offer a series of software modules that
enable complex applications to be developed quickly and efficiently. These modules include graphiqSPOT for graphics and display management, blueSPOT for Bluetooth communications, secureSPOT for managing security, and more. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>AI enablement software: </I></B>Ambiq assists our customers in developing AI features by providing novel
model factories specifically designed for edge AI, optimized AI inference engines, and neuralSPOT, our cross-platform AI SDK. These tools are designed to collectively address the challenges encountered when developing AI for edge products.
</P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For a more detailed description of our products, see &#147;Business&#151;Our Products&#148;. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Market Opportunity </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Most of our revenue today has come from <FONT STYLE="white-space:nowrap">ultra-low</FONT> power SoCs, tightly bundled with software and various
other solutions that combine <FONT STYLE="white-space:nowrap">32-bit</FONT> microcontrollers (MCUs) with wireless connectivity and additional circuitry, such as graphics processing units, serial interfaces, and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">analog-to-digital</FONT></FONT> interfaces. In the near future, we believe we can expand into embedded application processors, as well as stand-alone dedicated AI processors. Even though many of our customers today run
basic AI inferencing directly on our Apollo-class SoCs and on lightweight accelerators within our SoCs, we are now developing dedicated AI processor units purpose-built for accelerating AI compute. Today, we define our market opportunity as <FONT
STYLE="white-space:nowrap">32-bit</FONT> MCUs, discrete application processors (ASICs), wireless connectivity, and AI processors built for edge applications, markets totaling $12.8&nbsp;billion in 2023 and growing to $22.5&nbsp;billion in 2028,
according to Gartner.** This includes <FONT STYLE="white-space:nowrap">AI-enabled</FONT> devices spanning industrial edge, smart homes and buildings, as well as body-worn AI devices such as consumer wearables and digital health devices. In the
future, we believe our technology has the potential to address many semiconductor end markets that need much greater energy efficiency. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Within the edge end markets listed above, the market for <FONT STYLE="white-space:nowrap">32-bit</FONT> MCUs is expected to grow from
$4.7&nbsp;billion in 2023 to $6.0&nbsp;billion in 2028, representing a compound annual growth rate (CAGR) of 5%, according to Gartner.** The market for wireless connectivity semiconductors for the same end markets is expected to grow from
$2.4&nbsp;billion in 2023 to $4.7&nbsp;billion in 2028, representing a CAGR of 15%. The market for application processors is expected to grow from $5.7&nbsp;billion in 2023 to $10.2&nbsp;billion in 2028, representing a CAGR of 12%. According to
Gartner, the discrete AI processors market is expected to grow from $152&nbsp;million in 2023 to $1.6&nbsp;billion in 2028, representing a CAGR of 60%.** </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since AI solutions are often embedded into general processor SoCs, broader <FONT STYLE="white-space:nowrap">AI-enabled</FONT> market forecasts
are also relevant to our opportunity. According to Gartner, the market for <FONT STYLE="white-space:nowrap">AI-enabled</FONT> <FONT STYLE="white-space:nowrap">32-bit</FONT> MCUs and application processors in edge applications is expected to grow
from $788&nbsp;million in 2023 to $6.8&nbsp;billion in 2028, representing a CAGR of 54%.* </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Competitive Strengths </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe our core competitive strengths include the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Leading proprietary <FONT STYLE="white-space:nowrap">ultra-low</FONT> power chip design technology. </I></B>We exclusively focus on <FONT
STYLE="white-space:nowrap">ultra-low</FONT> power, <FONT STYLE="white-space:nowrap">sub-</FONT> and near-threshold chip design technology, which is our key differentiator and top development priority. Our SPOT platform comprises dozens of individual
circuit design techniques that are difficult to replicate, complemented by overall <FONT STYLE="white-space:nowrap">low-power</FONT> system design expertise and <FONT STYLE="white-space:nowrap">know-how</FONT> and our proprietary AmbiqSuite SDK,
making it easy for our end customers to quickly and effectively implement our products. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Extensible technology platform.
</I></B>We believe our SPOT platform is fully extensible to a wide variety of semiconductor applications that require substantially greater power efficiency in both battery-operated and wall-powered devices. Our technology is especially valuable for
battery-operated products by significantly improving performance on a fixed power budget or by extending the time between charges in edge devices. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Robust intellectual property portfolio. </I></B>Our IP is a key aspect of our business strategy, allowing us to maintain a competitive
and, we believe, sustainable edge in the market. Our robust IP portfolio encompasses patents, trade secrets, and design IP that safeguard our proprietary technology and innovations related to <FONT STYLE="white-space:nowrap">ultra-low</FONT> power
and <FONT STYLE="white-space:nowrap">sub-threshold</FONT> design. Our design IP has been proven over five generations of the Apollo family of products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Proven demand from blue-chip end customers. </I></B>We have demonstrated strong end customer growth with more than 260&nbsp;million
units shipped with international technology leaders such as Garmin, Google, Suunto, and others, which has validated the maturity of our technology platform and the robustness of our products. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Scalable design and manufacturing relationships. </I></B>Our SoC solutions
leverage existing mature semiconductor process technologies that are readily available and cost-effective. Since our founding, we have partnered with a leading semiconductor foundry, Taiwan Semiconductor Manufacturing Company Limited (TSMC), for our
SoC products in <FONT STYLE="white-space:nowrap">180-nanometer,</FONT> <FONT STYLE="white-space:nowrap">90-nanometer,</FONT> <FONT STYLE="white-space:nowrap">40-nanometer,</FONT> and <FONT STYLE="white-space:nowrap">22-nanometer</FONT> process
nodes. We leverage TSMC&#146;s mature fabrication processes, which are more cost-effective than the most advanced nodes, while still delivering products that consume a very small fraction of the power that our competitors require for their
comparable parts. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Top industry talent, experienced management team and engineering-focused culture. </I></B>We believe our
team&#146;s engineering, chip design, and AI talent is critical to our success. We employ an engineering-focused workforce, as well as a highly technical senior management team with deep industry and chip design experience. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Strategy </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Extend our
presence in current markets with higher-performing and lower-power versions of our existing products. </I></B>New members of the Apollo and Atomiq family of SoCs in development are designed to deliver even lower power and higher processing
performance to our existing customers, potentially enabling and accelerating new innovative edge AI use cases. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Expand
aggressively into new markets by broadening current product families. </I></B>We intend to apply our <FONT STYLE="white-space:nowrap">ultra-low</FONT> power value proposition to enable AI use cases in medical, digital health, industrial, security,
smart home and buildings, robotics, and automotive markets. We are developing a broader portfolio of Apollo and Atomiq SoC offerings that we believe will allow us to enter these additional markets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Bring SPOT to new classes of chip products to access both existing and new markets. </I></B>SPOT is a widely applicable, <FONT
STYLE="white-space:nowrap">ultra-low</FONT> power design methodology that can be quickly applied to new chip classes such as application processors (APs), dedicated AI processors, digital signal processors (DSPs), image processors, power management
chips, communications chips, network processors, and many more. We intend to develop new ultra-lower power chip product families that we believe will provide us access to additional sockets within current customers, as well as to entirely new
customers in new market segments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Leverage our
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">easy-to-use</FONT></FONT> software and AI model suite to speed customer adoption and drive higher-margin revenue. </I></B>We are working to increase our software suite to include new
AI software products, such as AI model libraries, AI compilers and runtimes, AI model development utilities, AI model factories and AI training data. Complementary to our existing SoC solutions, we believe these new AI software offerings will enable
us to reach a broader set of customers, will allow these customers to more quickly implement their AI functionalities, and are expected to help drive increased SoC gross margins. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Develop SPOT into a licensable technology platform. </I></B>We plan to develop SPOT into an IP and chip development platform that makes
it easier for other companies to license or partner with us to incorporate SPOT into their own <FONT STYLE="white-space:nowrap">low-power</FONT> chip designs, such as building next-generation AI data center chips. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I></I></B><B><I>Relentlessly advance the SPOT platform to help position us for future leadership. </I></B>New AI use cases enabled by
novel sensors drive a growing need for ultra-low power AI chips. We plan to continue to advance the SPOT platform with innovations in circuit hardware and software. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary of Risks Factors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Investing in
our common stock involves substantial risk. The risks described under the section titled &#147;Risk Factors&#148; immediately following this prospectus summary may cause us to not realize the full benefits of our
</P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
objectives or may cause us to be unable to successfully execute all or part of our strategy. Some of the more significant challenges include the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We have a history of net losses, and we may not achieve or maintain profitability in the future.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We currently depend on a limited number of end customers for most of our revenue. The loss of, or a significant
reduction in orders from, our key end customers would significantly reduce our revenue and adversely impact our business, financial condition, and results of operations. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We do not have long-term commitments from our end customers and our end customers may cease purchasing our
products at any time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The nature of the design win process requires us to incur expenses without any guarantee that research and
development efforts will generate material revenue, which could adversely affect our business, financial condition and results of operations. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We continue to invest in research and development efforts for several new markets. If we are unable to
commercialize these technologies, our business, financial condition and results of operations could be negatively affected. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We are subject to the cyclical nature of the semiconductor industry. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Some of our end customers and other third-party agreements provide for joint or custom product development, which
subjects us to a number of risks, and any failure to execute on any of these arrangements could have a material adverse effect on our business, financial condition, and results of operations. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The AI industry is subject to complex, evolving regulatory, statutory, and other requirements that may be
difficult and expensive to comply with and that could negatively impact our business. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The market for edge AI services and products is relatively new, and may decline or experience limited growth, and
our business is dependent on our clients&#146; continuing adoption and use of our services and products. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We have no manufacturing capabilities of our own. We are a fabless company, meaning that we do not own a
semiconductor foundry, and we rely on a single third-party supplier for the fabrication of semiconductor wafers and on a limited number of suppliers of other materials, and the failure of any of our suppliers to provide us with wafers and other
materials on a timely basis would harm our business, financial condition, and results of operations. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our dependence on TSMC as our sole supplier of wafers exposes us to certain political, social, and economic risks
that may harm our business. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Raw material and engineered material availability and price fluctuations have in the past and may in the future
increase the cost of our solutions, impact our ability to meet customer commitments, and may adversely affect our business, financial condition, and results of operations. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our failure to comply with the Outbound Investment Security Program could subject us to penalties and other
adverse consequences. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Changes in U.S. or foreign trade policies and other factors beyond our control may adversely impact our business
and operating results. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We are a global company, which subjects us to additional business risks, including logistical and financial
complexity, political instability and currency fluctuations. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We identified material weaknesses in our internal control over financial reporting, and we may experience
additional material weaknesses or otherwise fail to design and maintain effective internal control over financial reporting. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If we are unable to obtain, maintain and enforce patent protection for our current and future proprietary
technology and inventions, or if the scope of the patent protection obtained is not sufficiently broad, our ability to compete successfully and our business, financial condition, and results of operations could be adversely impacted.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Implications of Being an Emerging Growth Company and Smaller Reporting Company </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company,&#148; as defined in the Jumpstart Our Business Startups Act (the JOBS Act), enacted in April 2012. We
intend to take advantage of certain exemptions under the JOBS Act from various public company reporting requirements, including not being required to have our internal control over financial reporting audited by our independent registered public
accounting firm pursuant to Section&nbsp;404(b) of the Sarbanes-Oxley Act of 2002, as amended (the Sarbanes-Oxley Act), reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from
the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute payments not previously approved. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting
standards. This provision allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this provision of the JOBS Act.
As a result, we will not be subject to new or revised accounting standards at the same time as other public companies that are not emerging growth companies. Therefore, our consolidated financial statements may not be comparable to those of
companies that comply with new or revised accounting pronouncements as of public company effective dates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will remain an emerging
growth company and may take advantage of these exemptions until the earliest of: (i)&nbsp;the last day of the fiscal year following the fifth anniversary of the consummation of this offering; (ii)&nbsp;the last day of the fiscal year in which we
have total annual gross revenue of at least $1.235&nbsp;billion; (iii)&nbsp;the last day of the fiscal year in which we are deemed to be a &#147;large accelerated filer&#148; as defined in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> under the
Securities Exchange Act of 1934, as amended (Exchange Act), which would occur if the market value of our common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeded $700.0&nbsp;million as of the last business day of the
second fiscal quarter of such year; or (iv)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt securities during the prior three-year period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are also a &#147;smaller reporting company&#148; as defined in the Exchange Act. We may continue to be a smaller reporting company even
after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for so long as our voting and <FONT
STYLE="white-space:nowrap">non-voting</FONT> common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is less than $250.0&nbsp;million measured on the last business day of our second fiscal quarter, or our annual revenue is less
than $100.0&nbsp;million during the most recently completed fiscal year and our voting and <FONT STYLE="white-space:nowrap">non-voting</FONT> common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is less than
$700.0&nbsp;million measured on the last business day of our second fiscal quarter. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We were incorporated in Delaware on January&nbsp;20, 2010 under the name Cubiq Microchip, Inc., and in October 2012, changed our name to Ambiq
Micro, Inc. Our principal executive offices are located at 6500 River Place Blvd., Building 7, Suite 200, Austin, Texas 78730, and our telephone number is (512) <FONT STYLE="white-space:nowrap">879-2850.</FONT> Our corporate website address is
www.ambiq.com. Information contained on or accessible through our website is not a part of this prospectus and should not be relied on in determining whether to make an investment decision. The inclusion of our website address in this prospectus is
an inactive textual reference only. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Trademarks and Service Marks </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We use the Ambiq logo and other marks as trademarks in the United States and other countries. The Ambiq word mark and logos, SPOT, graphiqSPOT,
neuralSPOT, turboSPOT, secureSPOT, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Voice-on-SPOT,</FONT></FONT> and VoS, among others, are registered trademarks of Ambiq Micro, Inc. Other trademarks and trade names are those of
their respective owners. This prospectus contains references to our trademarks and service marks and to those belonging to other entities. Solely for convenience, the trademarks and trade names referred to in this prospectus, including logos,
artwork and other visual displays, may appear without the <SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, <SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> or SM symbols, but such references are not intended to indicate in any
way that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other entities&#146; trade names, trademarks or
service marks to imply a relationship with, or endorsement or sponsorship of us by, any other entity. </P>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_1a"></A>The Offering </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock offered by us </P></TD>
<TD>&#8195;&#8195;&#8195;shares </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Option to purchase additional shares </P></TD>
<TD>&#8195;&#8195;&#8195;shares </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock to be outstanding after this offering </P></TD>
<TD>&#8195;&#8195;&#8195;&#8195;shares (&#8195;&#8195;&#8195;shares if the underwriters exercise their over-allotment option in full) </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </P></TD>
<TD>We estimate that the net proceeds to us from this offering will be approximately $&#8195;&#8195;&#8195;&#8195;million (or $&#8195;&#8195;&#8195;million if the underwriters exercise their over-allotment option in full), based on an assumed
initial public offering price of $&#8195;&#8195;&#8195;per share (the midpoint of the price range set forth on the cover page of this prospectus), and after deducting underwriting discounts and commissions and estimated offering expenses payable by
us. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We currently intend to use the net proceeds from this offering primarily for general corporate purposes, including working capital, sales and marketing activities, product development, general and administrative
matters, and capital expenditures, although we do not currently have any specific or preliminary plans with respect to the use of proceeds for such purposes. We also may use a portion of the net proceeds to acquire complementary businesses,
products, services, or technologies. However, we do not have agreements or commitments for any specific acquisitions at this time. See &#147;Use of Proceeds.&#148; </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Dividend policy </P></TD>
<TD>We do not anticipate declaring or paying, in the foreseeable future, any cash dividends on our capital stock. See &#147;Dividend Policy.&#148; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk factors </P></TD>
<TD>You should read &#147;Risk Factors&#148; for a discussion of certain of the factors to consider carefully before deciding to purchase any shares of our common stock. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Listing </P></TD>
<TD>We intend to apply to list our common stock on the&#8195;&#8195;&#8195;&#8195;under the symbol &#147;AMBQ.&#148; </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless
otherwise indicated, the number of shares of our common stock to be outstanding after this offering is based on&#8195;&#8195;&#8195;shares of common stock outstanding as of December&nbsp;31, 2024, and excludes: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">up to &#8195;&#8195;&#8195;shares of our common stock issuable upon the vesting of restricted stock units (RSUs),
which we granted pursuant to our 2020 Equity Incentive Plan (the 2020 Plan) having a fair market value of $ &#8195;&#8195;&#8195;per share; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#8195;&#8195;&#8195;shares of our common stock issuable upon the exercise of outstanding stock options under our
2010 Equity Incentive Plan (the 2010 Plan) and the 2020 Plan as of December&nbsp;31, 2024, with a weighted- average exercise price of $&#8195;&#8195;&#8195;&#8195;&#8195;per share; </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#8195;&#8195;&#8195;shares of our common stock reserved for future issuance under our 2025 Equity Incentive Plan
(the 2025 Plan), which will become effective as of immediately prior to the completion of this offering, as well as any automatic increases in the number of shares of common stock reserved for future issuance under the 2025 Plan; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#8195;&#8195;&#8195;shares of our common stock reserved for future issuance under our 2025 Employee Stock
Purchase Plan (the ESPP), which will become effective as of immediately prior to the completion of this offering, as well as any automatic increases in the number of shares of common stock reserved for future issuance under the ESPP.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, all information contained in this prospectus assumes or gives effect to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the automatic conversion of all 347,983,712 outstanding shares of our convertible preferred stock as of
&#8195;&#8195;&#8195;&#8195;, 2025, into an aggregate of&#8195;&#8195;&#8195;shares of our common stock upon the closing of this offering; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise of the outstanding options described above; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the filing of our amended and restated certificate of incorporation and the adoption of our amended and restated
bylaws upon the closing of this offering; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise by the underwriters of their over-allotment option to purchase up to &#8195;&#8195;&#8195;additional
shares of our common stock from us to cover over-allotments, if any. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_1b"></A>SUMMARY CONSOLIDATED FINANCIAL DATA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The summary consolidated statements of operations data presented below for the years ended December&nbsp;31, 2024 and 2023, and the
consolidated balance sheet data as of December&nbsp;31, 2024 are derived from our audited consolidated financial statements included elsewhere in this prospectus. The following summary consolidated financial data should be read together with
&#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; and our consolidated financial statements and related notes included elsewhere in this prospectus. Our historical results are not necessarily
indicative of the results that may be expected for any period in the future. </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands, except share<BR>and per share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Statements of Operations Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46,096</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sales, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70,763</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(51,322</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss before income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(50,302</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(50,332</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deemed dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,941</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(52,273</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share attributable to common stockholders<SUP
STYLE="font-size:75%; vertical-align:top">(1)</SUP>:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5.38</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average common stock
outstanding<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,722,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share attributable to common stockholders (unaudited):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.18</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma weighted-average common stock outstanding (unaudited):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">292,732,177</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Currency translation adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(508</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(50,840</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deemed dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,941</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(52,781</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Financial Measures:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> net loss<SUP
STYLE="font-size:75%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(39,213</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> gross profit<SUP
STYLE="font-size:75%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See Notes 2 and 3 to our financial statements included elsewhere in this prospectus for a description of how we
compute basic and diluted net loss per common share and the number of shares used in computing these amounts. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We use <FONT STYLE="white-space:nowrap">non-GAAP</FONT> net loss and
<FONT STYLE="white-space:nowrap">non-GAAP</FONT> gross profit, both <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures, to help us make strategic decisions, establish budgets and operational goals for managing our business, analyze
our financial results, and evaluate our performance. We present the <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures, including <FONT STYLE="white-space:nowrap">non-GAAP</FONT> net loss and
<FONT STYLE="white-space:nowrap">non-GAAP</FONT> gross profit in this prospectus because we believe these <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures provide additional tools for investors to use in comparing our core
business and results of operations over multiple periods with other companies in our industry, many of which present similar <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures to investors. However, our presentation of <FONT
STYLE="white-space:nowrap">non-GAAP</FONT> net loss and <FONT STYLE="white-space:nowrap">non-GAAP</FONT> gross profit may not be comparable to similarly titled measures reported by other companies due to differences in the way that these measures
are calculated. <FONT STYLE="white-space:nowrap">Non-GAAP</FONT> net loss and <FONT STYLE="white-space:nowrap">non-GAAP</FONT> gross profit should not be considered as the sole measures of our performance and should not be considered in isolation
from, or as a substitute for, net loss and gross profit calculated in accordance with GAAP. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">We define <FONT
STYLE="white-space:nowrap">non-GAAP</FONT> net loss as our net loss adjusted to exclude expenses not directly attributable to the performance of our operations, such as income taxes, depreciation and amortization, stock-based compensation expense,
severance costs, initial public offering (IPO) and other transaction costs and warrant valuation changes. We define <FONT STYLE="white-space:nowrap">non-GAAP</FONT> gross profit as our gross profit adjusted to exclude expenses not directly
attributable to gross profit, such as depreciation and amortization, and stock-based compensation. Refer to additional discussion under the subsection titled &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of <FONT
STYLE="white-space:nowrap">Operations&#151;Non-GAAP</FONT> Financial Measures&#148; below. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables reconcile the most
directly comparable GAAP financial measure to each of these <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT
STYLE="white-space:nowrap">Non-GAAP</FONT> Net Loss: </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#8201;&#8195;2024&#8195;&#8201;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#8201;&#8195;2023&#8195;&#8201;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(50,332</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Add:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,623</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">481</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IPO and other transaction costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant valuation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(581</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(39,213</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-bottom:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Gross Profit: </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#8195;2024&#8195;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#8195;2023&#8195;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Add:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,420</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December&nbsp;31, 2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro<BR>Forma<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma&nbsp;As<BR>Adjusted<SUP STYLE="font-size:75%; vertical-align:top">(2)(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>&nbsp;</B></TD>
<TD VALIGN="bottom" COLSPAN="9" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Balance Sheet Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital<SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; (deficit) equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The pro forma consolidated balance sheet data gives effect to the: (i)&nbsp;automatic conversion of all
347,983,712 shares of our outstanding redeemable convertible preferred stock into an aggregate of&#8195;&#8195;&#8195;&#8195;number of shares of our common stock, which will occur upon the closing of this offering, and the related reclassification
of the carrying value of our redeemable convertible preferred stock to permanent equity upon the closing of this offering, and (ii)&nbsp;filing and effectiveness of our amended and restated certificate of incorporation upon the closing of this
offering. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The pro forma as adjusted consolidated balance sheet data gives effect to: (i)&nbsp;the pro forma items
described in footnote (1)&nbsp;above; and (ii)&nbsp;the issuance and sale by us of&#8195;&#8195;&#8195;&#8195;shares of common stock in this offering, assuming an initial public offering price of $&#8195;&#8195;&#8195;&#8195;per share (the midpoint
of the range set forth on the cover page of this prospectus), after deducting underwriting discounts and commissions and estimated offering expenses. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The pro forma as adjusted consolidated balance sheet data is illustrative only and will change based on the
actual initial public offering price and other terms of this offering determined at pricing. Each $1.00 increase (decrease) in the assumed initial public offering price of $&#8195;&#8195;&#8195;&#8195;per share would increase (decrease) each of our
pro forma as adjusted cash and cash equivalents, working capital, total assets and total stockholders&#146; equity (deficit) by $&#8195;&#8195;&#8195;&#8195;million, assuming the number of shares of common stock offered by us, as set forth on the
cover page of this prospectus, remains the same, and after deducting underwriting discounts and commissions and estimated offering expenses. Similarly, each increase (decrease) of 1.0&nbsp;million shares in the number of shares of common stock
offered by us would increase (decrease) each of our pro forma as adjusted cash and cash equivalents, working capital, total assets and total stockholders&#146; (deficit) equity by $&#8195;&#8195;&#8195;&#8195;million, assuming the assumed initial
public offering price of $&#8195;&#8195;&#8195;&#8195;per share remains the same, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Working capital is defined as total current assets less total current liabilities. See our consolidated
financial statements and related notes included elsewhere in this prospectus for further details regarding our current assets and current liabilities. </P></TD></TR></TABLE>
</div></div>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_2"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described below,
together with all of the other information in this prospectus, including our audited consolidated financial statements and related notes and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations,&#148;
before investing in our common stock. If any of the following risks are realized, in whole or in part, our business, financial condition and results of operations could be materially and adversely affected. In that event, the price of our common
stock could decline, and you could lose part or all of your investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operation. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Business </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have a history of
net losses, and we may not achieve or maintain profitability in the future. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have incurred net losses and negative cash flows
from operations since inception and we expect to continue to incur net losses and negative cash flows from operations for the foreseeable future, due in part to our continued investment in our business. We incurred a net loss of
$&#8195;&#8195;&#8195;&#8195;million and $50.3&nbsp;million for the years ended December 31, 2024 and 2023, respectively, and had an accumulated deficit of $&#8195;&#8195;&#8195;&#8195;million as of December&nbsp;31, 2024. We expect our costs to
increase in future periods as we continue to expend substantial resources on research and development, expansion into new markets, marketing and general administration (including expenses related to being a public company). The net losses we incur
may fluctuate significantly from quarter to quarter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our long-term success is dependent upon our ability to generate increased revenue,
obtain additional capital when needed and, ultimately, to achieve and maintain profitable operations. We will need to generate significant additional revenue and successfully manage our research and development and other expenses to achieve and
maintain profitability. It is possible that we will not achieve profitability or that, even if we do achieve profitability, we may not maintain or increase profitability in the future. Our failure to achieve or maintain profitability could
negatively impact our stock price. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We depend on a limited number of end customers for most of our revenue. The loss of, or a significant
reduction in orders from our key end customers that are not replaced by other orders from new or existing customers, would significantly reduce our revenue and adversely impact our business, financial condition and results of operations.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our largest end customer historically has accounted for a large portion of our sales, representing
approximately&#8195;&#8195;&#8195;&#8195;% and 30% of our sales for the years ended December&nbsp;31, 2024 and 2023, respectively. Two other single end customers directly or indirectly accounted for more than 10% of our revenue in the year ended
December&nbsp;31, 2024. In addition, our top ten end customers for the years ended December&nbsp;31, 2024 and 2023 accounted for&#8195;&#8195;&#8195;&#8195;% and 94% of our total sales, respectively. We believe that our operating results for the
foreseeable future will continue to depend to a significant extent on sales attributable to certain end customers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition,
historically, our sales were significantly concentrated with end customers in Mainland China. For example, in 2023, 66% of our total sales were to end customers in Mainland China, as compared to &#8195;% in 2024. Given geopolitical concerns,
subsidized competitors creating a price sensitive environment in Mainland China and our desire to service market segments outside of consumer wearable products, we have focused our management and sales efforts toward other critical geographies. As a
result, we expect to continue to experience a substantial shift over the next year in our underlying customer concentration, as we seek to reduce our sales to customers located in Mainland China. However, there can be no assurance that we will be
successful in our efforts to replace the revenue that we foresee from our end customers in Mainland China. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While we anticipate
revenue attributable to our top end customers will fluctuate from period to period and expect to reduce our concentration of revenue from Mainland China, we expect to remain dependent on a small </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
number of end customers for a meaningful portion of our revenue for the foreseeable future. If our end customers were to choose to reduce their orders or cease to order products from us or if our
relationships with our end customers or our distributors are disrupted for any reason and we are unable to replace those orders with orders from new or existing end customers, there could be a significant negative impact on our business. Any
reduction in sales attributable to our largest end customers would have a significant and disproportionate impact on our business, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We do not have long-term commitments from our end customers, and our end customers may cease purchasing our products at any time. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We sell our products to our end customers direct or through distributors and channel partners on a purchase order basis. While we do have
cancellation and reschedule terms established with our distribution and channel partners, our end customers do not have any minimum or binding purchase obligations to us under these purchase orders and orders may be cancelled, reduced or rescheduled
with little or no notice and without penalty. Cancellations of orders could result in the loss of anticipated sales without allowing us sufficient time to reduce our inventory and operating expenses. In addition, changes in forecasts or the timing
of orders from our end customers expose us to the risks of inventory shortages or excess inventory. This in turn could cause our operating results to fluctuate. Certain distributor contracts do include variable consideration, such as limited price
protection, return and stock rotation provisions, while direct customer contracts include general right of return provisions. These provisions require us to make judgments based on past experience and other factors.&nbsp;Our judgments may not be
correct and our reserves in respect of these provisions may be inadequate resulting in our having to record unanticipated charges in a particular period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our end customers, or the distributors or channel partners through which we sell to these end customers, may choose to use solutions in
addition to ours, use different solutions altogether, or develop <FONT STYLE="white-space:nowrap">in-house</FONT> solutions that compete directly with our solutions, which could affect our end customers&#146; future purchasing decisions. In
addition, the inability of our end customers or their contract manufacturers to obtain sufficient supplies of third- party components used with our products could result in a decline in the demand for our products and a loss of sales. Any of these
events could significantly harm our business, financial condition and results of operations. In addition, if our distributors&#146; relationships with our end customers, including our larger end customers are disrupted due to our inability to
deliver products and solutions in sufficient quantities or in a timely manner, or for any other reason, our end customers may cancel their purchase orders at any time, and there could be a significant negative impact on our business, financial
condition and results of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our end customers regularly evaluate alternative suppliers in order to diversify their supplier
bases, which increases their negotiating leverage with us and protects their ability to secure similar solutions. We believe that any expansion of our end customers&#146; supplier bases could have an adverse effect on the prices we are able to
charge and volume of product that we are able to sell to our end customers, which would negatively affect our business, financial condition and results of operations. For example, sales in Mainland China decreased $&#8195;in 2024 in part due to
pricing pressures from local competitors, which resulted in our selling two of our products at substantial discounts in order to liquidate inventories that were manufactured principally for sale in Mainland China. Any reduction in sales attributable
to our end customers, and in particular our largest end customers, would have a significant impact on our business, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The nature of the design win process requires us to incur expenses without any guarantee that research and development efforts will generate material
revenue, which could adversely affect our business, financial condition and results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We focus on winning competitive
bid selection processes, resulting in &#147;design wins,&#148; to develop solutions for use in our end customers&#146; products. These lengthy selection processes may require us to incur significant expenditures and dedicate significant engineering
resources to the development of new solutions without any assurance that we will achieve design wins. If we incur such expenditures but fail to be selected in the bid </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
selection process, our business, financial condition and results of operations may be adversely affected. Further, because of the significant costs associated with qualifying new suppliers, end
customers might use products or solutions that are functionally equivalent or that offer additional features from existing suppliers across a number of similar and successor products or solutions for a lengthy period of time. As we develop and
introduce new solutions, we face the risk that end customers may not value or be willing to bear the cost of incorporating these newer solutions into their end products, particularly if they believe their end users are satisfied with prior
offerings. Regardless of the improved features or superior performance of the newer solutions, end users may be unwilling to adopt our new solutions due to such implementation hurdles, or design or pricing constraints. As a result, if we fail to
secure an initial design win for any of our solutions to any particular end customer, we may lose the opportunity to make future sales of those solutions to that end customer for a significant period of time or at all, and we may also experience an
associated decline in revenue relating to those components. Failure to achieve initial design wins may also weaken our position in future competitive selection processes, which would harm our business, financial condition and results of operations.
Moreover, even if we achieve initial design wins with end customers, our end customers are not contractually obligated to purchase products from us in connection with such design wins. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Failure to adjust our inventory due to changing market conditions or failure to accurately estimate our end customers&#146; demands could adversely
affect our revenue and could result in charges for obsolete or excess inventories. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We make significant decisions, including
determining the levels of business that we will seek, and accept production schedules, levels of reliance on outsourced contract manufacturing, personnel needs and other resource requirements, based on our estimates of end customer requirements. The
lack of long-term commitments by our end customers and the possibility of rapid changes in demand for their products reduce our ability to accurately estimate future requirements of our end customers. On occasion, our end customers may require rapid
increases in production, which can challenge our resources. We may not have sufficient third-party wafer fabrication capacity at any given time to meet our end customers&#146; demands. Conversely, downturns in the end markets that our end customers
serve have in the past caused and may in the future cause our end customers to significantly reduce the quantities of our products or solutions they order from us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we base many of our operating decisions, and enter into purchase commitments, on the basis of anticipated revenue trends which
are highly unpredictable. Certain of our design service agreements and purchase commitments are <FONT STYLE="white-space:nowrap">non-cancelable,</FONT> and in some cases we may be required to recognize charges representing minimum commitments which
exceed our actual requirements. These types of commitments and agreements reduce our ability to adjust our inventory to address declining market demands. If demand for our solutions is less than we expect, we may experience additional excess and
obsolete inventory and be forced to incur charges for write-offs. If revenues in future periods fall substantially below our expectations, or if we fail to accurately forecast changes in demand mix, we could again be required to record substantial
charges for obsolete or excess inventory or <FONT STYLE="white-space:nowrap">non-cancelable</FONT> purchase commitments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During a market
upturn, we may not be able to purchase sufficient supplies or components to meet the increasing demand for our solutions, which could prevent us from taking advantage of business opportunities. In addition, a supplier could discontinue production of
a component necessary for our products, extend lead times, limit supply or increase prices due to capacity constraints or other factors. Our failure to adjust our supply chain volume, secure sufficient supply from our third-party vendors, including
our semiconductor wafer suppliers, or estimate our end customers&#146; demand could have a material adverse effect on our business, financial condition and results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, the risks described above have been and may be further amplified by global supply chain constraints and other macroeconomic
conditions, including rising interest rates, higher rates of inflation, higher costs of fuel and transportation, potential resulting logistics delays, market volatility, and impacts of global conflicts, such as the ongoing Russia-Ukraine and
Israel-Hamas conflicts on international trade and the economy generally, all of which could have a material adverse impact on our business, financial condition and results of operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Decreases in average selling prices of our products and increases in input costs may reduce our gross
margins. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The market for our products is generally characterized by declining average sale prices (ASP) resulting from factors such
as increased competition, the introduction of new products and increased unit volumes. We anticipate that ASPs for legacy products may decrease in the future in response to the introduction of new products by us or our competitors, or due to other
factors, including pricing pressures from our end customers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We typically conduct pricing negotiations for our existing products with our
largest end customers. In order to achieve and sustain profitable operations, we must continually reduce costs for our existing products and also develop and introduce new products with enhanced features on a timely basis that can be sold initially
at higher ASPs. Failure to do so could cause our revenue and gross margins to decline, which would negatively affect our business, financial condition and results of operations and could significantly harm our business. In addition, in connection
with the significant increase in semiconductor demand and supply shortages in recent years, the cost of certain materials used to manufacture our products, including for semiconductor wafers, has increased as demand has outpaced supply. We may be
unable to reduce the cost of our products sufficiently to enable us to compete with others. Our cost reduction efforts may not allow us to keep pace with competitive pricing pressures and the increased cost of certain materials, such as
semiconductor wafers and other raw materials, and could adversely affect our gross margins. We maintain a relatively small infrastructure of facilities and human capital in certain locations around the world and, as a result, have limited ability to
reduce our operating costs. Accordingly, in order to remain competitive, we must continually reduce the cost of manufacturing and assembling our products through design and engineering changes. We cannot assure you that we will be successful in
redesigning our products and bringing redesigned products or solutions to the market in a timely manner, or that any redesign will result in sufficient cost reductions to allow us to reduce the price of our products to remain competitive or maintain
or improve our gross margins. To the extent we are unable to reduce the prices of our products and remain competitive, our revenue will likely decline, resulting in further pressure on our gross margins, which could have a material adverse effect on
our business, financial condition and results of operations and our ability to grow our business. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to penetrate new markets or
introduce new capabilities into our solutions, or otherwise execute our business strategy, our revenue and financial condition would be harmed. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Most of our revenue is generated from SoCs, bundled with software and various other solutions that combine
<FONT STYLE="white-space:nowrap">32-bit</FONT> MCUs with wireless connectivity and additional circuitry, such as graphics processing units, serial interfaces,
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">analog-to-digital</FONT></FONT> interfaces, and more. In the future, we believe we can expand our solutions into embedded application processors and dedicated AI processors. We
generate the majority of our revenue from the personal devices market. We believe that our future revenue growth, if any, will significantly depend on our ability to expand or further penetrate existing markets, such as medical/healthcare,
industrial edge and smart homes and buildings, as well as expand into new markets such as automotive and data center and computing. In addition, we believe that our future revenue growth, if any, will significantly depend on our ability to develop
dedicated processor units purpose-built for AI in the future. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of these new or growth markets presents distinct and substantial
risks and, in many cases, requires us to develop new functionality or software to address the particular requirements of that market. We anticipate that as we continue to move into new markets, we will likely face competition from larger competitors
with greater resources and more history in these markets. If any of these markets do not develop as we currently anticipate, or if the development of such markets is delayed or impacted by factors outside of our control, such as global conflicts,
including the ongoing Russia-Ukraine and Israel-Hamas conflicts or other macroeconomic conditions, or if we are unable to penetrate any of these markets successfully with our solutions, our revenue could decline, and our financial condition would be
negatively impacted. Some of these markets are primarily served by only a few large, multinational OEMs and ODMs with substantial negotiating power relative to us and, in some instances, with internal solutions that are competitive to ours. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Meeting the technical requirements and securing design wins with any of the participants in
these markets will require a substantial investment of our time and resources and we cannot assure you that we will secure design wins from these or other companies, that we will achieve meaningful revenue from the sales of our solutions into these
markets, or that any revenue generated from these design wins will outweigh the costs of developing these designs. If we fail to penetrate these or other new markets we are targeting, our business, financial condition and results of operations would
likely suffer. Moreover, even if we are successful in winning competitive bid selection processes in these new markets, it will likely take longer to generate revenue from such design wins than in our current markets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also, in the future, seek to penetrate markets in new geographies. Certain of the markets we expect to target have higher barriers to
entry, are more heavily regulated or favor domestic production. If we fail to penetrate these or other new markets we are targeting, or expend time and resources on entering these markets, but fail to generate sufficient revenue in such new
geographies, our business, financial condition and results of operations would likely suffer. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also plan to develop SPOT into an IP
and chip development platform to make it easier for other companies to license or partner with us to incorporate SPOT into their own solutions. There is no guarantee that our efforts to develop SPOT into a licensing or partnership platform will
succeed, in which case the proliferation of our SPOT platform into certain markets (e.g., data center markets) is likely to be limited. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we
are unable to manage our growth effectively, we may not be able to execute our business plan and our business, financial condition and results of operations could suffer. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to succeed in executing our business plan, we will need to manage our growth effectively as we make significant investments in
research and development and sales and marketing, and expand our operations. If our revenue does not increase to offset these increases in our expenses, we may not achieve or maintain profitability in future periods. To manage our growth
effectively, we must continue to expand our operations, engineering, accounting and finance, internal management, and other systems, procedures, and controls. This may require substantial managerial and financial resources, and our efforts may not
be successful. Any failure to successfully implement systems enhancements and improvements will likely have a negative impact on our ability to manage our expected growth, as well as our ability to ensure uninterrupted operation of key business
systems and compliance with the rules and regulations applicable to public companies. If we are unable to manage our growth effectively, we may not be able to take advantage of market opportunities or develop new solutions, and we may fail to
satisfy end customer product or support requirements, maintain the quality of our solutions, execute our business plan or respond to competitive pressures, any of which could negatively affect our business, financial condition and results of
operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We continue to invest in research and development efforts for several new markets. If we are unable to commercialize these
technologies, our business, financial condition and results of operations could be negatively affected. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The semiconductor
industry requires substantial investment in research and development in order to bring to market new and enhanced solutions. Our research and development expense was $&#8195;&#8195;&#8195;&#8195;million and $44.0&nbsp;million for the years ended
December&nbsp;31, 2024 and 2023, respectively. We expect to increase our research and development expenditures as compared to prior periods as part of our strategy to focus on the development of new solutions, such as Apollo6, Atomiq, SoCs variants
within existing Apollo families, as well as further penetration of existing markets, such as medical/healthcare, industrial edge and smart homes and buildings, and expansion into new markets such as automotive and data center and computing. We are
unable to predict whether we will have sufficient resources to achieve the level of investment in research and development required to remain competitive. For example, development of our solutions using
<FONT STYLE="white-space:nowrap">sub-threshold</FONT> and near-threshold designs at 0.4 volts, 0.5 volts, or 0.6 volts costs significantly more than development at the standard 0.8 volts or 0.9 volts. This added development cost could prevent us
from being able to maintain a technological advantage over larger </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
competitors that have significantly greater resources to invest in research and development. In addition, we cannot assure you that the technologies which are the focus of our research and
development expenditures will become commercially successful or generate any revenue. If we incur increased research and development costs that do not result in revenue generation, our business, financial condition and results of operations would be
adversely affected. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our products are complex and may contain flaws which could lead to product liability, an increase in our costs and/or a
reduction in our revenue. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our products are complex and may contain software or hardware errors or defects (collectively, flaws),
particularly when first introduced and when new versions are released. Our products are increasingly designed and integrated into more complex products, including higher levels of software and hardware integration in modules and system-level
solutions and/or include elements provided by third parties which further increase the risk of flaws. We rely primarily on our <FONT STYLE="white-space:nowrap">in-house</FONT> testing personnel to design test operations and procedures to detect any
flaws or vulnerabilities prior to delivery of our products to our end customers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Should challenges occur in the operation or performance
of our products, we may experience delays in meeting key introduction dates or scheduled delivery dates to our end customers. These flaws could also cause significant <FONT STYLE="white-space:nowrap">re-engineering</FONT> costs, diversion of our
engineering personnel&#146;s attention from our product development efforts, and significant end customer relations and business reputation problems. Any unforeseen and undetected flaws could result in refunds, replacement, recall or other
liability. Any of the foregoing could impose substantial costs and harm our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Product liability, data breach or cybersecurity
liability claims may be asserted with respect to our products. Many of our solutions focus on security, storage, wireless connectivity, advanced graphics, and AI processing, which may make them particularly susceptible to cyberattacks. An undetected
flaw, failure or vulnerability in our products could cause failure in our end customers&#146; products, and we could face claims for damages that are disproportionately higher than the revenue we receive from the components involved, as our products
are typically sold at prices that are significantly lower than the cost of the end products into which they are incorporated. Furthermore, product liability risks are particularly significant with respect to any smart home and automotive
applications because of the risk of serious harm to users of these end products. There can be no assurance that any insurance or associated warranty liabilities we maintain will sufficiently protect us from such claims. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We compete against companies that have significantly greater resources and broader product lines than we do, and we may also face competition from other
technological approaches to low power. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The semiconductor industry is highly competitive and many of our direct and indirect
competitors have substantially greater financial, technological, manufacturing, marketing, and sales resources than we do. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Consolidation
in our industry may increasingly mean that our competitors have greater resources, including the ability to attract qualified employees or pass along higher cost components into product prices, that could put us at a competitive disadvantage. We
currently compete directly with numerous large MCU vendors, such as Infineon, Microchip, NXP, Renesas, Silicon Laboratories, STMicroelectronics, Texas Instruments, and others. In addition, we also compete with connectivity players such as Dialog
Semiconductor (now Renesas), Nordic Semiconductor, Synaptics, and Telink or connected processor platform players, such as Qualcomm. Competition from these companies may intensify as we offer more solutions in our existing end markets or expand into
new end markets. We also face competition from emerging companies. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is no guarantee that our approach to low power will remain
competitive. Our SPOT platform enables devices to consume two to five times less power than traditional technologies at the same manufacturing geometries. However, low power can be achieved using other, diversified technological approaches. There is
the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
possibility that novel, unique approaches to low power emerge that surpass the capabilities of our technology and produce solutions that are more efficient, more cost effective, or both. Should
this happen, our financial results would likely suffer. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, from time to time, governments may provide subsidies or make
other investments that could give competitive advantages to many semiconductor companies. For example, in August 2022, the United States enacted the U.S. CHIPS and Science Act of 2022 (the CHIPS Act), which, among other things, provides funding to
increase domestic production and research and development in the semiconductor industry. Because we operate a fabless business model, we do not believe we will be eligible for such investments from the government. Many of our competitors may benefit
from the investments, which will help increase their production capacity, shorten their lead time and gain market share. These competitive pressures could materially and adversely affect our business, financial condition and results of operations.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are subject to the cyclical nature of the semiconductor industry. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The semiconductor industry is highly cyclical and is characterized by constant and rapid technological change, rapid product obsolescence,
price erosion, evolving standards, short product life cycles, and wide fluctuations in product supply and demand. Historically, the industry experienced significant downturns during global recessions. These downturns have been characterized by
diminished demand, production overcapacity, high inventory levels, and accelerated erosion of average selling prices. Furthermore, any significant upturn in the semiconductor industry could result in increased competition for access to third-party
wafer fabrication and assembly capacity. We are dependent on the availability of this capacity to manufacture and assemble our products and we can provide no assurance that adequate capacity will be available to us in the future. Any downturns or
upturns in the semiconductor industry could harm our business, financial condition and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We depend on agreements with third
party developers and licensors in order to satisfy certain end customer requirements, which subjects us to a number of risks, and any failure to execute on any of these arrangements could have a material adverse effect on our business, financial
condition and results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into development, product collaboration and technology licensing arrangements
with third parties, such as ARM Limited and Cadence Design Systems, Inc., and we expect to enter into new arrangements of these kinds from time to time in the future. These agreements are typically
<FONT STYLE="white-space:nowrap">non-exclusive</FONT> contracts provided under royalty-accruing or <FONT STYLE="white-space:nowrap">paid-up</FONT> licenses. While we do not believe our business is dependent to any significant degree on any
individual third-party license, we expect to continue to use and may license additional third-party technology for our solutions. These agreements may increase risks for us, such as the risks related to timely delivery of new products, risks
associated with the ownership of the intellectual property developed, risks that such activities may not result in products that are commercially successful or available in a timely fashion, risks that third parties involved may abandon or fail to
perform their obligations related to such agreements, and risks that certain technologies provided under such arrangements may not continue to be available on reasonable terms or at all. Any failure to timely develop commercially successful products
under such arrangements as a result of any of these and other challenges could have a material adverse effect on our business, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If our information technology systems or data, or those of third parties, such as vendors and suppliers, with whom we work, are or were compromised, we
could experience adverse consequences resulting from such compromise, including but not limited to regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or
profits; loss of customers or sales; and other adverse consequences. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of our business, we and the third
parties with whom we work, routinely collect, receive, store, use, handle, transfer, disclose, make accessible, protect, secure, dispose of, transmit, share and otherwise process proprietary, confidential, and sensitive data, including intellectual
property, trade secrets, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
proprietary technology and information about our business customers, suppliers and partners, and proprietary technology and information owned by our customers (collectively, sensitive
information). We rely upon third party service providers and technologies to operate critical business systems to process sensitive information in a variety of contexts, including, without limitation, third party providers of cloud-based
infrastructure, encryption and authentication technology, employee email, content delivery to customers, and other functions. Our ability to monitor these third parties&#146; information security practices is limited, and these third parties may not
have adequate information security measures in place. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any of the previously identified or similar threats could cause a cybersecurity
incident or other interruption, which could result in unauthorized, unlawful, or accidental acquisition, modification, destruction, loss, alteration, encryption, disclosure of, or access to our sensitive information or our information systems, or
those of the third parties with whom we work. Further, a cybersecurity incident or other interruption could disrupt our ability (and that of third parties with whom we work) to provide our solutions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, and the third parties with whom we work, are subject to a variety of evolving cybersecurity-related threats. While we have implemented
various controls and defenses designed to prevent cybersecurity incidents, cybersecurity attacks and threats have continued to become more prevalent and sophisticated. These threats are constantly evolving, making it increasingly difficult to
successfully defend against or implement adequate preventive measures. Geopolitical tensions or conflicts have in the past led to, and may in the future lead to, increased risk of cybersecurity attacks. Notwithstanding defensive measures,
experienced programmers, hackers, state actors, or others may be able to penetrate our security controls, or those of our vendors, suppliers, or customers, through attacks such as, but not limited to, social-engineering attacks (including through
deep fakes, which may be increasingly more difficult to identify as fake, and phishing attacks), malicious code (such as viruses and worms), malware (including as a result of advanced persistent threat intrusions), <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">denial-of-service</FONT></FONT> attacks, access attacks, credential stuffing, credential harvesting, personnel misconduct or error, ransomware attacks, supply-chain attacks, software bugs, server malfunctions, software or
hardware failures, loss of data or other information technology assets, adware, telecommunications failures, earthquakes, fires, floods, attacks enhanced or facilitated by AI, and other similar threats. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Ransomware attacks, including those launched by organized criminal threat actors, nation-states, and nation-state-supported actors, are
becoming increasingly prevalent and severe and can lead to significant interruptions in our operations, ability to provide our solutions, loss of sensitive data and income, reputational harm, and diversion of funds. Extortion payments may alleviate
the negative impact of a ransomware attack, but we may be unwilling or unable to make such payments due to, for example, applicable laws or regulations prohibiting such payments. Similarly, supply-chain attacks have increased in frequency and
severity, and we cannot guarantee that third parties and infrastructure in our supply chain or our third party partners&#146; supply chains have not been compromised or that they do not contain exploitable flaws or bugs that could result in a breach
of or disruption to our information technology systems (including our solutions or the third party information technology systems that support us and our solutions). We are incorporated into the supply chain of a large number of companies worldwide
and, as a result, if our products are compromised, a significant number of such companies and their data could be simultaneously affected. The potential liability and associated consequences we could suffer as a result of such a large-scale event
could be catastrophic and result in irreparable harm. The growth of our remote workforce, and the increase in remote working arrangement by our vendors and other third parties, poses increased risks to our information technology systems and data
privacy, as more of our employees, and those of our vendors and other third parties, utilize network connections, computers and devices outside our premises or network, including working at home, while in transit and in public locations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Future or past business transactions (such as acquisitions or integrations) could also expose us to additional cybersecurity risks and
vulnerabilities, as our systems could be negatively affected by vulnerabilities present in acquired or integrated entities&#146; systems and technologies. Furthermore, we may discover cybersecurity issues that were not found during due diligence of
such acquired or integrated entities, and it may be difficult to integrate companies into our information technology environment and cybersecurity program. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While we have implemented security measures designed to protect against cybersecurity
incidents, there can be no assurance that these measures will be effective. We take steps designed to detect, mitigate, and remediate vulnerabilities in our information technology systems, products and solutions (including technologies from third
parties with whom we work), but we may not be able to detect, mitigate, and remediate all such vulnerabilities. We have not always been able in the past and may be unable in the future to detect vulnerabilities in our information technology systems
(including our solutions) because such threats and techniques change frequently, are often sophisticated in nature, and may not be detected until after a security incident has occurred. Despite our efforts, there can be no assurances that these
vulnerabilities mitigation measures will be effective. Further, we may experience delays in developing and deploying remedial measures and patches designed to address any such identified vulnerabilities. and vulnerabilities in our information
technology system could be exploited and result in a cybersecurity incident. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have in the past, and may in the future, expend
significant resources or modify our business activities to try to protect against cybersecurity incidents. Certain data privacy and cybersecurity obligations may, and could in the future, require us to implement and maintain specific security
measures, industry-standard or reasonable cybersecurity measures to protect our information technology systems and sensitive information. Applicable data privacy and cybersecurity obligations may require us, or we may voluntarily choose, to notify
relevant stakeholders, including affected individuals, customers, regulators, and investors, of cybersecurity incidents. Such disclosures and related actions can be costly, and the disclosure or the failure to comply with such applicable
requirements could lead to adverse consequences. If we (or a third party with whom we work with) experience a cybersecurity incident or are perceived to have experienced a cybersecurity incident, we may experience adverse consequences. These
consequences may include: government enforcement actions (for example, investigations, fines, penalties, audits, and inspections), additional reporting requirements and/or oversight, restrictions on processing sensitive information (including
personal data), litigation (including class-action claims), indemnification obligations, negative publicity, reputational harm, monetary fund diversions, interruptions in our operations (including availability of data), financial loss, and other
similar harms. Moreover, any such compromise of our information technology systems could result in the misappropriation or unauthorized publication of our confidential business or proprietary information, including trade secrets, or that of other
parties with which we do business, an interruption in our operations, the unauthorized transfer of cash or other of our assets, the unauthorized release of customer or employee data or a violation of privacy or other laws. Cybersecurity incidents
and attendant consequences may cause customers to stop using our solutions, deter new customers from using our solutions, and negatively impact our ability to grow and operate our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We must commit significant resources to ensuring that we develop secure technology, solutions and related devices. The process of ensuring the
security of new technology is complex and uncertain, and if we fail to secure these devices, we could face government enforcement actions, litigation (including class claims), indemnification obligations, negative publicity, reputational harm,
monetary fund diversions, interruptions in our operations, financial loss, and other similar harms. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our contracts may not contain
limitations of liability, and even where they do, there can be no assurance that limitations of liability in our contracts are sufficient to protect us from liabilities, damages, or claims related to our data privacy and cybersecurity obligations.
Additionally, our insurance coverage may be inadequate, and a large data privacy or cybersecurity-related incident claim may exceed our coverage and/or prevent us from getting coverage in the future. We cannot be sure that our insurance coverage
will be adequate or sufficient to protect us from or to mitigate liabilities arising out of our data privacy and cybersecurity practices, that such coverage will continue to be available on commercially reasonable terms or at all, or that such
coverage will pay future claims. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to experiencing a cybersecurity incident, third parties may gather, collect, or infer
sensitive information about us from public sources, data brokers, or other means that reveals competitively sensitive details about our organization and could be used to undermine our competitive advantage or market position. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our estimate of the market size for our solutions may prove to be inaccurate, and even if the market
size is accurate, we cannot ensure that we will serve a significant portion of the market. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our estimate of the market size for our
solutions that we have provided in this prospectus, sometimes referred to as total addressable market (TAM), is subject to significant uncertainty and is based on assumptions and estimates, including our internal analysis and industry experience and
third-party data, which may be inaccurate. These estimates are, in part, based upon the size of the markets and geographies we target and an estimated range of prices for our current solutions and future development plans. Our ability to serve a
significant portion of this estimated market is subject to many factors, including our success in implementing our business strategy and ability to maintain our product pricing levels, which are subject to many risks and uncertainties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Moreover, in order to address the entire TAM we have identified, we must continue to enhance and add to our existing markets and introduce our
solutions to new markets. Accordingly, even if our estimate of the market size is accurate, we cannot ensure that we will serve a significant portion of this estimated market or that our pricing levels will not decline. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We depend on key and highly skilled personnel to operate our business, and if we are unable to retain our current personnel and/or hire additional
personnel, our ability to develop and market our solutions could be harmed, which in turn could adversely affect our business, financial condition and results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our success depends to a large extent upon the continued services of our executive officers, managers and skilled personnel, including our
development engineers. In particular, we are highly dependent on the services of Scott Hanson, Ph.D. and Fumihide Esaka, our Founder and CEO, respectively, who, after over 15 and nine years of service, respectively, with our company, have been
critical in the development and growth of our business and strategic direction. From time to time, there may be changes in our executive management team or other key personnel, which could disrupt our business. Our employees are not bound by
obligations that require them to continue to work for us for any specified period and, therefore, they could terminate their employment with us at any time. Moreover, our employees are generally not subject to
<FONT STYLE="white-space:nowrap">non-competition</FONT> agreements. The loss of one or more of our executive officers or other key personnel or our inability to locate suitable or qualified replacements could be significantly detrimental to our
product development efforts and could have a material adverse effect on our business, financial condition and results of operations. In addition, we recruit from a limited pool of engineers with specialized expertise and the competition for such
personnel can be intense. Given these limitations, we may not be able to continue to attract, retain and motivate qualified personnel necessary for our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also must attract and retain highly qualified personnel, including certain foreign nationals who are not U.S. citizens or permanent
residents, many of whom are highly skilled and constitute an important part of our U.S. workforce, particularly in the areas of engineering and product development. Our ability to hire and retain these employees and their ability to remain and work
in the United States are impacted by laws and regulations, as well as by procedures and enforcement practices of various government agencies. Changes in immigration laws, regulations or procedures may adversely affect our ability to hire or retain
such workers, increase our operating expenses and negatively impact our ability to deliver our solutions, any of which would adversely affect our business, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Acquisitions, divestitures, strategic investments and strategic partnerships could adversely affect our business, financial condition and results of
operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may pursue growth opportunities by acquiring complementary businesses, products, solutions or technologies through
strategic transactions, investments or partnerships. The identification of suitable acquisition, strategic investment or strategic partnership candidates can be costly and time consuming and can distract our management team from our current
operations. If such strategic transactions require us to seek additional debt or equity financing, we may not be able to obtain such financing on terms favorable to us or at all, and such transaction may adversely affect our liquidity and capital
structure. We may also choose to divest </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
certain <FONT STYLE="white-space:nowrap">non-core</FONT> assets, which divestitures could lead to charges against earnings and may expose us to additional liabilities and risks. Any strategic
transaction might not strengthen our competitive position, may increase our risks, and may be viewed negatively by our end customers, partners or investors. Even if we successfully complete a strategic transaction, we may not be able to effectively
integrate the acquired business, technology, systems, control environment, products, personnel, or operations into our business or global tax structure. We may experience unexpected changes in how we are required to account for strategic
transactions pursuant to accounting principles generally accepted in the United States (GAAP) and may not achieve the anticipated benefits of any strategic transaction. We may incur unexpected costs, claims or liabilities that we incur during the
strategic transaction or that we assume from the acquired company, or we may discover adverse conditions post-acquisition for which we have limited or no recourse. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Downturns or volatility in general economic conditions, including as a result of international hostilities, such as the ongoing Russia-Ukraine and
Israel-Hamas conflicts, could have a material adverse effect on our business, financial condition and results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
revenue and gross margin depend significantly on general economic conditions and the demand for our solutions in the markets in which our end customers compete. Weaknesses in the global economy and financial markets, including the impact from global
conflicts, such as the ongoing Russia-Ukraine and Israel-Hamas conflicts, may in the future lead to lower demand for end customers&#146; products that incorporate our solutions, particularly in the semiconductor and battery-powered edge devices
markets. A decline in <FONT STYLE="white-space:nowrap">end-user</FONT> demand will adversely impact our end customers&#146; demand for our solutions and can affect the ability of our end customers to obtain credit and otherwise meet their payment
obligations and the likelihood of our end customers canceling or deferring existing orders. Our business, financial condition and results of operations could be negatively affected by a decline in <FONT STYLE="white-space:nowrap">end-user</FONT>
demand caused by weaknesses in the global economy and financial markets. Volatile and/or uncertain economic conditions, including increased inflation rates, can adversely impact revenue and gross margin and make it difficult for us to accurately
forecast and plan our future business activities. To the extent expected favorable economic conditions do not materialize or take longer to materialize than expected, we may face an oversupply of our products and have excess inventory, which could
result in lower demand, lower ASP, lower gross margin and charges for excess and obsolete inventory. Conversely, if we underestimate end customer demand, we may fail to meet end customer needs, which could impair our end customer relationships and
future sales orders. In addition, any disruption in the credit markets, including as a result of the current conflicts between Ukraine and Russia or Israel and Hamas could impede our access to capital. If we have limited access to additional
financing sources, we may be required to defer capital expenditures or seek other sources of liquidity, which may not be available to us on acceptable terms or at all. Similarly, if our suppliers face challenges in obtaining credit or other
financial difficulties, they may be unable to provide the materials we need to manufacture our products. Additionally, global macroeconomic conditions, including those affected by ongoing Russia-Ukraine and Israel-Hamas conflicts, or any future
geopolitical conflicts or pandemics, could make it difficult for our end customers and suppliers to forecast and plan future business activities and could cause global businesses to defer or reduce spending on our products or increase the costs of
manufacturing our products. All of these factors relate to global economic conditions, which are beyond our control, could adversely impact our business, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Uncertain risks relating to the adoption, use or application of emerging technologies, including AI, by our customers, could adversely impact our
financial results, cause operational challenges, and/or result in reputational harm, competitive harm and legal liability. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
products support AI functionality implemented by our customers&#146; products and solutions. Our latest generation of products also enable our customers to address computationally intense AI applications in edge devices. The adoption of AI solutions
by our customers may not develop in the manner or in the time periods we anticipate and, as the markets for AI solutions are still developing, demand for our products that support AI may be unpredictable and vary significantly from one period to
another. Even if the demand for <FONT STYLE="white-space:nowrap">AI-enabled</FONT> products develops in the manner or in the time periods we anticipate, if we do not have timely, competitively priced,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
market-accepted products available to meet our customers&#146; needs to develop products for the AI markets, we may miss a significant opportunity and our business, operating results and
financial condition could be materially and adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our customers are increasingly relying on our solutions to enhance their
product and technology AI capabilities. However, the development, adoption, integration and use of AI remains in early stages, and ineffective or inadequate AI or generative AI governance, development, use or deployment practices by us or our
customers could lead to unintended consequences. For example, AI algorithms may be flawed, or may be (or may be perceived to be) based on datasets that are insufficient. In addition, any latency, disruption or failure of our products in
customers&#146; AI solutions could result in flawed deployments, producing erroneous or harmful outputs, which could damage our reputation and lead to legal liabilities. Further AI algorithms may be of poor quality, reflect unwanted forms of bias,
or contain other errors or inadequacies, any of which may not be easily detectable. AI has been known to produce false or &#147;hallucinatory&#148; inferences or outputs. AI can present ethical issues and may subject us to new or heightened legal,
regulatory, ethical or other challenges. Additionally, inappropriate or controversial data practices by developers and <FONT STYLE="white-space:nowrap">end-users,</FONT> or other factors adversely affecting public opinion of AI, could impair the
acceptance of AI solutions, including those incorporated in our services. Furthermore, third parties may deploy AI technologies in a manner that reduces customer demand for our products and services. If we do not have sufficient rights to use the
data or other material or content on which our AI solutions or other AI tools we use rely, we also may incur liability through the violation of applicable laws, third-party intellectual property, privacy or other rights, or contracts to which we are
a party. Any of the foregoing may result in decreased demand for our products and services or harm to our business, financial results or reputation. If we or our customers enable or offer solutions that draw controversy due to their perceived or
actual impact on society, such as AI solutions that have unintended consequences or are controversial, we may experience reputational harm, competitive harm, financial harm or legal liability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We publish statements online and in our marketing materials describing the possible use and integration of our products in customers&#146; AI
products and solutions. Although we endeavor to be accurate with our public statements and documentation, we may at times fail to do so or be alleged to have failed to do so. If any such statements or documentation are found to be deceptive, unfair,
misleading, or misrepresentative of our actual practices, even though circumstances beyond our reasonable control, we may face litigation, disputes, claims, investigations, inquiries or other proceedings which could adversely affect our business,
reputation, results of operations and financial condition. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The AI industry is subject to complex, evolving regulatory, statutory, and other
requirements that may be difficult and expensive to comply with and that could negatively impact our business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The legal and
regulatory framework for our products and services, including our AI computing solutions and AI model services, is rapidly evolving as many federal, state, and foreign government bodies and agencies have introduced or are currently considering
additional laws, regulations and standards related to AI. Additionally, existing laws and regulations may be interpreted in ways that would affect our or our customers&#146; operations, or our ability to offer our AI products and services in the
markets in which we operate. As a result, implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future, and we cannot yet determine the impact future laws, regulations, standards, or market perception
of their requirements may have on our business, and we may not be able to adequately anticipate or respond to these evolving laws or regulations. In addition, because <FONT STYLE="white-space:nowrap">AI-related</FONT> technologies are themselves
highly complex and rapidly developing, it is not possible to predict all of the legal or regulatory risks that may arise relating to our use of such technologies. New laws, guidance or decisions in this area could provide a new regulatory framework
that may require us to adjust and make changes to our operations that may decrease our operational efficiency, resulting in an increase to operating costs and/or hindering our ability to improve our products and services. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, compliance with evolving government regulations worldwide related to AI may increase the costs related to the development of AI
products and solutions and limit global adoption, which may also </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
adversely impact demand for our products that support AI functionality. The regulation of AI is rapidly evolving as legislators and regulators are increasingly focused on these powerful emerging
technologies. The technologies underlying AI and its uses are subject to a variety of laws, including intellectual property, privacy, data protection and cybersecurity, consumer protection, competition, and equal opportunity laws, and are expected
to be subject to increased regulation and new laws or new applications of existing laws. AI is the subject of ongoing review by various U.S. governmental and regulatory agencies, and various U.S. states and other foreign jurisdictions are applying,
or are considering applying, their platform moderation, cybersecurity and data protection laws to AI or are considering general legal frameworks for AI. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For example, in August 2024, the EU Artificial Intelligence Act (EU AI Act), which establishes broad obligations for the development and use
of <FONT STYLE="white-space:nowrap">AI-based</FONT> technologies in the EU based on their potential risks and level of impact, came into force. The EU AI Act includes requirements around transparency, conformity assessments and monitoring, risk
assessments, human oversight, security, accuracy, general purpose AI, and foundation models, and provides for fines of up to the greater of &#128;35&nbsp;million or 7% of worldwide annual turnover for violations. We may not be able to anticipate how
to respond to these rapidly evolving frameworks, and we may need to expend resources to adjust our offerings in certain jurisdictions if the legal frameworks are inconsistent across jurisdictions. Furthermore, because AI technology itself is highly
complex and rapidly developing, it is not possible to predict all of the legal, operational or technological risks that may arise relating to the use of AI. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The market for&nbsp;edge AI&nbsp;services and products is relatively new, and may decline or experience limited growth, and our business is dependent on
its clients&#146; continuing adoption and use our services and products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The&nbsp;edge AI&nbsp;market is relatively new and is
subject to a number of risks and uncertainties. We believe that our future success will depend on the growth, if any, of this market and the use of our services and products.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The use of&nbsp;edge AI&nbsp;is still relatively new, and consumers may not recognize the need for or benefits of our services and products.
If consumers do not recognize the need for and benefits of our services and products, then they may decide to adopt alternative services to satisfy some portion of their business needs. The market for our services and products could fail to grow
significantly or there could be a reduction in demand for our services and/or products as a result of a lack of acceptance, technological challenges, competing services, a decrease in spending by current and prospective customers, weakening economic
conditions and other causes. If the&nbsp;edge AI&nbsp;market does not experience significant growth, or demand for its services and/or products decreases, then our business, financial condition and results of operations could be adversely affected.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Reliance on Third Parties </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We have no manufacturing capabilities of our own. We are a fabless company, meaning that we do not own a semiconductor foundry, and we rely on a single
third-party supplier for the fabrication of semiconductor wafers and on a limited number of suppliers of other materials, and the failure of any of our suppliers to provide us with wafers and other materials on a timely basis would harm our
business, financial condition and results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We rely heavily on TSMC, which is the only producer of semiconductor
wafers that are used in our products. If TSMC suspends operations or limits our allocation of wafers, our ability to manufacture such wafers would be materially impaired. Furthermore, any disruption in operations at TSMC could adversely affect our
ability to meet end customer demand in a timely manner, or at all, which would lead to a reduction in our revenue and may adversely affect our reputation, end customer relationships and future sales orders, potentially resulting in long-term harm to
our business. In addition, the locations of TSMC and our other suppliers present additional risks. See the section &#147;&#151;Risks Related to the Markets We Operate in and the Regulatory Landscape of Our Business&#148;. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to TSMC, we purchase a number of key material and components used in the manufacture of our products from single or a limited
number of suppliers. These suppliers, including TSMC, are in great demand and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the lead-time to expand capacity could be long. From time to time, we have encountered shortages and delays in obtaining wafers at desired specifications and other components and materials and
price increases, and we may encounter additional shortages and delays in the future. If we cannot supply our products due to a lack of components, including semiconductor wafers, or are unable to source materials from other suppliers or to redesign
products with other components in a timely manner, our business will be significantly harmed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not have long-term contracts with any
of our suppliers and third-party manufacturers. As a result, any such supplier or third-party manufacturer can discontinue supplying wafers, components or materials to us at any time and without penalty. Moreover, we depend on the quality of such
wafers, and other components and materials supplied by such suppliers and third-party manufacturers, over which we have limited control. Any one or more of our suppliers may become financially unstable as the result of global market conditions and
geopolitical developments. Moreover, our suppliers&#146; abilities to meet our requirements could be impaired or interrupted by factors beyond their control, such as natural disasters or other disruptions. In the event that any one or more of our
suppliers is unable or unwilling to deliver us products and we are unable to identify alternative sources of supply for such materials or components on a timely basis, our business, financial condition and results of operations may be adversely
affected. In addition, even if we identify any such alternative sources of supply, we could experience delays in testing, evaluating and validating materials or products of potential alternative suppliers or products we obtain through outsourcing.
Qualifying new contract manufacturers, and specifically semiconductor foundries, is time consuming and might result in unforeseen manufacturing and operations problems. Furthermore, financial or other difficulties faced by our suppliers, or
significant changes in demand for the components or materials they use in the products they supply to us, could limit the availability of those products, components or materials to us. We are also subject to potential delays in the development by
our suppliers of key components which may affect our ability to introduce new products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any of these challenges or delays could damage
our relationships with our end customers, adversely affect our reputation and adversely affect our business, financial condition, results of operations and our ability to grow our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our dependence on TSMC as our sole supplier of wafers exposes us to certain political, social and economic risks that may harm our business.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Deterioration in the political, social, business or economic conditions in the jurisdictions in which TSMC or other suppliers
operate could slow or halt product shipments or disrupt our ability to manufacture, package, test or post-process products. In response, we could be forced to transfer our manufacturing, packaging, testing and post-processing activities to more
stable, and potentially more costly, regions or find alternative suppliers. In particular, because we source all of our wafers from TSMC, located in Taiwan, our supply of wafers and other critical components may be materially and adversely affected
by diplomatic, geopolitical and other developments affecting the relationship between Mainland China and Taiwan. Since 1949, Taiwan and Mainland China have been separately governed. Although significant economic and cultural relations have been
established between Taiwan and Mainland China in recent years, there can be no assurances that relations between Taiwan and Mainland China will not deteriorate. Any such developments could materially and adversely affect our business, financial
condition and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we encounter sustained yield problems or other delays at our third-party wafer fabrication facilities or in
the final assembly and test of our products, we may lose revenue and damage our end customer relationships. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The manufacture of our
products, including the fabrication of semiconductor wafers, and the assembly and testing of our products, involve highly complex processes. For example, minute levels of contaminants in the manufacturing environment, difficulties in the wafer
fabrication process or other factors can cause a substantial portion of the components on a wafer to be nonfunctional. These problems may be difficult to detect at an early stage of the manufacturing process and often are time-consuming and
expensive to correct. From time to time, we have experienced problems achieving acceptable yields at our third-party wafer fabrication suppliers, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
resulting in delays in the availability of components. Moreover, an increase in the rejection rate of products during the quality control process before, during or after manufacture and/or
shipping of such products, results in lower yields and margins. In addition, changes in manufacturing processes required as a result of changes in product specifications, changing end customer needs and the introduction of new products have
historically significantly reduced our manufacturing yields, resulting in low margins on those products. Poor manufacturing yields over a prolonged period of time could adversely affect our ability to obtain the supplies needed to deliver our
components on a timely basis and harm our relationships with end customers, which could materially and adversely affect our business, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Raw material and engineered material availability and price fluctuations have in the past and may in the future increase the cost of our products,
impact our ability to meet customer commitments, and may adversely affect our business, financial condition and results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The cost of raw and engineered materials is a key element in the cost of our products. Our inability to offset material price inflation through
increased prices or improved productivity could adversely affect our business, financial condition and results of operations. Many major components, product equipment items, engineered materials, and wafers are procured or subcontracted on a single
or sole-source basis. It is difficult to predict what effects shortages or price increases may have in the future. Our inability to fill our supply needs would jeopardize our ability to ship our products to our end customers on time and in the
quantity required, which could, in turn, result in reduced sales and revenue and damage to our end customer relationships and future sales orders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, increases in the price of silicon wafers, testing costs, and commodities, which would result in increased production costs may
result in a decrease in our gross margins. Moreover, our suppliers may pass the increase in engineered materials, raw materials and commodity costs to us which would further reduce the gross margin of our products. In addition, global market trends,
such as a shortage of capacity to fulfill our fabrication needs, also may increase our raw material costs and thus decrease our gross margin. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We
may be subject to warranty claims and other costs related to our products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, we warrant our products for one year from
the delivery of the product against <FONT STYLE="white-space:nowrap">non-conformance</FONT> to our specifications and certain other flaws. Because our solutions, including hardware, software, and intellectual property cores, are highly complex and
increasingly incorporate advanced technology, our quality assurance programs and those of our third party test providers may not detect all flaws, whether specific manufacturing flaws affecting individual components or systematic flaws affecting
numerous shipments. Inability to detect flaws could result in a diversion of our engineering resources from component development efforts, increased engineering expenses to remediate the flaws, and increased costs due to end customer accommodation
or inventory impairment charges. On occasion, we have also repaired or replaced certain components, made software fixes, reimbursed end customers for reasonable
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> production cost caused by an issue in our product or refunded the purchase price or license fee paid by our end customers due to component or software
flaws. Our insurance may be unavailable or inadequate to protect against these issues. If there are significant component flaws, the costs to remediate such flaws, net of reimbursed amounts from our vendors, if any, or to resolve warranty claims,
would adversely affect our reputation, which would negatively impact our business, financial condition and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our revenue could
be materially impacted by the failure of other component suppliers to deliver required parts needed in the final assembly of our end customers&#146; end products. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The products we supply to our end customers are typically only a portion of the many components our end customers source from multiple
suppliers in order to complete the final assembly of an end product. If one or more of these other component suppliers are unable to deliver to end customers components needed to assemble end products, our end customers may delay, or ultimately
cancel, their orders from us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to the Markets We Operate in and the Regulatory Landscape of Our Business </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are a global company, which subjects us to additional business risks, including logistical and financial complexity, political instability and
currency fluctuations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have established international subsidiaries and have opened offices in international markets to support
our activities in Asia, the Americas and Europe, and we expect to continue to conduct business with companies that are located outside the United States, particularly in Asia. This has included the establishment of offices in Taiwan and Mainland
China for <FONT STYLE="white-space:nowrap">non-U.S.</FONT> operations. We purchase wafers from foreign entities, have our products assembled and tested by subcontractors located in Asia, and supply our products to end customers located outside of
the United States. Even end customers of ours that are based in the United States often use contract manufacturers based in Asia to manufacture their products, and these contract manufacturers typically purchase products directly from us. We
derived&#8195;&#8195;&#8195;&#8195;% and 74% of our revenue for the years ended December&nbsp;31, 2024 and 2023, respectively, from sales to end customers outside of the United States and&#8195;&#8195;&#8195;&#8195;%, and 66%, respectively, from end
customers located in Mainland China. Our international operations are subject to a number of risks, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Complexity and costs of managing international operations and related tax obligations, including for our offices
outside of the United States; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Trade tensions, geopolitical uncertainty, or governmental actions may lead
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> end customers to favor products from <FONT STYLE="white-space:nowrap">non-U.S.</FONT> companies which could put us at a competitive disadvantage and result in decreased end customer demand for our
solutions and our end customers&#146; products; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Restrictions imposed on sensitive technologies from certain countries and sanctions or export controls imposed on
end customers or suppliers may affect our ability to sell and source our products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Potential political, legal and economic instability, armed conflict, and civil unrest in the countries in which
we and our end customers are located, including instability caused by the conflicts between Ukraine and Russia or Israel and Hamas; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Unanticipated restrictions on our ability to sell to foreign end customers where sales of products and the
provision of services may require export licenses or are prohibited by government action, unfavorable foreign exchange controls and currency exchange rates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Public health crises may affect our international operations, suppliers and end customers and we may experience
delays in development, a decreased ability to support our end customers and reduced design win activity if the travel restrictions or business shutdowns or slowdowns continue for an extended period of time in any of the countries in which we, our
suppliers and our end customers operate and do business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Uncertainties related to the enforcement of intellectual property rights in various jurisdictions, including any
intellectual property rights that we may license to Taiwanese or Chinese entities, including any joint ventures we may form; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Multiple, conflicting and changing tax and other laws and regulations that may impact both our international and
domestic tax and other liabilities and result in increased complexity and costs, including the impact of the Tax Cuts and Jobs Act, which we expect to increase our effective tax rate, in part due to the impact of the requirement to capitalize and
amortize foreign research and development expenses that commenced in 2022; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Longer sales cycles and greater difficulty in accounts receivable collection and longer collection periods;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Difficulties in enforcing contracts generally; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">High levels of distributor inventory subject to price protection and rights of return to us;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Greater difficulty in hiring and retaining qualified personnel; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The need to have business and operations systems that can meet the needs of our business growth and international
business and operating structure. </P></TD></TR></TABLE>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In particular, we generated 50% of our revenue from end customers in Mainland
China for the year ended December&nbsp;31, 2024. Uncertainties with respect to the PRC legal system, including uncertainties regarding the enforcement of laws, and sudden or unexpected changes in policies, laws and regulations in the PRC could
adversely affect us. Furthermore, the PRC government has significant oversight over our PRC subsidiaries&#146; business conduct and may intervene or influence our operations in Mainland China. The PRC government has published policies that
significantly affect certain industries other than ours, and we cannot rule out the possibility that it will in the future release regulations or policies regarding our industry that could further adversely affect our business, financial condition
and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are subject to government regulation, including import, export and economic sanctions laws and regulations that may
expose us to liability and increase our costs or that may prohibit us from selling our products to specific targeted entities. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our products are subject to export control and import laws and regulations, including the U.S. Export Administration Regulations (EAR), U.S.
Customs regulations, and various economic and trade sanctions regulations administered by the U.S. Treasury Department&#146;s Office of Foreign Assets Controls. These regulations may limit the export of our products and technology, and provision of
services outside of the United States, or may require export authorizations, including by license, a license exception, or other appropriate government authorization. Exports of our products and technology must be made in compliance with these laws
and regulations. If we fail to comply with these laws and regulations, we and certain of our employees could be adversely affected through reputational harm, government investigations, penalties, or denial or curtailment of our ability to export our
products and technology. Although we take precautions to prevent our products and technology from being provided in violation of such laws, our products and technology may have previously been, and could in the future be, provided inadvertently in
violation of such laws, despite the precautions we take. In addition, changes in our products or changes in applicable export or import laws and regulations may create delays in the introduction and sale of our products in international markets,
prevent our end customers from deploying our products or, in some cases, prevent the export or import of our products to certain countries, governments or persons or entities altogether. Any change in export or import laws and regulations, shift in
the enforcement or scope of existing laws and regulations, or change in the countries, governments, persons or technologies targeted by such laws and regulations, could also result in decreased use of our products, or in our decreased ability to
export or sell our solutions to potential end customers. Any decreased use of our products or limitation on our ability to export or sell our products would likely adversely affect our business, financial condition and results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Export control and economic sanctions laws may also include prohibitions on the sale or supply of certain of our products to specific targeted
entities, or embargoed or sanctioned countries (including their governments, entities organized under their laws, and residents). Any deterioration in relations between the United States and Mainland China, Taiwan, the Middle East and other
jurisdictions could lead to additional sanctions or export controls on such countries, regions, and specific individuals or entities, which could impact our ability to sell to or source components from such locales or otherwise negatively impact our
business. In addition, trade regulations or other governmental actions targeted at one country or entity may impact other countries or entities. Any decreased use of our solutions or limitation on our ability to export or sell products to certain
regions would adversely affect our business, financial condition and results of operations. For example, one of our largest end customers historically was Huawei, which accounted for approximately &#8195;&#8195;&#8195;&#8195;% of our revenue during
2024 and is designated on the Entity List administered by the U.S. Department of Commerce Bureau of Industry and Security. Consequently, our sales to Huawei are subject to a license requirement from the U.S. Government for all items subject to the
licensing jurisdiction of the EAR. To date, our sales to Huawei have been authorized pursuant to licenses granted by the U.S. Government, which require among other things that our products not be used in
<FONT STYLE="white-space:nowrap">5G-compatible</FONT> devices. If we fail to comply with the terms of these licenses, we and certain of our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
employees could be adversely affected through reputational harm, government investigations, penalties, or denial or curtailment of our ability to export our products and technology in the future.
Moreover, such licenses could be revoked or amended by the U.S. Government at any time, and there is no guarantee that the U.S. Government will authorize future sales to Huawei of existing or new products. Further, we may lose business opportunities
as Huawei (or other <FONT STYLE="white-space:nowrap">non-U.S.</FONT> end customers affected by future U.S. export control measures or trade sanctions) may respond to U.S. export controls and trade sanctions by developing their own alternative
products to replace our products or by purchasing products from <FONT STYLE="white-space:nowrap">non-U.S.</FONT> competitors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
addition, our association with Huawei or other end customers that are or become subject to U.S. regulatory scrutiny or export restrictions could subject us to actual or perceived reputational harm among current or prospective investors, suppliers or
end customers, customers of our end customers, other parties doing business with us, or the general public. Any such reputational harm could result in the loss of investors, suppliers or end customers, which could harm our business, financial
condition and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our failure to comply with the Foreign Corrupt Practices Act, other applicable anti-corruption and anti-
bribery laws could subject us to penalties and other adverse consequences. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have extensive international operations and a
substantial portion of our business, particularly with respect to our manufacturing, assembly and testing processes, is conducted outside of the United States. Our operations are subject to the U.S. Foreign Corrupt Practices Act (FCPA), as well as
the anti-corruption and anti- bribery laws in the countries where we do business. The FCPA prohibits covered parties from offering, promising authorizing or giving anything of value, directly or indirectly, to a &#147;foreign government
official&#148; with the intent of improperly influencing the official&#146;s act or decision, inducing the official to act or refrain from acting in violation of lawful duty, or obtaining or retaining an improper business advantage. The FCPA also
requires publicly traded companies to maintain records that accurately and fairly represent their transactions, and to have an adequate system of internal accounting controls. In addition, other applicable anti-corruption laws prohibit bribery of
domestic government officials, and some laws that may apply to our operations prohibit commercial bribery, including giving or receiving improper payments to or from <FONT STYLE="white-space:nowrap">non-government</FONT> parties, as well as <FONT
STYLE="white-space:nowrap">so-called</FONT> &#147;facilitation&#148; payments. Though we maintain policies, internal controls and other measures reasonably designed to promote compliance with applicable anti-corruption and anti-bribery laws, our
employees or agents may nevertheless engage in improper conduct for which we might be held responsible. Any violations of these anti-corruption, or even allegations of such violations, can lead to an investigation and/or enforcement action, which
could disrupt our operations, cause significant management distraction, and lead to significant costs and expenses, including legal fees. If we, or our employees or agents acting on our behalf, are found to have engaged in practices that violate
these laws and regulations, we could suffer severe fines and penalties, profit disgorgement, injunctions on future conduct, securities litigation, bans on transacting government business, delisting from securities exchanges and other consequences
that may have a material adverse effect on our business, financial condition and results of operations. In addition, our reputation and our stock price could be adversely affected if we become the subject of any negative publicity related to actual
or perceived violations of anti-corruption or anti-bribery laws and regulations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our failure to comply with the Outbound Investment Security
Program could subject us to penalties and other adverse consequences. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Outbound Investment Security Program (OISP), issued to
implement the &#147;Executive Order on Addressing United States Investments in Certain National Security Technologies and Products in Countries of Concern&#148;, took effect on January&nbsp;2, 2025. The OISP prohibits or requires notification of
certain transactions involving U.S. persons and persons with a qualifying nexus to China (including Hong Kong and Macau) and specified covered activities in the semiconductors and microelectronics, quantum information technology, and artificial
intelligence sectors. The OISP is a highly complex program with the potential for broad application, even with respect to entities and transactions outside of China. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At present, we are not a &#147;covered foreign person&#148; under the OISP such that U.S.
person equity investments or other covered transactions would be implicated. However, as a U.S. company, the OISP has the potential to impact certain of our activities, including with respect to the strategic mergers and acquisitions, investments,
and the development of certain JVs or new operations. Further, the OISP is likely to result in increased compliance burden and costs, which could adversely affect us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Violations of the OISP may subject us or affiliated US persons to civil or criminal penalties, government investigations, business disruption,
and reputational harm. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Changes in U.S. or foreign trade policies and other factors beyond our control may adversely impact our business and
operating results. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Geopolitical tensions and trade disputes can disrupt supply chains and increase the cost of our products.
This could cause our products to be more expensive for customers, which could reduce the demand for or attractiveness of such products. In addition, a geopolitical conflict in a region where we operate could disrupt our ability to conduct business
operations in that region. Countries also could adopt restrictive trade measures, such as&nbsp;tariffs, laws and regulations concerning investments and limitations on foreign ownership of businesses, taxation, foreign exchange controls, capital
controls, employment regulations and the repatriation of earnings and controls on imports or exports of goods, technology, or data, any of which could adversely affect our operations and supply chain and limit our ability to offer our products and
services as intended. Changes in laws or policies governing the terms of foreign trade, and in particular increased trade restrictions,&nbsp;tariffs&nbsp;or taxes on imports from countries where we manufacture products or from where we import
products or raw materials (either directly or through our suppliers) could have an impact on our competitive position, business operations and financial results. For example, the United States and other countries continue to implement restrictive
trade actions, including&nbsp;tariffs, export controls, sanctions, legislation favoring domestic investment and other actions impacting the import and export of goods, foreign investment and foreign operations in jurisdictions in which we operate.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Recently, the United States has announced&nbsp;tariffs&nbsp;on products manufactured in several jurisdictions, including, Mexico, China
and Canada, and has made announcements regarding the potential imposition of&nbsp;tariffs&nbsp;on other jurisdictions, such as the European Union. The United States has and may in the future pause, reimpose or increase&nbsp;tariffs, and countries
subject to such&nbsp;tariffs&nbsp;have and in the future may impose reciprocal&nbsp;tariffs&nbsp;or other restrictive trade measures in response to the imposition of&nbsp;tariffs&nbsp;by the United States. We are actively monitoring and evaluating
the development and potential impacts of&nbsp;tariffs&nbsp;on our supply chain and results of operations. We maintain operations worldwide, including in the jurisdictions impacted by the recently announced and contemplated&nbsp;tariffs. If the
actual and potential&nbsp;tariffs&nbsp;and reciprocal&nbsp;tariffs&nbsp;are implemented as currently proposed, we expect that such actions could negatively impact our revenue growth and margins in future periods through increased costs, decreased
demand and other adverse economic impacts. The net effect of these actions will depend on our ability to successfully mitigate and offset their impact, which may not be effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Trade restrictions could be adopted with little to no advanced notice, and we may not be able to effectively mitigate the adverse impacts from
such measures. Political uncertainty surrounding trade or other international disputes also could have a negative impact on customer confidence and willingness to spend money, which could impair our future growth. Any of these events could increase
the cost of our products, create disruptions to our supply chain and impair our ability to effectively operate and compete in the countries where we do business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Techniques employed by short sellers may drive down the market price of our common stock. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Short selling is the practice of selling securities that the seller does not own but rather has borrowed from a third party with the intention
of buying identical securities back at a later date to return to the lender. The short seller hopes to profit from a decline in the value of the securities between the sale of the borrowed securities and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the purchase of the replacement shares, as the short seller expects to pay less in that purchase than it received in the sale. As it is in the short seller&#146;s interest for the price of the
security to decline, many short sellers publish, or arrange for the publication of, negative opinions regarding the relevant issuer and its business prospects in order to create negative market momentum and generate profits for themselves after
selling a security short. These short attacks have, in the past, led to selling of shares in the market. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some public companies in
China have been the subject of short selling in the past. Much of the scrutiny and negative publicity has centered on allegations of a lack of effective internal control over financial reporting resulting in financial and accounting irregularities
and mistakes, inadequate corporate governance policies or a lack of adherence thereto and, in many cases, allegations of fraud. If we were to become the subject of any unfavorable allegations, whether such allegations are proven to be true or
untrue, we could have to expend a significant amount of resources to investigate such allegations and/or defend ourselves. While we would strongly defend against any such short seller attacks, we may be constrained in the manner in which we can
proceed against the relevant short seller by principles of freedom of speech, applicable state law or issues of commercial confidentiality. Such a situation could be costly and time-consuming, and could distract our management from growing our
business. Even if such allegations are ultimately proven to be groundless, allegations against us could severely impact our business operations, and any investment in our common stock could be greatly reduced or even rendered worthless. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Financial Performance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our
quarterly revenue and operating results are difficult to predict accurately and may fluctuate significantly from period to period. As a result, this could prevent us from meeting our own guidance or expectations of securities analysts or investors.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We operate in a highly dynamic industry and our future operating results could be subject to significant fluctuations,
particularly on a quarterly basis. Our quarterly revenue and operating results have fluctuated significantly in the past and may continue to vary from quarter to quarter due to a number of factors, many of which are not within our control. Although
some of our end customers, for example those in the personal consumer devices market, provide us with forecasts of their future requirements for our solutions, a significant percentage of our revenue in each quarter is dependent on sales that are
booked and shipped during that quarter. As a result, accurately forecasting our operating results in any quarter is difficult. If our operating results do not meet the expectations of securities analysts and investors, our stock price would likely
decline. Additional factors that can contribute to fluctuations in our operating results include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rescheduling, increase, reduction or cancellation of significant end customer orders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing of end customer qualification of our products and commencement of volume sales by our end customers of
systems that include our products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing and amount of research and development and sales and marketing expenditures; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rate at which our present and future end customers and end users adopt our solutions in our target end
markets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing and success of the introduction of new solutions and technologies by us and our competitors, and the
acceptance of our new solutions by our end customers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to anticipate changing end customer product requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our gain or loss of one or more key end customers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability, cost and quality of wafers and other components that we purchase from third-party vendors and
any problems or delays in the fabrication, assembly, testing or delivery of our products; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of production capacity at our third-party wafer fabrication facilities or other third-party
subcontractors and other interruptions in the supply chain, including as a result of materials shortages, bankruptcies or other causes; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the manufacturing, assembly and testing costs of our products, including as a result of inflationary
pressures; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fluctuations in manufacturing yields; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the changes in our product mix or end customer mix; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">competitive pressures resulting in lower than expected ASPs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing of expenses related to the acquisition of technologies or businesses; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">products rates of return or price concessions in excess of those expected or forecasted; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the emergence of new industry standards; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product obsolescence; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unexpected inventory write-downs or write-offs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs associated with litigation over intellectual property rights and other litigation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the length and unpredictability of the purchasing and budgeting cycles of our end customers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">loss of key personnel or the inability to attract qualified management, technical, marketing and financial
personnel; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the quality of our products and any remediation costs; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adverse changes in economic conditions in various geographic areas where we or our end customers do business;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the general industry conditions and seasonal patterns in our target end markets, including the end user market;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">political developments related to Mainland China or Taiwan; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other conditions affecting the timing of end customer orders or our ability to fill orders of end customers
including end customers subject to export control or U.S. economic sanctions; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">geopolitical events, such as the current conflicts between Ukraine and Russia or Israel and Hamas, threat of war
or terrorist actions, or the occurrence of pandemics, epidemics or other outbreaks of disease, or natural disasters, and the impact of these events on the factors set forth above. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may experience a delay in generating or recognizing revenue for a number of reasons. Open orders at the beginning of each quarter are
typically lower than expected revenues for that quarter and are generally cancelable or reschedulable with minimal notice. Accordingly, we depend on obtaining orders during each quarter for shipment in that quarter to achieve our revenue objectives
and failure to fulfill such orders by the end of a quarter may adversely affect our operating results. Furthermore, we generally rely on end customers issuing purchase orders to buy our products rather than long-term supply contracts. In addition,
we maintain a small infrastructure of facilities and human capital in several locations around the world and have a limited ability to reduce the expenses. Because we base our operating expenses on anticipated revenue trends and a high percentage of
our expenses are fixed in the short term, any delay in generating or recognizing forecasted revenue or changes in levels of our end customers&#146; forecasted demand could materially and adversely impact our business, financial condition and results
of operations. Due to our limited ability to reduce expenses, in the event our revenue declines, or our revenue does not meet our expectations, it is likely that in some future quarters our operating results will decrease from the previous quarter
or fall below the expectations of securities analysts and investors. As a result of these factors, our operating results may vary significantly from quarter to quarter. For the years ended December&nbsp;31, 2024 and 2023, our revenue was
$&#8195;&#8195;&#8195;&#8195;million and $65.5&nbsp;million, respectively. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Accordingly, we believe that <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">period-to-period</FONT></FONT> comparisons of our results of operations should not solely be relied upon as indications of future performance. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our ability to raise capital in the future may be limited and could prevent us from executing our
growth strategy. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our ability to operate and expand our business depends on the availability of adequate capital, which in turn
depends on cash flow generated by our business and the availability of borrowing through debt and equity markets or other applicable financing arrangements. We believe that our existing cash resources and anticipated cash received from sales of our
products, together with the net proceeds from this offering, will be sufficient to finance our continued operations, growth strategy, planned capital expenditures and the additional expenses we expect to incur as a public company for at least the
next 12 months. However, we have based this estimate on our current operating plans and expectations, which are subject to change, and we cannot assure you that our resources will be sufficient to meet our future liquidity needs. We may require
additional capital to respond to business opportunities, challenges, acquisitions or other strategic transactions and/or unforeseen circumstances. The timing and amount of our working capital and capital expenditure requirements may vary
significantly depending on numerous factors, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">market acceptance of our products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the need to adapt to changing technologies and technical requirements; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the existence of opportunities for expansion; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">access to and availability of sufficient management, technical, marketing and financial personnel.
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If our capital resources are insufficient to satisfy our liquidity requirements, we may seek to sell additional equity
securities or debt securities or obtain debt financing. The sale of additional equity securities or convertible debt securities would result in additional dilution to our stockholders. Additional debt would result in increased expenses and could
result in covenants that would restrict our operations and our ability to incur additional debt or engage in other capital-raising activities. We have not made arrangements to obtain additional financing and there is no assurance that financing, if
required, will be available in amounts or on terms acceptable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us, when we require it, our ability to continue to grow and support our business and
respond to business opportunities and challenges could be significantly limited. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We could be subject to changes in tax rates or the adoption of new
tax legislation, whether in or out of the United States, or could otherwise have exposure to additional tax liabilities, which could adversely affect our business, financial condition and results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a multinational business, we are subject to income and other taxes in both the United States and various
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions. Changes to tax laws or regulations in the jurisdictions in which we operate, or in the interpretation of such laws or regulations, could significantly increase our effective tax rate
and reduce our cash flow from operating activities, and otherwise have a material adverse effect on our financial condition. In addition, other factors or events, including business combinations and investment transactions, changes in the valuation
of our deferred tax assets and liabilities, adjustments to taxes upon finalization of various tax returns or as a result of deficiencies asserted by taxing authorities, increases in expenses not deductible for tax purposes, changes in available tax
credits, changes in transfer pricing methodologies, other changes in the apportionment of our income and other activities among tax jurisdictions, and changes in tax rates, could also increase our effective tax rate. Future changes in enacted tax
rates could also negatively affect our results of operations. For example, on August&nbsp;16, 2022, President Biden signed into law the Inflation Reduction Act of 2022, which includes a minimum tax equal to fifteen percent of the adjusted financial
statement income of certain corporations as well as a one percent excise tax on share buybacks, effective for tax years beginning in 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is possible that the minimum tax could result in an additional tax liability over the regular federal corporate tax liability in a given
year based on differences between book and taxable income (including as a result of temporary differences). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our tax filings are subject to review or audit by the U.S. Internal Revenue Service (the
IRS) and state, local and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> taxing authorities. We exercise significant judgment in determining our worldwide provision for taxes and, in the ordinary course of our business, there may be transactions
and calculations where the proper tax treatment is uncertain. We may also be liable for taxes in connection with businesses we acquire. Our determinations are not binding on the IRS or any other taxing authorities, and accordingly the final
determination in an audit or other proceeding may be materially different than the treatment reflected in our tax provisions, accruals and returns. An assessment of additional taxes because of an audit could have a material adverse effect on our
business, financial condition and results of operations. Further changes in the tax laws of <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions could arise, in particular, as a result of the base erosion and profit shifting project that
was undertaken by the Organization for Economic <FONT STYLE="white-space:nowrap">Co-operation</FONT> and Development (the OECD). The OECD, which represents a coalition of member countries, recommended changes to numerous long-standing tax
principles. These changes could increase tax uncertainty and may adversely affect our provision for income taxes and increase our tax liabilities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our ability to use our net operating loss carryforwards and certain other tax attributes may be limited. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2024, we had federal and state net operating loss (NOLs) carryforwards of approximately
$&#8195;&#8195;&#8195;&#8195;million. Under current law, our NOLs generated in tax years beginning after December 31, 2017 may be carried forward indefinitely, but the deductibility of such federal NOLs in tax years beginning after December&nbsp;31,
2020, is limited to 80% of taxable income. It is uncertain if and to what extent various states will conform to the federal law. In addition, under Sections 382 and 383 of the U.S. Internal Revenue Code of 1986, as amended (the Code), if a
corporation undergoes an &#147;ownership change,&#148; generally defined as a greater than 50 percentage point change (by value) in its equity ownership by certain stockholders over a three-year period, the corporation&#146;s ability to use its <FONT
STYLE="white-space:nowrap">pre-change</FONT> NOLs and other <FONT STYLE="white-space:nowrap">pre-change</FONT> tax attributes (such as research and development tax credits) to offset its post-change income or taxes may be limited. We may have
experienced ownership changes in the past and may experience ownership changes in the future as a result of this offering and/or subsequent shifts in our stock ownership (some of which may be outside our control). As a result, our ability to use our
<FONT STYLE="white-space:nowrap">pre-change</FONT> NOLs and tax credits to offset post-change taxable income, if any, could be subject to limitations. Similar provisions of state tax law may also apply. In addition, at the state level, there may be
periods during which the use of NOLs is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related
to Our Intellectual Property </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we are unable to obtain, maintain and enforce patent protection for our current and future proprietary
technology and inventions, or if the scope of the patent protection obtained is not sufficiently broad, our ability to compete successfully and our business, financial condition and results of operations could be adversely impacted. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our future success depends, in part, upon our proprietary technology and inventions. We seek to protect our proprietary technology and
inventions, particularly those relating to the design of our products, through the use of patents. As of January&nbsp;31, 2025, we owned 51 issued U.S. patents, 8 issued foreign patents, 13 pending U.S. patent applications, 9 pending foreign patent
applications, and 2 pending Patent Cooperation Treaty application. The issued patents in the United States generally expire beginning in 2033 through 2042. Maintenance of patent portfolios, particularly outside of the United States, is expensive,
and the process of seeking patent protection is lengthy and costly. While we intend to maintain our current portfolio of patents and to continue to prosecute our currently pending patent applications and file future patent applications when
appropriate, the value of these actions may not exceed their expense. Existing patents and those that may be issued from any pending or future applications may be subject to challenges, opposition, invalidation or circumvention or designed around by
our competitors or declared invalid or unenforceable in judicial or administrative proceedings, and the rights granted under our patents may not provide us with meaningful protection or any commercial advantage. It is also possible that we will fail
to identify patentable aspects of our research and development output before it is too late to obtain patent protection. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our existing issued and granted patents and any future patents we obtain may not be
sufficiently broad to prevent others from using our technology or from developing competing technology. Although we enter into confidentiality agreements with parties who have access to confidential, proprietary or patentable aspects of our research
and development output, such as our employees, consultants, service providers, and third parties with whom we have strategic relationships and business alliances, such agreements may be insufficient or any of these parties could breach such
agreements and disclose such output before a patent application is filed, thereby jeopardizing our ability to seek patent protection and prevent competitors from using our technology. In addition, the protection afforded under the patent laws of one
country may not be the same as that in other countries. This means, for example, that our right to exclusively commercialize a product in those countries where we have patent rights for that product can vary on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis. We also may not have the same scope of patent protection in every country where we do business. Additionally, it is difficult and costly to monitor the use of our intellectual
property. It may be the case that our intellectual property is already being infringed, misappropriated, or otherwise violated, and infringement, misappropriation or other violations of our intellectual property may occur in the future without our
knowledge. The difficulty and failure to identify any violations of our intellectual property rights could materially and adversely affect our business, financial condition and result of operations and hurt our competitive advantage. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Significant litigation over intellectual property in our industry may cause us to become involved in costly and lengthy litigation which could adversely
affect our business, financial condition and results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The semiconductor industry has experienced significant
litigation involving patents and other intellectual property rights. From time to time, third parties, including <FONT STYLE="white-space:nowrap">non-practicing</FONT> entities, allege intellectual property infringement by our products, our
licensors&#146; intellectual property, our end customers&#146; products, or products using technologies or communications standards used in our industry. We periodically receive notices that claim we have infringed, misappropriated or otherwise
violated other parties&#146; intellectual property rights. As we gain greater public recognition, we may face a higher risk of being the subject of intellectual property claims. Litigation regarding intellectual property rights is inherently
uncertain due to the complex issues involved, and we may not be successful in defending ourselves in such matters. Third parties may assert infringement claims against us based on existing patents or patents that may be granted in the future,
regardless of their merit, and some of our competitors have, and will in the future have, extensive portfolios of issued patents. Any intellectual property claims against us, with or without merit, could be time consuming and expensive to settle or
litigate, divert the attention of our management and scientific personnel, or require us to enter into costly royalty or licensing agreements, if available. Many potential litigants, including some of our competitors and patent holding companies,
have the ability to dedicate substantial resources to enforcing their intellectual property rights. If such parties were to assert their intellectual property rights against us, even if we believe we would have defenses against any such assertion,
there can be no assurance that any such defenses will be successful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Patent and other types of intellectual property litigation can
involve complex factual and legal questions, and their outcome is uncertain. Even if we believe such claims are without merit, a court of competent jurisdiction could hold that these third-party patents are valid, enforceable and infringed, which
could adversely affect our ability to commercialize our proprietary technology. In order to successfully challenge the validity of any such U.S. patent in federal court, we would need to overcome a presumption of validity. As this burden is a high
one requiring us to present clear and convincing evidence as to the invalidity of any such U.S. patent claim, there is no assurance that a court of competent jurisdiction would invalidate the claims of any such U.S. patent or find that our
proprietary technology did not infringe any such claims. As discussed above, the outcome of litigation under the laws of foreign jurisdictions is similarly uncertain. Further, even if we were successful in defending against any such claims, such
claims could require us to divert substantial financial and management resources that we would otherwise be able to devote to our business. Any claims successfully brought against us could subject us to significant liability for damages, which could
include treble damages and attorneys&#146; fees if we are found to willfully infringe a third party&#146;s patent, and we may be required to stop using technology or other intellectual property alleged to be in violation of a third party&#146;s
rights. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also receive communications from end customers or suppliers requesting
indemnification for allegations brought against them by third parties. Some of these allegations may result in our involvement in litigation in the future. We have certain contractual obligations to defend and indemnify our end customers from
certain infringement claims. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Legal proceedings initiated by us to protect our intellectual property rights could also result in
counterclaims or countersuits against us, such as claims asserting that our patents are invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. Grounds for
a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness, <FONT STYLE="white-space:nowrap">non-enablement</FONT> or lack of statutory subject matter. Grounds for an
unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant material information from the USPTO, or made a materially misleading statement, during prosecution. Third parties also may
raise similar validity claims against our patents before the USPTO in post-grant proceedings such as ex parte reexaminations, inter partes review, or post-grant review, or oppositions or similar proceedings outside the United States, in parallel
with litigation or even outside the context of litigation. The outcome following legal assertions of invalidity and unenforceability is unpredictable. We cannot be certain that there is no invalidating prior art, of which we and the patent examiner
were unaware during prosecution. For the patents and patent applications that we have licensed, we may have limited or no right to participate in the defense of any licensed patents against challenge by a third party. If a defendant were to prevail
on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of any future patent protection on our current or future proprietary technologies. Such a loss of patent protection could materially and adversely
impact our business, financial condition and results of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, because of the substantial amount of discovery required
in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings,
motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could materially and adversely affect the trading price of our common stock. We may not have sufficient financial or
other resources to adequately conduct such litigation or proceedings. Some of our competitors or other third parties may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial
resources and more mature and developed intellectual property portfolios. Litigation or other legal proceedings relating to intellectual property claims can be complex and could distract our scientific and management personnel from their normal
responsibilities. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a material adverse effect on our business, financial condition and results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any litigation, regardless of its outcome or merit, could be time-consuming and expensive to resolve and could divert our management&#146;s
time and attention. Intellectual property litigation also could force us to take specific actions, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Cease using, selling or manufacturing certain products, solutions or processes; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Attempt to obtain a license, which license may require the payment of substantial royalties or may not be
available on reasonable terms or at all; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Incur significant costs, time delays and lost business opportunities to develop alternative, <FONT
STYLE="white-space:nowrap">non-infringing</FONT> technologies or redesign solutions; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Pursue legal remedies with third parties to enforce our indemnification rights, which may not adequately protect
our interests. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>There is a risk that our trade secrets, <FONT STYLE="white-space:nowrap">know-how</FONT> and other
confidential or proprietary information will be stolen, used in an unauthorized manner, or compromised, which could materially and adversely affect our business, financial condition and results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to the protection afforded by patents, we rely on trade secret protection and contractual arrangements to protect our proprietary <FONT
STYLE="white-space:nowrap">know-how,</FONT> confidential information and technology that is not covered by our patents. Our trade secrets, <FONT STYLE="white-space:nowrap">know-how</FONT> and other proprietary information may be stolen, used in an
unauthorized manner, or compromised through a direct intrusion by private parties or foreign actors, including those affiliated with or controlled by state actors, through cyber intrusions into our computer systems, physical theft through corporate
espionage or other means, or through more indirect routes, including by joint venture partners, licensees that do not honor the terms of the license, potential licensees that were ultimately not licensed, or other parties reverse engineering our
products, solutions, components or processes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We generally enter into confidentiality and invention assignment agreements with our
employees and consultants and confidentiality agreements with service providers and other third parties, including those with whom we have strategic relationships and business alliances. Despite the contractual provisions employed, no assurance can
be given that these agreements will be effective in controlling access to our proprietary information and trade secrets, and the need to share trade secrets and other confidential information increases the risk that such trade secrets become known
by our competitors or other third parties, are inadvertently incorporated into the technology of others or are disclosed or used in violation of these agreements. The confidentiality agreements on which we rely to protect certain technologies may be
breached, may not be adequate to protect our confidential information, trade secrets, and proprietary technologies, and may not provide an adequate remedy in the event of unauthorized use or disclosure of our confidential information, trade secrets,
or proprietary technology. Further, these agreements do not prevent our competitors or others from independently developing products that are substantially equivalent or superior to ours. In addition, others may independently discover our trade
secrets, and, in such cases, we may not be able to assert any trade secret rights against such parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also rely on physical and
electronic security measures to protect our confidential or proprietary information, but we cannot provide assurance that these security measures will not be breached or provide adequate protection for our property. There is a risk that third
parties may obtain and improperly utilize our confidential or proprietary information to our competitive disadvantage. We may not be able to detect or prevent the unauthorized use of such information or take appropriate and timely steps to protect
and enforce our intellectual property rights. Any of the foregoing factors could materially and adversely affect our business, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If our trademarks and trade names are not adequately protected, we may not be able to build name recognition in our markets of interest, and our
competitive position may be harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our registered or unregistered trademarks or trade names in the United States and in foreign
jurisdictions may be challenged, infringed, circumvented, declared generic, lapsed or determined to be infringing on or dilutive of other marks, and our current and future trademark applications may not be allowed or may subsequently be opposed. We
may not be able to protect our rights in these trademarks and trade names, which we need in order to build name recognition with potential end customers. At times, competitors may adopt trade names or trademarks similar to ours, thereby impeding our
ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other trademarks or trademarks that incorporate variations of our
registered or unregistered trademarks or trade names. As a means to enforce our trademark rights and prevent infringement, we may be required to file trademark claims against third parties or initiate trademark opposition proceedings. This can be
expensive and time-consuming, and we may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential partners or end customers in our markets of interest. Over the long term, if we
are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may license our trademarks and trade names to third parties, such as distributors. Though
these license agreements may provide guidelines for how our trademarks and trade names may be used, a breach of these agreements or misuse of our trademarks and trade names by our licensees may jeopardize our rights in or diminish the goodwill
associated with our trademarks and trade names. Moreover, effective trademark protection may not be available or may not be sought in every country in which our products are made available, in every market in which we operate, and contractual
disputes may affect the use of marks governed by private contract. Our efforts to enforce or protect our proprietary rights related to trademarks and trade names may be ineffective and could result in substantial costs and diversion of resources and
could materially adversely affect our business, financial condition and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may be subject to claims that our employees,
consultants or advisors have wrongfully used or disclosed trade secrets of their current or former employers or claims asserting ownership of what we regard as our own intellectual property. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Many of our employees were previously employed at other companies in our field, including our competitors or potential competitors, and many of
our consultants are currently or were previously engaged by these companies. Although we try to ensure that our employees and consultants do not use the confidential or proprietary information or <FONT STYLE="white-space:nowrap">know-how</FONT> of
others in their work for us, we may in the future be subject to claims that we or these individuals have used or disclosed intellectual property, including trade secrets or other confidential or proprietary information, of any such individual&#146;s
current or former employer. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel or be subject to
temporary or permanent injunctions against our solutions or processes. In addition, any such litigation or the threat thereof may adversely affect our ability to hire employees or contract with independent contractors. A loss of key personnel or
their work product could hamper or prevent our ability to commercialize our solutions, which would have a material adverse effect on our business, financial condition and results of operations. Even if we are successful in defending against such
claims, litigation could result in substantial costs and be a distraction to management and scientific personnel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, while it
is our policy to require our employees and contractors who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an
agreement with each party who, in fact, conceives or develops intellectual property that we regard as our own. The assignment of intellectual property rights may not be self- executing, or the assignment agreements may be breached, and we may be
forced to bring claims against third parties or defend claims that they may bring against us to determine the ownership of what we regard as our intellectual property. Furthermore, individuals executing agreements with us may have preexisting or
competing obligations to a third party, and thus an agreement with us may be ineffective in perfecting ownership of inventions developed by that individual. Disputes about the ownership of intellectual property that we may own could materially and
adversely affect our business, financial condition and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We, and the third parties with whom we work with, are subject to
stringent and evolving U.S. and foreign laws, regulations, rules, standards, contractual obligations, policies, and other obligations, related to data privacy and cybersecurity. Our (or the third parties with whom we work with) actual or perceived
failure to comply with such obligations could lead to regulatory investigations or actions; litigation (including class claims) and mass arbitration demands; fines and penalties; disruptions of our business operations; reputational harm; loss of
revenue or profits; loss of customers or sales; and other adverse business consequences. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The legislative and regulatory framework
for data privacy and protection and cybersecurity issues worldwide is rapidly evolving. In the ordinary course of business, we collect, receive, store, handle, transfer, use, make accessible, protect, secure, transmit, share, and otherwise process
personal data and other sensitive information, including proprietary and confidential business data, trade secrets, intellectual property, and sensitive third-party data. Our data processing activities subject us to numerous data privacy and
cybersecurity </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
obligations, such as various laws, regulations, rules, guidance, industry standards, external and internal privacy and cybersecurity policies, contractual requirements, and other obligations that
govern the processing of personal data by us and on our behalf. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the United States, federal, state, and local governments have enacted
numerous data privacy and cybersecurity laws, including data breach notification laws, personal data privacy laws, wiretapping laws, and consumer protection laws (e.g. Section&nbsp;5 of the Federal Trade Commission Act). For example, the California
Consumer Privacy Act, as amended by the California Privacy Rights Act (CCPA), applies to personal data of consumers, business representatives, and employees who are California residents, and requires businesses subject to the CCPA to provide
specific disclosures in privacy notices and honor requests of such individuals to exercise certain privacy rights. The CCPA, among other things, gives California residents the right to access, delete and opt out of certain sharing of their
information and imposes penalties for failure to comply, including allowing for private litigants affected by certain data breaches to recover significant statutory damages. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The enactment of the CCPA has led a wave of similar legislative developments in other states in the United States, which creates the potential
for a patchwork of overlapping but different state laws and could mark the beginning of a trend toward more stringent privacy legislation in the United States, which could increase our potential liability and adversely affect our business, financial
condition and results of operations. Many states have passed or are considering passing comprehensive data privacy legislation, and additional states could adopt data privacy legislation that may include more stringent data privacy requirements.
Further, to the extent multiple state-level laws are introduced with inconsistent or conflicting standards, it may require costly and difficult efforts to achieve compliance with such laws. All 50 states have passed some form of legislation relating
to data privacy or cybersecurity (for example, all 50 states have enacted laws requiring disclosure of certain personal data breaches). At the federal level, the United States Congress is considering various proposals for comprehensive federal data
privacy legislation and, while no comprehensive federal data privacy law currently exists, we are subject to applicable existing federal laws and regulations, such as the rules and regulations promulgated under the authority of the Federal Trade
Commission, which regulates unfair or deceptive acts or practices, including with respect to data privacy and security. These state statutes, and other similar state or federal laws, may require us to modify our data processing practices and
policies and incur substantial compliance-related costs and expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Outside the United States, an increasing number of laws,
regulations, rules, and industry standards govern data privacy and cybersecurity. Many foreign countries and governmental bodies, including throughout Europe, Asia and other relevant jurisdictions where we conduct business, have laws and regulations
concerning the collection, use, handling, transfer and other processing of personal data and other data obtained from their residents or by businesses operating within their jurisdictions that are more restrictive than those in the United States.
For example, the European Union&#146;s General Data Protection Regulation (EU GDPR), the United Kingdom&#146;s GDPR (UK GDPR) (collectively, GDPR), and China&#146;s Personal Information Protection Law (PIPL) impose strict requirements for the
collection, processing and transfer of personal data. For example, under the GDPR, government regulators may impose temporary or definitive bans on data processing, as well as fines of up to 20&nbsp;million Euros (in the case of the EU GDPR),
17.5&nbsp;million pounds sterling (in the case of the UK GDPR), or in each case, up to 4% of annual global revenue, whichever is greater. It may also lead to civil litigation related to processing of personal data brought by classes of data subjects
or consumer protection organizations authorized at law to represent their interests, with the risks of damages or injunctive relief. In addition, an actual or asserted violation of the GDPR could result in regulatory investigations, reputational
damage, orders to cease or change our processing of our data, enforcement notices and/or assessment notices (for a compulsory audit). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also target customers in Asia and may be subject to new and emerging data privacy regimes in Asia including China&#146;s PIPL, Japan&#146;s
Act on the Protection of Personal Information, and Singapore&#146;s Personal Data Protection Act. China&#146;s PIPL shares certain similarities with the GDPR, including extraterritorial application, requirements for data minimization, data
localization, and purpose limitation, and obligations to provide certain notices and rights to citizens of the PRC. The PIPL allows for fines of up to 50&nbsp;million renminbi or 5% of a covered company&#146;s revenue in the prior year. India&#146;s
new privacy legislation, the Digital Personal Data Protection Act (DPDP), may also apply to our operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of business, we may transfer personal data from Europe and other
jurisdictions to the United States or other countries. Europe, as well as other jurisdictions, have enacted data localization laws and cross-border personal data transfer laws, which could make it more difficult to transfer information across
jurisdictions. In particular, the European Economic Area (EEA) and the United Kingdom (UK) have significantly restricted the transfer of personal data to the United States and other countries whose privacy laws it generally believes are inadequate.
For example, absent appropriate safeguards or other circumstances, the EU GDPR generally restricts the transfer of personal data to countries outside of the EEA, that the European Commission does not consider to provide an adequate level of data
privacy and cybersecurity. Other jurisdictions may adopt similarly stringent interpretations of their data localization and cross-border data transfer laws. Additionally, existing mechanisms that facilitate cross-border personal data transfers such
as the EEA standard contractual clauses (SCC), the UK&#146;s International Data Transfer Agreement / Addendum, and the <FONT STYLE="white-space:nowrap">EU-U.S.</FONT> Data Privacy Framework and the UK extension thereto (which allows for transfers to
relevant U.S.-based organizations who self-certify compliance and participate in the Framework), are subject to legal challenges, and there is no assurance that we can satisfy or rely on these measures to lawfully transfer personal data to the
United States. Further, the SCCs impose additional compliance burdens, such as conducting transfer impact assessments to determine whether additional security measures are necessary to protect the <FONT STYLE="white-space:nowrap">at-issue</FONT>
personal data. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These developments regarding cross-border data transfers have created uncertainty and increased the risk around our
international operations and may require us to review and amend the legal mechanisms by which we make or receive personal data transfers to the United States and other jurisdictions. We may, among other things, be required to implement additional or
different contractual and technical safeguards for any personal data transferred out of the EEA, which may increase compliance costs, lead to increased regulatory scrutiny or liability, may require additional contractual negotiations, may impose
operational burdens or limitations, and may materially and adversely impact our business, financial condition and results of operations. If we cannot implement a valid compliance mechanism for cross-border data transfers, we may face increased
exposure to regulatory actions, substantial fines, and injunctions against processing or transferring personal data from Europe or other foreign jurisdictions. The inability to import personal data to the United States and other countries could
significantly and negatively impact our business operations including by limiting our ability to collaborate with parties that are subject to such cross-border data transfer or localization laws, or requiring us to increase our personal data
processing capabilities and infrastructure in foreign jurisdictions at significant expense. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, we have incurred, and may
continue to incur, significant expenses in an effort to comply with data privacy, data protection, and cybersecurity standards, rules, and protocols imposed by law, regulation, industry standards, or contractual obligations. Publication of our data
privacy statement and other policies regarding privacy, data protection, and cybersecurity may subject us to investigation or enforcement actions by regulators if those statements or policies are found to be deficient, lacking transparency,
deceptive, unfair, or misrepresentative of our practices. We are also bound by contractual obligations related to data privacy, data protection, and cybersecurity and our efforts to comply with such obligations may not be successful or may have
other negative consequences. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Obligations related to data privacy and cybersecurity (including and consumers&#146; data privacy
expectations) are quickly changing in an increasingly stringent fashion, creating some uncertainty as to the effective future legal framework. Additionally, these obligations may be subject to differing applications and interpretations, which may be
inconsistent or conflict among jurisdictions. Preparing for and complying with these obligations requires significant resources and may necessitate changes to our solutions, information technologies, systems, and practices and to those of any third
parties that process personal data on our behalf. In addition, these obligations may require us to change our business model. Despite our efforts to comply with all applicable data privacy and cybersecurity obligations, it is possible that our
interpretations of the law, regulations, rules, standards, practices, or policies could be inconsistent with, or fail or be alleged to fail to meet all requirements of such obligations. Moreover, despite our efforts, our personnel or third parties
with whom we work may fail to comply with such obligations, which could negatively impact our business operations and compliance posture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
For example, any failure by a third-party processor to comply with applicable law, regulations, or contractual obligations could result in adverse effects, including inability to or interruption
in our ability to operate our business and proceedings against us by governmental entities or others. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we, or the third parties with
whom we work, fail, or are perceived to have failed, to address or comply with data privacy and cybersecurity obligations, we could face significant consequences. These consequences may include, but are not limited to, government enforcement actions
(e.g., investigations, fines, penalties, audits, inspections, and similar), litigation (including class-related claims), additional reporting requirements and/or oversight, bans on processing personal data, and orders to destroy or not use personal
data. In particular, plaintiffs have become increasingly more active in bringing data privacy-related claims against companies, including class claims and mass arbitration demands. Some of these claims allow for the recovery of statutory damages on
a per violation basis, and, if viable, carry the potential for monumental statutory damages, depending on the volume of data and the number of violations. Any of these events could have a material adverse effect on our reputation, business, or
financial condition, including but not limited to: loss of customers, interruptions or stoppages in our business operations, interruptions or stoppages of data collection needed to train our algorithms, inability to process personal data or to
operate in certain jurisdictions, limited ability to develop or commercialize our solutions, expenditure of time and resources to defend any claim or inquiry, adverse publicity, or revision or restructuring of our operations. Even if not subject to
legal challenge, the perception of concerns relating to data privacy, data protection, or cybersecurity, whether or not valid, could materially and adversely affect our business, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our use of open source software could compromise the proprietary nature of our software, or the software we develop for our clients, and expose us to
other legal liabilities and technological risks. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our solutions and technology incorporate open source software, and we expect to
continue to incorporate open source software in our business in the future. Few of the licenses applicable to open source software have been interpreted by courts, and there is a risk that these licenses could be construed in a manner that could
impose unanticipated conditions or restrictions on our ability to commercialize our solutions. Certain open source licenses may give rise to requirements to disclose or license our proprietary source code or make available any derivative works or
modifications of the open source code on unfavorable terms or at no cost, and we may be subject to such terms if such open source software is combined, linked, or otherwise integrated with our proprietary software in certain ways. If we combine our
proprietary software with open source software in a certain manner, we could, under certain open source licenses, be required to release the source code of our proprietary software to the public. Although we believe that we have complied with our
obligations under the applicable licenses for open source software that we use, there is little or no legal precedent governing the interpretation of many of the terms of certain of these licenses. As a result, the potential impact of these terms is
uncertain and may result in unanticipated obligations or restrictions regarding those of our products, technologies or solutions affected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a third party were to allege that we had not complied with the conditions of one or more of these licenses, we could be required to incur
significant legal expenses defending against such allegations, and could be subject to significant damages and required to comply with onerous conditions or restrictions on the use of our proprietary software. In any of these events, we could be
required to seek licenses from third parties and pay royalties in order to continue using the open source software necessary to operate our business, or we could be required to discontinue use of our website and software in the event <FONT
STYLE="white-space:nowrap">re-engineering</FONT> cannot be accomplished on a timely basis. Additionally, the use of open-source software can lead to vulnerabilities that may make our solutions, software and technology susceptible to attack, and
although some open-source vendors provide warranty and support agreements, it is common for such software to be available &#147;as is&#148; with no warranty, indemnity, support, or other contractual protection regarding infringement claims or the
quality of the code. Any of the foregoing could require us to devote additional research and development resources to <FONT STYLE="white-space:nowrap">re-engineer</FONT> our website and software, could result in customer dissatisfaction, could allow
our competitors to create similar technology with lower development effort and time and may adversely affect our business, financial condition, and results of operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Ownership of Our Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our issuance of additional capital stock in connection with financings, acquisitions, investments, our stock incentive plans or otherwise could dilute
the ownership and voting power of existing stockholders. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of&#8195;, 2024, we had&#8195;shares of common stock authorized but
unissued. In addition, our amended and restated certificate of incorporation authorizes us to issue up to &#8195;&#8195;&#8195;&#8195;shares of preferred stock with such rights and preferences as may be determined by our board of directors. Our
amended and restated certificate of incorporation authorizes us to issue shares of common stock or other securities convertible into or exercisable or exchangeable for shares of our common stock from time to time, for the consideration and on the
terms and conditions established by our board of directors in its sole discretion, whether in connection with a financing, an acquisition, an investment, our stock incentive plans or otherwise. Such additional shares of our common stock or such
other securities may be issued at a discount to the market price of our common stock at the time of issuance. Our preferred stock could be issued with voting, liquidation, dividend and other rights superior to the rights of our common stock. The
potential issuance of preferred stock may delay or prevent a change in control of us, discourage bids for our common stock at a premium to the market price, and materially and adversely affect the market price and the voting and other rights of the
holders of our common stock. Any issuance of such securities could result in substantial dilution to our existing stockholders and cause the market price of shares of our common stock to decline. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We do not expect to declare or pay any cash dividends on our common stock for the foreseeable future. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not expect to pay cash dividends on our common stock for the foreseeable future. Consequently, investors must rely on sales of their
shares of our common stock after price appreciation, which may never occur, as the only way to realize any future gains on their investment. Investors seeking dividends should not purchase shares of our common stock. Any future determination to pay
dividends will be at the discretion of our board of directors and subject to, among other things, our compliance with applicable law, and depending on, among other things, our business prospects, financial condition, results of operations, cash
requirements and availability, debt repayment obligations, capital expenditure needs, the terms of any preferred equity securities we may issue in the future, covenants in the agreements governing our current and future indebtedness, other
contractual restrictions, industry trends, the provisions of the DGCL affecting the payment of dividends and distributions to stockholders and any other factors or considerations our board of directors may regard as relevant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our management will have broad discretion in the application of the net proceeds from this offering designated for general corporate purposes and may
apply such net proceeds to uses that do not increase our market value or improve our operating results. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to use the net
proceeds received by us from this offering for research and development, working capital and other general corporate purposes as set forth under &#147;Use of Proceeds.&#148; We may also use a portion of our net proceeds to acquire or invest in
complementary businesses, products, solutions or technologies, though we do not have any agreements or commitments for any significant acquisitions or investments at this time. Other than as described above, we have not reserved or allocated the net
proceeds for any specific purpose, and we cannot state with certainty how our management will use the net proceeds from this offering designated for general corporate purposes. Accordingly, our management will have considerable discretion in
applying such net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether we are using such net proceeds appropriately. We may use our net proceeds for purposes that do not result in any improvement in
our results of operations or increase the market value of our common stock. The failure by our management team to apply the net proceeds from this offering effectively could impair our growth prospects and result in financial losses that could have
a material adverse effect on our business, financial condition and results of operations and cause the price of our common stock to decline. Until the net proceeds from this offering designated for general corporate purposes are used, they may be
placed in investments that do not produce income or that lose value. Provisions in our amended and restated certificate of incorporation and bylaws will provide and the DGCL contains anti-takeover provisions that could prevent or discourage a
takeover. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Provisions in our amended and restated certificate of incorporation and bylaws to be in
effect upon the closing of this offering may discourage, delay or prevent an unsolicited merger, acquisition or other change in control of our company that stockholders may consider to be in their best interest, including transactions in which you
might otherwise receive a premium for your shares. These provisions could also limit the price that investors might be willing to pay in the future for shares of our common stock, thereby depressing the market price of our common stock. In addition,
because our board of directors is responsible for appointing the members of our management team, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for
stockholders to replace members of our board of directors. Among other things, these provisions include those establishing: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a classified board of directors with three-year staggered terms, which may have the effect of deferring, delaying
or discouraging hostile takeovers, or changes in control of us or our management; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no cumulative voting in the election of directors, which limits the ability of minority stockholders to elect
director candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the exclusive right of our board of directors to elect a director to fill a vacancy created by, among other
things, the expansion of the board of directors or the resignation, death or removal of a director, which prevents stockholders from filling vacancies on our board of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability of our board of directors to authorize the issuance of shares of preferred stock and to determine the
terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the required approval of the holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the shares
of common stock entitled to vote at an election of directors to amend or repeal our bylaws or amend the provisions of our amended and restated certificate of incorporation regarding the election and removal of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual
or special meeting of our stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a prohibition on stockholders calling a special meeting and the requirement that a meeting of stockholders may be
called only by a majority of our board of directors, which may delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advance notice procedures that stockholders must comply with in order to nominate candidates to our board of
directors or to propose matters to be acted upon at an annual meeting or special meeting of stockholders, which may discourage or delay a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#146;s own slate of
directors or otherwise attempting to obtain control of us until the next stockholder meeting or at all. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our amended and restated
certificate of incorporation includes forum selection clauses, which could discourage claims or limit stockholders&#146; ability to make a claim against us, our directors, officers, other employees or stockholders. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation will provide that, unless we consent in writing to the selection of an alternative forum,
the Court of Chancery in the State of Delaware shall be the sole and exclusive forum for any stockholder (including a beneficial owner) to bring: (a)&nbsp;any derivative action or proceeding brought on behalf of the Company; (b)&nbsp;any claim or
cause of action for breach of a fiduciary duty owed by any current or former director, officer or other employee of the Company, to the Company or the Company&#146;s stockholders; (c)&nbsp;any claim or cause of action against the Company or any
current or former director, officer or other employee of the Company, arising out of or pursuant to any provision of the DGCL or our certificate of incorporation or bylaws; (d)&nbsp;any claim or cause of action seeking to interpret, apply, enforce
or determine the validity of our certificate of incorporation or bylaws (as each may be amended from time to time, including any right, obligation, or remedy thereunder), (e) any claim or cause of action as to which the DGCL confers
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
jurisdiction on the Court of Chancery of the State of Delaware; and (f)&nbsp;any claim or cause of action against the Company or any current or former director, officer or other employee of the
Company, governed by the internal- affairs doctrine, in all cases to the fullest extent permitted by law and subject to the court having personal jurisdiction over the indispensable parties named as defendants. In addition, our amended and restated
certificate of incorporation will provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of
action arising under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the Securities Act forum selection clause will not apply to suits
brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America shall be the sole and exclusive forum. These forum selection clauses may discourage claims
or limit stockholders&#146; ability to submit claims in a judicial forum that they find favorable and may result in additional costs for a stockholder seeking to bring a claim. While we believe the risk of a court declining to enforce these forum
selection clauses is low, if a court were to determine a forum selection clause to be inapplicable or unenforceable in an action, we may incur additional costs in conjunction with our efforts to resolve the dispute in an alternative jurisdiction,
which could have a negative impact on our business, financial condition and results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>New investors in our common stock will
experience immediate and substantial dilution in book value after this offering. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The initial public offering price is expected to
be substantially higher than the pro forma as adjusted net tangible book value per share of our common stock. If you purchase common stock in this offering, you will incur immediate dilution of $&#8195;&#8195;&#8195;&#8195;per share, representing
the difference between the assumed initial public offering price of $&#8195;&#8195;&#8195;&#8195;per share, the midpoint of the price range set forth on the cover page of this prospectus, and the pro forma as adjusted net tangible book value per
share of our common stock as of, 2024. For additional information on the dilution you may experience as a result of investing in this offering, see &#147;Dilution.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our stock price may be volatile, and investors in our common stock may not be able to resell shares of our common stock at or above the price paid, or
at all. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There has been no public market for our common stock prior to this offering. The initial public offering price for our
common stock will be determined through negotiations between the underwriters and us and may vary from the market price of our common stock following this offering. If you purchase our common stock in this offering, you may not be able to resell
those shares at or above the initial public offering price, or at all. An active market in our common stock may not develop upon the closing of this offering or, if it does develop, it may not be sustainable or liquid enough for you to sell your
shares. We have applied to list our common stock on&#8195; , but we cannot assure you that an active trading market will develop. The trading price and volume of our common stock is likely to be volatile and could fluctuate significantly in response
to numerous factors, many of which are beyond our control, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">variations in our actual or anticipated annual or quarterly operating results or those of others in our industry;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">results of operations that otherwise fail to meet the expectations of securities analysts and investors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in earnings estimates or recommendations by securities analysts, or other changes in investor perceptions
of the investment opportunity associated with our common stock relative to other investment alternatives; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">market conditions in the semiconductor industry; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">publications, reports or other media exposure of our solutions or those of others in our industry, or of our
industry generally; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">announcements by us or others in our industry including our competitors, or by our or their respective suppliers,
distributors or other business partners, regarding, among other things, announcements of new solutions, significant contracts, price reductions, capital commitments or other business developments, the entry into or termination of strategic
transactions or relationships, securities offerings or other financing initiatives, and public reaction thereto; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">general economic and political conditions, such as the effects of the conflicts between Russia and Ukraine or
Israel and Hamas, global health crises, recessions, interest rates, local and national elections, fuel prices, international currency fluctuations, corruption, political instability and acts of war or terrorism; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">imposition of trade or similar sanctions by the United States or other countries in which we operate or do
business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">commencement of, or involvement in, litigation, in particular, litigation concerning our intellectual property;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additions or departures of key management personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory actions involving us or others in our industry, or actual or anticipated changes in applicable
government regulations or enforcement thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the development and sustainability of an active trading market for our common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sales, or anticipated sales, of large blocks of our common stock; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">technical factors in the public trading market for our common stock that may produce price movements that may or
may not comport with macro, industry or company-specific fundamentals, including, without limitation, the sentiment of retail investors (including as may be expressed on financial trading and other social media sites), the amount and status of short
interest in our securities, access to margin debt, trading in options and other derivatives on our common stock and any related hedging or other technical trading factors. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, the stock market in general has experienced extreme price and volume fluctuations that have often been unrelated or
disproportionate to the operating performance of particular companies. Broad market and industry factors may significantly affect the market price of our common stock, regardless of our actual operating performance. These and other factors may cause
the market price and demand for our common stock to fluctuate significantly, which may limit or prevent investors from readily selling their shares of common stock and may otherwise negatively affect the liquidity of our common stock. In addition,
in the past, when the market price of a stock has been volatile, holders of that stock have sometimes instituted securities class action litigation against the company that issued the stock. If any of our stockholders were to bring a lawsuit against
us, we could incur substantial costs defending the lawsuit. Such a lawsuit could also divert the time and attention of our management from our core business operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General Risks </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We will incur significantly
increased costs as a result of operating as a company whose common stock is publicly traded in the United States, and our management will be required to devote substantial time to new compliance initiatives. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a public company in the United States, we will incur significant legal, accounting, and other expenses that we did not incur previously.
These expenses will likely be even more significant after we no longer qualify as an emerging growth company. The Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the listing requirements
of&#8195;&#8195;&#8195;&#8195;, and other applicable securities rules and regulations impose various requirements on public companies in the United States, including the establishment and maintenance of effective disclosure and financial controls
and corporate governance practices. Our senior management and other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations will increase our legal and financial compliance costs and will
make some activities more time- consuming and costly. For example, we expect that these rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability insurance, which in turn could make it more
difficult for us to attract and retain qualified senior management personnel or members for our board of directors. We cannot predict or estimate the amount of additional costs we may incur or the timing of such costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Compliance with these rules and regulations can be burdensome. Our management and other personnel need to devote a substantial amount of time
to these compliance initiatives. Moreover, these rules and regulations have increased, and will continue to increase, our historical legal and financial compliance costs and will make some activities more time-consuming and costly. For example, we
expect that these rules and regulations may make it more difficult and more expensive for us to attract and retain qualified members of our board of directors as compared to a private company. In particular, we incur significant expenses and devote
substantial management effort toward ensuring compliance with the requirements of Section&nbsp;404 of the Sarbanes-Oxley Act. We have hired additional accounting and financial staff, and engaged outside consultants, all with appropriate public
company experience and technical accounting knowledge, which increased our operating expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our executive officers have limited
experience in the management of a publicly traded company. Their limited experience in dealing with the increasingly complex laws pertaining to public companies could be a significant disadvantage in that it is likely that an increasing amount of
their time may be devoted to these activities, which will result in less time being devoted to the management and growth of the post-combination company. We may not have adequate personnel with the appropriate level of knowledge, experience and
training in the accounting policies, practices or internal control over financial reporting required of public companies. Our management will need to continually assess our staffing and training procedures to improve our internal control over
financial reporting. Further, the development, implementation, documentation and assessment of appropriate processes, in addition to the need to remediate any potential deficiencies, will require substantial time and attention from management. The
development and implementation of the standards and controls necessary for us to achieve the level of accounting standards required of a public company may require costs greater than expected. It is possible that we will be required to expand our
employee base and hire additional employees to support our operations as a public company which will increase our operating costs in future periods. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to maintain an effective system of disclosure controls and internal control over financial reporting, our ability to produce timely and
accurate financial statements or comply with applicable regulations could be impaired. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a public company, we will be subject to
the reporting requirements of the Exchange Act, the Sarbanes- Oxley Act and the rules and regulations of the applicable listing standards of&#8195;&#8195;&#8195;&#8195;. We expect that the requirements of these rules and regulations will continue to
increase our legal, accounting and financial compliance costs, make some activities more difficult, time-consuming and costly and place significant strain on our personnel, systems and resources. The Sarbanes-Oxley Act requires, among other things,
that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are continuing to develop and refine our disclosure controls and other procedures that are designed to ensure that information required
to be disclosed by us in the reports that we will file with the SEC is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that information required to be disclosed in reports under the Exchange
Act is accumulated and communicated to our principal executive and financial officers. We are also continuing to improve our internal control over financial reporting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to maintain and improve the effectiveness of our disclosure controls and procedures and internal control over financial reporting, we
have expended, and anticipate that we will continue to expend, significant resources, including accounting-related costs and significant management oversight. Our current controls and any new controls that we develop may become inadequate because of
changes in conditions in our business. In addition, changes in accounting principles or interpretations could also challenge our internal controls and require that we establish new business processes, systems and controls to accommodate such
changes. We have </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
limited experience with implementing the systems and controls that will be necessary to operate as a public company, as well as adopting changes in accounting principles or interpretations
mandated by the relevant regulatory bodies. Additionally, if these new systems, controls or standards and the associated process changes do not give rise to the benefits that we expect or do not operate as intended, it could adversely affect our
financial reporting systems and processes, our ability to produce timely and accurate financial reports or the effectiveness of internal control over financial reporting. Moreover, our business may be harmed if we experience problems with any new
systems and controls that result in delays in their implementation or increased costs to correct any post-implementation issues that may arise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Further, weaknesses in our disclosure controls and internal control over financial reporting may be discovered in the future. Any failure to
develop or maintain effective controls or any difficulties encountered in their implementation or improvement could harm our business or cause us to fail to meet our reporting obligations and may result in a restatement of our financial statements
for prior periods. Any failure to implement and maintain effective internal control over financial reporting also could adversely affect the results of periodic management evaluations and annual independent registered public accounting firm
attestation reports regarding the effectiveness of our internal control over financial reporting that we will eventually be required to include in our periodic reports that will be filed with the SEC. Ineffective disclosure controls and procedures
and internal control over financial reporting could also cause investors to lose confidence in our reported financial and other information, which would likely have a negative effect on the trading price of our common stock. In addition, if we are
unable to continue to meet these requirements, we may not be able to remain listed on&#8195;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are not currently required to comply
with the SEC rules that implement Section&nbsp;404 of the Sarbanes- Oxley Act and are therefore not required to make a formal assessment of the effectiveness of our internal control over financial reporting for that purpose. As a public company, we
will be required to provide an annual management report on the effectiveness of our internal control over financial reporting commencing with our second annual report on Form <FONT STYLE="white-space:nowrap">10-K.</FONT> Our independent registered
public accounting firm is not required to formally attest to the effectiveness of our internal control over financial reporting until our first annual report filed with the SEC where we are an accelerated filer or a large accelerated filer, which
will not occur until at least our second annual report on Form <FONT STYLE="white-space:nowrap">10-K.</FONT> At such time, our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the
level at which our internal control over financial reporting is documented, designed or operating. Any failure to maintain effective disclosure controls and internal control over financial reporting could harm our business and could cause a decline
in the trading price of our common stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We identified a material weakness in our internal control over financial reporting, and we may experience
additional material weaknesses or otherwise fail to design and maintain effective internal control over financial reporting. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
the course of preparing the financial statements that are included in this prospectus, management has determined that a material weakness exists within the internal controls over financial reporting. The material weakness identified relate to
controls to address segregation of certain accounting duties and information technology controls. We concluded that the material weakness in our internal control over financial reporting occurred because we did not have the necessary business
processes, systems, and related internal controls necessary to satisfy the accounting and financial reporting requirements of a public company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As part of our plan to remediate this material weakness, we have made progress in several actions and will continue to implement our
remediation plans. To remediate the material weakness, we have implemented a new financial system, are implementing a new operational system and have enhanced control procedures to mitigate segregation of duties. We have also implemented additional
review controls and processes that require additional levels of review by those charged with financial governance of our company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will
not be able to fully remediate the identified material weakness until the ongoing steps described above have been completed and our internal controls have been operating effectively for a sufficient period of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
time. We cannot assure you that we will be able to fully remediate the material weakness in a timely manner. We also may incur significant costs to execute various aspects of our remediation plan
but cannot provide a reasonable estimate of such costs at this time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We cannot assure you that we have identified all material
weaknesses. Material weaknesses may still exist when we report on the effectiveness of our internal control over financial reporting as required under Section&nbsp;404 of the Sarbanes-Oxley Act after the completion of this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the future, it is possible that additional material weaknesses or significant deficiencies may be identified. Our ability to comply with
the annual internal control reporting requirements will depend on the effectiveness of our financial reporting and data systems and controls across our company. Any weaknesses or deficiencies or any failure to implement new or improved controls, or
difficulties encountered in the implementation or operation of these controls, could harm our operating results and cause us to fail to meet our financial reporting obligations, or result in material misstatements in our consolidated financial
statements, which could adversely affect our business, financial condition and results of operations and reduce our stock price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If we
are unable to conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with Section&nbsp;404, our independent registered public accounting firm may not issue an unqualified opinion. If we are unable
to conclude that we have effective internal control over financial reporting, investors could lose confidence in our reported financial information, which could have a material adverse effect on the trading price of our common stock. Failure to
remedy any material weakness in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict our future access to the capital markets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our management team has limited experience managing a public company. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our management team has limited experience managing a publicly traded company, interacting with public company investors and securities
analysts, and complying with the increasingly complex laws pertaining to public companies. These new obligations and constituents require significant attention from our management team and could divert their attention away from the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> management of our business, which could harm our business, financial condition and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are an &#147;emerging growth company,&#148; and a &#147;smaller reporting company&#148; and we cannot be certain if the reduced disclosure
requirements applicable to emerging growth companies and smaller reporting companies will make our common stock less attractive to investors. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company,&#148; as defined in the JOBS Act, and we could remain an emerging growth company until the last day of
our fiscal year following the fifth anniversary of the closing of the IPO. For as long as we continue to be an emerging growth company, we may choose to take advantage of certain exemptions from various reporting requirements that are applicable to
other public companies that are not emerging growth companies, including, but not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not being required to engage an auditor to report on our internal controls over financial reporting pursuant to
Section&nbsp;404(b) of the Sarbanes-Oxley Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight
Board regarding mandatory audit firm rotation or a supplement to the auditor&#146;s report providing additional information about the audit and the financial statements (i.e., an auditor discussion and analysis); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not being required to submit certain executive compensation matters to stockholder advisory votes, such as <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-pay,&#148;</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;say-on-frequency,&#148;</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">&#147;say-on-golden-parachutes&#148;;</FONT></FONT> and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not being required to disclose certain executive compensation related items such as the correlation between
executive compensation and performance and comparisons of the chief executive officer&#146;s compensation to median employee compensation. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, as an emerging growth company, we are only required to provide two years of
audited financial statements and two years of selected financial data (in addition to any required interim financial statements and selected financial data) in this prospectus, and to present correspondingly reduced disclosure in
&#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations.&#148; We have elected to take advantage of this reduced disclosure obligation and certain of the other exemptions described above and we may elect to
take advantage of these and other reduced reporting requirements in the future. As a result, the information that we provide to our stockholders may be different than the information you might receive from other public reporting companies in which
you hold equity interests. In addition, the JOBS Act permits emerging growth companies to delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have elected to use this extended
transition period for complying with new or revised accounting standards until the earlier of the date we are no longer an emerging growth company or affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act.
As a result, our consolidated financial statements and the reported results of operations contained herein may not be directly comparable to those of other public companies. We cannot predict whether investors will find our common stock less
attractive because of our reliance on these exemptions. If some investors do find our common stock less attractive, there may be a less active trading market for our common stock and our stock price may be reduced or more volatile. We will remain an
emerging growth company, and will be able to take advantage of the foregoing exemptions, until the last day of our fiscal year following the fifth anniversary of the closing of this offering or such earlier time that we otherwise cease to be an
emerging growth company, which will occur upon the earliest of (i)&nbsp;the last day of the first fiscal year in which our annual gross revenues are $1.235&nbsp;billion or more; (ii)&nbsp;the date on which we have, during the previous three-year
period, issued more than $1.0&nbsp;billion in <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt securities; and (iii)&nbsp;the date that we become a &#147;large accelerated filer&#148; as defined in Rule
<FONT STYLE="white-space:nowrap">12b-2</FONT> under the Exchange Act, which will occur as of the end of any fiscal year in which (x)&nbsp;the market value of our common equity held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is
$700&nbsp;million or more as of the last business day of our most recently completed second fiscal quarter, (y)&nbsp;we have been required to file annual and quarterly reports under the Exchange Act for a period of at least 12 months and
(z)&nbsp;have filed at least one annual report pursuant to the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are also a &#147;smaller reporting company&#148; as
defined in the Exchange Act. We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain of the scaled disclosures available to smaller reporting companies and will be
able to take advantage of these scaled disclosures for so long as our common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is less than $250.0&nbsp;million measured on the last business day of our second fiscal quarter, or our
annual revenue is less than $100.0&nbsp;million during the most recently completed fiscal year and our common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> is less than $700.0&nbsp;million measured on the last business day of
our second fiscal quarter. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If equity research analysts or industry analysts do not publish research or reports about our business, or if they
adversely change their recommendations regarding our stock, our stock price and trading volume could decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The trading market
for our common stock is influenced by the research and reports that industry or equity research analysts publish about us or our business. If any of the analysts who cover us issue an adverse or misleading opinion regarding us, our business model,
financial performance, stock price or otherwise, our stock price would likely decline. In addition, if we fail to meet the expectations of our results published by these analysts, our stock price would likely decline. If one or more of these
analysts ceases coverage of our company or fails to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline and result in the loss of all or a part of
your investment in us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_3"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus, including &#147;Prospectus Summary,&#148; &#147;Risk Factors,&#148; &#147;Management&#146;s Discussion and Analysis of
Financial Condition and Results of Operations,&#148; and &#147;Business,&#148; contains forward-looking statements. We may, in some cases, use words such as &#147;anticipate,&#148; &#147;believe,&#148; &#147;could,&#148; &#147;estimate,&#148;
&#147;expect,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;potential,&#148; &#147;predict,&#148; &#147;project,&#148; &#147;should,&#148; &#147;will,&#148; &#147;would,&#148; or the negative of those terms, and similar
expressions that convey uncertainty of future events or outcomes to identify these forward- looking statements. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking statements.
Forward-looking statements in this prospectus include, but are not limited to, statements about: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing and success of new features, integrations, capabilities, and enhancements by us, or by our competitors
to their products, including the successful integration of AI; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our end customer relationships and our ability to retain and expand our end customer relationships and to achieve
design wins; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the success, cost, and timing of new products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to compensate for decreases in average selling prices of our products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to address market and end customer demands and to timely develop new or enhanced products to meet
those demands; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">anticipated trends, challenges and growth in our business and the markets in which we operate, including pricing
expectations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding our revenue, gross margin and expenses; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size and growth potential of the markets for our products, and our ability to serve those markets;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our plans to expand sales and marketing efforts through increased collaboration with our distributors, resellers,
and contracted sales representatives; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the loss of one or more significant end customers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding competition in our existing and new markets, including our expectations concerning our
mix of revenue by geography; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory developments in the United States and foreign countries, the deterioration in economic factors arising
from trade disputes and the imposition of trade sanctions or increased tariffs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our dependence on international end customers and operations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the performance of our third-party suppliers and manufacturers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our and our end customers&#146; ability to respond successfully to technological or industry developments;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cyclical nature of the semiconductor industry; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract and retain key management personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">intellectual property and related litigation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the accuracy of our estimates regarding capital requirements and needs for additional financing;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the period during which we qualify as an emerging growth company under the JOBS Act;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding our ability to obtain, maintain, protect, and enforce intellectual property protection
for our technology; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our use of the net proceeds from this offering; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential impact of macroeconomic conditions and geopolitical conflicts, including the recent conflicts
between Russia and Ukraine or Israel and Hamas, recession fears, rising interest rates, foreign exchange volatility and inflationary pressures, on our business and the businesses of our suppliers and end customers. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These forward-looking statements reflect our management&#146;s beliefs and views with respect to future events and are based on estimates and
assumptions as of the date of this prospectus and are subject to risks and uncertainties. We discuss many of these risks in greater detail under &#147;Risk Factors.&#148; Moreover, we operate in a very competitive and rapidly changing environment.
New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to
differ materially from those contained in any forward-looking statements we may make. Given these uncertainties, you should not place undue reliance on these forward-looking statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should read this prospectus and the documents that we reference in this prospectus and have filed as exhibits to the registration
statement, of which this prospectus is a part, completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of the forward- looking statements in this prospectus by these
cautionary statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You should not rely upon forward-looking statements as predictions of future events. Although we believe that the
expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance, or events and circumstances reflected in the forward-looking statements will be achieved or occur.
Moreover, neither we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this
prospectus to conform these statements to actual results or to changes in our expectations, except as required by law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_4"></A>INDUSTRY AND MARKET DATA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus includes statistical and other industry and market data that we obtained from industry publications and research, surveys, and
studies conducted by third parties, as well as estimates by our management based on such data. Certain information in this prospectus is contained in independent industry publications. These independent industry publications are provided below: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">McKinsey Report titled &#147; The Next Big Arenas of Competition,&#148; C. Bradley, M. Chui et al., October
2024. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Gartner<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, Forecast: AI Semiconductors, Worldwide,
2022-2028, 3Q24 Update, Alan Priestley et al., 1&nbsp;October 2024, Revenue basis. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">*The Market for <FONT STYLE="white-space:nowrap">AI-enabled</FONT> <FONT STYLE="white-space:nowrap">32-bit</FONT>
MCUs and Application Processors in edge applications = Sorted by Agriculture, Appliances, Automation, Head Mounted Displays, Hearable, Industrial Smart Robot, Medical/Healthcare, Personal Asset Tracker, Personal Robots, Smart Speakers, Smart
Watches, Survelliance, Test/Measurement, Transportation and Wristbands. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Gartner<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>, Forecast: Semiconductors and Electronics,
Worldwide, 2022-2028, 4Q24 Update, Rajeev Rajput et al., 16&nbsp;December 2024 Revenue basis. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">**The Edge End Market/End markets=Sorted by Head Mounted Displays, Hearable, Smart Watches, Wristbands,
Appliances, Smart Speakers, Personal Asset Tracker, Surveillance, Other Security, Automation, Medial/Healthcare, Energy Management, Transportation, Test/Measurement, Agriculture, Personal Robots and Industrial Smart Robots. Wireless
Connectivity=Wireless Connectivity (NFC; WiFi; BT; GPS; Combo), Application Processors=Discrete Application/Multimedia Processor, <FONT STYLE="white-space:nowrap">32-bit</FONT> MCU=Microcontroller <FONT STYLE="white-space:nowrap">32-bit</FONT> and
Above. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">***Personal Devices=Wearables, Medical and Healthcare = Medical / Healthcare, Smart Home/Buildings=Sorted by
Appliances, Smart Speakers, Personal Asset Tracker and Personal Robots, Industrial Edge=Sorted by Surveillance, Other Security, Automation, Energy Management, Transportation, Test/Measurement, Agriculture and Industrial Smart Robots.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="14%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">****Personal Device Market = Sorted by Wearables. Medical and Healthcare = Medical / Healthcare. Industrial Edge
Device Market = Sorted by Surveillance, Other Security, Automation, Energy Management, Transportation, Test/Measurement, Agriculture and Industrial Smart Robots. Smart Home and Smart Buildings Market = Sorted by Appliances, Smart Speakers, Personal
Asset Tracker and Personal Robots. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its
affiliates in the United States and internationally and is used herein with permission. All rights reserved. The Gartner content described herein (the Gartner Content) represents research opinion or viewpoints published, as part of a syndicated
subscription service, by Gartner, Inc. (Gartner), and is not a representation of fact. Gartner Content speaks as of its original publication date (and not as of the date of this report), and the opinions expressed in the Gartner Content are subject
to change without notice. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In presenting this information, we have made certain assumptions that we believe to be reasonable based on
such data and other similar sources and on our knowledge of, and our experience to date in, the markets in which we operate. While we believe the estimated market and industry data included in this prospectus are generally reliable, such
information, which is derived in part from management&#146;s estimates and beliefs, is inherently uncertain and imprecise, and you are cautioned not to give undue weight to such estimates. Market and industry data are subject to change and may be
limited by the availability of raw data, the voluntary nature of the data gathering process and other limitations inherent in any statistical survey of such data. In addition, projections, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
assumptions and estimates of the future performance of the markets in which we operate are necessarily subject to uncertainty and risk due to a variety of factors, including those described in
&#147;Risk Factors&#148; and &#147;Cautionary Note Regarding Forward-Looking Statements.&#148; These and other factors could cause results to differ materially from those expressed in the estimates made by third parties and by us. Accordingly, you
are cautioned not to place undue reliance on such market and industry data or any other such estimates. The content of the sources identified herein, except to the extent specifically set forth in this prospectus, does not constitute a part of this
prospectus and is not incorporated herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We estimate that we will receive net proceeds of approximately $&#8195;&#8195;&#8195;&#8195;million (or approximately
$&#8195;&#8195;&#8195;&#8195;million if the underwriters&#146; over-allotment option is exercised in full) from the sale of the shares of common stock offered by us in this offering, based on an assumed initial public offering price of
$&#8195;&#8195;&#8195;&#8195;per share (the midpoint of the price range set forth on the cover page of this prospectus), and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A $1.00 increase (decrease) in the assumed initial public offering price of $&#8195;&#8195;&#8195;&#8195;per share would increase (decrease)
the net proceeds to us from this offering by approximately $&#8195;&#8195;&#8195;&#8195;million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting
discounts and commissions and estimated offering expenses payable by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Similarly, a 1.0&nbsp;million share increase (decrease) in the
number of shares offered by us, as set forth on the cover of this prospectus, would increase (decrease) the net proceeds to us by $&#8195;&#8195;&#8195;&#8195;million, assuming no change in the assumed initial public offering price per share, and
after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The principal purposes of this
offering are to increase our capitalization and financial flexibility, establish a public market for our common stock, and facilitate future access to the public equity markets by us, our employees and our stockholders, obtain additional capital to
support our operations, and increase our visibility in the marketplace. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to use the net proceeds from this offering primarily
for general corporate purposes, including working capital, sales and marketing activities, product development, general and administrative matters, and capital expenditures, although we do not currently have any specific plans with respect to use of
proceeds for such purposes. We also may use a portion of the net proceeds to acquire complementary businesses, products, services, or technologies. However, we do not have agreements or commitments for any specific acquisitions at this time. Our
expected use of the net proceeds from this offering represents our current intentions based upon our present plans and business condition. As of the date of this prospectus, we cannot predict with certainty all of the particular uses for the net
proceeds to be received upon completion of this offering, or the amounts that we will actually spend on the uses set forth above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pending
the uses described above, we intend to invest the net proceeds from this offering in short term, interest-bearing securities such as money market accounts, certificates of deposit, commercial paper and guaranteed obligations of the U.S. government.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amounts and timing of our actual use of the net proceeds will vary depending on numerous factors, including our ability to gain
access to additional financing and the relative success and cost of our research and development programs. As a result, our management will have broad discretion in the application of the net proceeds, and investors will be relying on our judgment
regarding the application of the net proceeds of this offering. In addition, we might decide to postpone or not pursue certain development activities if the net proceeds from this offering and any other sources of cash are less than expected. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_6"></A>DIVIDEND POLICY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have never declared or paid cash dividends on our capital stock. We do not anticipate declaring or paying, in the foreseeable future, any
cash dividends on our capital stock. We currently intend to retain all available funds and any future earnings to support our operations and finance the growth and development of our business. Any future determination related to our dividend policy
will be made at the discretion of our board of directors and will depend upon, among other factors, our results of operations, financial condition, capital requirements, contractual restrictions, business prospects, and other factors our board of
directors may deem relevant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_7"></A>CAPITALIZATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth our cash and cash equivalents, and our capitalization as of December 31, 2024: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on an actual basis; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a pro forma basis, giving effect to the (i)&nbsp;automatic conversion of all 347,983,712 shares of our
outstanding redeemable convertible preferred stock into an equivalent number of shares of our common stock, which will occur upon the closing of this offering, and the related reclassification of the carrying value of our redeemable convertible
preferred stock to permanent equity upon the closing of this offering, and (ii)&nbsp;filing and effectiveness of our amended and restated certificate of incorporation upon the closing of this offering; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a pro forma as adjusted basis, giving effect to the pro forma adjustments discussed above, and giving further
effect to the sale of shares of our common stock by us in this offering at an assumed initial public offering price of $&#8195;&#8195;&#8195;&#8195;per share (the midpoint of the range set forth on the cover of this prospectus), after deducting
underwriting discounts and commissions and estimated offering expenses payable by us. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The pro forma and pro forma as
adjusted information below is illustrative only, and our capitalization following the completion of this offering will be adjusted based on the actual initial public offering price and other terms of this offering determined at pricing. You should
read this table together with &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; and our consolidated financial statements and the related notes appearing elsewhere in this prospectus. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December&nbsp;31, 2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma<BR>As<BR>Adjusted<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in&nbsp;thousands,&nbsp;except&nbsp;share&nbsp;and&nbsp;per&nbsp;share&nbsp;data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series Seed redeemable convertible preferred stock, $0.000001 par value; 5,045,368 shares
authorized, 5,045,368 shares issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A redeemable convertible preferred stock, $0.000001 par value; 8,276,659 shares authorized,
8,255,614 shares issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B redeemable convertible preferred stock, $0.000001 par value; 18,990,249 shares
authorized, 18,894,315 shares issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C redeemable convertible preferred stock, $0.000001 par value; 43,181,403 shares
authorized, 42,890,840 shares issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series D redeemable convertible preferred stock, $0.000001 par value; 39,656,811 shares
authorized, 39,656,811 shares issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>As of December&nbsp;31, 2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma As<BR>Adjusted<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in&nbsp;thousands,&nbsp;except&nbsp;share&nbsp;and&nbsp;per&nbsp;share&nbsp;data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series E redeemable convertible preferred stock, $0.000001 par value; 29,019,153 shares
authorized, 29,019,153 shares issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series F redeemable convertible preferred stock, $0.000001 par value; 74,840,147 shares
authorized, 74,840,147 shares issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">F-1</FONT> redeemable convertible preferred stock,
$0.000001 par value; 23,906,231 shares authorized, 23,664,027 shares issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series G redeemable convertible preferred stock, $0.000001 par value; 105,067,691 shares
authorized, 99,229,883 shares issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; (deficit) equity:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock, $0.000001 par value: 347,983,712 shares authorized and 341,496,158 issued or
outstanding, actual; &#8195;&#8195;&#8195;&#8195;shares authorized, pro forma and pro forma as adjusted; no shares issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.000001 par value per share; 500,000,000 shares authorized and 12,173,766 shares
issued and outstanding, actual; &#8195;&#8195;&#8195;&#8195;shares authorized, pro forma and pro forma as adjusted; &#8195;&#8195;&#8195;&#8195;shares issued and outstanding, pro forma; &#8195;&#8195;&#8195;&#8195;shares issued and outstanding, pro
forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; (deficit) equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each $1.00 increase (decrease) in the assumed initial public offering price of
$&#8195;&#8195;&#8195;&#8195;&#8195;per share (the midpoint of the price range set forth on the cover page of this prospectus) would increase (decrease) each of the amount of cash and cash equivalents, additional
<FONT STYLE="white-space:nowrap">paid-in</FONT> capital and total capitalization by approximately $&#8195;&#8195;&#8195;&#8195;&#8195;million, assuming the number of shares offered by us, as set forth on the cover page of this prospectus, remains
the same and after deducting underwriting discounts and commissions and estimated offering costs payable by us. Each 1.0&nbsp;million increase (decrease) in the number of shares offered by us as set forth on the cover page of this prospectus, would
increase (decrease) each of our cash and cash equivalents, additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital, and total stockholders&#146; (deficit) equity by approximately $&#8195;&#8195;&#8195;&#8195;&#8195;million, assuming no
change in the assumed initial public offering price per share, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, the number of shares of our common stock to be outstanding after this offering is based
on&#8195;&#8195;&#8195;&#8195; shares of common stock outstanding as of December&nbsp;31, 2024 and the automatic conversion of all 347,983,712 shares of our outstanding redeemable convertible preferred stock into &#8195;&#8195;&#8195;&#8195; number
of shares of our common stock upon the closing of this offering, and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">up to &#8195;&#8195;&#8195;&#8195;shares of our common stock issuable upon the vesting of RSUs under our 2020
Plan, outstanding as of December 31, 2024; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#8195;&#8195;shares of our common stock issuable upon the exercise of outstanding stock options under our 2010
Plan and the 2020 Plan as of December&nbsp;31, 2024, with a weighted-average exercise price of $&#8195;&#8195;&#8195;&#8195;per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#8195;&#8195;shares of our common stock reserved for future issuance under the 2025 Plan, as well as any
automatic increases in the number of shares of common stock reserved for future issuance under the 2025 Plan; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#8195;&#8195;shares of our common stock reserved for future issuance under the ESPP, as well as any automatic
increases in the number of shares of common stock reserved for future issuance under the ESPP. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_8"></A>DILUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you invest in our common stock in this offering, your ownership interest will be immediately diluted to the extent of the difference
between the initial public offering price per share of our common stock and the pro forma as adjusted net tangible book value per share of our common stock after this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our historical net tangible book value (deficit) as of December&nbsp;31, 2024 was approximately $&#8195;&#8195;&#8195;&#8195;million, or
$&#8195;&#8195;&#8195;&#8195; per share of our common stock. Our historical net tangible book value (deficit) is the amount of our total tangible assets less our total liabilities. Historical net tangible book value (deficit) per share is our
historical net tangible book value (deficit) divided by the number of shares of common stock outstanding as of December&nbsp;31, 2024. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our pro forma net tangible book value as of December&nbsp;31, 2024 was $&#8195;&#8195;&#8195;&#8195;million, or
$&#8195;&#8195;&#8195;&#8195;per share of common stock. Our pro forma net tangible book value per share represents the amount of our total tangible assets reduced by the amount of our total liabilities and divided by the total number of common
shares outstanding as of December&nbsp;31, 2024, assuming the automatic conversion of all 347,983,712 of our outstanding convertible preferred shares into an aggregate of &#8195;&#8195;&#8195;&#8195;common shares, which conversion will occur
immediately prior to the completion of this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After giving effect to the sale by us of&#8195;&#8195;&#8195;&#8195; shares of
common stock in this offering at the assumed initial public offering price of $&#8195;&#8195;&#8195;&#8195;per share, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us, our pro forma as adjusted
net tangible book value as of December&nbsp;31, 2024 would have been $&#8195;&#8195;&#8195;&#8195;million, or $&#8195;&#8195;&#8195;&#8195;per share. This amount represents an immediate increase in pro forma as adjusted net tangible book value of
$&#8195;&#8195;&#8195;&#8195;per share to our existing stockholders and an immediate dilution in pro forma as adjusted net tangible book value of $&#8195;&#8195;&#8195;&#8195;per share to investors purchasing common stock in this offering. We
determine dilution by subtracting the pro forma as adjusted net tangible book value per share after this offering from the amount of cash paid by an investor for a share of common stock in this offering. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The following table illustrates this dilution on a per share basis: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed initial public offering price per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Historical net tangible book value (deficit) per share as of December&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma increase in net tangible book value (deficit) per share as of December&nbsp;31, 2024
before giving effect to this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net tangible book value per share as of December&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in pro forma net tangible book value per share attributable to investors participating in
this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma as adjusted net tangible book value per share as of December&nbsp;31, 2024 after giving
effect to this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dilution per share to investors participating in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A $1.00 increase (decrease) in the assumed initial public offering price of $&#8195;&#8195;&#8195;&#8195; per
share (the midpoint of the price range set forth on the cover page of this prospectus) would increase (decrease) the pro forma as adjusted net tangible book value per share after this offering by approximately $&#8195;&#8195;&#8195;&#8195;per share
and the dilution in pro forma per share to investors participating in this offering by approximately $&#8195;&#8195;&#8195;&#8195;per share, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains
the same and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Similarly, a
1.0&nbsp;million share increase (decrease) in the number of shares offered by us, as set forth on the cover of this prospectus, would increase (decrease) the pro forma as adjusted net tangible book value per share after this offering by
approximately $&#8195;&#8195;&#8195;&#8195;and decrease (increase) the dilution in pro forma per share to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
investors participating in this offering by approximately $&#8195;&#8195;&#8195;&#8195;, assuming the assumed initial public offering price of $&#8195;&#8195;&#8195;&#8195;per share (the midpoint
of the price range set forth on the cover of this prospectus) remains the same, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the underwriters exercise their over-allotment option in full, the pro forma as adjusted net tangible book value will increase to
$&#8195;&#8195;&#8195;&#8195;per share, representing an immediate increase in pro forma as adjusted net tangible book value to our existing stockholders of $&#8195;&#8195;&#8195;&#8195;per share and an immediate decrease of dilution of
$&#8195;&#8195;&#8195;&#8195;per share to new investors participating in this offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes, on a pro forma as
adjusted basis as of December&nbsp;31, 2024, the number of shares purchased or to be purchased from us, the total consideration paid or to be paid to us, and the average price per share paid or to be paid to us by our existing stockholders, and
investors participating in this offering at an assumed initial public offering price of $&#8195;&#8195;&#8195;&#8195;per share (the midpoint of the price range set forth on the cover of this prospectus), before deducting underwriting discounts and
commissions and estimated offering expenses payable by us. As the table below shows, investors participating in this offering will pay an average price per share substantially higher than our existing stockholders paid. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total&nbsp;Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Average<BR>Price<BR>Per&nbsp;Share</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Existing stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investors participating in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The table above assumes no exercise of the underwriters&#146; over-allotment option to purchase up to an
additional&#8195;&#8195;&#8195;&#8195;shares in this offering. If the underwriters&#146; over-allotment option is exercised in full, the number of shares of our common stock held by the existing stockholder would be reduced to &#8195;% of the total
number of shares of our common stock outstanding after this offering, and the number of shares of common stock held by new investors participating in the offering would be increased to &#8195;% of the total number of shares outstanding after this
offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A $1.00 increase (decrease) in the assumed initial public offering price of $&#8195;&#8195;&#8195;&#8195;per share (the
midpoint of the price range set forth on the cover page of this prospectus) would increase (decrease) the total consideration paid by investors participating in this offering, total consideration paid by all stockholders and the average price per
share paid by all stockholders by approximately $&#8195;&#8195;&#8195;&#8195;million, $&#8195;&#8195;&#8195;&#8195;million and $&#8195;&#8195;&#8195;&#8195;, respectively, assuming that the number of shares offered by us, as set forth on the cover
page of this prospectus, remains the same and before deducting underwriting discounts and commissions and estimated offering expenses payable by us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Similarly, a 1.0&nbsp;million share increase (decrease) in the number of shares offered by us, as set forth on the cover of this prospectus,
would increase (decrease) the total consideration paid by investors participating in this offering, total consideration paid by all stockholders and the average price per share paid by all stockholders by approximately
$&#8195;&#8195;&#8195;&#8195;million, $&#8195;&#8195;&#8195;&#8195;million and $&#8195;&#8195;&#8195;&#8195;, respectively, assuming the assumed initial public offering price of $ &#8195;&#8195;&#8195;&#8195;per share (the midpoint of the price
range set forth on the cover of this prospectus) remains the same, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing discussion and table are based on&#8195;&#8195;&#8195;&#8195;shares of common stock outstanding as of December&nbsp;31, 2024, and
excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">up to &#8195;&#8195;&#8195;&#8195;shares of our common stock issuable upon the vesting of RSUs under our 2020
Plan, outstanding as of December 31, 2024; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#8195;&#8195;&#8195;&#8195;shares of our common stock issuable upon the exercise of outstanding stock options
under our 2010 Plan and the 2020 Plan as of&#8195;&#8195;&#8195;&#8195;, &#8195;&#8195;&#8195;&#8195;with a weighted-average exercise price of $&#8195;&#8195;&#8195;&#8195;per share; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#8195;&#8195;&#8195;&#8195;shares of our common stock reserved for future issuance under the 2025 Plan, as well
as any automatic increases in the number of shares of common stock reserved for future issuance under the 2025 Plan; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#8195;&#8195;&#8195;&#8195;shares of our common stock reserved for future issuance under the ESPP, as well as
any automatic increases in the number of shares of common stock reserved for future issuance under the ESPP. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may
choose to raise additional capital through the sale of equity or convertible debt securities due to market conditions or strategic considerations even if we believe we have sufficient funds for our current or future operating plans. To the extent we
issue additional shares of common stock or other equity or convertible debt securities in the future, there will be further dilution to investors participating in this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_9"></A>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>The following discussion and analysis is intended to highlight and supplement data and information
presented elsewhere in this prospectus, including our historical consolidated financial statements and related notes, and should be read in conjunction with the information presented in our historical financial statements and related notes thereto
included elsewhere in this prospectus. This discussion and analysis contains forward- looking statements based upon current beliefs, plans and expectations that involve risks, uncertainties and assumptions, such as statements regarding our plans,
objectives, expectations, intentions and projections. Our actual results and the timing of selected events could differ materially from those anticipated in these forward- looking statements as a result of several factors, including those set forth
under &#147;Risk Factors&#148; and elsewhere in this prospectus. You should carefully read the &#147;Risk Factors&#148; section of this prospectus to gain an understanding of the important factors that could cause actual results to differ materially
from forward-looking statements. Please also see the section titled &#147;Cautionary Note Regarding Forward-Looking Statements.&#148; </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a pioneer and leading provider of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">ultra-low-power</FONT></FONT> semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI compute, especially at the edge. </P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our customers rely on Ambiq to deliver AI compute closer to end users (edge environments) where power consumption challenges are the most
severe. We seek to drive growth in AI adoption at the edge in the personal devices, medical/healthcare, industrial edge, and smart home and building markets and continue to set new standards in edge AI performance and power efficiency. Over time, we
expect to integrate our <FONT STYLE="white-space:nowrap">ultra-low</FONT> power technology into additional chip products that benefit from greater power efficiency, including high-performance compute applications such as AI data centers and
automotive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, a majority of AI compute has been deployed in data centers due to its large physical scale and the need for wall
plug energy, as AI compute requires enormous and steady energy resources. At the edge, however, power limitations have been especially acute due to small device size and limited battery life. We believe this greatly constrains the potential of AI to
improve our daily <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">on-the-go</FONT></FONT> lives. Enabling AI at the edge, where the action takes place, with vastly improved power efficiency will allow faster real-time
decision-making due to data proximity, greater data privacy, higher energy efficiency from reduced network usage, and less dependence on constant costly connections to the cloud. We believe new AI use cases will only be possible if edge devices are
much more power efficient. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our proprietary <FONT STYLE="white-space:nowrap">Sub-threshold</FONT> Power Optimized Technology (SPOT<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP>) platform is designed to fundamentally and cost-effectively reduce power consumption of battery- and wireline-powered devices alike. Depending on the application, devices incorporating SPOT
demonstrate a two to five times reduction in power consumption compared to conventional integrated circuit designs. SPOT is a ground-breaking approach at the chip design level that incorporates <FONT STYLE="white-space:nowrap">sub-</FONT> and
near-threshold hardware, without using expensive manufacturing processes. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We provide a full stack solution encompassing tightly
integrated hardware and software. Our solutions include a diverse family of <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">systems-on-chip</FONT></FONT> (SoCs) and the software required to enable
<FONT STYLE="white-space:nowrap">on-chip</FONT> AI processing, general compute, sensing, security, storage, wireless connectivity, and advanced graphics. Our SoC solutions deliver compute at a very small fraction of the power consumed by our
competitors&#146; products. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our <FONT STYLE="white-space:nowrap">ultra-low</FONT> power SoCs serve a wide range of markets requiring <FONT
STYLE="white-space:nowrap">on-device</FONT> and real-time AI, including smartwatches and fitness trackers, augmented and virtual reality (AR/VR) glasses, smart rings, digital health monitors, security systems and access control, livestock tracking,
crop monitoring, and factory automation. These devices increasingly offer <FONT STYLE="white-space:nowrap">on-chip</FONT> <FONT STYLE="white-space:nowrap">AI-powered</FONT> features such as speech recognition, image and video processing, and
sensing, further straining power consumption, which our solutions are positioned to address. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As global demand for our SoC solutions accelerates, our sales and marketing efforts are
increasingly focused on our end customers in target geographies such as the United States, Europe and Asia <FONT STYLE="white-space:nowrap">(ex-Mainland</FONT> China). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2024, we had 189 full-time employees. For the years ended December&nbsp;31, 2024 and 2023, we recognized revenue of
$&#8195;&#8195;&#8195;&#8195;million and $65.5&nbsp;million, respectively and a net loss of $&#8195;million and $50.3&nbsp;million, respectively. As of December&nbsp;31, 2024, we had an accumulated deficit of $&#8195;million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Key Factors Affecting Our Business </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
believe that the growth of our business and our future success are dependent upon many factors including those described above under &#147;Risk Factors&#148; and elsewhere in this prospectus and the following key factors. While these factors present
significant opportunities for us, they also pose challenges that we must successfully address in order to sustain the growth of our business and enhance our results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Geographical Concentration </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As
we focus on creating meaningful benefits to our end customers for their edge AI capabilities, we are shifting our geographic concentration. Historically, our sales were significantly concentrated with end customers in Mainland China. Given
geopolitical concerns, subsidized competitors creating a price sensitive environment in Mainland China, and our desire to service new markets in medical/healthcare, industrial edge, and smart home and buildings, we continue to prioritize our
management and sales efforts toward other meaningful geographies. As a result, we expect to continue to experience a substantial shift over the next year in our underlying geographical concentration. For example, in 2023 66% of our total sales were
to end customers in Mainland China, as compared to&#8195;&#8195;&#8195;&#8195;% in 2024. We currently anticipate this trend will continue in 2025 and beyond. We believe this shift will result in a significant margin improvement opportunity given the
benefits available in other markets outside of Mainland China. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>End Customer Concentration </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our operating results for the foreseeable future will continue to depend to a significant extent on sales attributable to
certain end customers. Our largest end customer historically has accounted for a large portion of our sales, representing approximately&#8195;&#8195;&#8195;&#8195;% and 30% of our sales for the years ended December&nbsp;31, 2024 and 2023,
respectively. In addition, our top ten end customers for the years ended December&nbsp;31, 2024 and 2023 accounted for&#8195;&#8195;&#8195;&#8195;% and 94% of our total sales, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have demonstrated strong end customer growth with technology leaders validating our technology platform and our robust product offerings.
We work with our end customers at the front end of their design cycles, helping them develop next-generation products. The collaborative nature of these relationships provides us with enhanced visibility into our end customers&#146; future
requirements, allowing us to expand our business and increase our content in future products. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Product Development and Adoption </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We develop and sell leading-edge ultra-low power SoCs, tightly bundled with software and various other solutions that combine 32-bit
microcontrollers (MCUs) with wireless connectivity and additional circuitry, such as graphics processing units, serial interfaces, and analog-to-digital interfaces. Our success is dependent on end customers adopting our new technology and preferring
our products over competing offerings or technologies. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our current end customer products are characterized by rapidly changing
technologies, industry standards and technological obsolescence. We work closely with our end customers to understand their product roadmaps </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and strategies to forecast their future needs, which significantly influence our technology roadmap and development priorities. Our revenue performance is dependent on our ability to continually
develop and introduce new products to meet the changing technology and performance requirements of the market and our end customers. Maintaining our competitive advantage is critical to our financial performance. We continue to expect to make
significant investments in research and development, and our research and development expenses in a particular period may be significantly impacted by a specific product launch or engineering initiatives that we have undertaken to maintain our
competitiveness or expand our product portfolio. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Unit Price and Volume and Gross Margins </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our revenue is driven by the number of units and average selling price (ASP) of our products, which can fluctuate from period to period based
on the timing of our product lifecycle. The ASPs of our products vary significantly. While the ASP of any individual product generally decreases over time, our average ASPs have historically increased as we continue to introduce new <FONT
STYLE="white-space:nowrap">higher-end</FONT> products with higher ASPs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our product gross margins may fluctuate from period to period due
to changes in our average selling price per unit due to new product launches and existing product mix with our end customer base. Our gross margins are also impacted by any changes to our manufacturing yield and wafer assembly and testing costs. We
routinely experience increased prices for silicon wafers, packaging, printed circuit boards, and testing costs, which are used in our manufacturing process. As a result, our gross margins are impacted by our ability to offset any increases in our
cost structure through increased prices, productivity improvements, or other means. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cyclical Nature of the Semiconductor Industry </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The semiconductor industry is highly cyclical and is characterized by constant and rapid technological change, rapid product obsolescence,
price erosion, evolving standards, short product lifecycles and wide fluctuations in product supply and demand. Historically, the industry has experienced significant downturns during global recessions. These downturns have been characterized by
diminished product demand, production overcapacity, high inventory levels and accelerated erosion of average selling prices. Furthermore, any significant upturn in the semiconductor industry could result in increased competition for access to
third-party wafer fabrication and assembly capacity. We are dependent on the availability of this capacity to manufacture and assemble our products and we can provide no assurance that adequate capacity will be available to us in the future. Any
downturns or upturns in the semiconductor industry could harm our business, financial condition and results of operations. Our revenue has historically been subject to some seasonal variation. However, with rapid changes in technology development
and our markets, the seasonal factors that affect our business may change from time to time. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Economic Volatility </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our sales and gross margin depend significantly on general economic conditions and the demand for products in the markets where our end
customers compete. Weaknesses in the global economy and financial markets, including the impact of the ongoing global conflicts, such as the Russia-Ukraine and Israel-Hamas conflicts, may in the future lead to lower demand for our end
customers&#146; products that incorporate our products. Volatile and/or uncertain economic conditions, including increased inflation rates, can adversely impact sales and gross margin and make it difficult for us to accurately forecast and plan our
future business activities. In addition, any disruption in the credit markets, could impede our access to capital, which could be further adversely affected if we are unable to obtain or maintain favorable credit ratings. If we have limited access
to additional financing sources, we may be required to defer capital expenditures or seek other sources of liquidity, which may not be available to us on acceptable terms or at all. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Components of our Operating Results </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Sales </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a
products-focused business. Our net sales are recognized when control of our products is transferred to our customers for consideration that we expect to receive for our products, net of returns and allowances. Our net sales are driven by the average
selling price of our products, product volumes, and mix of products sold. Our end customers represent the actual user of our product, whether sold directly to or through a distributor. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cost of Sales </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our cost of sales
includes the cost of purchasing finished wafers manufactured by independent foundries and costs associated with the assembly, testing, shipping and handling of products along with allocated costs for salary, stock compensation and related benefits
for personnel involved in the manufacturing of our products. Cost of sales also includes depreciation for equipment and photomasks supporting the manufacturing process, write downs of inventory, IP royalties, licensing fees, logistics, quality
assurance, warranty, and other costs incurred by us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Gross Profit </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gross profit is calculated as net sales less cost of sales. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Operating Expenses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our operating
expenses are categorized as research and development costs or selling, general, and administrative expenses and classified based on the descriptions below: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Research and Development Costs </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development costs are expensed as incurred. Research and development costs consist primarily of compensation-related expenses,
including salaries, benefits, and stock-based compensation expense for employees that support our research and development organization, external consulting and services costs, licensing fees, equipment tooling and allocations of other costs we
incur. Assets purchased to support our ongoing research and development activities are capitalized when related to products that have achieved technological feasibility or have an alternative future use and are amortized over their estimated useful
lives. We expect research and development costs to increase as a public company as we intend to reinvest our proceeds into our future product development and the expansion of our current product offerings. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Selling, General, and Administrative Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our selling, general, and administrative expenses consist of compensation-related expenses, including salaries, benefits, and stock-based
compensation expense for employees that support our sales, finance, human resources, marketing, and other corporate functional support. Selling, general, and administrative also include insurance costs, rent and lease expenses, travel and
entertainment, and general corporate expenses, such as accounting, audit, legal, regulatory, and tax compliance. We expect selling, general, and administrative expenses to increase in absolute dollars as we incur increased accounting, legal, and
professional fees and other costs associated with being a public company. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Income (Expense), net </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other income (expense), net reflects interest income generated from our cash on hand being invested in short-term money market account
activity. Our other expenses are principally the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> valuation of our warrant liabilities and the impact of foreign exchange gains and losses on our
results.&#8195; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Provision for Income Taxes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our provision for income taxes includes federal, foreign and state taxes. Income taxes are accounted for using the asset and liability method.
</P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Results of Operations </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following table summarizes our results of our operations for each of the past two years: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46,096</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Gross profit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general, and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss from operations</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(51,322</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(50,302</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(50,332</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the results of our operations for each of the past two years as a percentage of
net sales. All percentage amounts were calculated using the underlying data: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in<BR>thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">67</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss from operations</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Loss before income taxes</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(77</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(77</TD>
<TD NOWRAP VALIGN="bottom">)%&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Comparison of Year Ended December&nbsp;31, 2024 and 2023 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Sales </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%&nbsp;Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands, except percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Net sales increased $&#8195;&#8195;&#8195;&#8195;million,
or&#8195;&#8195;&#8195;&#8195;%, to $&#8195;&#8195;&#8195;&#8195;million in 2024 from $65.5&nbsp;million in 2023. Sales to our end customers outside of Mainland China for 2024 and 2023 were $&#8195;&#8195;&#8195;&#8195;million and
$22.4&nbsp;million, respectively. The increase in 2024 was driven by the return of our customers purchasing patterns subsequent to the recent semiconductor downturn. Sales to our end customers in Mainland China for 2024 and 2023 were
$&#8195;&#8195;&#8195;&#8195;million and $43.1&nbsp;million, respectively. The decrease was primarily driven by the strategic prioritization of non-China opportunities and increased pricing pressures that resulted in fewer customer product launches.
In addition, our 2024 top ten end customer sales increased by&#8195;&#8195;&#8195;&#8195;% to $&#8195;&#8195;&#8195;&#8195;million, from $61.9&nbsp;million in 2023. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Gross Profit and Gross Margin </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%&nbsp;Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands, except percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross margin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Gross profit increased $&#8195;&#8195;&#8195;&#8195;million, or&#8195;&#8195;&#8195;&#8195;%,
$&#8195;&#8195;&#8195;&#8195;million in 2024 from $19.4&nbsp;million in 2023, representing an overall gross margin increase of&#8195;&#8195;&#8195;&#8195;basis points, from 29.7% in 2023 to&#8195;&#8195;&#8195;&#8195;% in 2024. Gross profit from our
end customers outside of Mainland China for 2024 and 2023 were $&#8195;&#8195;&#8195;&#8195;million and $10.0&nbsp;million, respectively, driven by the return of our customers purchasing patterns subsequent to the recent semiconductor downturn.
Gross profit from our end customers in Mainland China for 2024 and 2023 were $&#8195;&#8195;&#8195;&#8195;million and $9.4&nbsp;million, respectively.&nbsp;The decrease was driven by pricing pressures from local competitors which led to two products
being sold at a discount in 2024.</P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Expenses </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%&nbsp;Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands, except percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Research and development expenses decreased $&#8195;&#8195;&#8195;&#8195;million,
or&#8195;&#8195;&#8195;&#8195;%, to $&#8195;&#8195;&#8195;&#8195;million in 2024 from $44.0&nbsp;million in 2023. The overall decrease in research and development was primarily attributable to a reduction in compensation-related expenses driven by a
net headcount decrease of 14, driven by the geographical realignment of certain engineering functions, which began in the third quarter of 2023. These decreases were partially offset by an increase of $&#8195;&#8195;&#8195;&#8195;million due to
increased product development spending related to our Apollo5 product design and launch. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Selling, General and Administrative Expenses </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%&nbsp;Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands, except percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Selling, general and administrative expenses increased $&#8195;&#8195;&#8195;&#8195;million,
or&#8195;&#8195;&#8195;&#8195;%, to $&#8195;&#8195;&#8195;&#8195;million in 2024 from $26.7&nbsp;million in 2023. The increase was primarily attributable to a warrant issuance to an investor of $1.9&nbsp;million and increased stock-based
compensation expenses, partially offset by a reduction in other compensation-related expenses driven by a net headcount reduction of nine during 2024 as a result of cost control initiatives and attrition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Income (Expense), Net </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>%&nbsp;Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands, except percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Other income (expense) decreased $&#8195;&#8195;&#8195;&#8195;million, or&#8195;&#8195;&#8195;&#8195;%, to
$&#8195;&#8195;&#8195;&#8195;million in 2024 from $1.0&nbsp;million in 2023. The decrease was primarily related to the mark to market of our warrant liability partially offset by higher interest income related to our cash raised from the Series G
convertible preferred stock financing held in interest bearing accounts in 2024. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Provision for Income Taxes </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We recorded minimal income tax expense in 2024 on a <FONT STYLE="white-space:nowrap">pre-tax</FONT> loss of
$&#8195;&#8195;&#8195;&#8195;million, yielding an effective tax rate of&#8195;&#8195;&#8195;&#8195;%. Our effective tax rate was lower than the U.S. statutory rate of 21.0%, primarily due to the change in valuation allowance. We recorded income tax
expense in 2023 on a <FONT STYLE="white-space:nowrap">pre-tax</FONT> loss of $50.3&nbsp;million, yielding an effective tax rate of (0.06)%, primarily due to the change in valuation allowance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We established a valuation allowance equal to the net deferred tax assets due to uncertainties regarding the realization of the deferred tax
assets based on our lack of earnings history. The valuation allowance was approximately $&#8195;&#8195;&#8195;&#8195;million and $55.4&nbsp;million for the years ended December&nbsp;31, 2024 and 2023, respectively, primarily due to net losses from
operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2024 and 2023, we had NOL carryforwards of approximately $&#8195;&#8195;&#8195;&#8195;million and
$139.4&nbsp;million, respectively, for federal tax reporting purposes. NOL carryforwards of $&#8195;&#8195;&#8195;&#8195;million will expire in fiscal years 2032 through 2037 if not utilized prior to that time. As of December&nbsp;31, 2024 and 2023,
we had $&#8195;&#8195;&#8195;&#8195;million and $13.4&nbsp;million, of foreign NOL carryforwards, respectively. The foreign NOL carryforwards will begin to expire after 2026 if not utilized. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Utilization of NOL carryforwards may be subject to substantial annual limitation due to the &#147;change in ownership&#148; provisions of the
Code. The annual limitation may result in the expiration of NOL carryforwards and other tax attributes before utilization. The NOL carryforwards are subject to Internal Revenue Service adjustments until the statute closes on the year the NOL
carryforward is utilized. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity and Capital Resources </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since inception, we had negative cash flows and losses from operations. We have funded operations primarily through equity financing and cash
from operations. We anticipate incurring losses and negative cash flows from operations until such time, if ever, that we can generate significant sales of our products currently in development and are highly dependent on our ability to find
additional sources of funding in the form of debt and equity financing. As of December&nbsp;31, 2024, we had $&#8195;&#8195;&#8195;&#8195;million in cash<B>. </B>Our principal use of cash is to fund our operations, invest in research and development
to support our growth and other general corporate needs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our cash on hand and anticipated cash from operations, together
with proceeds from this offering, will be sufficient to finance our operations for at least the next twelve months from the date of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our future capital requirements will depend on many factors including our growth rate, the timing and extent of our selling, general and
administrative and research and development expenditures, and the continuing market acceptance of our products. Additionally, we anticipate a significant increase in accounting, legal, and professional fees and other costs associated with being a
public company. If our current financial resources are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
not sufficient to satisfy our liquidity requirements, we may be required to seek additional financing. If we raise additional funds by issuing equity securities, our stockholders will experience
dilution. Debt financing, if available, may contain covenants that significantly restrict our operations or our ability to obtain additional debt financing in the future. In the event that we need to borrow funds or issue additional equity, we
cannot assure you that any such additional financing will be available on terms acceptable to us, if at all. If we are unable to raise additional capital when we need it, our business, results of operations, and financial condition would be
adversely affected. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash Flows from Operating, Investing and Financing Activities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Changes in the net cash provided by and (used in) our operating, investing, and financing activities for the years ended December&nbsp;31, 2024
and December&nbsp;31, 2023 are set forth in the following table: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(26,958</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,021</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Operating Activities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2024, cash flow used in operations was $&#8195;&#8195;&#8195;&#8195;million. Operating cash flow during 2024 was related to the cash
components of our net loss and $&#8195;&#8195;&#8195;&#8195;of million changes in working capital, driven primarily by a net use of cash of $&#8195;&#8195;&#8195;&#8195;million to build sufficient inventory levels to meet end customer demand and
$&#8195;&#8195;&#8195;&#8195;million resulting from the timing of our sales to customers and payments to our vendors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2023, cash flow
used in operations was $26.9&nbsp;million. Operating cash flow use during 2023 was related to the cash components of our net loss and by $12.9 of million favorable changes in working capital, driven primarily by $15.2&nbsp;million of lower inventory
purchases. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Investing Activities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2024, we used $&#8195;million in cash for investing activities, which related to $&#8195;&#8195;&#8195;&#8195;million of technology
investments in intangible assets and $&#8195;&#8195;&#8195;&#8195;million in capital expenditures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2023, we used approximately
$3.0&nbsp;million in cash for investing activities, which related to $2.6&nbsp;million of technology investments in intangible assets and $0.4&nbsp;million in capital expenditures. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Financing Activities </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
2024, we generated $&#8195;&#8195;&#8195;&#8195;million related to financing activities, driven primarily by $&#8195;&#8195;&#8195;&#8195;million from our Series G preferred stock issuance and proceeds from the exercise of stock options and warrants
of $&#8195;&#8195;&#8195;&#8195;million and $&#8195;&#8195;&#8195;&#8195;million, respectively. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2023, we generated
$31.8&nbsp;million in financing activities, driven primarily by $31.3&nbsp;million from our Series G preferred stock issuance and proceeds from the exercise of stock options and warrants of $0.3&nbsp;million and $0.2&nbsp;million, respectively. </P>
 <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Financial Measures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We use <FONT STYLE="white-space:nowrap">non-GAAP</FONT> net loss and <FONT STYLE="white-space:nowrap">non-GAAP</FONT> gross profit, both <FONT
STYLE="white-space:nowrap">non-GAAP</FONT> financial measures, to help us make strategic decisions, establish budgets and operational goals for managing our business, analyze our financial results, and evaluate our performance. We define <FONT
STYLE="white-space:nowrap">non-GAAP</FONT> net loss as our net loss adjusted to exclude </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
expenses not directly attributable to the performance of our operations, such as income taxes, depreciation and amortization, stock-based compensation, severance costs, transaction costs and
warrant valuation. We define <FONT STYLE="white-space:nowrap">non-GAAP</FONT> gross profit as our gross profit adjusted to exclude expenses not directly attributable to gross profit, such as depreciation and amortization and stock-based
compensation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We present the <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure
<FONT STYLE="white-space:nowrap">non-GAAP</FONT> net loss and <FONT STYLE="white-space:nowrap">non-GAAP</FONT> gross profit in this prospectus because we believe this <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure provides an
additional tool for investors to use in comparing our core business and results of operations over multiple periods with other companies in our industry, many of which present similar <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial
measures to investors. However, our presentation of <FONT STYLE="white-space:nowrap">non-GAAP</FONT> net loss and <FONT STYLE="white-space:nowrap">non-GAAP</FONT> gross profit may not be comparable to similarly titled measures reported by other
companies due to differences in the way that these measures are calculated. <FONT STYLE="white-space:nowrap">Non-GAAP</FONT> net loss and <FONT STYLE="white-space:nowrap">non-GAAP</FONT> gross profit have limitations, and should not be considered as
the sole measures of our performance and should not be considered in isolation from, or as a substitute for, net loss and gross profit calculated in accordance with GAAP. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some of these limitations are that <FONT STYLE="white-space:nowrap">non-GAAP</FONT> net loss and
<FONT STYLE="white-space:nowrap">non-GAAP</FONT> gross profit: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">do not reflect incomes taxes, which are necessary costs incurred in connection with our operations and reduce
cash available to us </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exclude depreciation and amortization, and although these are <FONT STYLE="white-space:nowrap">non-cash</FONT>
expenses, the assets being depreciated may have to be replaced in the future, increasing our cash requirements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">do not reflect stock-based compensation expenses, which represent a significant cost of attracting and retaining
qualified employees, and excluding them may underestimate the true economic cost of our workforce; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">do not reflect severance costs, which represent costs associated with reductions in force; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exclude IPO and related transaction costs, which represent non-recurring professional fees for advisory, legal,
accounting, valuation and other professional or consulting services incurred related to this offering and; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exclude warrant valuation costs, which represent the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">mark-to-market</FONT></FONT> valuation of liability-classified warrants. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Because of
these limitations, we consider, and you should consider, <FONT STYLE="white-space:nowrap">non-GAAP</FONT> net loss and <FONT STYLE="white-space:nowrap">non-GAAP</FONT> gross profit alongside other financial performance measures, including net loss
and gross profit and our other GAAP results. A reconciliation of our <FONT STYLE="white-space:nowrap">non-GAAP</FONT> net loss to net loss and <FONT STYLE="white-space:nowrap">non-GAAP</FONT> gross profit to gross profit, the most directly
comparable financial measures stated in accordance with GAAP, are provided below. Investors are encouraged to review the related GAAP financial measures and the reconciliation of the <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measure
to their most directly comparable GAAP financial measure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following tables reconcile the most directly comparable GAAP financial
measure to each of these <FONT STYLE="white-space:nowrap">non-GAAP</FONT> financial measures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Net Loss: </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Net loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(50,332</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Add:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,623</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Severance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">481</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">IPO and other transaction costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant valuation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(581</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> net loss</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(39,213</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> Gross Profit: </I></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2024</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Gross profit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Add:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,420</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-GAAP</FONT> gross profit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,008</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Critical Accounting Policies and Estimates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our discussion and analysis of financial condition are based upon the consolidated financial statements of this business, which have been
prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, sales and expenses, and related disclosure of contingent assets and
liabilities. On an <FONT STYLE="white-space:nowrap">on-going</FONT> basis, we evaluate our estimates, including those related to bad debts, revenue reserves, inventory valuation, stock-based compensation, taxes on income, warranty obligations and
contingencies and litigation. We based our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying
values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates and such differences may be material to the financial statements. We believe that the accounting policies and estimates
described below are the most meaningful to our operations or require management&#146;s most difficult, subjective or complex judgments. Judgments or uncertainties affecting the application of these policies may result in materially different amounts
being reported under different conditions or using different assumptions. Accordingly, we believe these are the most critical to aid in fully understanding and evaluating our financial condition and results of operations. Our significant accounting
policies are fully described in Note 2 to our consolidated financial statements included in the footnotes of this prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Revenue Recognition </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our
sales consist of the sale of our products to our customers. Our customers are distributors, large global OEMs and other direct customers who design and manufacture devices for the consumer and industrial markets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Revenues are recognized when control of the product is transferred to a customer in an amount that reflects the consideration the Company is
expected to be entitled to in exchange for those products, in accordance with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
ASC 606, <I>Revenue from Contracts with Customers</I>. For direct customers and large global OEMS, revenue is recognized either when the product is shipped to the customer or upon delivery,
depending on the prevailing contract terms. For distributor customers, revenues are recognized with the product is shipped to the distributor, as in these cases, the distributor is the contracted customer. Revenues are recognized net of sales
credits and allowances for returns and discounts when applicable. Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental authorities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transaction price is the amount of consideration to which we expect to be entitled in exchange for transferring the promised goods to the
customer. The transaction price is specified in the standard price list or contract and is confirmed at the time the order for products is placed by the customer and acknowledged by the Company. Certain distributor contracts do include variable
consideration, such as limited price protection, return and stock rotation provisions, while direct customer contracts include general right of return provisions. We estimate variable consideration using all available information, including
historical experience and current expectations of return and pricing credits and records an allowance to reduce revenue recognized. These estimates take into consideration a range of possible outcomes that are probability-weighted in accordance with
the expected value method in ASC 606 for relevant factors such as current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall, these reserves
reflect our best estimates of the amount of consideration to which it is entitled based on the terms of the respective underlying contracts. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Inventories, net </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Inventories are stated at the lower of cost or net realizable value. Cost is calculated on a weighted moving average basis. In estimating net
realizable value, the Company considers (among other things) the age of its inventories and its product market acceptance based on known business factors and conditions by comparing forecasted customer unit demand for products over a specific future
period, or demand horizon, to quantities on hand at the end of each accounting period. These estimates may include uncertain elements such as our demand forecast which are developed based on current backlog, inputs from our customer and internal
analysis of customer purchasing trends and level of inventory in the distribution channel, actual and anticipated design wins, market and economic conditions, technological changes, new product introductions, and other factors. If our demand
forecast for specific products is greater than actual demand, we could be required to write down additional inventory, which would have a negative impact on our gross margin. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Stock-Based Compensation and Fair Value of Equity Components </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We record stock-based compensation expense based upon the grant date fair value for all stock options issued to all persons to the extent such
options vest. That expense is determined under the fair value method using the Black-Scholes option pricing model. We recognize the compensation cost for awards on a straight-line basis over the vesting period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Black-Scholes option pricing model used to compute stock-based compensation expense requires extensive use of accounting judgment and
financial estimates. Items requiring estimation include the fair value of our common stock, expected term option-holders will retain their vested stock options before exercising them, and the estimated volatility of our common stock price over the
expected term of a stock option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The absence of an active market for the Company&#146;s equity components, including our preferred stock,
common stock and related securities, requires its board of directors, the members of which the Company believes have extensive business, finance and venture capital experience, to determine the fair value of its common stock for purposes of granting
options, calculating stock-based compensation expense, valuing warrants and other equity transactions for the periods presented. We obtained contemporaneous third-party valuations to assist the board of directors in determining fair value. These
contemporaneous third-party valuations used the methodologies, approaches and assumptions consistent with the American Institute of Certified Public Accountants Practice Guide, <I>Valuation of Privately-Held-Company Equity Securities Issued as
Compensation</I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In valuing our common stock, our board of directors determined the equity value of our
business using various valuation methods, including combinations of income and market approaches with input from management. The income approach estimates value based on the expectation of future cash flows that a company will generate. These future
cash flows are discounted to their present values using a discount rate derived from an analysis of the cost of capital of comparable companies in our industry or similar business operations as of each valuation date and is adjusted to reflect the
risks inherent in our cash flows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we considered any secondary transactions involving our preferred and common stock. In our
evaluation of those transactions, we considered the facts and circumstances of each transaction to determine the extent to which they represented a fair value exchange. Factors considered include transaction volume and timing, whether the
transactions occurred among willing and unrelated parties, and whether the transactions involved investors with access to our financial information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Application of these approaches involves the use of estimates, judgment and assumptions that are highly complex and subjective, such as those
regarding our expected future net sales, gross margin, operating expenses, future cash flows, discount rates, market multiples, the selection of comparable companies, and the probability of possible future events. Changes in any or all of these
estimates and assumptions or the relationships between those assumptions impact our valuations as of each valuation date and may have a material impact on the valuation of our common stock, which could impact various estimates in the financial
statements including stock-based compensation, valuation of the deemed dividend for preferred stock, and impairment assessments of the Company&#146;s long-lived tangible and intangible assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For valuations after the completion of this offering, our board of directors will determine the fair value of the common stock underlying our
stock-based awards based on the closing price of our common stock on as reported on the date of grant. Future expense amounts for any particular period could be affected by changes in our assumptions or market conditions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recently Issued and Adopted Accounting Pronouncements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For more information regarding recently issued accounting pronouncements, see Note 2 to our consolidated financial statements included
elsewhere in this prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Controls and Procedures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are not currently required to fully comply with the Sarbanes-Oxley Act. We will be required to fully comply with the internal control
requirements of the Sarbanes-Oxley Act during the second annual filing following the initial public offering. Only in the event that we are deemed to be a large accelerated filer or an accelerated filer and no longer qualify as an emerging growth
company will we be required to fully comply with the independent registered public accounting firm attestation requirement on internal control over financial reporting. Further, for as long as we remain an emerging growth company as defined in the
JOBS Act, we intend to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not &#147;emerging growth companies,&#148; including, but not limited to, not being required to
comply with the independent registered public accounting firm attestation requirement. However, we do have internal controls in place in key areas of risk. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Quantitative and Qualitative Disclosures about Market Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are exposed to market risk in the ordinary course of business, which consists primarily of interest rates risk associated with our cash and
cash equivalents, foreign currency risk and impact of inflation. We do not engage in speculative trading activities. The following analysis provides additional information regarding these risks. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Interest Rate Risk </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our assets have limited exposure to market risk. As of December&nbsp;31, 2024 and 2023, we maintained a portfolio of cash and cash equivalents,
including money market funds. None of these investments have a maturity date in excess of three months. Certain interest rates are variable and fluctuate with current market conditions. Because of the short-term nature of these instruments, we would
not expect a sudden change in market interest rates to have a material impact on our financial condition or results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Foreign Currency Exchange Risk </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Operating in international markets involves exposure to possible volatile movements in currency exchange rates. A majority of our sales and
expenses are transacted in U.S. dollars and our assets and liabilities together with our cash holdings are predominately denominated in U.S. dollars reducing the exposure to currency fluctuations. Due to our international operations, a portion of
our cost of sales and operating expenses is denominated in currencies other that the U.S. dollar, principally the Chinese RMB, the Taiwanese dollar, and the Singapore dollar. Our international operations give rise to transactional market risk
associated with exchange rate movements of the U.S. dollar, Chinese RMB, Taiwanese dollar and Singapore dollar. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we are
exposed to foreign currency translation risk for those subsidiaries whose functional currency is not the U.S.&nbsp;dollar as changes in the value of their functional currency relative to the U.S.&nbsp;dollar can adversely affect the translated
amounts of our sales, expenses, net income, assets and liabilities. This can, in turn, affect the reported value and relative growth of sales and net income from one period to the next. In addition, changes in the translated value of assets and
liabilities due to changes in functional currency exchange rates relative to the U.S.&nbsp;dollar result in foreign currency translation adjustments that are a component of other comprehensive income or loss. Foreign currency derivative instruments
can be used to hedge exposures and reduce the risks of certain foreign currency transactions; however, these instruments provide only limited protection and can carry significant cost. We had no foreign currency derivative instrument hedges as of
December&nbsp;31, 2024 or 2023. We will continue to analyze our exposure to currency exchange rate fluctuations and may engage in financial hedging techniques in the future to attempt to minimize the effect of these potential fluctuations. Exchange
rate fluctuations may adversely affect our financial results in the future. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the volume of our international operations increases
and foreign currency exchange rates change, the impact to our consolidated statements of operations could be significant and may affect the comparability of our operating results. The impact from foreign currency transactions during 2024 and 2023
were not material. We do not believe a 10% increase or decrease in foreign exchange rates would have resulted in a material impact to our operating results. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Emerging Growth Company Status </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are an
&#147;emerging growth company,&#148; as defined in the JOBS Act, enacted in April 2012. We intend to take advantage of certain exemptions under the JOBS Act from various public company reporting requirements, including not being required to have our
internal control over financial reporting audited by our independent registered public accounting firm pursuant to Section&nbsp;404(b) of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports
and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute payments not previously approved. In addition, an emerging growth company can take advantage of an
extended transition period for complying with new or revised accounting standards. This provision allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private
companies. We have elected to avail ourselves of this provision of the JOBS Act. As a result, we will not be subject to new or revised accounting standards at the same time as other public companies that are not emerging growth companies. Therefore,
our consolidated financial statements may not be comparable to those of companies that comply with new or revised accounting pronouncements as of public company effective dates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will remain an emerging growth company and may take advantage of these exemptions
until the earliest of: (i)&nbsp;the last day of the fiscal year following the fifth anniversary of the consummation of this offering; (ii)&nbsp;the last day of the fiscal year in which we have total annual gross revenue of at least
$1.235&nbsp;billion; (iii)&nbsp;the last day of the fiscal year in which we are deemed to be a &#147;large accelerated filer&#148; as defined in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> under the Exchange Act, which would occur if the
market value of our common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeded $700.0&nbsp;million as of the last business day of the second fiscal quarter of such year; or (iv)&nbsp;the date on which we have issued more
than $1.0&nbsp;billion in <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt securities during the prior three-year period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_10"></A>BUSINESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Mission </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our mission is to enable
intelligence (AI and beyond) everywhere by delivering the lowest power semiconductor solutions. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are a pioneer and leading provider of <FONT STYLE="white-space:nowrap">ultra-low</FONT> power semiconductor solutions designed to address
the significant power consumption challenges of general purpose and AI compute &#150; especially at the edge. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our customers rely on Ambiq
to deliver AI compute closer to end users (edge environments) where power consumption challenges are the most severe. Our hardware plus software innovations deliver two to five times lower power consumption than traditional semiconductor designs.
Our products power over 260&nbsp;million devices today. We shipped more than 42&nbsp;million units in 2024, and we estimate that over 40% of them ran AI algorithms. We seek to drive growth in AI adoption at the edge in the personal devices,
medical/healthcare, industrial edge, and smart home and building markets and continue to set new standards in edge AI performance and power efficiency. Over time, we expect to integrate our <FONT STYLE="white-space:nowrap">ultra-low</FONT> power
technology into additional chip products that benefit from greater power efficiency, including high-performance compute applications such as AI data centers and automotive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">AI is perhaps the most disruptive and revolutionary technology trend of recent history, estimated to represent $23 trillion of global annual
spend by 2040, according to McKinsey. AI use cases continue to permeate our lives and improve our daily productivity by enabling us to interact with devices via voice and gestures, unlock our homes with facial recognition, track health accurately
and intelligently, and hold clear calls amidst loud background noise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To date, a majority of AI compute has been deployed in data centers
due to its large physical scale and the need for wall plug energy, as AI compute requires enormous and steady energy resources. At the edge, however, power limitations have been especially acute due to small device size and limited battery life. We
believe this greatly constrains the potential of AI to improve our daily <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">on-the-go</FONT></FONT> lives. Enabling AI at the edge &#150; where the action takes place &#150; with vastly
improved power efficiency will allow faster real-time decision-making due to data proximity, greater data privacy, higher energy efficiency from reduced network usage, and less dependence on constant costly connections to the cloud. We believe new
AI use cases will only be possible if edge devices are much more power efficient. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our proprietary
<FONT STYLE="white-space:nowrap">Sub-threshold</FONT> Power Optimized Technology (SPOT<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP>) platform is designed to fundamentally and cost-effectively reduce power consumption of battery- and
wireline-powered devices alike. Depending on the application, devices incorporating SPOT demonstrate a two to five times reduction in power consumption compared to conventional integrated circuit designs. SPOT is a ground-breaking approach at the
chip design level that incorporates <FONT STYLE="white-space:nowrap">sub-</FONT> and near-threshold hardware without using expensive manufacturing processes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We provide a full-stack solution encompassing tightly integrated hardware and software. Our solutions include a diverse family of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">systems-on-chip</FONT></FONT> (SoCs) and the software required to enable <FONT STYLE="white-space:nowrap">on-chip</FONT> AI processing, general compute, sensing, security, storage, wireless
connectivity, and advanced graphics. Our SoC solutions deliver compute at a very small fraction of the power consumed by our competitors&#146; products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our <FONT STYLE="white-space:nowrap">ultra-low</FONT> power SoCs serve a wide range of markets requiring
<FONT STYLE="white-space:nowrap">on-device</FONT> and real-time AI, including smartwatches and fitness trackers, augmented and virtual reality (AR/VR) glasses, smart rings, digital health monitors, security systems and access control, livestock
tracking, crop monitoring, and factory automation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Body-worn AI devices drive a significant portion of our revenue today and often require weeks of battery life while running advanced <FONT STYLE="white-space:nowrap">AI-driven</FONT> features.
These devices increasingly offer <FONT STYLE="white-space:nowrap">on-chip</FONT> <FONT STYLE="white-space:nowrap">AI-powered</FONT> features such as speech recognition, image and video processing, and sensing, further straining power consumption,
which our solutions are positioned to address. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We leverage our internal direct sales force and our global network of distributors and
sales representatives to pursue and support our core end markets. For our largest end customers, dedicated sales personnel work with the manufacturers to help ensure our solutions address their <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">go-to-market</FONT></FONT> needs. As global demand for our SoC solutions accelerates, our sales and marketing efforts are increasingly focused on our end customers in target geographies such as the United States, Europe,
and Asia <FONT STYLE="white-space:nowrap">(ex-Mainland</FONT> China). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the years ended December&nbsp;31, 2024 and December&nbsp;31,
2023, we recognized revenue of $&#8195;&#8195;&#8195;&#8195;million and $65.5&nbsp;million, respectively. Revenue from end customers in the United States, Europe, and Asia (outside of Mainland China) grew by &#8195;%, to $&#8195;&#8195; million in
2024 and achieved a gross margin of &#8195;%. We intend to continue to focus on business outside of Mainland China. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Industry </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Growing Need for AI at the Edge </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Edge AI is expanding as machine learning outperforms traditional algorithms&#151;enabling tasks like speech recognition&#151;and meets customer
demand for cloud-independent solutions. Meanwhile, large language models (LLMs) in the cloud rely on quality edge inputs, which is evident in industrial automation, healthcare, and consumer devices. To fully realize AI&#146;s potential, computation
must move to the edge, where data originates, ensuring faster decisions, enhanced privacy, improved energy efficiency, and reduced cloud reliance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">However, realizing this vision requires overcoming a fundamental challenge: <B>power efficiency.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Despite the substantial advantages of deploying AI directly on edge devices, power limitations have predominantly relegated AI inferencing to
the cloud. While power efficiency is crucial for all markets, it is existential for battery-powered devices, which must simultaneously provide compute, connectivity, graphics, battery management, and sensing within a stringent power envelope. Neural
networks, the backbone of modern AI, demand significantly more computation than traditional algorithms. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Key Challenges of <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Edge-to-Cloud</FONT></FONT> Data Processing </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Today, advanced analytics
and AI inference are often processed in the cloud due to the difficulty or impossibility of running them at the edge. However, this approach has several drawbacks: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Latency.</I></B> The round trip to the cloud adds significant latency, preventing real-time behaviors and
feedback. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Connectivity.</I></B><I> </I>Wireless connectivity often consumes significant power and is limited to those
applications with reliable connections. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Security and Privacy. </I></B>Sending sensitive data to the cloud increases privacy breach risks.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Cost.</I></B> Cloud services represent a significant expense that usually scales with the amount of data
transferred to/from the cloud. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Key Challenges to AI Inferencing at the Edge </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Power Consumption. </I></B>Optimizing power consumption for all functions, from AI inferencing to wireless
connectivity to sensor management, is a fundamental challenge for edge devices. This challenge is significantly amplified as processing, performance, connectivity, and AI compute needs increase. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Real-Time Inferencing. </I></B>Most of today&#146;s AI models are designed to run in the cloud, processing
large batches of data. Edge AI is often called on to act on streams of data in real time, which requires a significant redesign of the data processing and inferencing algorithms. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Size. </I></B>Many edge devices are physically <FONT STYLE="white-space:nowrap">size-constrained,</FONT>
thereby limiting the capacity of the battery and battery life. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Integration. </I></B>Given device size constraints, vendors increasingly opt for highly integrated SoCs to
drive their devices instead of complex designs with many discrete chips having relatively narrow functionalities. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Privacy and Security. </I></B>While bringing AI to the edge improves system security and reduces the attack
surface, it creates high-security expectations for small edge devices with minimal compute resources. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Resource Constrained AI Model Development. </I></B>Most AI models today are built for the cloud, where
compute performance, memory, and power are readily available. Building <FONT STYLE="white-space:nowrap">&#147;right-sized&#148;</FONT> models that execute efficiently on the edge is extremely challenging. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our <FONT STYLE="white-space:nowrap">ultra-low</FONT> power SoC solutions are designed to fundamentally address our end customers&#146; needs
for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">ultra-low-power</FONT></FONT> consumption for all functions, better connectivity, and increased AI compute (especially at the edge). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Technology </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Power consumption is
the most critical challenge for edge AI devices. SPOT<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> is our proprietary <FONT STYLE="white-space:nowrap">ultra-low</FONT> power chip design platform created to solve this severe power
consumption problem. As described below, SPOT consists of a set of chip design techniques that allow standard transistors to operate in an <FONT STYLE="white-space:nowrap">ultra-low</FONT> power mode called
<FONT STYLE="white-space:nowrap">&#147;sub-threshold&#148;</FONT> and &#147;near-threshold&#148;. When combined with other <FONT STYLE="white-space:nowrap">low-power</FONT> chip architecture techniques (also described below), SPOT enables our SoCs
to deliver two to five times lower power consumption than leading alternative solutions. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Traditional Approach to Design Comes at an Energy
Cost </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Every electronic circuit is made up of a number of transistors that work together to perform a set of functions. In
conventional digital design, these transistors operate like a switch and change between &#147;on&#148; and &#147;off&#148; states to signal digital &#147;0&#148; and &#147;1&#148; values. This &#147;super-threshold&#148; operating mode is achieved
by switching the transistors between a voltage of 0 volts and a much higher supply voltage (e.g., 0.8 volts or 1.2 volts) that is well above the <FONT STYLE="white-space:nowrap">turn-on</FONT> voltage of the transistor (known as the threshold
voltage). This &#147;super-threshold&#148; operating mode consumes significant power, given the extremely high dependence of switching power on voltage. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Sub-threshold</FONT> and Near-threshold Design Offers Substantially Improved Power Efficiency </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Power consumption can be significantly reduced by dropping supply voltage from the conventional high value (e.g., 0.8 volts or 1.2 volts) to a
lower value (e.g., 0.4 volts, 0.5 volts, or 0.6 volts). Though the conventional high supply voltages have long been considered fundamental limits, it is possible to operate at supply voltages near or below the threshold voltage (i.e., the &#147;turn
on&#148; voltage) of the transistor. When the supply voltage is close to the threshold voltage of the transistor, the circuit is operating in &#147;near-threshold&#148; mode. When the supply voltage drops below the threshold voltage of the
transistor, the circuit is operating in <FONT STYLE="white-space:nowrap">&#147;sub-threshold&#148;</FONT> mode. The benefits and challenges are similar for both near-threshold and <FONT STYLE="white-space:nowrap">sub-threshold</FONT> operations, so
we use the term <FONT STYLE="white-space:nowrap">&#147;sub-threshold&#148;</FONT> to encompass both modes of operation. Challenges for operating in the <FONT STYLE="white-space:nowrap">sub-threshold</FONT> region include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Difficulty modeling and simulating transistors accurately in the
<FONT STYLE="white-space:nowrap">non-standard</FONT> <FONT STYLE="white-space:nowrap">sub-threshold</FONT> region; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">High sensitivity to small manufacturing variations, which can lead to significant performance deviations and
functional failure; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">High sensitivity to environmental variations (e.g., temperature, voltage, and light variations), which can lead
to performance issues and functional failure in the field; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Lack of circuit designers familiar with <FONT STYLE="white-space:nowrap">sub-threshold</FONT> concepts and lack
of design IP and computer-aided design tool flows capable of supporting <FONT STYLE="white-space:nowrap">sub-threshold</FONT> operation. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Ambiq SPOT Platform is Built to Solve the Challenges of <FONT STYLE="white-space:nowrap">Sub-threshold</FONT> and Near-threshold </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our SPOT platform is a collection of dozens of proprietary techniques designed to solve the typical challenges associated with <FONT
STYLE="white-space:nowrap">sub-threshold</FONT> technologies. Given the disruptive approach to basic circuit building block design, we developed new analog, digital, and memory architectures while utilizing standard communication interfaces,
packages, design flows, and manufacturing processes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have spent 15 years building our
<FONT STYLE="white-space:nowrap">sub-threshold</FONT> expertise, reusable design IP, and patent portfolio. Specifically, we have developed wide-ranging chip architectures, IP building blocks, and IC design methodologies for digital circuits, analog
circuits, and embedded memories&#151;accumulating significant expertise and IP related to product design, validation, and production testing. Our proven expertise in, and experience with, <FONT STYLE="white-space:nowrap">ultra-low</FONT> power
design provides us with a substantial competitive advantage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we have developed a wide range of chip architecture techniques
that are designed to enable even lower power than <FONT STYLE="white-space:nowrap">sub-threshold</FONT> and near-threshold operation alone. Many of these chip design techniques are protected by IP rights, including patents and trade secrets. </P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While many <FONT STYLE="white-space:nowrap">high-end</FONT> processor chip companies can increase performance or decrease power
consumption with advanced process technology nodes, such as <FONT STYLE="white-space:nowrap">7-</FONT> and <FONT STYLE="white-space:nowrap">5-nanometers,</FONT> these expensive manufacturing processes are typically not cost-effective for edge
devices. With our SPOT platform, we are able to manufacture our products at much more cost-effective process technology nodes, such as 12 nanometers, 22 nanometers, and 40&nbsp;nanometers. Furthermore, reliance on advanced process technology nodes
and Moore&#146;s Law to solve the power problem is particularly limiting as Moore&#146;s Law is viewed by many as dead or broken. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Products
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our SPOT platform serves as the foundation for a series of SoCs for edge AI devices that deliver
<FONT STYLE="white-space:nowrap">ultra-low</FONT> power for AI computations, general purpose computations, sensing, communications, power conversion, and more. These SoCs are paired with a full-stack software solution that is designed to enable
efficient resource-</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
constrained AI application development and a fast <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">time-to-market.</FONT></FONT> Details about both hardware and software products
are described below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377490g57z26.jpg" ALT="LOGO" STYLE="width:5.95145in;height:3.21608in;">
 </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>SoC Products for Edge AI </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our SoCs are built on the SPOT platform to enable every function to achieve <FONT STYLE="white-space:nowrap">ultra-low</FONT> power. Based on
our experience, the ideal edge AI SoC (shown below) includes a host processor, power conversion, wireline and wireless communications, sensor interfaces and user interfaces, memories, and a variety of accelerated compute blocks for graphics,
security, and more. Importantly, for the most demanding edge AI use cases, neural processing units (NPUs, or AI accelerators) are also included. These elements are all critical for edge AI use cases, and SPOT is designed to reduce energy consumption
for each of them. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377490g90w94.jpg" ALT="LOGO" STYLE="width:5.43049in;height:3.17116in;">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our portfolio includes two flagship SoC product families, both with rich sets of peripherals
as shown in the diagram above: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Apollo: </I></B>The first Apollo family of products was launched in 2015. New families have been launched
every few years with the newest Apollo5 family launching in 2024. The Apollo family of products pair rich peripheral sets with host processors capable of software-based AI computations (e.g., Apollo3 and Apollo4 families) or vector-accelerated AI
computations (e.g., Apollo5 family). For most edge AI use cases, we believe the combination of the Apollo products with our full-stack software solution provides the optimal power, performance, feature, and cost
<FONT STYLE="white-space:nowrap">trade-off.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Atomiq: </I></B>The first Atomiq family product is currently in development. This novel product targets AI
applications requiring demanding edge AI compute requirements and is thus expected to provide the highest performance and lowest power ever delivered by our products. Atomiq is expected to feature a full NPU for high-performance AI acceleration
along with new memory innovations &#151; all with the goal of achieving minimum power and maximum performance on AI model execution at the edge. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Software Products for Edge AI </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To
truly unlock edge AI use cases, our <FONT STYLE="white-space:nowrap">ultra-low</FONT> power SoCs must be paired with carefully optimized proprietary software. To make edge AI application development easier for our customers, Ambiq provides a series
of core software products: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>General enablement firmware: </I></B>Our AmbiqSuite Software Development Kit (SDK) provides <FONT
STYLE="white-space:nowrap">low-level</FONT> firmware and drivers required to operate our SoCs efficiently. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Feature enablement software: </I></B>On top of AmbiqSuite SDK, we offer a series of software modules that
enable complex applications to be developed quickly and efficiently. These modules include graphiqSPOT for graphics and display management, blueSPOT for Bluetooth communications, secureSPOT for managing security, and more. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>AI enablement software: </I></B>Ambiq assists our customers in developing AI features by providing novel
model factories specifically designed for edge AI, optimized AI inference engines, and neuralSPOT, our cross-platform AI SDK. These tools are designed to collectively address the challenges encountered when developing AI for edge products.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Value Proposition for Edge AI Customers </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The multi-fold energy improvement delivered by SPOT-enabled products is indispensable for edge AI use cases. By reducing the energy required
for sensing, communication, security, and AI, customers are given flexibility in their energy budgets. They can use this flexibility in a number of key ways without compromising battery life, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Moving AI from the cloud to the edge to the benefit of security, cloud costs, response time, and radio overhead;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Running larger AI models and running them faster; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Adding more sensors and sampling them faster; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Extending battery life (e.g., from hours to days or from days to weeks); or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reducing the size of batteries and industrial designs for compact use cases. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Market Opportunity </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Most of our
revenue has come from <FONT STYLE="white-space:nowrap">ultra-low</FONT> power SoCs, tightly bundled with software and various other solutions that combine <FONT STYLE="white-space:nowrap">32-bit</FONT> microcontrollers (MCUs) with wireless
connectivity and additional circuitry, such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
as graphics processing units, serial interfaces, and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">analog-to-digital</FONT></FONT> interfaces. In the near future, we believe
we can expand into embedded application processors, as well as stand-alone dedicated AI processors. Even though many of our customers today run basic AI inferencing directly on our Apollo-class SoCs and on lightweight accelerators within our SoCs,
we are now developing dedicated AI processor units purpose-built for accelerating AI compute. Today, we define our market opportunity as <FONT STYLE="white-space:nowrap">32-bit</FONT> MCUs, discrete application processors (ASICs), wireless
connectivity, and AI processors built for edge applications, markets totaling $12.8&nbsp;billion in 2023 and growing to $22.5&nbsp;billion in 2028.** This includes <FONT STYLE="white-space:nowrap">AI-enabled</FONT> devices spanning industrial edge,
smart homes and buildings, as well as body-worn AI devices such as consumer wearables and digital health devices. In the future, we believe our technology has the potential to address many semiconductor end markets that need much greater energy
efficiency. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Within the edge end markets listed above, the market for <FONT STYLE="white-space:nowrap">32-bit</FONT> MCUs is expected
to grow from $4.7&nbsp;billion in 2023 to $6.0&nbsp;billion in 2028, representing a compound annual growth rate (CAGR) of 5%, according to Gartner.** The market for wireless connectivity semiconductors for the same end markets is expected to grow
from $2.4&nbsp;billion in 2023 to $4.7&nbsp;billion in 2028, representing a CAGR of 15%. The market for application processors is expected to grow from $5.7&nbsp;billion in 2023 to $10.2&nbsp;billion in 2028, representing a CAGR of 12%. According to
Gartner, the discrete AI processors market is expected to grow from $152&nbsp;million in 2023 to $1.6&nbsp;billion in 2028, representing a CAGR of 60%.** </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since AI solutions are often embedded into general processor SoCs, broader <FONT STYLE="white-space:nowrap">AI-enabled</FONT> market forecasts
are also relevant to our opportunity. According to Gartner, the market for <FONT STYLE="white-space:nowrap">AI-enabled</FONT> <FONT STYLE="white-space:nowrap">32-bit</FONT> MCUs and application processors in edge applications is expected to grow
from $788&nbsp;million in 2023 to $6.8&nbsp;billion in 2028, representing a CAGR of 54%.* </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B></B><B><I></I></B><B>Projected Addressable
Market Size in Our End Markets ($ billion)** </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377490g91n91.jpg" ALT="LOGO" STYLE="width:5.46454in;height:2.59175in;">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Projected Addressable Market Size for Our Products ($ billion)*** </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377490g92n92.jpg" ALT="LOGO" STYLE="width:5.83011in;height:2.76382in;">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Opportunities in Core Markets </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our core end markets are divided into two broad categories: Body-worn AI and Ambient AI. Body-worn AI comprises personal devices and medical /
healthcare applications, while Ambient AI comprises industrial edge devices and smart homes/buildings. Each of our end markets is described in detail below: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Personal Devices.</I></B><B> </B>Personal devices, including smartwatches and fitness bands, smart rings,
AR/VR glasses, and hearable products, such as wireless earphones and hearing aids, must be comfortable, fashionable, and portable while maintaining long battery life and small size. Our <FONT STYLE="white-space:nowrap">low-power</FONT> <FONT
STYLE="white-space:nowrap">MCU-based</FONT> SoC products act as central control units of many such devices or are implemented as <FONT STYLE="white-space:nowrap">co-processing</FONT> products. They offer power-efficient communication, display and
audio capabilities, <FONT STYLE="white-space:nowrap">always-on,</FONT> real-time information, and seamless connectivity to other smart devices like mobile phones and home appliances. In addition, our solutions incorporate AI processing, such as
voice activation, activity recognition, and tracking. For instance, in most smartwatches, heart health and sleep quality analyses are now done with neural networks rather than traditional filters. For the year ended December&nbsp;31, 2024, we
generated approximately 94% of our revenue from the personal devices market. According to Gartner, the personal device market was $3.7&nbsp;billion in 2023 and is expected to grow to $5.1&nbsp;billion in 2028, representing a CAGR of 7%.****
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Medical / Healthcare Applications</I></B><B>. </B>The healthcare industry is experiencing a revolution as
it enters the digital age through enhanced diagnostics and precise treatments designed to improve patient outcomes.<B> </B>Patient data collection in applications like heart health monitors, pulse oximeters, glucose monitors, and blood pressure
monitors are using AI to better predict the likelihood of developing certain conditions and diseases.<B> </B>Our <FONT STYLE="white-space:nowrap">low-power</FONT> semiconductor products can enable the tracking of myriad patient data, transforming
disease diagnosis and allowing earlier, more accurate, and personalized treatment choices. Innovative products based on novel data sensing such as in-ear blood flow are creating new opportunities to improve health, both on a personal level and by
involving healthcare professionals. According to Gartner, the market for medical and healthcare semiconductors is expected to grow from $887&nbsp;million in 2023 to $1.3&nbsp;billion in 2028, representing a CAGR of 8%.**** </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Industrial Edge Devices.</I></B> Industrial edge devices cater to commercial applications, such as
manufacturing, supply chain logistics, smart metering, and other <FONT STYLE="white-space:nowrap">end-use</FONT> applications. These products typically help perform critical functions such as predictive maintenance, productivity monitoring, asset
tracking, and inventory management. Our solutions enable <FONT STYLE="white-space:nowrap">AI-driven</FONT> predictive maintenance for <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">hard-to-access</FONT></FONT> legacy industrial
assets, connected devices for workers at large industrial sites, livestock </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
management, and low power wide area (LPWA) solutions to deploy remotely without relying on existing telecom infrastructure. For instance, one of our customers utilizes our solution in wireless
sensor devices for anomaly detection. This device utilizes a neural network to identify when that signature has changed and thus, when a failure may be looming. According to Gartner, the industrial edge device market is expected to grow from
$5.8&nbsp;billion in 2023 to $11.0&nbsp;billion in 2028, representing a CAGR of 14%.**** </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Smart Homes and Buildings.</I></B><B> </B>Smart homes, or fully connected household environments, enable
voice-activated remote control of heating and thermostats, smart meters, lighting, security, and a multitude of other appliances from their smart devices. Our solutions enable various applications, such as
<FONT STYLE="white-space:nowrap">AI-enabled</FONT> voice-controlled smart remotes, fast identify online (FIDO) fingerprints biometric security cards, biometric credentials for physical and logical access, and smart locks. Today&#146;s
battery-powered smart doorbells and security cameras use a passive infrared (PIR) sensor to detect motion and then turn on the camera to record interesting events. Our solution can eliminate the &#147;dumb&#148; PIR sensor and constantly monitor
video using AI models to identify not just motion but specific events like &#147;a delivery person knocked on the door.&#148; According to Gartner, the smart home and smart buildings market is expected to grow from $2.5&nbsp;billion in 2023 to
$5.2&nbsp;billion in 2028, representing a CAGR of 16%.**** </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Future Market Opportunities </I></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Automotive.</I></B><B> </B>We believe we can further design and optimize our technology for use in
automobiles, which inherently require fundamentally lower power products throughout than have historically been created using conventional power techniques. While we do not currently address this market, we intend to develop products for the
automotive market using our expertise in <FONT STYLE="white-space:nowrap">low-power</FONT> processing and complex integrated design. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Data Center and Compute.</I></B><B> </B>We believe our <FONT STYLE="white-space:nowrap">ultra-low</FONT>
power SPOT platform can be extended for use in wall-powered applications including data centers and compute, enabling power efficiency gains. While we do not currently address this market, we intend to develop products using our expertise in <FONT
STYLE="white-space:nowrap">low-power</FONT> processing. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Competitive Strengths </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe our core competitive strengths include the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Leading proprietary <FONT STYLE="white-space:nowrap">ultra-low</FONT> power chip design technology. </I></B>We exclusively focus on <FONT
STYLE="white-space:nowrap">ultra-low</FONT> power, <FONT STYLE="white-space:nowrap">sub-,</FONT> and near-threshold chip design technology, which is our key differentiator and top development priority. We have spent nearly 15 years developing our
SPOT platform, enabling our products to consume a demonstrated two to five times less power than traditional super-threshold technologies at the same manufacturing geometries. Our SPOT platform comprises dozens of individual circuit design
techniques that are difficult to replicate, complemented by overall <FONT STYLE="white-space:nowrap">low-power</FONT> system design expertise and <FONT STYLE="white-space:nowrap">know-how</FONT> and our proprietary AmbiqSuite SDK, making it easy for
our end customers to quickly and effectively implement our products. Our exclusive focus on <FONT STYLE="white-space:nowrap">low-power</FONT> technologies and our culture of continuous innovation gives us a significant competitive advantage, as many
of our competitors have focused on other priorities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Extensible technology platform. </I></B>We believe our SPOT platform is fully
extensible to a wide variety of semiconductor applications that require substantially greater power efficiency in both battery-operated and wall-powered devices. We can apply our technology to products such as MCUs, application processors, MPUs,
GPUs, AI accelerators, connectivity, and complex chipsets that combine a number of products into complex SoCs. Our technology is especially valuable for battery-operated products by significantly improving performance on a fixed power budget or by
extending the time between charges in body-worn applications such as wristbands, smart clothing, hearables, smart glasses, and digital health devices. In addition, our <FONT STYLE="white-space:nowrap">ultra-low</FONT> power solutions can be applied
to wall-powered applications. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Robust intellectual property portfolio. </I></B>Our IP is a key aspect of our
business strategy, allowing us to maintain a competitive and, we believe, sustainable edge in the market. Our robust IP portfolio encompasses patents, trade secrets, and design IP that safeguard our proprietary technology and innovations related to <FONT
STYLE="white-space:nowrap">ultra-low</FONT> power and <FONT STYLE="white-space:nowrap">sub-threshold</FONT> design. Our design IP is proven over five generations of the Apollo family of products. Our team is focused on developing new inventions, for
which we seek patent protection to the extent practicable. As of December&nbsp;31, 2024, we owned a portfolio of approximately 59 issued patents and had approximately 24 patent applications pending worldwide. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Proven demand from blue-chip end customers. </I></B>We have demonstrated strong end customer growth across more than 260&nbsp;million
units shipped with international technology leaders such as Garmin, Google, Suunto, and others, which has validated the maturity of our technology platform and the robustness of our solutions offering. With our SPOT and SDK solutions, we have
successfully enabled our customers to achieve much higher energy efficiency levels with increased battery life, allowing them to add new functions and deliver better performance. Our customers typically spend multiple years working with us on their
product design, optimization, and productization. Moving to a competitor would typically require similar resources and time commitment along with hardware and software redesign, which makes transferring vendors more difficult. Furthermore, we work
with our customers throughout their design cycles to help develop next-generation products. The long-lasting and collaborative nature of these relationships provides us with enhanced visibility into our customers&#146; future requirements, allowing
us to expand our business and increase our content in future products. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Scalable design and manufacturing
relationships.</I></B><B> </B>Our SoC solutions leverage existing mature semiconductor process technologies that are readily available and cost-effective. Since our founding, we have partnered with a leading semiconductor foundry, TSMC, for our SoC
products in <FONT STYLE="white-space:nowrap">180-nanometer,</FONT> <FONT STYLE="white-space:nowrap">90-nanometer,</FONT> <FONT STYLE="white-space:nowrap">40-nanometer,</FONT> and <FONT STYLE="white-space:nowrap">22-nanometer</FONT> process nodes. We
leverage TSMC&#146;s mature fabrication processes, which are more cost-effective than the most advanced nodes, while still delivering products that consume a very small fraction of the power that our competitors require for their comparable parts.
We also work closely with <FONT STYLE="white-space:nowrap">top-tier</FONT> <FONT STYLE="white-space:nowrap">back-end</FONT> partners such as ASE Group to test and assemble our products. Through these long-standing strategic partnerships, we are able
to quickly scale production using mainstream semiconductor manufacturing and wafer scale integration and reduce our capital expenditures without compromising the quality of our products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Top industry talent, experienced management team and engineering-focused culture. </I></B>We believe our team&#146;s engineering, chip
design, and AI talent is critical to our success. We employ an engineering-focused workforce, as well as a highly technical senior management team with deep industry and chip design experience. As of December&nbsp;31, 2024, we had 189 employees,
with engineers comprising approximately 66% of our total workforce. In recognition of our engineering focus and talent base, we have won several prestigious awards, including &#147;IoT Semiconductor Company of the Year&#148; by Tech Breakthrough
Organization in 2021, 2023 and 2024, &#147;Artificial Intelligence Excellence&#148; award by The Business Intelligence Group in both 2021 and 2023, &#147;Big Innovation&#148; Award by the Business Intelligence Group in both 2021 and 2022 for our
SPOT platform, &#147;2024 Distinguished Golden Bull&#148; award by Business Media International, and &#147;Embedded Award for the Apollo510 MCU&#148; for 2024 under the Hardware category. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Strategy </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Extend our presence
in current markets with higher-performing and lower-power versions of our existing products. </I></B>We have a strong foothold in the battery-powered personal devices market, which we believe will be further boosted by the growing adoption of edge
AI. Our customers choose our <FONT STYLE="white-space:nowrap">ultra-low</FONT> power SoC products because of their differentiated power efficiency. New members of the Apollo and Atomiq family of SoCs in development are designed to deliver even lower
power and higher processing performance to our existing customers, potentially enabling and accelerating new innovative edge AI use cases.<B><I> </I></B>This will allow customers to innovate and accelerate edge AI adoption without compromising
device usability or battery life. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Expand aggressively into new markets by broadening current product families.
</I></B>The success of the Apollo family in battery-powered personal devices has proven the value proposition of SPOT. We intend to apply our <FONT STYLE="white-space:nowrap">ultra-low</FONT> power value proposition to enable AI use cases in
medical, digital health, industrial, security, smart home and buildings, robotics, and automotive markets. We are developing a broader portfolio of Apollo and Atomiq SoC offerings that we believe will allow us to enter these additional markets.
These SPOT-enabled variants are expected to be offered at different price points, different radio standards, and different peripheral sets alongside a full AI software solution stack. We anticipate that these products require only incremental
investment and development time, so a broader portfolio can be built out quickly. For most new products, we will attach high-volume &#147;alpha&#148; customers to the product launch, a practice that has been successful for us to date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Bring SPOT to new classes of chip products to access both existing and new markets. </I></B>SPOT is a widely applicable, <FONT
STYLE="white-space:nowrap">ultra-low</FONT> power design methodology that can be quickly applied to new chip classes such as application processors (APs), dedicated AI processors, digital signal processors (DSPs), image processors, power management
chips, communications chips, network processors, and many more. By building on 15 years of <FONT STYLE="white-space:nowrap">pre-existing</FONT> SPOT IP, we intend to develop new ultra-lower power chip product families that we believe will provide us
access to additional sockets within current customers, as well as to entirely new customers in new market segments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Leverage our <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">easy-to-use</FONT></FONT> software and AI model suite to speed customer adoption and drive higher-margin revenue. </I></B>Our customers face challenges in edge AI development, hindering the
rollout of new features and products. We are working to increase our software suite to include new AI software products, such as AI model libraries, AI compilers and runtimes, AI model development utilities, AI model factories, and AI training data.
Complementary to our existing SoC solutions, we believe these new AI software offerings will enable us to reach a broader set of customers, will allow these customers to more quickly implement their AI functionalities, and are expected to help drive
increased SoC gross margin. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Develop SPOT into a licensable technology platform. </I></B>We are presently using the SPOT platform to
reach a high-growth set of edge AI markets. However, there are specialized compute and AI markets that greatly depend on power efficiency (e.g., AI processing in data centers and automotive) but which we are not resourced to address today. To reach
these markets, we plan to develop SPOT into an IP and chip development platform that makes it easier for other companies to license or partner with us to incorporate SPOT into their own <FONT STYLE="white-space:nowrap">low-power</FONT> chip designs,
such as building next-generation AI data center chips. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Relentlessly advance the SPOT platform to help position us for future
leadership. </I></B>The pace of edge AI development is breathtaking. New sensors, new AI model architectures, and new AI use cases from our customers drive a growing need for low power. We must therefore continue to advance the SPOT platform itself
in parallel with Apollo and Atomiq product development. Innovation will focus on delivering even lower power and higher performance than is possible today. Key hardware innovation areas will include scaling SPOT to the 12 nanometer process node and
beyond, developing ultra-low power sensing interfaces, developing new memories, and more. We expect our software innovations to include compiler development, runtime development, among others. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our End Customers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We work closely with
our OEM and original design manufacturers (ODM) end customers throughout their design cycles, allowing us to develop long-term relationships with them as our technology becomes embedded in their products. As a result, we believe we are
well-positioned to be designed into their current products and to continue developing next-generation AI platforms and <FONT STYLE="white-space:nowrap">low-power</FONT> products for their future products. During the year ended December&nbsp;31,
2024, we sold our products to more than 200 end customers via third-party distributors and, to a lesser extent, through resellers and direct sales. Our major end customers in 2024 included, among others, Huawei, Garmin and Google. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We typically fulfill the needs of our OEM and ODM end customers through direct relationships
and select distributors. For the year ended December&nbsp;31, 2023, Max Electron (Hong Kong) Limited and Kaga EI Electronics Pacific Asia Ltd. accounted for approximately 32% and 17% of our revenue, respectively. Revenue from these same distributors
comprised &#8195;% and &#8195;% of our revenue for the year ended December&nbsp;31, 2024, respectively.&nbsp;In addition to our direct OEM and ODM relationships, we also address a significant portion of our business through demand creation by our
distribution and reseller network, which we intend to continue to broaden in the future. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We currently rely, and expect to continue to
rely, on a limited number of end customers for a significant portion of our revenue. For the years ended December&nbsp;31, 2023, and 2024, our top five end customers accounted for 86% and &#8195;&#8195;&#8195;&#8195;% of our revenue, respectively,
based on the sell-through information provided to us by our distributors. For 2023, revenues from Xiaomi, Huawei, and Google comprised approximately 31%, 30% and 13% of our revenue, respectively. Two other single end customers directly or indirectly
accounted for more than 10% of our revenue in the year ended December&nbsp;31, 2023.&nbsp;In 2024, revenues from &#8195;&#8195;&#8195;&#8195;, &#8195;&#8195;&#8195;&#8195; and &#8195;&#8195;&#8195;&#8195; comprised approximately &#8195;%, &#8195;%
and &#8195;% of our revenue, respectively. Sales to end customers in Mainland China accounted for 66% and 50% of our revenue in the years ended December&nbsp;31, 2023, and 2024, as we expanded our sales and marketing efforts outside of Mainland
China. We expect to continue to increase our sales and marketing efforts outside of Mainland China. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sales and Marketing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We primarily engage with our end customers directly using a combination of a direct sales force and field application engineers, fulfilling
sales directly or through third-party distributors. Our direct sales force and field applications engineers are located near our existing OEM and ODM end customers in Germany, Japan, Mainland China, Poland, Singapore, Taiwan, and the United States.
Our salesforce has varied <FONT STYLE="white-space:nowrap">end-market</FONT> expertise. </P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have contracts in place with distributors
and third-party sales representatives throughout Asia, particularly in Taiwan, Korea, Japan, Singapore and Mainland China, as well as in the United States and Europe. We selected these independent distributors and representatives based on their
ability to provide effective field sales, marketing communications, and technical support for our products. Following initial sales efforts, these third-party distributors assist predominantly in the fulfillment of orders from our end customers.
</P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our sales have historically been made based on purchase orders rather than end customer-specific long-term agreements. Our material
terms and conditions are generally consistent with general industry practice but vary from distributor and end customer to end customer. We typically receive purchase orders 16 weeks ahead of the end customer&#146;s desired delivery date; however,
this can extend up to 36 weeks, particularly in times of global supply constraints. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Manufacturing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We operate a fabless business model and use third-party foundries, packaging, and testing contractors to manufacture, assemble, and test our
semiconductor products. This outsourced manufacturing approach allows us to focus our resources on the design, sale, and marketing of our products. In addition, we believe that outsourcing our manufacturing activities provides us with the
flexibility and scalability needed to respond to new market opportunities, simplifies our operations, and significantly reduces our capital commitments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We subject our third-party manufacturing contractors to qualification requirements to meet our solutions&#146; high quality and reliability
standards. We qualify each of our partners and their processes before applying the technology to our solutions. Our engineers work closely with all our manufacturing partners to keep material flowing quickly and consistently, with high quality. All
sides look for continuous improvements to lower product costs by, for example, optimizing flow steps and improving yields. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Wafer Fabrication</I></B><B>.</B> We use various generations of semiconductor processes to develop and
manufacture our products. We contract with TSMC to produce semiconductor wafers. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Packaging and Testing</I></B><B>.</B> Upon the completion of processing at the foundry, we use third-party
contractors for packaging and testing, including the ASE group, King Yuan Electronics Group (KYEC) and Sigurd in Taiwan and Mainland China. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>Suppliers</I></B>.<I> </I>We also rely upon a limited number of other manufacturing partners for our
modules, boards, and other components. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Given the disruptive nature of our technology and design, we have historically
worked very closely with our manufacturing partners to ensure they provide high-quality fabrication and an outstanding support team for continuous improvement. For instance, we worked with TSMC to identify the source of excessive circuit leakage and
quickly optimized the process to resolve it. In addition, to ensure the highest reliability, <FONT STYLE="white-space:nowrap">sub-threshold</FONT> circuits built on our SPOT platform have been subjected to the same testing standards of
super-threshold technologies, including those that measure performance in extreme conditions over extended periods. We believe our ability to work closely with our third-party partners to optimize the production processes used by our technologies
provides us with a meaningful competitive advantage. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and Development </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that our success depends in large part on our ability to enhance our existing proprietary SPOT platform, expand our <FONT
STYLE="white-space:nowrap">low-power</FONT> SoC product portfolio, develop new innovative solutions based on our SPOT platform, and integrate additional capabilities to serve our existing and future target markets. We engage in research and
development efforts in the following core areas: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Core SPOT platform; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Digital, analog, and radio-frequency chipset design (including MCUs, GPUs, AI accelerators, wireless
connectivity, power management, security, imaging, audio, and sensing); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">General and feature enablement software development (including connectivity, graphics, security, and audio); and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">AI enablement software development (including AI model factories, AI runtimes, and AI libraries); and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">System-level solutions development (including algorithms, reference hardware, reference software, and end
customer design references). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our research and development team comprises highly skilled engineers and technologists
with extensive experience in digital, mixed-signal, RF chipset design, system-level architecture, and software development. We have assembled our engineering team in the United States (our headquarters in Austin, Texas, and our California location),
Mainland China (Shanghai and Shenzhen), Taiwan, and Singapore. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the years ended December&nbsp;31, 2024, and 2023, respectively,
our research and development expenses were $&#8195;&#8195;&#8195;&nbsp;million and $44.0&nbsp;million, representing &#8195;&#8195;% and 67.2% of 2024 and 2023 revenues, respectively. We intend to continue to invest in research and development to
support and enhance our existing <FONT STYLE="white-space:nowrap">low-power</FONT> <FONT STYLE="white-space:nowrap">sub-threshold</FONT> solutions and design and develop future product offerings.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We rely on a
combination of intellectual property rights, including patents, trade secrets, copyrights and trademarks, and contractual protections, to protect our core technology and intellectual property. As of January&nbsp;31, 2025, we owned 51 issued U.S.
patents, 8 issued foreign patents, 13 pending U.S. patent applications, 9 pending foreign patent applications, and 2 pending Patent Cooperation Treaty application. The issued patents in the United States generally expire beginning in 2033 through
2042. Our issued patents and pending patent applications relate to key <FONT STYLE="white-space:nowrap">sub-threshold</FONT> analog and digital techniques and algorithms, memory techniques, circuits, and system-level optimization. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition to our own intellectual property, we also use third-party licenses for certain
technologies embedded in our solutions. These are typically granted to us in <FONT STYLE="white-space:nowrap">non-exclusive</FONT> contracts provided under royalty-accruing or <FONT STYLE="white-space:nowrap">paid-up</FONT> licenses. While we do not
believe our business is dependent to any significant degree on any individual third-party license, we expect to continue to use and may license additional third-party technology for our solutions. We also invest in the latest commercially available
software design and simulation tools, which enable us to leverage our intellectual property portfolio, improve time to commercialization, and deliver high-performance products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We generally control access to and use of our proprietary and confidential information by employing internal and external controls, including
contractual protections with employees, consultants, contractors, customers, partners, and suppliers. Our employees and consultants are required to execute confidentiality and invention assignment agreements in connection with their employment or
consulting relationships with us. We also require them to agree to disclose and assign to us inventions conceived or made in connection with the employment or consulting relationship. Despite our efforts to protect our IP, such agreements may be
insufficient or breached, and unauthorized parties may copy or otherwise obtain and use our software, technology, or other information that we regard as proprietary intellectual property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The semiconductor industry is characterized by vigorous protection and pursuit of intellectual property rights and positions, resulting in
protracted and expensive litigation for many companies. We have in the past received, and we expect that in the future we may receive, allegations of infringement, misappropriation or other violations or liability for damages that may invalidate our
proprietary rights and harm our business and our ability to compete. Any litigation, regardless of success or merit, could cause us to incur substantial expenses, reduce our sales, and divert the efforts of our technical and management personnel. In
the event we receive an adverse result in any litigation, we could be required to pay substantial damages, seek licenses from third parties, which may not be available on reasonable terms or at all, cease the sale of our solutions, expend
significant resources to develop alternative technology or discontinue the use of processes requiring the relevant IP or technology. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Data Privacy and
Cybersecurity </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Numerous data privacy and security obligations, including state, federal, and foreign laws, regulations, rules and
standards, govern the collection, use, access to, handling, transmission, processing, confidentiality, and security of personal data and could apply now or in the future to our operations or the operations of our partners. Data privacy and
cybersecurity laws, regulations, rules, standards, and other obligations are constantly evolving, may conflict with each other to complicate compliance efforts, and can result in investigations, proceedings, or actions that lead to significant civil
penalties and restrictions on data collection, transfers, and processing. Such federal U.S. and foreign obligations may include, without limitation, the Federal Trade Commission Act, the EU General Data Protection Regulation (EU GDPR), the UK
General Data Protection Regulation (UK GDPR), and Mainland China&#146;s Personal Information Protection Law (PIPL). Additionally, several states within the United States have enacted or proposed data privacy laws. For example, California passed the
California Consumer Privacy Act, as amended by the California Privacy Rights Act (collectively, CCPA), Virginia passed the Consumer Data Protection Act, Colorado passed the Colorado Privacy Act, and Utah passed the Consumer Privacy Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, we are, or may become, subject to various U.S. federal and state consumer protection laws, which require us to publish
statements that accurately and fairly describe how we handle personal data and the choices individuals may have about how we handle their personal data. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The CCPA and EU GDPR are increasingly stringent and evolving regulatory frameworks related to personal data processing that may increase our
compliance obligations and exposure to <FONT STYLE="white-space:nowrap">non-compliance.</FONT> For example, the CCPA imposes obligations on covered businesses to provide specific disclosures related to a business&#146;s collecting, using, and
disclosing personal data, including certain sensitive personal data, and to respond to certain requests from California residents related to their personal data (for example, requests to know of the business&#146;s
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
personal data processing activities, to delete the individual&#146;s personal information, and to opt out of certain personal data disclosures). Also, the CCPA provides civil penalties and a
private right of action for data breaches, which may include the award of statutory damages. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Foreign data privacy and cybersecurity laws
(including, but not limited to, the EU GDPR, UK GDPR, and PIPL) impose significant and complex compliance obligations on entities subject to those laws. For example, the EU GDPR applies to any company established in the European Economic Area (EEA)
and to companies based outside the EEA that process personal data in connection with offering goods or services to data subjects or monitoring the behavior of data subjects in the EEA. These obligations may include limiting personal data processing
to only what is necessary for specified, explicit, and legitimate purposes, requiring a legal basis for personal data processing, requiring the appointment of a data protection officer in certain circumstances, imposing transparency obligations to
data subjects, requiring data protection impact assessments in certain circumstances, limiting the collection and retention of personal data, providing certain rights for data subjects related to their personal data, imposing specific standards for
data subject consents, requiring the implementation and maintenance of technical and organizational safeguards for personal data, mandating notice of certain personal data breaches to the relevant supervisory authority(ies) and affected individuals,
and mandating the appointment of representatives in the UK and/or the EU in certain circumstances. Some of these laws and regulations authorize the governing agencies to investigate companies under their jurisdiction to ensure compliance and to
impose fines and other measures against companies who are not in compliance. See the section titled &#147;Risk Factors &#150; Risks Related to Our Intellectual Property&#148; for additional information about the laws and regulations to which we may
become subject and about the risks to our business associated with such laws and regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Cyber-attacks, malicious internet-based
activity, online and offline fraud, and other similar activities threaten the confidentiality, integrity, and availability of our sensitive information and information technology systems, as well as those of the third parties we work with. Such
threats are prevalent and continue to rise, are increasingly challenging to detect, and come from a variety of sources, including traditional computer &#147;hackers,&#148; threat actors, &#147;hacktivists,&#148; organized criminal threat actors,
personnel (such as through theft or misuse), sophisticated nation states, and nation-state-supported actors. Some actors now engage and are expected to continue to engage in cyber-attacks, including, without limitation nation-state actors for
geopolitical reasons and in conjunction with military conflicts and defense activities. See the section titled &#147;Risk Factors &#150; Risks Related to Our Business&#148; for additional information about the cybersecurity risks to our business.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The semiconductor
market is intensely competitive. We anticipate that the market for our products will continually evolve and be subject to rapid technological change. We believe the principal competitive factors in our industry are: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Power consumption and battery life; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Product capabilities, functionality and performance; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Product size; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level of integration; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">End customer support; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Reliability; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ability to rapidly introduce new products to market; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Price; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Intellectual property protection; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Software capabilities. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that we are competitive with respect to these factors, particularly because our
SPOT platform is designed to enable our products to have significantly lower power consumption than alternative products, allowing for greater adoption of AI at the edge. Our products are manufactured in standard CMOS, which generally allows us to
supply them relatively rapidly so that end customers can meet their product introduction schedules. However, the disadvantages we face include our relatively short operating history in certain of our markets and our smaller size and customer base
relative to many of our competitors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Today, we generally compete with large MCU vendors, such as Infineon, Microchip, NXP, Renesas,
Silicon Laboratories, STMicroelectronics, Texas Instruments, and others. In addition, we also compete with connectivity players such as Dialog Semiconductor (now Renesas), Nordic Semiconductor, Synaptics, and Telink. In addition, we sometimes
compete (and other times work alongside certain designs) with connected processor platform players such as Qualcomm. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2024, we had 189 full-time equivalent employees located in the United States, Mainland China, Taiwan, and Singapore,
including 125 in research and development (including 43 in software and system-level design and 12 in operations), 43 in sales and marketing and 21 in general and administrative. We consider relations with our employees to be good and have never
experienced a work stoppage. None of our employees are either represented by a labor union or subject to a collective bargaining agreement.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Facilities </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our principal executive
offices are located in a leased facility in Austin, Texas, consisting of approximately 12,500 square feet of office space under a lease expiring in June 2025. This facility accommodates our principal engineering, sales, marketing, operations,
finance, and administrative activities. We are working closely with our current landlord in Austin to renew the lease or move offices to a larger space within the same office complex. We also lease offices in Taiwan, Singapore, and Mainland China.
We do not own any real property. We believe that our leased facilities are adequate to meet our current needs and that additional facilities will be available on commercially reasonable terms for lease to meet future needs.</P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal Proceedings </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are currently not a
party to any material legal proceedings. We may, from time to time, become involved in litigation relating to claims arising from our ordinary course of business. These claims, even if not meritorious, could result in the expenditure of significant
financial and managerial resources. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_11"></A>MANAGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officers and Directors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following table sets forth information regarding our executive officers and directors as of December&nbsp;31, 2024: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="46%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Times New Roman"><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Position</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Executive Officers</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fumihide Esaka</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Executive Officer and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sean Chen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>President and Chief Operating Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Hanson, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">41</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Technology Officer and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Goodwin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Financial Officer</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wen Hsieh, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chairman</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ker Zhang, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">62</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph Tautges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Timothy Chen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD></TR>
</TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Fumihide Esaka </I>has served as our Chief Executive Officer and as a member of our board of directors since December 2015. Prior to joining
Ambiq, Mr.&nbsp;Esaka served as chief executive officer of Transphorm Inc., a global semiconductor development company, from June 2013 to November 2015 and president and chief executive officer of Nihon Inter Electronics Corporation (NIEC) from June
2010 to May 2013. Mr.&nbsp;Esaka holds a B.A. in electrical engineering and computer science from the University of California San Diego. We believe that Mr.&nbsp;Esaka&#146;s current role as our Chief Executive Officer and his extensive executive
leadership and management experience at semiconductor companies qualify him to serve on our board of directors. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Scott Hanson,
Ph.D. </I>founded Ambiq and has served as our Chief Technology Officer since February 2013. Previously, Dr.&nbsp;Hanson served as our CEO from January 2010 to January 2013. Dr.&nbsp;Hanson has served on our board of directors since January 2010.
Dr.&nbsp;Hanson has won numerous awards, including the ECE Alumni Rising Star Award and Arbor Networks Ph.D. Research Impact Award from University of Michigan. Dr.&nbsp;Hanson holds a BSE in electrical engineering, a MSE in electrical engineering
and a Ph.D. in electrical engineering from the University of Michigan. We believe that Dr.&nbsp;Hanson&#146;s role as our founder and Chief Technology Officer and his extensive knowledge of our technology qualify him to serve on our board of
directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Sean Chen </I>has served as our President since November 2016 and is currently also serving as Chief Operation Officer.
Previously, Mr.&nbsp;Chen served as our Group V.P., Greater China and Global Operations from November 2015 to October 2016. Mr.&nbsp;Chen has over 20 years of semiconductor experience and has previously served as Vice President of Marketing and
Business Development at mCube, and held several management positions at various startups and at Nagevtech, Intel, IDT, and TSMC. Mr.&nbsp;Chen holds a M.S. in Chemical Engineering from the National Cheng-Kung University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Scott Goodwin </I>has served as our Chief Financial Officer since September 2022. Prior to joining us full-time, Mr.&nbsp;Goodwin served as
an outside consultant and our Interim Chief Financial Officer since January 2022 through Bridgepoint Consulting. Prior to his employment at Bridgepoint Consulting, Mr.&nbsp;Goodwin was Chief Financial Officer at Madison Energy, a division of Madison
Industries, from March 2018 until June 2020. Before Madison Energy, Mr.&nbsp;Goodwin served as Chief Financial Officer at Cenveo, Inc., a $2&nbsp;billion public manufacturer of envelopes, labels, and commercial print products from August 2012 to
March 2018 and previously served as its Assistant Corporate Controller from June 2006 to August 2012. Mr.&nbsp;Goodwin is a Certified Public Accountant and holds a B.S. in Accounting from The Citadel. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Dr.&nbsp;Wen Hsieh</I> has been a member of our board of directors since November 2014. He co-founded Matter Venture Partners (MVP) in
January 2023. MVP is a $311&nbsp;million Silicon Valley-based venture fund focused on early-stage investments in semiconductors, robotics/Robotics-as-a-Service, AI infrastructure, manufacturing tech, energy building blocks and automation tools for
life sciences. Prior to MVP, Dr. Hsieh was a General Partner of Kleiner Perkins (KP), from February 2006 to January 2023, where he led the HardTech practice. Before joining KP, Dr.&nbsp;Hsieh was an Associate Principal at McKinsey &amp; Co. San
Francisco, and a leader of McKinsey&#146;s semiconductor practice. Prior to McKinsey, Dr.&nbsp;Hsieh founded OnChip Technologies, a startup developing MEMS microfluidic biochips. Dr.&nbsp;Hsieh currently sits on the public company boards of Desktop
Metal and Amprius Technologies. He earned a B.S. with honors, an M.S. and Ph.D. in electrical engineering, plus a Ph.D. minor in biology, all from the California Institute of Technology. We believe that Dr.&nbsp;Hsieh&#146;s extensive experience as
an investor in the semiconductor and other HardTech industries, as well as his experience serving on boards of directors of various technology companies qualifies him to serve on our board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Ker Zhang, Ph.D</I>. has been a member of our board of directors since August 2017. Dr.&nbsp;Zhang is a technology expert with over 30
years of hard tech experience as an engineer, executive, entrepreneur, CEO, Chairman, and investor. Dr.&nbsp;Zhang is the Executive Chairman of Crossbar Inc., a Kleiner Perkins portfolio company that develops innovative memory technology since April
2019. Dr.&nbsp;Zhang also has been a member of the board of Valens Semiconductor Co. since September 2021. Dr.&nbsp;Zhang also advises Intel Capital and served on the board of Keyssa on behalf of Intel. Previously, from February 2018 to September
2023, Dr. Zhang was an Entrepreneur In Residence at Kleiner Perkins. In addition, he was Vice President and General Manager of Intel&#146;s CDMA product and development group from October 2015 to February 2018. Dr.&nbsp;Zhang was the CEO of VIA
Telecom from 2002 until it was acquired by Intel in 2015. Dr.&nbsp;Zhang holds an M.S. in physics from the University of Massachusetts and a Ph.D. in Electrical Engineering from Worcester Polytechnic Institute. He holds 3 U.S. patents. We believe
that Dr.&nbsp;Zhang&#146;s experience and expertise in hardware engineering and years of senior management experience qualify him to serve on our board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Joseph Tautges </I>has been a member of our board of directors since November 2022. Mr.&nbsp;Tautges is currently the EVP and Chief
Operating Officer at Worldpay Inc. and has served in this role since March 2024 to present. Mr.&nbsp;Tautges previously served as the Executive Vice President, Chief Operating Officer of CDK Global from January 2021 to July 2022, and as its
Executive Vice President, Chief Financial Officer from August 2017 to January 2021. Prior to joining CDK, Mr.&nbsp;Tautges served as Chief Financial Officer of the $18&nbsp;billion Enterprise Services segment of Hewlett Packard Enterprise (HPE) from
May 2014 to April 2017. Prior to HPE, Mr.&nbsp;Tautges held various levels of increasing responsibility in both operations and financial management with Sears Holdings from 2011 to 2014 and Aon Hewitt from 2002 to 2011. Mr.&nbsp;Tautges is a
Certified Public Accountant. Mr.&nbsp;Tautges holds a degree in accountancy from Northern Illinois University. We believe that Mr.&nbsp;Tautges&#146; decades of experience in various leadership roles at CDK Global and HPE and his experience as a COO
and CFO qualify him well to serve on our board of directors. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Timothy Chen&nbsp;</I>has been a member of our board of directors
since November 2023. Mr. Chen is a founding partner of ACHI and KQ Capital, and has served as the CEO of VIA China since September 2015. Prior to serving as CEO, Mr. Chen was the Head of Sales and Business Development at VIA China, where he began in
2007. From October 2019 to February 2022, Mr. Chen served as Chairman for Via Telecom, a CDMA alternative chip supplier to Qualcomm, Inc. In addition, Mr. Chen served as Chief Financial Officer of PTK Acquisition Corp., who, in 2021, announced an
SPAC business combination with Valens Semiconductor, Ltd., resulting in their listing on the New York Stock Exchange. In December 2014, Mr. Chen founded EMQ, an Asian cross-border startup developing global payment network solutions, where he now
serves as Chairman and board member. In addition, since June 2006, Mr. Chen has served as a board member of CatchPlay, a leading Taiwanese multimedia and digital content provider. Mr. Chen holds a degree in Engineering from the University of
California Berkely. We believe that Mr. Chen&#146;s experience in various leadership roles and his expertise in hardware engineering qualify him to serve on our board of directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Family Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There are no family relationships among any of our directors or executive officers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Composition </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our business and
affairs are organized under the direction of our board of directors, which currently consists of six members. Our board of directors may establish the authorized number of directors from time to time by resolution and the authorized number of
directors comprising our board of directors is currently set at ten with four vacancies. The primary responsibilities of our board of directors are to provide oversight, strategic guidance, counseling, and direction to our management. Our board of
directors meets on a regular basis and additionally as required. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certain members of our board of directors were elected under the
provisions of our Amended and Restated Voting Agreement entered into in August 2023 (the Voting Agreement), which will terminate upon the closing of this offering. Under the terms of our Voting Agreement, the stockholders who are party to the Voting
Agreement have agreed to vote their respective shares to elect: (i)&nbsp;one director designated by a majority of holders of our Series A redeemable convertible preferred stock, which seat is currently vacant; (ii)&nbsp;two directors designated by a
majority of holders of our Series C redeemable convertible preferred stock, which individuals are initially Wen Hsieh, Ph.D. and Timothy Chen; (iii)&nbsp;one director designated by a majority of holders of our Series E redeemable convertible
preferred stock, which is currently vacant; (iv)&nbsp;three directors designated by a majority of holders of our common stock, voting as a separate class, which individuals are initially Fumihide Esaka as CEO Director, Scott Hanson, Ph.D. and one
vacancy; and (v)&nbsp;three directors designated by a majority of holders of our common stock and preferred stock, voting together as a single class on an
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">as-if-converted</FONT></FONT> to common stock basis, which individuals are currently Ker Zhang, Ph.D. and Joseph Tautges, and one vacancy. The Voting Agreement will terminate upon the
closing of this offering, and upon the closing of the offering no stockholder will have any special rights regarding the election or designation of the members of our board of directors. Our current directors elected to our board of directors
pursuant to the Voting Agreement will continue to serve as directors until their successors are duly elected and qualified by holders of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has determined that &#8195;&#8195;&#8195; of our six directors are independent directors, as defined under the
&#8195;&#8195;&#8195; listing rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In accordance with the terms of our amended and restated bylaws, which will be effective immediately
prior to the completion of this offering, our board of directors will be divided into three classes, Class&nbsp;I, Class&nbsp;II, and Class&nbsp;III, with members of each class serving staggered three-year terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Effective upon the closing of this offering, our board of directors will be comprised of &#8195;&#8195;&#8195; directors divided into the
following classes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Class&nbsp;I, which will consist of &#8195;&#8195;&#8195; and &#8195;&#8195;&#8195;, whose terms will expire at
our first annual meeting of stockholders to be held after the completion of this offering; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Class&nbsp;II, which will consist of &#8195;&#8195;&#8195;, &#8195;&#8195;&#8195;, and &#8195;&#8195;&#8195;,
whose terms will expire at our second annual meeting of stockholders to be held after the completion of this offering; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Class&nbsp;III, which will consist of &#8195;&#8195;&#8195;, &#8195;&#8195;&#8195;, and &#8195;&#8195;&#8195;,
whose terms will expire at our third annual meeting of stockholders to be held after the completion of this offering. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At each annual meeting of stockholders to be held after the initial classification, the successors to directors whose terms then expire will
be elected to serve from the time of election and qualification until the third annual meeting following their election and until their successors are duly elected and qualified. The authorized size of our board of directors is currently
&#8195;&#8195;&#8195; members and may be changed only by resolution by a majority of our board of directors. We currently anticipate that our board of directors will consist of &#8195;&#8195;&#8195; members prior to the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
completion of this offering. This classification of our board of directors may have the effect of delaying or preventing changes in our control or management. Our directors may be removed for
cause by the affirmative vote of the holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> (2/3) of our voting stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director
Independence </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the &#8195;&#8195;&#8195; listing rules, independent directors must comprise a majority of our board of directors
as a listed company within one year of the listing date. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors has undertaken a review of the independence of each
director. Based on information provided by each director concerning her or his background, employment and affiliations, including family relationships, our board of directors has determined that none of our directors, other than Fumihide Esaka and
Scott Hanson, Ph.D., has any relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director and that each of these directors is &#147;independent&#148; as that term is defined under the
&#8195;&#8195;&#8195; listing rules. Our board of directors has determined that Fumihide Esaka and Scott Hanson, Ph.D. by virtue of their positions as our Chief Executive Officer and Chief Technology Officer, respectively, are not independent under
applicable rules and regulations of the U.S. Securities and Exchange Commission (the SEC) and the &#8195;&#8195;&#8195; listing rules. In making these determinations, our board of directors considered the current and prior relationships that each <FONT
STYLE="white-space:nowrap">non-employee</FONT> director has with our company and all other facts and circumstances our board of directors deemed relevant in determining their independence, including the beneficial ownership of our shares by each <FONT
STYLE="white-space:nowrap">non-employee</FONT> director and the transactions described in the section titled &#147;Certain Relationships and Related Person Transactions.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Role of our Board of Directors in Risk Oversight/Risk Committee </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">One of the key functions of our board of directors is informed oversight of our risk management process. Our board of directors does not have a
standing risk management committee but rather administers this oversight function directly through our board of directors as a whole, as well as through various standing committees of our board of directors that address risks inherent in their
respective areas of oversight. In particular, our board of directors is responsible for monitoring and assessing strategic risk exposure and our audit committee has the responsibility to consider and discuss our major financial risk exposures and
the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. The audit committee also monitors compliance with legal and
regulatory requirements. Our compensation committee also assesses and monitors whether our compensation plans, policies, and programs comply with applicable legal and regulatory requirements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Committees </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of
directors has established a compensation committee, and will establish an audit committee and a nominating and corporate governance committee. Our board of directors has adopted a charter for each of these committees, which complies with the
applicable requirements of current &#8195;&#8195;&#8195; rules. We intend to comply with future requirements to the extent they are applicable to us. Following the completion of this offering, copies of the charters for each committee will be
available on the investor relations portion of our website. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our audit committee consists of &#8195;&#8195;&#8195;, &#8195;&#8195;&#8195;, and &#8195;&#8195;&#8195;. Our board of directors has determined
that each of the members of our audit committee satisfies the independence requirements of &#8195;&#8195;&#8195; and Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Exchange Act. Each member of our audit committee can read and
understand fundamental financial statements in accordance with &#8195;&#8195;&#8195; audit committee requirements. In arriving at this determination, our board of directors has examined each audit committee member&#146;s scope of experience and the
nature of their prior and/ or current employment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#8195;&#8195;&#8195;serves as the chair of our audit committee. Our board of directors has
determined that qualifies as an audit committee financial expert within the meaning of SEC regulations and meets the financial sophistication requirements of the listing rules. In making this determination, our board has considered
&#8195;&#8195;&#8195;&#146;s formal education and previous experience in financial roles. Both our independent registered public accounting firm and management periodically meet privately with our audit committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The functions of this committee include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the performance, independence, and qualifications of our independent auditors and determining whether
to retain our existing independent auditors or engage new independent auditors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing our financial reporting processes and disclosure controls; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the engagement of our independent auditors to perform audit services and any permissible <FONT
STYLE="white-space:nowrap">non-audit</FONT> services; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the adequacy and effectiveness of our internal control policies and procedures, including the
responsibilities, budget, staffing, and effectiveness of our internal audit function; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with the independent auditors the annual audit plan, including the scope of audit activities and all
critical accounting policies and practices to be used by us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtaining and reviewing at least annually a report by our independent auditors describing the independent
auditors&#146; internal quality control procedures and any material issues raised by the most recent internal quality-control review; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">monitoring the rotation of partners of our independent auditors on our engagement team as required by law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to engagement of any independent auditor, and at least annually thereafter, reviewing relationships that
may reasonably be thought to bear on their independence, and assessing and otherwise taking the appropriate action to oversee the independence of our independent auditor; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing our annual and quarterly financial statements and reports, including the disclosures contained in
&#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations,&#148; and discussing the statements and reports with our independent auditors and management; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with our independent auditors and management significant issues that arise regarding accounting
principles and financial statement presentation and matters concerning the scope, adequacy, and effectiveness of our financial controls and critical accounting policies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with management and our auditors any earnings announcements and other public announcements regarding
material developments; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing procedures for the receipt, retention, and treatment of complaints received by us regarding
financial controls, accounting, auditing, or other matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing the report that the SEC requires in our annual proxy statement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and providing oversight of any related person transactions in accordance with our related person
transaction policy and reviewing and monitoring compliance with legal and regulatory responsibilities, including our code of ethics; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing our major financial risk exposures, including the guidelines and policies to govern the process by
which risk assessment and risk management is implemented; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and evaluating on an annual basis the performance of the audit committee and the audit committee
charter. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that the composition and functioning of our audit committee complies with all applicable
requirements of the Sarbanes-Oxley Act and all applicable SEC rules and regulations. We intend to comply with future requirements to the extent they become applicable to us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our compensation committee consists of &#8195;&#8195;&#8195;, &#8195;&#8195;&#8195;, and &#8195;&#8195;&#8195;. serves as the chair of our
compensation committee. Our board of directors has determined that each of the members of our compensation committee is a <FONT STYLE="white-space:nowrap">non-employee</FONT> director, as defined in Rule <FONT STYLE="white-space:nowrap">16b-3</FONT>
promulgated under the Exchange Act, and satisfies the independence requirements of &#8195;&#8195;&#8195;. The functions of this committee include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the corporate objectives that pertain to the determination of executive compensation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the compensation and other terms of employment of our executive officers;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving performance goals and objectives relevant to the compensation of our executive officers
and assessing their performance against these goals and objectives; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">making recommendations to our board of directors regarding the adoption or amendment of equity and cash incentive
plans and approving amendments to such plans to the extent authorized by our board of directors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and making recommendations to our board of directors regarding the type and amount of compensation to
be paid or awarded to our <FONT STYLE="white-space:nowrap">non-employee</FONT> board members; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and assessing the independence of compensation consultants, legal counsel, and other advisors as
required by Section&nbsp;10C of the Exchange Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">administering our equity incentive plans, to the extent such authority is delegated by our board of directors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the terms of any employment agreements, severance arrangements, change in control
protections, indemnification agreements, and any other material arrangements for our executive officers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with management our disclosures under the caption &#147;Compensation Discussion and Analysis&#148; in
our periodic reports or proxy statements to be filed with the SEC, to the extent such caption is included in any such report or proxy statement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing an annual report on executive compensation that the SEC requires in our annual proxy statement; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and evaluating on an annual basis the performance of the compensation committee and recommending such
changes as deemed necessary with our board of directors. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that the composition and functioning of our
compensation committee complies with all applicable requirements of the Sarbanes-Oxley Act and all applicable SEC and &#8195;&#8195;&#8195; rules and regulations. We intend to comply with future requirements to the extent they become applicable to
us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the effectiveness of the registration statement of which this prospectus forms a part, our nominating and corporate governance committee
will consist of &#8195;&#8195;&#8195;, &#8195;&#8195;&#8195;, and &#8195;&#8195;&#8195;. Our board of directors has determined that each of the members of our nominating and corporate governance committee satisfies the independence requirements of
&#8195;&#8195;&#8195;. &#8195;&#8195;&#8195;serves as the chair of our nominating and corporate governance committee. The functions of this committee include, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying, reviewing, and making recommendations of candidates to serve on our board of directors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the performance of our board of directors, committees of our board of directors, and individual
directors and determining whether continued service on our board is appropriate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating nominations by stockholders of candidates for election to our board of directors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the current size, composition, and organization of our board of directors and its committees and
making recommendations to our board of directors for approvals; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing a set of corporate governance policies and principles and recommending to our board of directors any
changes to such policies and principles; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing issues and developments related to corporate governance and identifying and bringing to the attention
of our board of directors current and emerging corporate governance trends; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing periodically the nominating and corporate governance committee charter, structure, and membership
requirements and recommending any proposed changes to our board of directors, including undertaking an annual review of its own performance. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe that the composition and functioning of our nominating and corporate governance committee complies with all applicable requirements
of the Sarbanes-Oxley Act and all applicable SEC and &#8195;&#8195;&#8195; rules and regulations. We intend to comply with future requirements to the extent they become applicable to us. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None of our executive officers currently serve, or has served during the last completed fiscal year, on the compensation committee or board of
directors of any other entity that has one or more executive officers serving as a member of our board of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitation on Liability and
Indemnification of Directors and Officers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation, which will be effective upon the
closing of this offering, limits our directors&#146; and officers&#146; liability to the fullest extent permitted under Delaware General Corporation Law (the DGCL). The DGCL provides that directors of a corporation will not be personally liable for
monetary damages for breach of their fiduciary duties as directors, except for liability: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for any transaction from which the director derives an improper personal benefit; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for any unlawful payment of dividends or redemption of shares; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">for any breach of a director&#146;s duty of loyalty to the corporation or its stockholders.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of
directors or officers, then the liability of our directors and officers shall be eliminated or limited to the fullest extent permitted by the DGCL, as so amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delaware law and our amended and restated bylaws provide that we will, in certain situations, indemnify our directors and officers and may
indemnify other employees and other agents, to the fullest extent permitted by law. Any indemnified person is also entitled, subject to certain limitations, to advancement, direct payment, or reimbursement of reasonable expenses (including
attorneys&#146; fees and disbursements) in advance of the final disposition of the proceeding. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, we have entered, and intend
to continue to enter, into separate indemnification agreements with our directors and officers. These agreements, among other things, require us to indemnify our directors and officers for certain expenses, including attorneys&#146; fees, judgments,
fines, and settlement amounts incurred by a director or officer in any action or proceeding arising out of their services as one of our directors or officers or any other company or enterprise to which the person provides services at our request.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We maintain a directors&#146; and officers&#146; insurance policy pursuant to which our directors and officers are insured against
liability for actions taken in their capacities as directors and officers. We believe that these provisions in our amended and restated certificate of incorporation and amended and restated bylaws and these indemnification agreements are necessary
to attract and retain qualified persons as directors and officers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act of 1933, as
amended (Securities Act), may be permitted to directors, officers, or control persons, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Code of Business Conduct and Ethics for Employees, Executive Officers and Directors </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to adopt a Code of Business Conduct and Ethics (the Code of Conduct), applicable to all of our employees, executive officers, and
directors. The Code of Conduct will be available on our website at www.ambiq.com. Information contained on or accessible through our website is not a part of this prospectus, and the inclusion of our website address in this prospectus is an inactive
textual reference only. The nominating and corporate governance committee of our board of directors is responsible for overseeing the Code of Conduct and must approve any waivers of the Code of Conduct for employees, executive officers, and
directors. We expect that any amendments to the Code of Conduct, or any waivers of its requirements, will be disclosed on our website. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">During the year ended December 31, 2024, each of the
following individuals served on our board of directors as <FONT STYLE="white-space:nowrap">non-employee</FONT> directors: Kim Stevenson, Timothy Chen, Wen Hsieh, Ph.D., Edward Hill, Ker Zhang, Ph.D. and Huang Lee. Ms.&nbsp;Stevenson, Mr.&nbsp;Hill
and Mr.&nbsp;Lee resigned from our board of directors, effective November&nbsp;15, 2024. In connection with their resignations, each of Ms.&nbsp;Stevenson and Mr.&nbsp;Hill entered into advisor agreements with us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table presents all of the compensation awards to or earned by or paid to our named
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors during the year ended December&nbsp;31, 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="59%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees&nbsp;Earned&nbsp;or&nbsp;Paid<BR>in Cash ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock&nbsp;Awards&nbsp;($)<SUP STYLE="font-size:75%; vertical-align:top">(1)(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kim Stevenson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">45,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">345,833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ker Zhang, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">253,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">253,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph Tautges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">350,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Timothy Chen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All of the stock awards were granted under the 2020 Equity Incentive Plan (the &#147;2020 Plan&#148;), the
terms of which are described below under &#147;Executive Compensation&#151;Equity Benefit Plans&#151;2020 Equity Incentive Plan.&#148; The amounts shown represent the grant date fair values of RSUs granted in 2024 as computed in accordance with
Financial Accounting Standards Board (FASB) Accounting Standard Codification (ASC) Topic 718. See Note 13, Stock Option Plan and Stock- Based Compensation, to our consolidated financial statements included elsewhere in this prospectus for a
discussion of the assumptions used in the calculation. This amount does not reflect the actual economic value that may be realized by the <FONT STYLE="white-space:nowrap">non-employee</FONT> director. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of December&nbsp;31, 2024, the aggregate number of shares underlying outstanding RSUs under our 2020 Plan
and options to purchase shares of common stock under our 2010 Equity Incentive Plan (the &#147;2010 Plan&#148;), the terms of which are described below under &#147;Executive Compensation&#151;Equity Benefit Plans&#151;2010 Equity Incentive
Plan,&#148; and our 2020 Plan held by each of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors was as follows: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="17%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares&nbsp;Underlying<BR>RSUs </B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Shares&nbsp;Underlying<BR>Outstanding Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Edward Hill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">102,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(a)</SUP>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ker Zhang, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">666,666</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(b)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">900,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Kim Stevenson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">936,936</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(c)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joeseph Tautges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">916,666</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(d)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Timothy Chen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">666,666</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(e)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In connection with Mr.&nbsp;Hill&#146;s provision of advisory services to us, his option awards continue to
vest pursuant to their original vesting schedules until Mr.&nbsp;Hill&#146;s continuous service (as defined in the 2020 Plan) under the 2020 Plan is otherwise terminated or interrupted. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents 666,666 RSUs, 1/4th of which vest on December&nbsp;1, 2025, and 1/16 of which vest quarterly
thereafter. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 270,270 RSUs, 1/4th of which vested on March&nbsp;1, 2023, and 1/16 of which vest quarterly
thereafter, and (ii) 666,666 RSUs, 1/4th of which will vest on June&nbsp;1, 2025, and 1/16 of which vest quarterly thereafter. In connection with Ms.&nbsp;Stevenson&#146;s provision of advisory services to us, her RSUs continue to vest pursuant to
their original vesting schedules until Ms.&nbsp;Stevenson&#146;s continuous service (as defined in the 2020 Plan) under the 2020 Plan is otherwise terminated or interrupted. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 250,000 RSUs, 1/4th of which vested on December&nbsp;1, 2023, and 1/16 of which vest quarterly
thereafter, and (ii) 666,666 RSUs, 1/4th of which vest on June&nbsp;1, 2025, and 1/16 of which vest quarterly thereafter. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents 666,666 RSUs, 1/4th of which vested on December&nbsp;1, 2024, and 1/16 of which vest quarterly
thereafter. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Wen Hsieh, Ph.D., Huang Lee and Edward Hill were not compensated for their service on our board of
directors during the year ended December&nbsp;31, 2024. Mr.&nbsp;Esaka, Mr.&nbsp;Sean Chen and Dr.&nbsp;Hanson each also served on our board of directors during the year ended December&nbsp;31, 2024, but did not receive any additional compensation
for their service as a director. See the section titled &#147;Executive Compensation&#148; for more information regarding the compensation earned by Mr.&nbsp;Esaka, Mr.&nbsp;Sean Chen and Dr.&nbsp;Hanson. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have reimbursed and will continue to reimburse all of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors for their
reasonable expenses incurred in attending meetings of our board of directors and committees of our board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect to adopt
a director compensation policy for <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation that will become effective following the completion of this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_12"></A>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our named executive officers, who consist of our principal executive officer and our two other most highly compensated executive officers, for
the year ended December&nbsp;31, 2024 were: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Fumihide Esaka, our Chief Executive Officer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Sean Chen, our President and Chief Operating Officer; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Scott Hanson, Ph.D., our Chief Technology Officer. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary Compensation Table </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
following table presents all of the compensation awarded to, or earned by, our named executive officers during the fiscal year ended December&nbsp;31, 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards</B><br><B>($)<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($)<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Fumihide Esaka</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">614,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">518,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,434,119</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">178,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,744,676</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Sean Chen</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">420,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">227,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">766,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29,946</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,443,562</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>President and Chief Operating Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Scott Hanson, Ph.D.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">410,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">184,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">618,281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,216,381</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Technology Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts disclosed represent the sum of (a)&nbsp;the aggregate grant date fair value of the awards granted
to our named executive officers during 2024 under our 2020 Plan, as computed in accordance with FASB ASC Topic 718 and (b)&nbsp;the incremental fair values to the option awards resulting from the Repricing (defined below). The assumptions used in
calculating are set forth in Note 13 to our consolidated financial statements included elsewhere in this prospectus. This amount does not reflect the actual economic value that may be realized by the named executive officer. </P></TD></TR></TABLE>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts disclosed represent: (i)&nbsp;for Mr.&nbsp;Esaka, $50,000 of US housing allowance, $69,480 for
Singapore housing allowance, $42,000 for Singapore car allowance and $17,077 of company matching contributions to a 401(k) plan, and (ii)&nbsp;for Mr.&nbsp;Chen, $29,946 in Taiwan housing allowance and (iii) $4,100 of company matching contributions
to a 401(k) plan. </P></TD></TR></TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Narrative to Summary Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In setting executive base salaries and bonuses, we consider compensation for comparable positions in the market, the historical compensation
levels of our executives, individual performance as compared to our expectations and objectives, our desire to motivate our employees to achieve short- and long-term results that are in the best interests of our stockholders, and a long-term
commitment to us. We do not target a specific competitive position or a specific mix of compensation among base salary or bonus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Annual Base Salary
and Bonuses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Base salaries for our executive officers are initially established through
<FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> negotiations at the time of the executive officer&#146;s hiring, taking into account such executive officer&#146;s qualifications, experience, the scope of such executive officer&#146;s
responsibilities and competitive market compensation paid by other companies for similar positions within the industry and geography. Base salaries are reviewed periodically and adjusted from time to time to realign salaries with market levels after
taking into account individual responsibilities, performance, experience and adjustments to reflect cost of living increases. In making decisions regarding salary increases, we may also draw upon the experience of members of its board of directors
with executives at other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
companies. The base salaries for Messrs.&nbsp;Esaka and Chen and Dr. Hanson for 2024 were $614,000, $420,000 and $410,000, respectively. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In 2024, our named executive officers were eligible to receive discretionary annual performance bonuses based on individual performance,
company performance or as otherwise deemed appropriate, as determined by our board of directors. As disclosed in the summary compensation table, our board of directors approved discretionary bonuses to each of Messrs.&nbsp;Esaka and Chen and Dr.
Hanson of $518,000, $227,000 and $184,000, respectively for fiscal year 2024. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Equity-Based Incentive Awards </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our equity award program is the primary vehicle for offering long-term incentives to our executive officers. We believe that equity awards
provide our executives with a strong link to our long-term performance, create an ownership culture and help align the interests of our executives and stockholders. To date, we have primarily used stock option grants for this purpose because we
believe they are an effective means by which to align the long-term interests of our executive officers with those of stockholders. We believe that the equity awards are an important retention tool for executive officers, as well as for our other
employees. Grants to executive officers and other employees have historically been made at the discretion of our board of directors and are not made at any specific time period during a year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In July 2024, each of Messrs. Esaka and Chen and Dr. Hanson was granted an option to purchase 5,352,055, 2,631,427 and 2,000,000 shares of our
common stock, respectively. The options have an exercise price of $0.45 per share and are subject to a four-year vesting schedule, with 25% of the shares vesting on the first anniversary of the vesting commencement date and the balance vesting
monthly over 36&nbsp;months thereafter, subject to the continued service of the respective executive officers. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In May 2024, our
board of directors approved, effective May&nbsp;13, 2024, a <FONT STYLE="white-space:nowrap">one-time</FONT> repricing of certain stock options that had been granted to date under the 2020 Plan. The repricing impacted stock options with exercise
prices equal to or greater than $0.61, and each such stock option was repriced to have a per share exercise price of $0.45, the fair market value of a share of our common stock as determined by our board of directors on the date of the repricing
(the Repricing). No changes were made to the expiration dates of or number of shares underlying the repriced stock options. The incremental fair values from the Repricing to the impacted stock options for the named executive officers are included in
the &#147;Option Awards&#148; column in the Summary Compensation Table above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards as of December 31, 2024 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information concerning outstanding equity-based incentive awards held by our named executive officers as of
December&nbsp;31, 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:9pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant&nbsp;Date<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vesting<BR>Commencement<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Options (#)<BR>Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Options (#)<BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Fumihide Esaka </B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">01/12/2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12/01/2015</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,502,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">01/11/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">02/21/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">02/21/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,725,163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">02/20/2029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">05/26/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">05/26/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,058,751</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">355,569</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">05/25/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">07/21/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">01/01/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,564,526</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,787,529</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">07/20/2034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Sean Chen</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">03/11/2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">03/11/2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,559,229</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">03/10/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">02/21/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">02/21/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,603,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">02/20/2029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">05/26/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">05/26/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,863,699</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">332,989</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">05/25/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">07/21/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">01/01/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,260,892</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,370,535</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">07/20/2034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="22" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option Awards</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:9pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant&nbsp;Date<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vesting<BR>Commencement<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Options (#)<BR>Exercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Options (#)<BR>Unexercisable</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Exercise<BR>Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Scott Hanson, Ph.D. </B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10/02/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">08/16/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,452,219</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10/01/2028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">02/21/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">02/21/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,879,645</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">02/20/2029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">05/26/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">05/26/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,931,708</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">340,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.45</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">05/25/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">07/21/2024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">01/01/2023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">958,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,041,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.45</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">07/20/2034</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Options shown in the table with grant dates before 2020 were granted under our 2010 Plan and options shown in
the table with grant dates from and after 2021 were granted under our 2020 Plan, the terms of which are described below under &#147;&#151;Equity Incentive Plans.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The options vest in equal monthly installments over 48 months measured from the vesting commencement date,
subject to the named executive officer&#146;s continuous service with us. If a change in control (as defined in the 2020 Plan) occurs and the named executive officer&#146;s continuous service to us has not terminated as of the effective time of the
change in control, then, as of the effective time of the change in control, the vesting and exercisability of the option will be accelerated in full, subject to the named executive officer timely executing and allowing to become irrevocable a
general release of claims in our favor. Pursuant to the Repricing, the exercise price of the options was modified to be $0.45 per share, the fair market value of our common stock on the repricing date (May 13, 2024), as determined by our board of
directors. There was no change to the expiration dates of or number of shares underlying the options made in connection with the Repricing. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">25% of the options vest on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the vesting
commencement date and thereafter the remaining 75% of the options vest in equal monthly installments over <FONT STYLE="white-space:nowrap">thirty-six</FONT> months, subject to the named executive officer&#146;s continuous service with us. If we are
subject to a change in control (as defined in the 2010 Plan) and the named executive officer&#146;s continuous service to us has not terminated as of, or immediately prior to, the effective time of such change in control, then, as of the effective
time of such change in control, the vesting and exercisability of the option will be accelerated in full, subject to the named executive officer timely executing and allowing to become irrevocable a general release of claims in our favor.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Agreements with Our Named Executive Officers and Potential Payments Upon Termination or Change of Control </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into offer letters with Mr.&nbsp;Esaka and Mr.&nbsp;Chen, the material terms of which are described below. We have not entered
into an offer letter with Dr. Hanson. Each of our named executive officers has also executed our standard confidentiality and inventions assignment agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Agreement with Fumihide Esaka </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
November 2015, we entered into an offer letter with Fumihide Esaka, our Chief Executive Officer. The offer letter has no specific term and provides for <FONT STYLE="white-space:nowrap">at-will</FONT> employment. Mr.&nbsp;Esaka&#146;s current annual
base salary is $614,000. In addition, under the terms of Mr.&nbsp;Esaka&#146;s offer letter, we are required to reimburse him up to $50,000 per year (prorated for any partial year of employment) for <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses he incurs in connection with his primary housing in Austin, Texas, subject to his timely submission of substantiation for such expenses to the Company in accordance with its
reimbursement policies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Agreement with Sean Chen </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In September 2015, we entered into an offer letter with Sean Chen, our President and Chief Operating Officer. The offer letter has no specific
term and provides for <FONT STYLE="white-space:nowrap">at-will</FONT> employment. Mr.&nbsp;Chen&#146;s current annual base salary is $420,000. In addition, under the terms of Mr.&nbsp;Chen&#146;s offer letter, if he elects to attend an advanced
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
management program with a leading business school, we are required to reimburse him for reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT>
expenses he incurs in connection with attending such program, subject to his continued employment with the company and timely submission of substantiation for such expenses to the Company in accordance with its reimbursement policies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Potential Payments upon Termination or Change of Control </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not currently maintain any agreements or arrangements under which our name executive officers are eligible to receive cash severance
benefits. Certain options granted to our named executive officers are subject to acceleration of vesting and exercisability upon a change in control or a termination of the named executive officer&#146;s employment under certain circumstances, as
described in more detail above in the section titled &#147;Outstanding Equity Awards as of December&nbsp;31, 2024.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Health, Welfare and
Retirement Benefits </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All our current named executive officers are eligible to participate in our employee benefit plans, including our
life, medical, dental, and vision insurance plans and 401(k) plan (as described below), in each case on the same basis as all of our other employees. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nonqualified Deferred Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">None
of our named executive officers participates in or has account balances in nonqualified defined contribution plans or other nonqualified deferred compensation plans maintained by us. Our board of directors may elect to provide our officers and other
employees with nonqualified defined contribution or other nonqualified deferred compensation benefits in the future if it determines that doing so is in our best interests. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>401(k) Plan </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We sponsor a qualified
retirement plan that is intended to qualify for favorable tax treatment under Section&nbsp;401(a) of the Code and contains a cash or deferred feature that is intended to meet the requirements of Section&nbsp;401(k) of the Code. Participants may make
<FONT STYLE="white-space:nowrap">pre-tax</FONT> and certain <FONT STYLE="white-space:nowrap">after-tax</FONT> (Roth) salary deferral contributions to the plan from their eligible compensation up to the statutorily prescribed annual limit under the
Code. Participants who are 50 years of age or older may contribute additional amounts based on the statutory limits for <FONT STYLE="white-space:nowrap">catch-up</FONT> contributions. The plan also permits us to make annual discretionary matching
contributions to the plan accounts of eligible participants. Contributions are held in trust as required by law. No minimum benefit is provided under the plan. An employee&#146;s interest in his or her salary deferral contributions are 100% vested
when contributed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Incentive Plans </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2025
Equity Incentive Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In &#8195;&#8195;&#8195;, our board of directors adopted, and our stockholders approved the 2025 Plan. We
expect our 2025 Plan will become effective on the date of this prospectus. Our 2025 Plan came into existence upon its adoption by our board of directors, but no grants will be made under our 2025 Plan prior to its effectiveness. Once our 2025 Plan
becomes effective, no further grants will be made under our 2020 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Awards</I>. Our 2025 Plan provides for the grant of incentive
stock options (ISOs), within the meaning of Section&nbsp;422 of the Code, to our employees and our parent and subsidiary corporations&#146; employees, and for the grant of nonstatutory stock options (NSOs), stock appreciation rights, restricted
stock awards, restricted stock unit awards, performance awards and other forms of awards to our employees, directors and consultants and any of our affiliates&#146; employees and consultants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Authorized shares</I>. Initially, the maximum number of shares of our common stock that may be issued under our 2025 Plan after it becomes
effective will not exceed &#8195;&#8195;&#8195; shares of our common stock, which is the sum of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(i) &#8195;&#8195;&#8195; new shares, plus (ii)&nbsp;an additional number of shares not to exceed &#8195;&#8195;&#8195; shares, consisting of (a) shares that remain available for the issuance of
awards under our 2020 Plan as of immediately prior to the time our 2025 Plan becomes effective and (b)&nbsp;any shares of our common stock subject to outstanding stock options or other stock awards granted under our 2020 Plan that, on or after our
2025 Plan becomes effective, terminate or expire prior to exercise or settlement; are not issued because the award is settled in cash; are forfeited because of the failure to vest; or are reacquired or withheld (or not issued) to satisfy a tax
withholding obligation or the purchase or exercise price. In addition, the number of shares of our common stock reserved for issuance under our 2025 Plan will automatically increase on January&nbsp;1 of each year for a period of ten years, beginning
on January&nbsp;1, 2026 and continuing through January&nbsp;1, 2035, in an amount equal to (1) &#8195;&#8195;&#8195;% of the total number of shares of our common stock outstanding on December 31 of the immediately preceding year, or (2) a lesser
number of shares determined by our board of directors no later than December&nbsp;31 of the immediately preceding year. The maximum number of shares of our common stock that may be issued on the exercise of ISOs under our 2025 Plan is
&#8195;&#8195;&#8195; shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares subject to stock awards granted under our 2025 Plan that expire or terminate without being exercised
in full or that are paid out in cash rather than in shares will not reduce the number of shares available for issuance under our 2025 Plan. Shares withheld under a stock award to satisfy the exercise, strike or purchase price of a stock award or to
satisfy a tax withholding obligation will not reduce the number of shares available for issuance under our 2025 Plan. If any shares of our common stock issued pursuant to a stock award are forfeited back to or repurchased or reacquired by us
(i)&nbsp;because of a failure to meet a contingency or condition required for the vesting of such shares; (ii)&nbsp;to satisfy the exercise, strike or purchase price of a stock award; or (iii)&nbsp;to satisfy a tax withholding obligation in
connection with a stock award, the shares that are forfeited or repurchased or reacquired will revert to and again become available for issuance under our 2025 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Plan administration</I>. Our board of directors, or a duly authorized committee of our board of directors, administers our 2025 Plan. Our
board of directors may delegate to one or more of our officers the authority to (i) designate employees (other than officers) to receive specified stock awards; and (ii)&nbsp;determine the number of shares subject to such stock awards. Under our
2025 Plan, our board of directors has the authority to determine stock award recipients, the types of stock awards to be granted, grant dates, the number of shares subject to each stock award, the fair market value of our common stock, and the
provisions of each stock award, including the period of exercisability and the vesting schedule applicable to a stock award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our
2025 Plan, our board of directors also generally has the authority to effect, with the consent of any materially adversely affected participant, (i)&nbsp;the reduction of the exercise, purchase, or strike price of any outstanding option or stock
appreciation right; (ii)&nbsp;the cancellation of any outstanding option or stock appreciation right and the grant in substitution therefor of other awards, cash, or other consideration; or (iii)&nbsp;any other action that is treated as a repricing
under generally accepted accounting principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Stock options</I>. ISOs and NSOs are granted under stock option agreements adopted by
the administrator. The administrator determines the exercise price for stock options, within the terms and conditions of our 2025 Plan, except the exercise price of a stock option generally will not be less than 100% of the fair market value of our
common stock on the date of grant. Options granted under our 2025 Plan will vest at the rate specified in the stock option agreement as determined by the administrator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The administrator determines the term of stock options granted under our 2025 Plan, up to a maximum of 10 years. Unless the terms of an
optionholder&#146;s stock option agreement, or other written agreement between us and the optionholder, provide otherwise, if an optionholder&#146;s service relationship with us or any of our affiliates ceases for any reason other than disability,
death, or cause, the optionholder may generally exercise any vested options for a period of three months following the cessation of service. This period may be extended in the event that exercise of the option is prohibited by applicable securities
laws. If an optionholder&#146;s service relationship with us or any of our affiliates ceases due to death, or an optionholder dies within a certain period following cessation of service, the optionholder or a beneficiary may generally exercise any
vested options for a period of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">108 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
18 months following the date of death. If an optionholder&#146;s service relationship with us or any of our affiliates ceases due to disability, the optionholder may generally exercise any vested
options for a period of 12 months following the cessation of service. In the event of a termination for cause, options generally terminate upon the termination date. In no event may an option be exercised beyond the expiration of its term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Acceptable consideration for the purchase of common stock issued upon the exercise of a stock option will be determined by the administrator
and may include (i)&nbsp;cash, check, bank draft or money order; (ii)&nbsp;a broker- assisted cashless exercise; (iii)&nbsp;the tender of shares of our common stock previously owned by the optionholder; (iv) a net exercise of the option if it is an
NSO; or (v)&nbsp;other legal consideration approved by the administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the administrator provides otherwise, options or stock
appreciation rights generally are not transferable except by will or the laws of descent and distribution. Subject to approval of the administrator or a duly authorized officer, an option may be transferred pursuant to a domestic relations order,
official marital settlement agreement, or other divorce or separation instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Tax limitations on ISOs</I>. The aggregate fair
market value, determined at the time of grant, of our common stock with respect to ISOs that are exercisable for the first time by an award holder during any calendar year under all of our stock plans may not exceed $100,000. Options or portions
thereof that exceed such limit will generally be treated as NSOs. No ISO may be granted to any person who, at the time of the grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any of our
parent or subsidiary corporations unless (i)&nbsp;the option exercise price is at least 110% of the fair market value of the stock subject to the option on the date of grant; and (ii)&nbsp;the term of the ISO does not exceed five years from the date
of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Restricted stock unit awards</I>. Restricted stock unit awards are granted under restricted stock unit award agreements
adopted by the administrator. Restricted stock unit awards may be granted in consideration for any form of legal consideration that may be acceptable to our board of directors and permissible under applicable law. A restricted stock unit award may
be settled by cash, delivery of stock, a combination of cash and stock as deemed appropriate by the administrator, or in any other form of consideration set forth in the restricted stock unit award agreement. Additionally, dividend equivalents may
be credited in respect of shares covered by a restricted stock unit award. Except as otherwise provided in the applicable award agreement, or other written agreement between us and the recipient, restricted stock unit awards that have not vested
will be forfeited once the participant&#146;s continuous service ends for any reason. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Restricted stock awards</I>. Restricted stock
awards are granted under restricted stock award agreements adopted by the administrator. A restricted stock award may be awarded in consideration for cash, check, bank draft or money order, past or future services to us, or any other form of legal
consideration that may be acceptable to our board of directors and permissible under applicable law. The administrator determines the terms and conditions of restricted stock awards, including vesting and forfeiture terms. If a participant&#146;s
service relationship with us ends for any reason, we may receive any or all of the shares of common stock held by the participant that have not vested as of the date the participant terminates service with us through a forfeiture condition or a
repurchase right. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Stock appreciation rights</I>. Stock appreciation rights are granted under stock appreciation right agreements
adopted by the administrator. The administrator determines the purchase price or strike price for a stock appreciation right, which generally will not be less than 100% of the fair market value of our common stock on the date of grant. A stock
appreciation right granted under our 2025 Plan will vest at the rate specified in the stock appreciation right agreement as determined by the administrator. Stock appreciation rights may be settled in cash or shares of our common stock or in any
other form of payment as determined by our board of directors and specified in the stock appreciation right agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The administrator
determines the term of stock appreciation rights granted under our 2025 Plan, up to a maximum of 10 years. If a participant&#146;s service relationship with us or any of our affiliates ceases for any reason
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">109 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
other than cause, disability, or death, the participant may generally exercise any vested stock appreciation right for a period of three months following the cessation of service. This period may
be further extended in the event that exercise of the stock appreciation right following such a termination of service is prohibited by applicable securities laws. If a participant&#146;s service relationship with us, or any of our affiliates,
ceases due to disability or death, or a participant dies within a certain period following cessation of service, the participant or a beneficiary may generally exercise any vested stock appreciation right for a period of 12 months in the event of
disability and 18 months in the event of death. In the event of a termination for cause, stock appreciation rights generally terminate upon the termination date. In no event may a stock appreciation right be exercised beyond the expiration of its
term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Performance awards</I>. Our 2025 Plan permits the grant of performance awards that may be settled in stock, cash or other
property. Performance awards may be structured so that the stock or cash will be issued or paid only following the achievement of certain <FONT STYLE="white-space:nowrap">pre-established</FONT> performance goals during a designated performance
period. Performance awards that are settled in cash or other property are not required to be valued in whole or in part by reference to, or otherwise based on, our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The performance goals may be based on any measure of performance selected by our board of directors. The performance goals may be based on
company-wide performance or performance of one or more business units, divisions, affiliates, or business segments, and may be either absolute or relative to the performance of one or more comparable companies or the performance of one or more
relevant indices. Unless specified otherwise by our board of directors at the time the performance award is granted, our board will appropriately make adjustments in the method of calculating the attainment of performance goals as follows: (i) to
exclude restructuring or other nonrecurring charges; (ii)&nbsp;to exclude exchange rate effects; (iii)&nbsp;to exclude the effects of changes to generally accepted accounting principles; (iv)&nbsp;to exclude the effects of any statutory adjustments
to corporate tax rates; (v)&nbsp;to exclude the effects of items that are &#147;unusual&#148; in nature or occur &#147;infrequently&#148; as determined under generally accepted accounting principles; (vi)&nbsp;to exclude the dilutive effects of
acquisitions or joint ventures; (vii)&nbsp;to assume that any business divested by us achieved performance objectives at targeted levels during the balance of a performance period following such divestiture; (viii)&nbsp;to exclude the effect of any
change in the outstanding shares of our common stock by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, <FONT STYLE="white-space:nowrap">spin-off,</FONT> combination or exchange of
shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends; (ix)&nbsp;to exclude the effects of stock based compensation and the award of bonuses under our bonus plans; (x)&nbsp;to exclude
costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; and (xi)&nbsp;to exclude the goodwill and intangible asset impairment charges that are required
to be recorded under generally accepted accounting principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Other stock awards</I>. The administrator may grant other awards based
in whole or in part by reference to our common stock. The administrator will set the number of shares under the stock award (or cash equivalent) and all other terms and conditions of such awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-employee</FONT> director compensation limit</I>. The aggregate value of all compensation granted or
paid to any <FONT STYLE="white-space:nowrap">non-employee</FONT> director with respect to any calendar year, including awards granted and cash fees paid by us to such <FONT STYLE="white-space:nowrap">non-employee</FONT> director, will not exceed $
&#8195;&#8195;&#8195; in total value, except such amount will increase to $&nbsp;&#8195;&#8195;&#8195; for the first year for newly appointed or elected <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Changes to capital structure</I>. In the event there is a specified type of change in our capital structure, such as a stock split, reverse
stock split, or recapitalization, appropriate adjustments will be made to (i)&nbsp;the class and maximum number of shares reserved for issuance under our 2025 Plan, (ii)&nbsp;the class and maximum number of shares by which the share reserve may
increase automatically each year, (iii)&nbsp;the class and maximum number of shares that may be issued on the exercise of ISOs, and (iv)&nbsp;the class and number of shares and exercise price, strike price, or purchase price, if applicable, of all
outstanding stock awards. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">110 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Corporate transactions</I>. In the event of a corporate transaction (as defined in the
2025 Plan), unless otherwise provided in a participant&#146;s stock award agreement or other written agreement with us or one of our affiliates or unless otherwise expressly provided by the administrator at the time of grant, any stock awards
outstanding under our 2025 Plan may be assumed, continued or substituted for by any surviving or acquiring corporation (or its parent company), and any reacquisition or repurchase rights held by us with respect to the stock award may be assigned to
the successor (or its parent company). If the surviving or acquiring corporation (or its parent company) does not assume, continue or substitute for such stock awards, then (i)&nbsp;with respect to any such stock awards that are held by participants
whose continuous service has not terminated prior to the effective time of the corporate transaction, or current participants, the vesting (and exercisability, if applicable) of such stock awards will be accelerated in full (or, in the case of
performance awards with multiple vesting levels depending on the level of performance, vesting will accelerate at 100% of the target level) to a date prior to the effective time of the corporate transaction (contingent upon the effectiveness of the
corporate transaction), and such stock awards will terminate if not exercised (if applicable) at or prior to the effective time of the corporate transaction, and any reacquisition or repurchase rights held by us with respect to such stock awards
will lapse (contingent upon the effectiveness of the corporate transaction); and (ii)&nbsp;any such stock awards that are held by persons other than current participants will terminate if not exercised (if applicable) prior to the effective time of
the corporate transaction, except that any reacquisition or repurchase rights held by us with respect to such stock awards will not terminate and may continue to be exercised notwithstanding the corporate transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event a stock award will terminate if not exercised prior to the effective time of a corporate transaction, the administrator may
provide, in its sole discretion, that the holder of such stock award may not exercise such stock award but instead will receive a payment equal in value to the excess (if any) of (i)&nbsp;the value of the property the participant would have received
upon the exercise of the stock award, over (ii)&nbsp;any per share exercise price payable by such holder, if applicable. In addition, any escrow, holdback, earn out or similar provisions in the definitive agreement for the corporate transaction may
apply to such payment to the same extent and in the same manner as such provisions apply to the holders of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Change in
control</I>. Stock awards granted under our 2025 Plan may be subject to acceleration of vesting and exercisability upon or after a change in control (as defined in the 2025 Plan) as may be provided in the applicable stock award agreement or in any
other written agreement between us or any affiliate and the participant, but in the absence of such provision, no such acceleration will automatically occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Plan amendment or termination</I>. Our board of directors has the authority to amend, suspend, or terminate our 2025 Plan at any time,
provided that such action does not materially impair the existing rights of any participant without such participant&#146;s written consent. Certain material amendments also require the approval of our stockholders. No ISOs may be granted after the
tenth anniversary of the date our board of directors adopted our 2025 Plan. No stock awards may be granted under our 2025 Plan while it is suspended or after it is terminated. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2025 Employee Stock Purchase Plan </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
&#8195;&#8195;&#8195;, our board of directors adopted, and our stockholders approved, our ESPP. We expect our ESPP will become effective on the date of this prospectus. The purpose of our ESPP is to secure the services of new employees, to retain
the services of existing employees, and to provide incentives for such individuals to exert maximum efforts toward our success and that of our affiliates. Our ESPP includes two components. One component is designed to allow eligible U.S. employees
to purchase our common stock in a manner that may qualify for favorable tax treatment under Section&nbsp;423 of the Code. The other component permits the grant of purchase rights that do not qualify for such favorable tax treatment in order to allow
deviations necessary to permit participation by eligible employees who are foreign nationals or employed outside of the United States while complying with applicable foreign laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Share reserve</I>. Our ESPP authorizes the issuance of &#8195;&#8195;&#8195; shares of our common stock under purchase rights granted to
our employees or to employees of any of our designated affiliates. The number of shares of our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
common stock reserved for issuance will automatically increase on January&nbsp;1 of each year for a period of ten years, beginning on January&nbsp;1, 2026 and continuing through January&nbsp;1,
2035, by the lesser of (i) &#8195;&#8195;&#8195;% of the total number of shares of our common stock outstanding on December 31 of the immediately preceding year; and (ii) &#8195;&#8195;&#8195; shares, except before the date of any such increase, our
board of directors may determine that such increase will be less than the amount set forth in clauses (i)&nbsp;and (ii). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Administration</I>. Our board of directors administers our ESPP and may delegate its authority to administer our ESPP to our compensation
committee. Our ESPP is implemented through a series of offerings under which eligible employees are granted purchase rights to purchase shares of our common stock on specified dates during such offerings. Under our ESPP, our board of directors may
specify offerings with durations of not more than 27 months and to specify shorter purchase periods within each offering. Each offering will have one or more purchase dates on which shares of our common stock will be purchased for employees
participating in the offering. Our ESPP provides that an offering may be terminated under certain circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Payroll
deductions</I>. Generally, all regular employees, including executive officers, employed by us or by any of our designated affiliates, may participate in our ESPP and to contribute, normally through payroll deductions, up to 15% of their earnings
(as defined in our ESPP) for the purchase of our common stock under our ESPP. Unless otherwise determined by our board of directors, common stock will be purchased for the accounts of employees participating in our ESPP at a price per share that is
not less than the lesser of (i) 85% of the fair market value of a share of our common stock on the first day of an offering; or (ii) 85% of the fair market value of a share of our common stock on the date of purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Limitations</I>. Employees may have to satisfy one or more of the following service requirements before participating in our ESPP, as
determined by our board of directors: (i)&nbsp;being customarily employed for more than 20 hours per week; (ii)&nbsp;being customarily employed for more than five months per calendar year; or (iii) continuous employment with us or one of our
affiliates for a period of time (not to exceed two years). No employee may purchase shares under our ESPP at a rate in excess of $25,000 worth of our common stock (based on the fair market value per share of our common stock at the beginning of an
offering) for each calendar year such a purchase right is outstanding. Finally, no employee will be eligible for the grant of any purchase rights under our ESPP if immediately after such rights are granted, such employee has voting power over 5% or
more of our outstanding capital stock measured by vote or value under Section&nbsp;424(d) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Changes to capital
structure</I>. Our ESPP provides that in the event there occurs a change in our capital structure through such actions as a stock split, merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property
other than cash, large nonrecurring cash dividend, liquidating dividend, combination of shares, exchange of shares, change in corporate structure, or similar transaction, our board of directors will make appropriate adjustments to: (i)&nbsp;the
class(es) and maximum number of shares reserved under our ESPP; (ii)&nbsp;the class(es) and maximum number of shares by which the share reserve may increase automatically each year; (iii)&nbsp;the class(es) and number of shares subject to, and
purchase price applicable to, outstanding offerings and purchase rights; and (iv)&nbsp;the class(es) and number of shares that are subject to purchase limits under ongoing offerings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Corporate transactions</I>. Our ESPP provides that in the event of a corporate transaction (as defined in the ESPP), any then-outstanding
rights to purchase our common stock under our ESPP may be assumed, continued, or substituted for by any surviving or acquiring entity (or its parent company). If the surviving or acquiring entity (or its parent company) elects not to assume,
continue, or substitute for such purchase rights, then the participants&#146; accumulated payroll contributions will be used to purchase shares of our common stock within 10 business days before such corporate transaction, and such purchase rights
will terminate immediately after such purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Plan amendment or termination</I>. Our board of directors has the authority to amend
or terminate our ESPP, except in certain circumstances such amendment or termination may not materially impair any outstanding </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">112 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purchase rights without the holder&#146;s consent. We will obtain stockholder approval of any amendment to our ESPP as required by applicable law or listing requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Clawback</I>. All awards granted under the 2025 Plan will be subject to recoupment in accordance with any clawback policy that we are
required to adopt pursuant to the listing standards of any national securities exchange or association on which our securities are listed or as is otherwise required by the U.S. Dodd-Frank Wall Street Reform and Consumer Protection Act or other
applicable law. In addition, our board of directors may impose such other clawback, recovery or recoupment provisions in a stock award agreement as our board of directors determines necessary or appropriate. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2020 Equity Incentive Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
October 2020, our board of directors adopted, and our stockholders approved, our 2020 Plan. Our 2020 Plan was last amended in May 2024. No further stock awards will be granted under our 2020 Plan on or after the effectiveness of our 2025 Plan;
however, awards outstanding under our 2020 Plan will continue to be governed by their existing terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2024,
options to purchase &#8195;&#8195;&#8195; shares of our common stock and &#8195;&#8195;&#8195; RSUs were outstanding under our 2020 Plan, and &#8195;&#8195;&#8195; shares of our common stock remained available for future awards under our 2020 Plan.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Awards</I>. Our 2020 Plan provides for the grant of ISOs to our employees and our parent and subsidiary corporations&#146; employees,
and for the grant of NSOs, stock appreciation rights, restricted stock awards, restricted stock unit awards and other forms of awards to our employees, directors and consultants and any of our affiliates&#146; employees and consultants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Plan administration</I>. Our board of directors, or a duly authorized committee of our board of directors, administers our 2020 Plan. The
administrator has the authority to determine stock award recipients, the types of stock awards to be granted, grant dates, the number of shares subject to each stock award, the fair market value of our common stock, and the provisions of each stock
award, including the period of exercisability and the vesting schedule applicable to a stock award. Under our 2020 Plan, the administrator also generally has the authority to effect, with the consent of any adversely affected participant,
(i)&nbsp;the reduction of the exercise, purchase, or strike price of any outstanding stock award; (ii)&nbsp;the cancellation of any outstanding stock award and the grant in substitution therefor of other awards, cash, or other consideration; or
(iii)&nbsp;any other action that is treated as a repricing under generally accepted accounting principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Stock options</I>. Stock
options granted under the 2020 Plan are subject to substantially similar terms as options that may be granted under the 2025 Plan once effective, except with respect to the treatment of options in the event of a corporate transaction, as described
in more detail below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Restricted Stock Units. </I>Restricted stock units granted under our 2020 Plan have terms substantially similar
to restricted stock units that may be granted under our 2025 Plan once it becomes effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Changes to capital structure.</I> In the
event there is a specified type of change in our capital structure, such as a stock split, reverse stock split, or recapitalization, appropriate adjustments will be made to (i)&nbsp;the class and maximum number of shares reserved for issuance under
our 2020 Plan, (ii)&nbsp;the class and maximum number of shares that may be issued on the exercise of ISOs, and (iii)&nbsp;the class and number of shares and exercise price, strike price, or purchase price, if applicable, of all outstanding stock
awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Corporate transaction. </I>Our 2020 Plan provides that in the event of a corporate transaction (as defined in our 2020 Plan),
unless otherwise provided in an award agreement or other written agreement between us and the participant, the administrator may take one or more of the following actions with respect to outstanding stock awards: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">arrange for the assumption, continuation, or substitution of a stock award by the surviving or acquiring
corporation or its parent company; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">113 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">arrange for the assignment of any reacquisition or repurchase rights held by us to the surviving or acquiring
corporation or its parent company; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accelerate the vesting, in whole or in part, of the stock award and, if applicable, the time at which the stock
award may be exercised, to a date prior to the effective time of the corporate transaction and provide for its termination if not exercised (if applicable) at or prior to the effective time of the corporate transaction; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by us;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cancel the stock award, to the extent not vested or not exercised prior to the effective time of the corporate
transaction, in exchange for such cash consideration, if any, as the administrator deems appropriate; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make a payment, in such form as determined by the administrator, equal to the excess, if any, of the value of the
property the participant would have received upon the exercise of the stock award immediately prior to the effective time of the corporate transaction over any exercise price payable by the holder in connection with such exercise.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The administrator is not obligated to treat all stock awards or portions of stock awards in the same manner and is not
obligated to treat all participants in the same manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Change in control</I>. Stock awards granted under our 2020 Plan may be subject
to acceleration of vesting and exercisability upon or after a change in control (as defined in the 2020 Plan) as may be provided in the applicable stock award agreement or in any other written agreement between us or any affiliate and the
participant, but in the absence of such provision, no such acceleration will automatically occur. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Plan amendment or termination</I>.
Our board of directors has the authority to amend, suspend, or terminate our 2020 Plan at any time, provided that such action does not materially impair the existing rights of any participant without such participant&#146;s written consent. Certain
material amendments also require the approval of our stockholders. As noted above, no further stock awards will be granted under our 2020 Plan on or after the effectiveness of our 2025 Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2010 Equity Incentive Plan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
October 2010, our board of directors adopted, and our stockholders approved, our 2010 Plan. Our 2010 Plan was amended on several occasions and was most recently amended in February 2019. On and after our 2020 Plan became effective, no further stock
awards could be granted under our 2010 Plan; however, stock awards outstanding under our 2010 Plan continue to be governed by their existing terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December 31, 2024, options to purchase 24,693,977&nbsp;shares of our common stock were outstanding under our 2010 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Awards. </I>Our 2010 Plan provided for the grant of ISOs to our employees and our parent and subsidiary corporations&#146; employees, and
for the grant of NSOs, stock appreciation rights, restricted stock awards, and restricted stock unit awards to our employees, directors and consultants and any of our affiliates&#146; employees and consultants. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Plan administration. </I>Our board of directors, or a duly authorized committee of our board of directors, administers our 2010 Plan. The
administrator has the authority to construe and interpret our 2010 Plan and stock awards granted under it and to make all other determinations necessary or expedient for the administration of our 2010 Plan. Under our 2010 Plan, the administrator
also has the authority to effect, with the consent of any adversely affected optionholder, (i) the reduction of the exercise price of any outstanding option; (ii) the cancellation of any outstanding option and the grant in substitution therefor of
other awards, cash, or other consideration; or (iii) any other action that is treated as a repricing under generally accepted accounting principles. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">114 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Stock options. </I>Stock options granted under our 2010 Plan are subject to substantially
similar terms as stock options that may be granted under our 2025 Plan once effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Changes to capital structure. </I>If there is a
specified type of change in our capital structure, such as a stock split, reverse stock split, or recapitalization, the administrator will appropriately and proportionately adjust the class(es) and number of shares and price per share, if
applicable, of stock subject to outstanding stock awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Corporate transactions.</I> In the event of a corporate transaction (as
defined in the 2010 Plan), unless otherwise provided in a participant&#146;s stock award agreement or other written agreement with us or one of our affiliates or unless otherwise expressly provided by the administrator at the time of grant, any
stock awards outstanding under our 2010 Plan may be assumed, continued or substituted for by any surviving or acquiring corporation (or its parent company), and any reacquisition or repurchase rights held by us with respect to the stock award may be
assigned to the successor (or its parent company). If the surviving or acquiring corporation (or its parent company) does not assume, continue or substitute for such stock awards, then (i) with respect to any such stock awards that are held by
participants whose continuous service has not terminated prior to the effective time of the corporate transaction, or current participants, the vesting (and exercisability, if applicable) of such stock awards will (contingent upon the effectiveness
of the corporate transaction) be accelerated in full to a date prior to the effective time of the corporate transaction, and such stock awards will terminate if not exercised (if applicable) at or prior to the effective time of the corporate
transaction, and any reacquisition or repurchase rights held by us with respect to such stock awards will lapse (contingent upon the effectiveness of the corporate transaction); and (ii) any such stock awards that are held by persons other than
current participants will terminate if not exercised (if applicable) prior to the effective time of the corporate transaction, except that any reacquisition or repurchase rights held by us with respect to such stock awards will not terminate and may
continue to be exercised notwithstanding the corporate transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event a stock award will terminate if not exercised prior to
the effective time of a corporate transaction, the administrator may provide, in its sole discretion, that the holder of such stock award may not exercise such stock award but instead will receive a payment equal in value to the excess (if any) of
(i) the value of the property the participant would have received upon the exercise of the stock award, over (ii) any per share exercise price payable by such holder, if applicable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Change in control. </I>A stock award under our 2010 Plan may be subject to additional acceleration of vesting and exercisability upon or
after a change in control (as defined in our 2010 Plan) as may be provided in the award agreement or any other written agreement between us and the participant, but in the absence of such provision, no such acceleration will occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><I>Plan amendment and termination. </I>The administrator may amend, suspend, or terminate our 2010 Plan at any time, provided that such action
does not impair the existing rights of any participant without such participant&#146;s written consent. Certain material amendments of our 2010 Plan also require the approval of our stockholders. As noted above, no further stock awards could be
granted under our 2010 Plan on or after the effectiveness of our 2020 Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> Sales Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our directors and executive officers may adopt written plans, known as Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> plans (Rule <FONT
STYLE="white-space:nowrap">10b5-1</FONT> Plans), in which they will contract with a broker to buy or sell our common shares on a periodic basis. Under a Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan, a broker executes trades pursuant to
parameters established by the director or officer when entering into the plan, without further direction from them. The director or officer may amend a Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan in some circumstances and may terminate
a plan at any time. Our directors and executive officers also may buy or sell additional shares outside of a Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan when they are not in possession of material nonpublic information subject to
compliance with the terms of our insider trading policy. Prior to 180 days after the date of this offering, subject to early termination, the sale of any shares under such plan would be prohibited by the
<FONT STYLE="white-space:nowrap">lock-up</FONT> agreement that the director or officer has entered into with the underwriters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">115 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_13"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following includes a summary of transactions since January&nbsp;1, 2022 to which we have been a party, in which the amount involved in the
transaction exceeded the lesser of $120,000 or one percent of the average of our total assets at <FONT STYLE="white-space:nowrap">year-end</FONT> for the last two completed years, and in which any of our directors, executive officers or, to our
knowledge, beneficial owners of more than 5% of our capital stock or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect material interest, other than equity and other compensation, termination,
change of control, and other arrangements, which are described under &#147;Executive Compensation.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Series
<FONT STYLE="white-space:nowrap">F-1</FONT> Redeemable Convertible Preferred Stock Financing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In multiple closings held between
February 2022 and March 2022, we issued and sold an aggregate of 23,664,027 shares of our Series <FONT STYLE="white-space:nowrap">F-1</FONT> redeemable convertible preferred stock at a purchase price of $2.091505 per share for an aggregate purchase
price of approximately $49.49&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Series <FONT STYLE="white-space:nowrap">F-1</FONT>
redeemable convertible preferred stock purchased by holders of more than 5% of our capital stock and entities affiliated with our executive officers and members of our board of directors. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Participants<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series <FONT STYLE="white-space:nowrap">F-1</FONT><BR>Redeemable<BR>Convertible<BR>Preferred<BR>Stock<BR>Purchased<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate</B><br><B>Purchase Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with KPCB<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,343,738</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29,999,999.75</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">El Camino Fund, L.P.<SUP STYLE="font-size:75%; vertical-align:top">(3) </SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">956,249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 1,999,999.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total </B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,299,987</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,999,999.31</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Additional details regarding these stockholders and their equity holdings are included in this prospectus under
the section titled &#147;Principal Stockholders.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">KPCB is a holder of 5% or more of our capital stock, and is affiliated with Wen Hsieh, Ph.D. and Ker Zhang,
Ph.D., two of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">El Camino Fund, L.P. is affiliated with Ker Zhang, Ph.D., one of our
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors. </P></TD></TR></TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Series G Redeemable Convertible Preferred Stock Financing
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In multiple closings held between August 2023 and July 2024, we issued and sold an aggregate of 99,229,883 shares of our Series G
redeemable convertible preferred stock at a purchase price of $0.904179 per share for an aggregate purchase price of approximately $89.7&nbsp;million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">116 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Series G redeemable convertible preferred stock purchased
by holders of more than 5% of our capital stock and entities affiliated with our executive officers and members of our board of directors. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Participants<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series F<BR>Redeemable<BR>Convertible<BR>Preferred<BR>Stock<BR>Purchased<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate<BR>Purchase&nbsp;Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">EDB Investments Pte Ltd<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,059,756</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,999,999.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Matter Venture Partners Fund I,
L.P.<SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,059,756</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,999,999.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">El Camino Fund, L.P.<SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,105,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> 999,999.37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total </B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,225,487</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,999,997.61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Additional details regarding these stockholders and their equity holdings are included in this prospectus under
the section titled &#147;Principal Stockholders.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">EDB Investments PTE Ltd is a holder of 5% or more of our capital stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Matter Venture Partners Fund I, L.P. is affiliated with Wen Hsieh, Ph.D., one of our <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">El Camino Fund, L.P. is affiliated with Ker Zhang, Ph.D., one of our
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors. </P></TD></TR></TABLE>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As a result of our issuance of our Series G
redeemable convertible preferred stock, subject to the terms of our amended and restated certificate of incorporation then in effect, the conversion prices of our Series E redeemable convertible preferred stock, Series F redeemable convertible
preferred stock and Series <FONT STYLE="white-space:nowrap">F-1</FONT> redeemable convertible preferred stock were adjusted from $1.033800, $1.827990 and $2.091505, respectively, to $1.002756, $1.606742 and $1.807146, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the issuance of our Series G redeemable convertible preferred stock, on June&nbsp;1, 2024, we issued a warrant to purchase
up to 6,690,069 shares of our common stock at an exercise price of $0.45 per share to Matter Venture Partners Fund I, L.P., which is affiliated with Wen Hsieh, Ph.D., our Chairman. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock&nbsp;Option Repricing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In May 2024,
our board of directors approved a stock&nbsp;option repricing&nbsp;whereby the exercise prices of previously granted and unexercised options held by certain employees and directors with exercise prices between $0.61 and $1.20 per share, were
adjusted to equal the fair market value of our common stock as of December&nbsp;31, 2023. Options to purchase a total of 22,267,883 shares of our common stock are subject to the repricing. No other modifications were made to these options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth the stock options held by current executive officers and directors that are subject to the repricing: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="29%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Grant Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Securities<BR>Underlying&nbsp;Each&nbsp;Option</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Exercise&nbsp;Price&nbsp;Pre-Stock</FONT><BR>Option&nbsp;Repricing</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Exercise&nbsp;Price&nbsp;Post-Stock</FONT><BR>Option
Repricing<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Executive Officers</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fumihide Esaka</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5/26/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,414,420</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sean Chen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5/26/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,195,688</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Hanson, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5/26/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,272,605</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Goodwin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11/16/2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">945,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.09</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Directors</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ker Zhang, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3/3/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">117 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employment Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have entered into employment agreements and offer letter agreements with certain of our executive officers. See &#147;Executive
Compensation&#151;Agreements with our Named Executive Officers and Potential Payments Upon Termination or Change of Control.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Rights
Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In August 2023, we entered into an Amended and Restated Investor Rights Agreement (the Rights Agreement) with certain
holders of more than 5% of our outstanding capital stock and certain affiliates of our directors. The Rights Agreement grants to the holders of our outstanding convertible preferred stock certain rights, including certain registration rights
(subject to <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements entered into in connection with this offering and federal securities laws) with respect to the registrable securities held by them, which would allow such holders to trade these
shares when the applicable registration statement is declared effective. Certain holders are entitled to demand registration rights, which allows them to request that we register all or a portion of their shares under certain circumstances;
piggyback registration rights, which allows them to include their shares (subject to certain limitations) in the same registration if, after this offering, we propose to register any of our securities under the Securities Act; and form <FONT
STYLE="white-space:nowrap">S-3</FONT> registration rights, which allows them to request that we register their shares on Form <FONT STYLE="white-space:nowrap">S-3</FONT> if we are qualified to file a registration statement on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> and net proceeds would equal or exceed $1.0&nbsp;million. See the section titled &#147;Description of Capital Stock&#151;Registration Rights&#148; for additional information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the Rights Agreement imposes certain affirmative obligations on us, including our obligation to, among other things,
(i)&nbsp;grant certain holders, including each holder who holds at least 3% of the fully diluted shares of common stock on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis (the Major Investors) a right of first offer with respect to
future sales of our equity, excluding the shares to be offered and sold in this offering, and (ii)&nbsp;grant certain information and inspection rights to such Major Investors. Each of these obligations will terminate in connection with the closing
of this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In August 2023, we entered into an Amended and Restated Voting Agreement (the Voting Agreement) with certain holders of more than 5% of our
outstanding capital stock and certain affiliates of our directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Voting Agreement, certain holders of preferred stock,
collectively, have the right to designate four members to be elected to our board of directors. See the section titled &#147;Management&#151;Board Composition.&#148; The Voting Agreement will terminate by its terms in connection with the closing of
this offering and none of our stockholders will have any continuing rights regarding the election or designation of members of our board of directors following this offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Right of First Refusal and <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In August 2023, we entered into an Amended and Restated Right of First Refusal and <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreement
(the <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreement) with certain holders of more than 5% of our outstanding capital stock and certain affiliates of our directors. Pursuant to the <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreement,
we have a right of first refusal in respect of certain sales of securities by certain holders of our common stock and convertible preferred stock. To the extent we do not exercise such right in full, certain holders, including the Major Investors,
are granted certain rights of first refusal and <FONT STYLE="white-space:nowrap">co-sale</FONT> in respect of such sale. The <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreement will terminate in connection with the closing of this offering.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have
entered, and intend to continue to enter, into separate indemnification agreements with our directors and executive officers, in addition to the indemnification provided for in our amended and restated
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">118 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
certificate of incorporation and amended and restated bylaws. These agreements, among other things, require us to indemnify our directors and executive officers for certain expenses, including
attorneys&#146; fees, judgments, fines, and settlement amounts incurred by a director or executive officer in any action or proceeding arising out of their services as one of our directors or executive officers or as a director or executive officer
of any other company or enterprise to which the person provides services at our request. For more information regarding these indemnification arrangements, see &#147;Management&#151;Limitation on Liability and Indemnification of Directors and
Officers.&#148; We believe that these charter provisions and indemnification agreements are necessary to attract and retain qualified persons as directors and officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The limitation of liability and indemnification provisions in our amended and restated certificate of incorporation and amended and restated
bylaws may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against directors and officers, even though an action, if successful,
might benefit us and our stockholders. A stockholder&#146;s investment may decline in value to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policies and Procedures for Transactions with Related Persons </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will adopt a written Related Person Transactions Policy that sets forth our policies and procedures regarding the identification, review,
consideration, and oversight of &#147;related person transactions.&#148; For purposes of our policy only, a &#147;related person transaction&#148; is a transaction, arrangement, or relationship (or any series of similar transactions, arrangements or
relationships) in which we or any of our subsidiaries are participants involving an amount that exceeds $120,000, in which any &#147;related person&#148; has a material interest. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Transactions involving compensation for services provided to us as an employee, consultant, or director are not considered related person
transactions under this policy. A related person is any executive officer, director, nominee to become a director or a holder of more than 5% of any class of our voting securities (including our common stock), including any of their immediate family
members and affiliates, including entities owned or controlled by such persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under the policy, the related person in question or, in
the case of transactions with a holder of more than 5% of any class of our voting securities, an officer with knowledge of the proposed transaction, must present information regarding the proposed related person transaction to our audit committee
(or, where review by our audit committee would be inappropriate, to another independent body of our board of directors) for review. To identify related person transactions in advance, we rely on information supplied by our executive officers,
directors, and certain significant stockholders. In considering related person transactions, our audit committee takes into account the relevant available facts and circumstances, which may include, but not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risks, costs, and benefits to us; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the impact on a director&#146;s independence in the event the related person is a director, immediate family
member of a director or an entity with which a director is affiliated; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms of the transaction; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of other sources for comparable services or products; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms available to or from, as the case may be, unrelated third parties. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our audit committee will approve only those transactions that it determines are fair to us and in our best interests. All of the transactions
described above were entered into prior to the adoption of such policy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">119 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_14"></A>PRINCIPAL STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding beneficial ownership of our capital stock as of
&#8195;&#8195;&#8195;,&#8195;&#8195;&#8195; by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person, or group of affiliated persons, known by us to beneficially own more than 5% of our common stock;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our named executive officers; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of our current executive officers and directors as a group. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The percentage ownership information under the column &#147;Shares beneficially owned before offering&#148; is based on
&#8195;&#8195;&#8195;shares of common stock outstanding as of &#8195;&#8195;&#8195;, &#8195;&#8195;&#8195; assuming conversion of all 347,983,712 of our outstanding convertible preferred stock into an aggregate of &#8195;&#8195;&#8195;shares of
common stock. The percentage ownership information under the column &#147;Shares beneficially owned after offering&#148; is based on the sale of shares of common stock in this offering by us, based on an assumed initial public offering price of
$&#8195;&#8195;&#8195;per share (the midpoint of the price range set forth on the cover page of this prospectus). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Information with
respect to beneficial ownership has been furnished by each director, officer, or beneficial owner of more than 5% of our common stock. We have determined beneficial ownership in accordance with the rules of the SEC. These rules generally attribute
beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities. In addition, the rules include shares of our common stock issuable pursuant to the exercise of stock options
or warrants that are either immediately exercisable or exercisable within 60 days of &#8195;&#8195;&#8195;, &#8195;&#8195;&#8195;. These shares are deemed to be outstanding and beneficially owned by the person holding those options or warrants for
the purpose of computing the percentage ownership of that person, but they are not treated as outstanding for the purpose of computing the percentage ownership of any other person. Unless otherwise indicated, the persons or entities identified in
this table have sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to applicable community property laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise noted below, the address for each person or entity listed in the table is c/o Ambiq Micro Inc., 6500 River Place Blvd.,
Building 7, Suite 200, Austin, Texas 78730. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Beneficially<BR>Owned<BR>(#)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage&nbsp;of&nbsp;Shares<BR>Beneficially Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Before<BR>Offering<BR>(%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>After<BR>Offering<BR>(%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Greater than 5% Holders:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#8195;&#8195;&#8195;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#8195;&#8195;&#8195;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>&#8195;&#8195;&#8195;</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with KPCB</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with EDB Investments Pte Ltd.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Directors and Named Executive Officers:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fumihide Esaka</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Hanson, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sean Chen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wen Hsieh, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joseph Tautges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ker Zhang, Ph.D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Timothy Chen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All directors and executive officers as a group (8 persons)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">120 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_15"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the rights of our common and preferred stock and some of the provisions of our amended and restated certificate
of incorporation and amended and restated bylaws, which will become effective upon the closing of this offering, and of the DGCL. This summary is not complete. For more detailed information, please see our amended and restated certificate of
incorporation and amended and restated bylaws, which are filed as exhibits to the registration statement of which this prospectus is a part, as well as the relevant provisions of the DGCL. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the closing of this
offering and upon the filing of our amended and restated certificate of incorporation, our authorized capital stock will consist of&#8195;&#8195;&#8195;shares of common stock, $0.000001 par value per share and &#8195;&#8195;shares of preferred
stock, $0.000001 par value per share. All of our authorized preferred stock upon the closing of this offering will be undesignated. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Outstanding Shares </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of
December&nbsp;31, 2024, there were 12,173,766 shares of common stock outstanding and 341,496,158 shares of convertible preferred stock outstanding. Upon the closing of this offering and assuming no exercise by the underwriters of their
over-allotment option to purchase additional shares,&#8195;&#8195;&#8195;&#8195;shares of common stock will be outstanding. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Voting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our common stock is entitled to one vote for each share held of record on all matters submitted to a vote of the stockholders, including the
election of directors, and does not have cumulative voting rights. Accordingly, the holders of a majority of the shares of our common stock entitled to vote in any election of directors can elect all of the directors standing for election. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dividends </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to preferences
that may be applicable to any then outstanding preferred stock, the holders of common stock are entitled to receive dividends, if any, as may be declared from time to time by our board of directors out of legally available funds. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Liquidation </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of our
liquidation, dissolution, or winding up, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities, subject to the
satisfaction of any liquidation preference granted to the holders of any outstanding shares of preferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Rights and Preferences </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Holders of our common stock have no preemptive, conversion, or subscription rights, and there are no redemption or sinking fund provisions
applicable to our common stock. The rights, preferences, and privileges of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of our preferred stock that we may
designate and issue in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">121 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Fully Paid and Nonassessable </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All of our outstanding shares of common stock are, and the shares of common stock to be issued in this offering will be, fully paid and
nonassessable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under our amended and restated certificate of incorporation, our board of directors will have the authority, without further action by the
stockholders, to issue up to &#8195;&#8195;&#8195;shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each such series, to fix the rights, preferences, and privileges of the shares
of each wholly unissued series and any qualifications, limitations, or restrictions thereon, and to increase or decrease the number of shares of any such series, but not below the number of shares of such series then outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting
power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying,
deferring, or preventing a change in our control that may otherwise benefit holders of our common stock and may adversely affect the market price of our common stock and the voting and other rights of the holders of common stock. We have no current
plans to issue any shares of preferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock Options </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2024, 62,407,870 shares of common stock were issuable upon the exercise of outstanding stock options, at a
weighted-average exercise price of $0.38 per share. For additional information regarding terms of our equity incentive plans, see the section titled &#147;Executive Compensation &#151; Equity Benefit Plans.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Restricted Stock Units </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of
December&nbsp;31, 2024, restricted stock units to purchase an aggregate of 3,186,934 shares of common stock were outstanding. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the closing of this offering and subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements entered into in
connection with this offering and federal securities laws, certain holders of shares of our common stock, including those shares of our common stock that will be issued upon the conversion of our convertible preferred stock in connection with this
offering, will initially be entitled to certain rights with respect to registration of such shares under the Securities Act. These shares are referred to as registrable securities. The holders of these registrable securities possess registration
rights pursuant to the terms of our amended and restated investor rights agreement and are described in additional detail below. The registration of shares of our common stock pursuant to the exercise of the registration rights described below would
enable the holders to trade these shares without restriction under the Securities Act when the applicable registration statement is declared effective. We will pay the registration expenses, other than underwriting discounts, selling commissions and
stock transfer taxes, of the shares registered pursuant to the demand, piggyback and Form <FONT STYLE="white-space:nowrap">S-3</FONT> registrations described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, in an underwritten offering, the managing underwriter, if any, has the right, subject to specified conditions and limitations, to
limit the number of shares the holders may include. The demand, piggyback and Form <FONT STYLE="white-space:nowrap">S-3</FONT> registration rights described below will expire no later than five years after the closing of this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">122 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Demand Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the closing of this offering, holders of an aggregate of&#8195;&#8195;&#8195;shares of our common stock will be entitled to certain demand
registration rights. At any time beginning 180 days after the closing of this offering, the holders of a majority of these shares may request that we register all or a portion of their shares. We are not required to effect more than two registration
statements which are declared or ordered effective. Such request for registration must cover shares with an anticipated aggregate offering price of at least $10.0&nbsp;million. With certain exceptions, we are not required to effect the filing of a
registration statement during the period starting with the date of the filing of, and ending on a date 180 days following the effective date of the registration statement for this offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Piggyback Registration Rights </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In
connection with this offering, the holders of an aggregate of&#8195;&#8195;&#8195;shares of our common stock were entitled to, and the necessary percentage of holders waived, their rights to notice of this offering and to include their shares of
registrable securities in this offering. After this offering, in the event that we propose to register any of our securities under the Securities Act, either for our own account or for the account of other security holders, the holders of these
shares will be entitled to certain piggyback registration rights allowing the holder to include their shares in such registration, subject to certain marketing and other limitations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Form <FONT STYLE="white-space:nowrap">S-3</FONT> Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the closing of this offering, holders of an aggregate of&#8195;&#8195;&#8195;shares of common stock will be entitled to certain Form <FONT
STYLE="white-space:nowrap">S-3</FONT> registration rights. Holders of these shares can make a request that we register their shares on Form <FONT STYLE="white-space:nowrap">S-3</FONT> if we are qualified to file a registration statement on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> and if the reasonably anticipated aggregate net proceeds of the shares offered would equal or exceed $1.0&nbsp;million. We will not be required to effect more than two registrations on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> within any <FONT STYLE="white-space:nowrap">12-month</FONT> period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Effects of Provisions of Our
Certificate of Incorporation, Our Bylaws and Delaware Law </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some provisions of Delaware law, our amended and restated certificate of
incorporation, and our amended and restated bylaws contain or will contain provisions that could make the following transactions more difficult: an acquisition of us by means of a tender offer; an acquisition of us by means of a proxy contest or
otherwise; or the removal of our incumbent officers and directors. It is possible that these provisions could make it more difficult to accomplish or could deter transactions that stockholders may otherwise consider to be in their best interest or
in our best interests, including transactions which provide for payment of a premium over the market price for our shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These
provisions, summarized below, are intended to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of
directors. We believe that the benefits of the increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these
proposals because negotiation of these proposals could result in an improvement of their terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Preferred Stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors will have the authority, without further action by our stockholders, to issue up to&#8195;&#8195;&#8195;shares of
undesignated preferred stock with rights and preferences, including voting rights, designated from time to time by our board of directors. The existence of authorized but unissued shares of preferred stock would enable our board of directors to
render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest, or other means. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">123 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stockholder Meetings </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated bylaws will provide that a special meeting of stockholders may be called only by our chairperson of the board, chief
executive officer or president, or by a resolution adopted by a majority of our board of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Requirements for Advance Notification of
Stockholder Nominations and Proposals </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated bylaws will establish advance notice procedures with respect to
stockholder proposals to be brought before a stockholder meeting and the nomination of candidates for election as directors, other than nominations made by or at the direction of the board of directors, or a committee of the board of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Elimination of Stockholder Action by Written Consent </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation and amended and restated bylaws will eliminate the right of stockholders to act by
written consent without a meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Staggered Board </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our board of directors will be divided into three classes. The directors in each class will serve for a three- year term, one class being
elected each year by our stockholders. For more information on the classified board, see &#147;Management&#151;Board Composition.&#148; This system of electing and removing directors may tend to discourage a third-party from making a tender offer or
otherwise attempting to obtain control of us, because it generally makes it more difficult for stockholders to replace a majority of the directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Removal of Directors </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended
and restated certificate of incorporation will provide that no member of our board of directors may be removed from office by our stockholders except for cause and, in addition to any other vote required by law, upon the approval of not less than <FONT
STYLE="white-space:nowrap">two-thirds</FONT> of the total voting power of all of our outstanding voting stock then entitled to vote in the election of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stockholders Not Entitled to Cumulative Voting </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation will not permit stockholders to cumulate their votes in the election of directors.
Accordingly, the holders of a majority of the outstanding shares of our common stock entitled to vote in any election of directors can elect all of the directors standing for election, if they choose, other than any directors that holders of our
preferred stock may be entitled to elect. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Choice of Forum </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation will provide that the Court of Chancery of the State of Delaware is, unless we consent in
writing to the selection of an alternate forum, the sole and the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law: (1)&nbsp;any derivative action or proceeding brought on our behalf;
(2)&nbsp;any action asserting a claim of breach of a fiduciary duty or other wrongdoing by any of our directors, officers, employees, or agents to us or our stockholders; (3)&nbsp;any action asserting a claim against us arising pursuant to any
provision of the General Corporation Law of the State of Delaware or our amended and restated certificate of incorporation or amended and restated bylaws; (4)&nbsp;any action to interpret, apply, enforce, or determine the validity of our amended and
restated certificate of incorporation or amended and restated bylaws; or (5)&nbsp;any action asserting a claim governed by the internal affairs doctrine. The provisions would not apply to suits brought to enforce a duty or liability created by the
Securities </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">124 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Act, the Exchange Act, or any other claim for which the U.S. federal courts have exclusive jurisdiction. However, as Section&nbsp;22 of the Securities Act creates concurrent jurisdiction for
federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act, and an investor cannot waive compliance with the federal securities laws and the rules and regulations thereunder, there is uncertainty
as to whether a court would enforce such a provision. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our amended and restated
certificate of incorporation provides that the U.S. federal district courts will be the exclusive forum for resolving any complaint asserting a cause or causes of action arising under the Securities Act, including all causes of action asserted
against any defendant to such complaint. For the avoidance of doubt, this provision is intended to benefit and may be enforced by us, our officers and directors, the underwriters to any offering giving rise to such complaint, and any other
professional entity whose profession gives authority to statement made by that person or entity and who has prepared or certified any part of the documents underlying the offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to
bring a claim in a venue other than those designated in the exclusive forum provisions. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our amended and restated certificate
of incorporation. This may require significant additional costs associated with resolving such action in other jurisdictions and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These exclusive forum provisions may limit a stockholder&#146;s ability to bring a claim in a judicial forum that it finds favorable for
disputes with us or our directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers and other employees. If a court were to find either exclusive-forum provision in our amended and restated
certificate of incorporation to be inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving the dispute in other jurisdictions, all of which could seriously harm our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amendment of Charter Provisions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amendment of any of the above provisions, except for the provision making it possible for our board of directors to issue preferred stock,
would require approval by holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the total voting power of all of our outstanding voting stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of Delaware law, our amended and restated certificate of incorporation, and our amended and restated bylaws could have the
effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover attempts. These
provisions may also have the effect of preventing changes in the composition of our board and management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to be in
their best interests. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Delaware Anti-Takeover Law </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are subject to Section&nbsp;203 of the DGCL (Section 203). Section&nbsp;203 generally prohibits a public Delaware corporation from engaging
in a &#147;business combination&#148; with an &#147;interested stockholder&#148; for a period of three years after the date of the transaction in which the person became an interested stockholder, unless: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prior to the date of the transaction, the board of directors of the corporation approved either the business
combination or the transaction which resulted in the stockholder becoming an interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the
transaction commenced, excluding for purposes of determining the number of shares outstanding (but not the outstanding voting stock owned by the interested stockholder) shares owned
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">125 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
(a) by persons who are directors and also officers, and (b)&nbsp;by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held
subject to the plan will be tendered in a tender or exchange offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon or subsequent to the consummation of the transaction, the business combination is approved by the board and
authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock which is not owned by the interested stockholder. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;203 defines a business combination to include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any merger or consolidation involving the corporation and the interested stockholder; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation to or with the
interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to exceptions, any transaction involving the corporation that has the effect of increasing the
proportionate share of the stock of any class or series of the corporation owned by the interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock
of the corporation to the interested stockholder; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other
financial benefits provided by or through the corporation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, Section&nbsp;203 defines an interested
stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to apply to list our
common stock on&#8195;&#8195;&#8195;under the symbol &#147;AMBQ&#148;. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for our common stock is&#8195;&#8195;&#8195;. The transfer agent and registrar&#146;s address is
&#8195;&#8195;&#8195;and the telephone number is&#8195;&#8195;&#8195;. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">126 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_16"></A>SHARES ELIGIBLE FOR FUTURE SALE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Immediately prior to this offering, there has been no public market for our common stock. Future sales of substantial amounts of common stock
in the public market could adversely affect prevailing market prices. Furthermore, since only a limited number of shares will be available for sale shortly after this offering because of contractual and legal restrictions on resale described below,
sales of substantial amounts of common stock in the public market after the restrictions lapse could adversely affect the prevailing market price for our common stock as well as our ability to raise equity capital in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based on the number of shares of common stock outstanding as of&#8195;&#8195;&#8195;, 2024, upon the closing of this offering,
&#8195;&#8195;&#8195;shares of common stock will be outstanding, assuming no exercise of the underwriters&#146; option to purchase additional shares to cover any over-allotments. All of the shares sold in this offering will be freely tradable unless
purchased by our &#147;affiliates&#148; as that term is defined in Rule 144 under the Securities Act. The remaining&#8195;&#8195;&#8195;shares of common stock outstanding after this offering will be restricted as a result of securities laws or <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements. These remaining shares will generally become available for sale in the public market as follows: </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">No restricted shares will be eligible for immediate sale upon the closing of this offering; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Up to &#8195;&#8195;&#8195; restricted shares will be eligible for sale under Rule 144, subject to the volume
limitations, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale,</FONT></FONT> and notice provisions described below under &#147;Rule 144,&#148; upon expiration of <FONT STYLE="white-space:nowrap">lock-up</FONT>
agreements at least six months after the date of this offering. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Rights Agreement, after the closing of this offering, the holders of up to&#8195;&#8195;&#8195;shares of our common stock, or
certain transferees, will be entitled to certain rights with respect to the registration of the offer and sale of those shares under the Securities Act. See the section titled &#147;Description of Capital Stock&#151; Registration Rights&#148; for a
description of these registration rights. If the offer and sale of these shares of our common stock are registered, the shares will be freely tradable without restriction under the Securities Act, subject to the Rule 144 limitations applicable to
affiliates, and a large number of shares may be sold into the public market. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, all of our directors and executive officers and holders of substantially all of our outstanding shares of common stock and other equity
securities, including options to acquire shares of our common stock have agreed that, for a period of 180 days after the date of this prospectus, subject to certain limited exceptions, not to sell or transfer any common stock or securities
convertible into, exchangeable for, exercisable for, or repayable with common stock, without first obtaining the written consent of BofA Securities, Inc. and UBS Securities LLC. Upon the expiration of the
<FONT STYLE="white-space:nowrap">lock-up</FONT> period, substantially all of the shares subject to such <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions will become eligible for sale, subject to the limitations discussed above. For a
further description of these <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements, please see <FONT STYLE="white-space:nowrap">&#147;Underwriting&#151;Lock-Up</FONT> Agreements.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule 144 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In general, under Rule 144 as
currently in effect, beginning 90 days after the effective date of the registration statement of which this prospectus is a part, any person who is not an affiliate of ours and has held their shares for at least six months, including the holding
period of any prior owner other than one of our affiliates, may sell shares without restriction, provided current public information about us is available. In addition, under Rule 144, any person who is not an affiliate of ours and has held their
shares for at least one year, including the holding period of any prior owner other than one of our affiliates, would be entitled to sell an unlimited number of shares immediately upon the closing of this offering without regard to whether current
public information about us is available. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">127 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beginning 90 days after the effective date of the registration statement of which this
prospectus is a part, a person who is an affiliate of ours and who has beneficially owned restricted securities for at least six months, including the holding period of any prior owner other than one of our affiliates, is entitled to sell a number
of restricted shares within any three-month period that does not exceed the greater of: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1% of the number of shares of our common stock then outstanding, which will equal approximately
&#8195;&#8195;&#8195; shares immediately after this offering; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the average weekly trading volume of our common stock on during the four calendar weeks preceding the filing of a
notice on Form 144 with respect to the sale. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sales of restricted shares under Rule 144 held by our affiliates are also
subject to requirements regarding the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale,</FONT></FONT> notice, and the availability of current public information about us. Rule 144 also provides that affiliates relying
on Rule 144 to sell shares of our common stock that are not restricted shares must nonetheless comply with the same restrictions applicable to restricted shares, other than the holding period requirement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule 701 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Rule 701, shares of
common stock acquired upon the exercise of outstanding options or pursuant to other rights granted under compensatory stock plans may be resold by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons other than affiliates, beginning 90 days after the effective date of the registration statement of which
this prospectus is a part, subject only to the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> provisions of Rule 144; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our affiliates, beginning 90 days after the effective date of the registration statement of which this prospectus
is a part, subject to the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">manner-of-sale</FONT></FONT> and volume limitations, current public information, and filing requirements of Rule 144, in each case, without compliance with
the <FONT STYLE="white-space:nowrap">six-month</FONT> holding period requirement of Rule 144. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Form
<FONT STYLE="white-space:nowrap">S-8</FONT> Registration Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As soon as practicable after the completion of this offering, we
intend to file with the SEC one or more registration statements on Form <FONT STYLE="white-space:nowrap">S-8</FONT> under the Securities Act to register the offer and sale of shares of our common stock that are issuable pursuant to the 2025 Plan and
the ESPP. These registrations statements will become effective immediately upon filing. Shares covered by these registration statements will then be eligible for sale in the public markets, subject to vesting restrictions, any applicable <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements described below and Rule 144 limitations applicable to affiliates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">128 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_17"></A>CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS OF OUR COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a summary of the material U.S. federal income tax considerations relating to the ownership and disposition of common stock
acquired pursuant to this offering by <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders (as defined below). This summary deals only with common stock held as a capital asset within the meaning of Section&nbsp;1221 of the Code (generally,
property held for investment) and does not discuss all of the U.S. federal income tax considerations applicable to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder in light of such <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
holder&#146;s particular circumstances. This discussion also does not consider the specific facts or circumstances that may be relevant to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is subject to special treatment under U.S.
federal income tax laws, including, but not limited to: a dealer in securities; a <FONT STYLE="white-space:nowrap">broker-dealer;</FONT> a bank, investment fund, insurance company, or other financial institution; a qualified retirement plan,
individual retirement plan, or other <FONT STYLE="white-space:nowrap">tax-deferred</FONT> account; a regulated investment company; a real estate investment trust; a <FONT STYLE="white-space:nowrap">tax-exempt</FONT> organization; a governmental
organization; a person holding common stock as part of a hedging, integrated, conversion, or straddle transaction or a person deemed to sell common stock under the constructive sale provisions of the Code; a trader in securities that has elected the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">mark-to-market</FONT></FONT> method of tax accounting; an entity that is treated as a partnership or other pass-through entity for U.S. federal income tax purposes; a person that
received such common stock through the exercise of an option or otherwise as compensation for services; a corporation that accumulates earnings to avoid U.S. federal income tax; a corporation organized outside the United States, any state thereof or
the District of Columbia that is nonetheless treated as a U.S. taxpayer for U.S. federal income tax purposes; a person that is not a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder; a &#147;controlled foreign corporation;&#148; a
&#147;passive foreign investment company;&#148; a qualified pension fund as defined in Section&nbsp;897(l)(2) of the Code or an entity all of the interests of which are held by qualified foreign pension funds; or a U.S. expatriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This summary is based upon provisions of the Code, its legislative history, applicable U.S. Treasury Regulations promulgated thereunder,
published rulings, and judicial decisions, all as in effect as of the date hereof. We have not sought, and will not seek, any ruling from the Internal Revenue Service (IRS), with respect to the tax consequences discussed herein, and there can be no
assurance that the IRS will not take a position contrary to the tax consequences discussed below or that any position taken by the IRS would not be sustained. Those authorities may be repealed, revoked, or modified, perhaps retroactively, or may be
subject to differing interpretations, which could result in U.S. federal income tax consequences different from those discussed below. This summary does not address all aspects of U.S. federal income tax, does not deal with all tax considerations
that may be relevant to stockholders in light of their personal circumstances, and does not address the Medicare tax imposed on certain investment income or any state, local, foreign, gift, estate, or alternative minimum tax considerations, or the
special tax accounting rules under Section&nbsp;451(b) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this discussion, a
<FONT STYLE="white-space:nowrap">&#147;non-U.S.</FONT> holder&#148; is a beneficial owner of common stock that is neither a U.S. holder nor a partnership (or any other entity or arrangement that is treated as a partnership) for U.S. federal income
tax purposes regardless of its place of organization or formation. A &#147;U.S. holder&#148; is a beneficial holder of common stock that is for U.S. federal income tax purposes: (a)&nbsp;an individual citizen or resident of the United States;
(b)&nbsp;a corporation (or any other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia; (c) an estate the income of
which is subject to U.S. federal income taxation regardless of its source; or (d)&nbsp;a trust if it (1)&nbsp;is subject to the primary supervision of a court within the United States and one or more U.S. persons have the authority to control all
substantial decisions of the trust, or (2)&nbsp;was in existence on August 20, 1996 and has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a U.S. person. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a partnership (or an entity or arrangement that is treated as a partnership for U.S. federal income tax purposes) holds common stock, the
tax treatment of a partner will generally depend upon the status of the partner and the activities of the partnership. A partner of a partnership holding common stock is urged to consult its own tax advisors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS DISCUSSION IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT TAX ADVICE. PROSPECTIVE INVESTORS ARE URGED TO CONSULT THEIR OWN TAX ADVISORS
CONCERNING </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">129 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
THE U.S. FEDERAL INCOME TAX CONSEQUENCES OF OWNING AND DISPOSING OF OUR COMMON STOCK IN LIGHT OF THEIR SPECIFIC SITUATIONS, AS WELL AS THE TAX CONSEQUENCES ARISING UNDER ANY STATE, LOCAL, OR <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> TAX LAWS AND ANY OTHER U.S. FEDERAL TAX LAWS (INCLUDING THE U.S. FEDERAL ESTATE AND GIFT TAX LAWS). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions on Our Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As
described under the section titled &#147;Dividend Policy,&#148; we do not anticipate declaring or paying, in the foreseeable future, any cash dividends on our capital stock. Distributions with respect to common stock, if any, generally will
constitute dividends for U.S. federal income tax purposes to the extent paid out of current or accumulated earnings and profits, as determined for U.S. federal income tax purposes. Any portion of a distribution in excess of current or accumulated
earnings and profits will be treated as a return of capital and will first be applied to reduce the holder&#146;s tax basis in its common stock, but not below zero. Any remaining amount will then be treated as gain from the sale or exchange of the
common stock and will be treated as described under &#147;&#151;Disposition of Our Common Stock&#148; below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussions
below regarding effectively connected income, backup withholding and FATCA (as defined below), distributions treated as dividends that are paid to a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder, if any, with respect to shares of our
common stock generally will be subject to U.S. federal withholding tax at a rate of 30% (or such lower rate as may be specified in an applicable income tax treaty) of the gross amount of the dividends. A
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder who wishes to claim the benefit of a reduced rate of withholding tax under an applicable treaty must furnish to us or our paying agent (or to a financial institution through which such <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder holds common stock) a valid IRS Form <FONT STYLE="white-space:nowrap">W-8BEN</FONT> or IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (or applicable
successor form) certifying such holder&#146;s qualification for the exemption or reduced rate. If a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is eligible for a reduced rate of U.S. withholding tax pursuant to an income tax treaty and
does not timely furnish the required certification, it may obtain a refund of any excess amounts withheld by timely filing an appropriate claim for refund with the IRS. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> holders are urged to consult
their tax advisors regarding their entitlement to benefits under a relevant income tax treaty. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is engaged in a trade or business in the United States and dividends with respect to the common stock are effectively connected with the conduct of that trade or business and, if required by an
applicable income tax treaty, are attributable to a U.S. permanent establishment or fixed base maintained by such holder in the United States, then the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will generally be exempt from the 30%
U.S. federal withholding tax, provided certain certification requirements are satisfied. However, the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will be subject to U.S. federal income tax on those dividends on a net income basis at
regular U.S. federal income tax rates in the same manner as if such holder were a resident of the United States. Any such effectively connected income received by a foreign corporation may, under certain circumstances, be subject to an additional
branch profits tax equal to 30% (or lower applicable income tax treaty rate) of its effectively connected earnings and profits for the taxable year, as adjusted under the Code. To claim the exemption from withholding with respect to any such
effectively connected income, the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder must generally furnish to us or our paying agent a properly executed IRS Form <FONT STYLE="white-space:nowrap">W-8ECI</FONT> (or applicable successor form).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the case of a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is an entity, Treasury Regulations and the relevant tax
treaty provide rules to determine whether, for purposes of determining the applicability of a tax treaty, dividends will be treated as paid to the entity or to those holding an interest in that entity. If a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder holds stock through a financial institution or other agent acting on the holder&#146;s behalf, the holder will be required to provide appropriate documentation to such agent. Such holder&#146;s
agent will then be required to provide certification to us or our paying agent. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Disposition of Our Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the discussions below regarding backup withholding and FATCA, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder generally
will not be subject to U.S. federal income tax on any gain from a sale, exchange or other disposition of our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">130 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
common stock unless: (a)&nbsp;that gain is effectively connected with the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s conduct of a trade or business in the United States (and,
if required by an applicable income tax treaty, is attributable to a U.S. permanent establishment or fixed base maintained by the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder); (b) the <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
holder is a nonresident alien individual who is present in the United States for 183 days or more in the taxable year of that disposition, and certain other conditions are met; or (c)&nbsp;we are or have been a &#147;United States real property
holding corporation&#148; within the meaning of Code Section&nbsp;897(c)(2) for U.S. federal income tax purposes at any time during the shorter of the five-year period preceding the date of disposition or the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s holding period for our common stock, and certain other requirements are met. Determining whether we are a United States real property holding corporation depends on the fair market value
of our &#147;United States real property interests relative to fair market value of our other trade or business assets and our foreign real property interests. Although there can be no assurance, we believe that we are not, and we do not anticipate
becoming, a United States real property holding corporation for U.S. federal income tax purposes. Even if we are treated as a United States real property holding corporation, gain realized by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder
on a disposition of our common stock will not be subject to U.S. federal income tax so long as (1)&nbsp;the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder owned, directly, indirectly and constructively, no more than five percent of our
common stock at all times within the shorter of (x)&nbsp;the five-year period preceding the disposition, or (y)&nbsp;the holder&#146;s holding period, and (2)&nbsp;our common stock is regularly traded on an established securities market. There can
be no assurance that our common stock will qualify as regularly traded on an established securities market. If any gain on a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s disposition is taxable because we are a United States real
property holding corporation and either (x)&nbsp;such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s ownership of our common stock exceeds five percent during the relevant period described above, or (y)&nbsp;our common stock is not
regularly traded on an established securities market at any time during the calendar year in which the disposition occurs, such <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will be taxed on such gain generally in the same manner as gain
that is effectively connected with the conduct of a U.S. trade or business, except that the branch profits tax generally will not apply. In addition, a purchaser of your common stock may be required to withhold tax with respect to that obligation.
</P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If gain recognized by a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is described in clause (a)&nbsp;of the preceding
paragraph, the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will generally be subject to tax on the net gain derived from the disposition at the regular U.S. federal income tax rates in the same manner as if such <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder were a U.S. person. In addition, a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder that is a corporation may be subject to the branch profits tax at a rate equal to 30% (or lower applicable
income tax treaty rate) of its effectively connected earnings and profits. If a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is an individual described in clause (b)&nbsp;of the preceding paragraph, the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder will generally be subject to a flat 30% tax on the gain derived from the disposition, which may be offset by certain U.S.-source capital losses even though the
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder is not considered a resident of the United States, provided that the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder has timely filed U.S. federal income tax returns with respect to
such losses. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Information Reporting and Backup Withholding Tax </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We report to our <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holders and the IRS certain information with respect to any dividends we pay
on our common stock, including the amount of dividends paid during each year, the name and address of the recipient, and the amount, if any, of tax withheld. Information reporting requirements apply even if no withholding was required because the
distributions were effectively connected with the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder&#146;s conduct of a U.S. trade or business or withholding was reduced by an applicable income tax treaty. This information also may be made
available under a specific treaty or agreement with the tax authorities in the country in which the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder resides or is established. Under U.S. federal income tax law, interest, dividends, and other
reportable payments may, under certain circumstances, be subject to &#147;backup withholding&#148; at the then applicable rate (currently, 24%). Backup withholding, however, generally will not apply to distributions on our common stock to a <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> holder, provided the <FONT STYLE="white-space:nowrap">non-U.S.</FONT> holder furnishes to us or our paying agent the required certification as to its <FONT STYLE="white-space:nowrap">non-U.S.</FONT> status,
such as by providing a valid IRS Form <FONT STYLE="white-space:nowrap">W-8BEN,</FONT> IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or IRS Form <FONT STYLE="white-space:nowrap">W-8ECI,</FONT> or
certain other requirements are met. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, backup withholding may apply if either we or our paying agent has
actual knowledge, or reason to know, that the holder is a U.S. person that is not an exempt recipient. Backup </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">131 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
withholding is not an additional tax. It may be credited against the tax liability of persons subject to backup withholding or refunded to the extent it results in an overpayment of tax and the
appropriate information is timely supplied to the IRS. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Foreign Accounts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Under Sections 1471 through 1474 of the Code, which are commonly referred to as FATCA, certain withholding taxes may apply to certain types of
payments made to &#147;foreign financial institutions&#148; (as specially defined under these rules) and certain other <FONT STYLE="white-space:nowrap">non-U.S.</FONT> entities if certification, information reporting and other specified requirements
are not met. A 30% withholding tax may apply to &#147;withholdable payments&#148; if they are paid to a foreign financial institution or to a <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity, unless (a)&nbsp;the foreign financial
institution undertakes certain diligence and reporting obligations and other specified requirements are satisfied, or (b)&nbsp;the <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity either certifies it does not have any substantial
U.S. owners or furnishes identifying information regarding each substantial U.S. owner and other specified requirements are satisfied. &#147;Withholdable payment&#148; generally means any payment of interest, dividends, rents, and certain other
types of generally passive income if such payment is from sources within the United States. Treasury Regulations proposed in December 2018 (and upon which taxpayers and withholding agents are entitled to rely) eliminate possible withholding under
these rules on the gross proceeds from any sale or other disposition of our common stock, previously scheduled to apply beginning January&nbsp;1, 2019. If the payee is a foreign financial institution, it must enter into an agreement with the U.S.
Treasury requiring, among other things, that it undertake to identify accounts held by certain U.S. persons or U.S.-owned foreign entities, annually report certain information about such accounts and withhold 30% on payments to account holders whose
actions prevent it from complying with these reporting and other requirements, or comply with comparable requirements under an applicable inter- governmental agreement between the United States and the foreign financial institution&#146;s home
jurisdiction. If an investor does not provide us with the information necessary to comply with these rules, it is possible that distributions to such investor that are attributable to withholdable payments, such as dividends, will be subject to the
30% withholding tax. Holders should consult their own tax advisors regarding the implications of these rules for their investment in our common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">132 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_18"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc. and UBS Securities LLC are acting as representatives of each of the underwriters named below. Subject to the terms and
conditions set forth in an underwriting agreement among us and the underwriters, we have agreed to sell to the underwriters, and each of the underwriters has agreed, severally and not jointly, to purchase from us, the number of shares of common
stock set forth opposite its name below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of</B><br><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">UBS Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the terms and conditions set forth in the underwriting agreement, the underwriters have
agreed, severally and not jointly, to purchase all of the shares sold under the underwriting agreement if any of these shares are purchased. If an underwriter defaults, the underwriting agreement provides that the purchase commitments of the
nondefaulting underwriters may be increased or the underwriting agreement may be terminated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have agreed to indemnify the underwriters
against certain liabilities, including liabilities under the Securities Act, or to contribute to payments the underwriters may be required to make in respect of those liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters are offering the shares, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal
matters by their counsel, including the validity of the shares, and other conditions contained in the underwriting agreement, such as the receipt by the underwriters of officer&#146;s certificates and legal opinions. The underwriters reserve the
right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Commissions and Discounts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The representatives have advised us that the underwriters propose initially to offer the shares to the public at the public offering price set
forth on the cover page of this prospectus and to dealers at that price less a concession not in excess of $&#8195;&#8195;&#8195;per share. After the initial offering, the public offering price, concession or any other term of the offering may be
changed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table shows the public offering price, underwriting discount and proceeds before expenses to us. The information
assumes either no exercise or full exercise by the underwriters of their option to purchase additional shares. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Without&nbsp;Option</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>With&nbsp;Option</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;&#8195;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The expenses of the offering, not including the underwriting discount, are estimated at
$&#8195;&#8195;&#8195;and are payable by us. We have agreed to reimburse the underwriters for expenses of up to $&#8195;&#8195;&#8195;relating to clearance of this offering with the Financial Industry Regulatory Authority (FINRA). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">133 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Option to Purchase Additional Shares </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have granted an option to the underwriters, exercisable for 30 days after the date of this prospectus, to purchase up
to&#8195;&#8195;&#8195;additional shares at the public offering price, less the underwriting discount. If the underwriters exercise this option, each will be obligated, subject to conditions contained in the underwriting agreement, to purchase a
number of additional shares proportionate to that underwriter&#146;s initial amount reflected in the above table. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Sales of Similar Securities
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We, our executive officers and directors and holders of substantially all of our outstanding shares of common stock and other equity
securities, including options to acquire shares of our common stock (such persons, the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Parties) have agreed that, for a period of 180 days after the date of this prospectus (such <FONT
STYLE="white-space:nowrap">180-day</FONT> period, the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period) subject to certain limited exceptions as described below, we and they will not directly or indirectly, without the prior written consent of
BofA Securities, Inc. and UBS Securities LLC, (1)&nbsp;offer for sale, sell, pledge, lend or otherwise dispose of (or enter into any transaction or device that is designed to, or could be expected to, result in the disposition by any person at any
time in the future of) any shares of common stock (including, without limitation, shares of common stock that may be deemed to be beneficially owned by us or them in accordance with the rules and regulations of the SEC and shares of common stock
that may be issued upon exercise of any options or warrants) or securities convertible into or exercisable or exchangeable for common stock (other than the stock and shares issued pursuant to employee benefit plans, qualified stock option plans, or
other employee compensation plans existing on the date of this prospectus or pursuant to currently outstanding options, warrants or rights not issued under one of those plans), or sell or grant options, rights or warrants with respect to any shares
of common stock or securities convertible into or exchangeable for common stock (other than the grant of options pursuant to option plans existing on the date of this prospectus), (2) enter into any swap or other derivatives transaction that
transfers to another, in whole or in part, any of the economic benefits or risks of ownership of shares of common stock, whether any such transaction described in clause (1)&nbsp;or (2) above is to be settled by delivery of common stock or other
securities, in cash or otherwise, (3)&nbsp;make any demand for or exercise any right or confidentially submit or publicly file or cause a registration statement to be filed or confidentially submitted, including any amendments thereto, with respect
to the registration of any shares of common stock or securities convertible, exercisable or exchangeable into common stock or any of our other securities (other than any registration statement on Form <FONT STYLE="white-space:nowrap">S-8),</FONT> or
(4)&nbsp;publicly disclose the intention to do any of the foregoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The restrictions above do not apply to: (a)&nbsp;transactions
relating to shares of common stock or other securities acquired in the offering or in the open market, in each case after the completion of the offering, (b)&nbsp;transfer of shares of common stock or any security convertible into common stock as a
bona fide gift or charitable contribution or for bona fide estate planning purposes, (c)&nbsp;sales or other dispositions of shares of any class of our capital stock or any security convertible into shares of our capital stock, in each case that are
made exclusively between and among (i)&nbsp;the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Parties or members of their family (including to a trust, limited partnership, limited liability company or other entity for the direct or indirect
benefit of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Parties or members of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Parties&#146; family, or (ii)&nbsp;affiliates of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Parties,
including their partners (if a partnership) or members (if a limited liability company), stockholders (if a corporation) or any investment fund or other entity controlling, controlled by, managing, or managed by or under common control with the <FONT
STYLE="white-space:nowrap">Lock-Up</FONT> Parties or affiliates of them (including, for the avoidance of doubt, where the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Parties are partnerships, to their general partner or successor partnership or
fund, or any other funds managed by such partnership), or to a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clause (b)&nbsp;and this clause (c)(i), (d) transfers of shares of common stock or
any security convertible into common stock by will, testamentary document or intestate succession upon the death of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Parties, by operation of law or pursuant to a court order or settlement agreement
related to the distribution of assets in connection with the dissolution of a marriage or civil union; (e)&nbsp;transfers to the Company (i)&nbsp;from an employee or other service provider of the Company upon death, disability or termination of
employment or other service relationship, in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">134 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
each case, of such employee or service provider or (ii)&nbsp;in connection with the vesting, settlement, or exercise of restricted stock units, options, warrants or other rights to purchase
shares of common stock (including, in each case, by way of &#147;net&#148; or &#147;cashless&#148; exercise), including for the payment of exercise price and tax and remittance payments due as a result of the vesting, settlement, or exercise of such
restricted stock units, options, warrants or rights, pursuant to any plan or agreement granting such an award to an employee or other service provider of the Company, which plan or agreement is described in the registration statement relating to the
offering or the final prospectus relating to the offering; provided further that it shall be a condition to any transaction or transfer pursuant to clause (a), (b), (c), (d) and (e), that each party (the
<FONT STYLE="white-space:nowrap">Lock-Up</FONT> Parties, donor, donee, transferor or transferee, as applicable) shall not be required by law (including without limitation the disclosure requirements of the Securities Act and the Exchange Act to
make, and shall agree to not voluntarily make, any filing or public announcement of the transfer or disposition prior to the expiration of the <FONT STYLE="white-space:nowrap">180-day</FONT> period referred to above (other than a filing on Form 4 in
the case of a transfer pursuant to clause (b), (d), or (e)&nbsp;required by Section&nbsp;16(a) of the Exchange Act clearly stating the nature and conditions of such transfer and that, if applicable, such shares remain subject to the terms of the <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreement and that, in the case of clause (e)(i), no common stock was sold by the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Parties other than such transfer to the Company as described above);
<I>provided further </I>that it shall be a condition to any transfer pursuant to clause (b), (c), (d) and (e)&nbsp;that such transfer shall not involve a disposition for value and the transferee/donee agrees to be bound by the terms of the <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreement (including, without limitation, the restrictions set forth in the preceding sentence) to the same extent as if the transferee/donee were a party thereto, (f)&nbsp;the exercise of warrants or the
exercise of stock options granted pursuant to our stock option/incentive plans or otherwise outstanding on the date hereof; <I>provided</I>, that the restrictions shall apply to shares of common stock issued upon such exercise or conversion,
(g)&nbsp;the establishment of any contract, instruction or plan that satisfies all of the requirements of Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act; <I>provided</I>, <I>however</I>, that no sales of common stock or
securities convertible into, or exchangeable or exercisable for, common stock, shall be made pursuant to a Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan prior to the expiration of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period
(as the same may be extended pursuant to the provisions hereof); <I>provided further</I>, that, to the extent a public report or filing under the Exchange Act, if any, is required to be made by or on behalf of the
<FONT STYLE="white-space:nowrap">Lock-Up</FONT> Parties or us to report the establishment of such Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan, such report or filing shall include a statement to the effect that no transfer of shares
pursuant to such Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> Plan during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period and no public report or filing under the Exchange Act regarding the establishment of such Rule <FONT
STYLE="white-space:nowrap">10b5-1</FONT> Plan shall otherwise be voluntarily effected by or on behalf of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Parties or us during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period,
(h)&nbsp;any demands or requests for, exercises of any right with respect to, or taking of any action in preparation of, the registration by us under the Securities Act of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Parties&#146; shares of
common stock, provided that no transfer of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Parties&#146; shares of common stock registered pursuant to the exercise of any such right and no registration statement shall be filed under the
Securities Act with respect to any of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Parties&#146; shares of common stock during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, and (i)&nbsp;sales or other dispositions to a bona fide
third party pursuant to a merger, consolidation, tender offer or other similar transaction made to all holders of common stock and involving a Change of Control of the Company and approved by the Company&#146;s board of directors; provided that, in
the event that such Change of Control is not completed, the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Parties&#146; common stock and any security convertible into common stock shall remain subject to the restrictions contained herein.
(&#147;Change of Control&#148; shall mean the transfer (whether by tender offer, merger, consolidation or other similar transaction), in one transaction or a series of related transactions, to a person or group of affiliated persons, of the
Company&#146;s voting securities if, after such transfer, such person or group of affiliated persons would hold more than 50% of the outstanding voting securities of the Company or the surviving entity). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc. and UBS Securities LLC may, at their sole discretion and at any time, release the common stock and other securities
subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements described above in whole or in part at any time. At least three business days before the effectiveness of any release or waiver of any of the restrictions described above with
respect to an officer or director of the Company, BofA Securities, Inc. and UBS Securities LLC will notify us of the impending release or waiver and we have agreed to announce the impending release or waiver in accordance with any method permitted
by applicable law or regulation (which may include a press release), except where the release or waiver is effected solely to permit a transfer of common stock that is not for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">135 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consideration and where the transferee has agreed in writing to be bound by the same terms as the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements described above to the extent and for
the duration that such terms remain in effect at the time of transfer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We expect the shares to be approved for listing on the&#8195;&#8195;&#8195;under the symbol &#147;AMBQ.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before this offering, there has been no public market for our common stock. The initial public offering price will be determined through
negotiations between us and the representatives. In addition to prevailing market conditions, the factors to be considered in determining the initial public offering price are </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the valuation multiples of publicly traded companies that the representatives believe to be comparable to us,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our financial information, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the history of, and the prospects for, our company and the industry in which we compete, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an assessment of our management, its past and present operations, and the prospects for, and timing of, our
future revenues, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the present state of our development, and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the above factors in relation to market values and various valuation measures of other companies engaged in
activities similar to ours. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An active trading market for the shares may not develop. It is also possible that after the
offering the shares will not trade in the public market at or above the initial public offering price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters do not expect to
sell more than 5% of the shares in the aggregate to accounts over which they exercise discretionary authority. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Price Stabilization, Short Positions
and Penalty Bids </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Until the distribution of the shares is completed, SEC rules may limit underwriters and selling group members from
bidding for and purchasing our common stock. However, the representatives may engage in transactions that stabilize the price of the common stock, such as bids or purchases to peg, fix or maintain that price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the offering, the underwriters may purchase and sell our common stock in the open market. These transactions may include
short sales, purchases on the open market to cover positions created by short sales and stabilizing transactions. Short sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in the offering.
&#147;Covered&#148; short sales are sales made in an amount not greater than the underwriters&#146; option to purchase additional shares described above. The underwriters may close out any covered short position by either exercising their option to
purchase additional shares or purchasing shares in the open market. In determining the source of shares to close out the covered short position, the underwriters will consider, among other things, the price of shares available for purchase in the
open market as compared to the price at which they may purchase shares through the option granted to them. &#147;Naked&#148; short sales are sales in excess of such option. The underwriters must close out any naked short position by purchasing
shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of our common stock in the open market after pricing that could adversely affect
investors who purchase in the offering. Stabilizing transactions consist of various bids for or purchases of shares of common stock made by the underwriters in the open market prior to the completion of the offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The underwriters may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the
underwriting discount received by it because the representatives have repurchased shares sold by or for the account of such underwriter in stabilizing or short covering transactions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">136 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Similar to other purchase transactions, the underwriters&#146; purchases to cover the
syndicate short sales may have the effect of raising or maintaining the market price of our common stock or preventing or retarding a decline in the market price of our common stock. As a result, the price of our common stock may be higher than the
price that might otherwise exist in the open market.&#8195;The underwriters may conduct these transactions on the &#8195;&#8195;&#8195;&#8195;&#8195;, in the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or otherwise. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither we nor
any of the underwriters make any representation or prediction as to the direction or magnitude of any effect that the transactions described above may have on the price of our common stock. In addition, neither we nor any of the underwriters make
any representation that the representatives will engage in these transactions or that these transactions, once commenced, will not be discontinued without notice. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Electronic Distribution </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection
with the offering, certain of the underwriters or securities dealers may distribute prospectuses by electronic means, such as <FONT STYLE="white-space:nowrap">e-mail.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Relationships </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Some of the
underwriters and their affiliates have engaged in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business with us or our affiliates. They have received, or may in the future receive,
customary fees and commissions for these transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in the ordinary course of their business activities, the underwriters
and their affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their
customers. Such investments and securities activities may involve securities and/or instruments of ours or our affiliates. The underwriters and their affiliates may also make investment recommendations and/or publish or express independent research
views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Selling Restrictions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective
Investors in the European Economic Area </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In relation to each member state of the European Economic Area (each a &#147;Relevant
State&#148;), no shares have been offered or will be offered pursuant to the offering to the public in that Relevant State prior to the publication of a prospectus in relation to the shares which has been approved by the competent authority in that
Relevant State or, where appropriate, approved in another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation, except that offers of shares may be made to the public in that
Relevant State at any time under the following exemptions under the Prospectus Regulation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any legal entity which is a qualified investor as defined under the Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to fewer than 150 natural or legal persons (other than qualified investors as defined under the Prospectus
Regulation), subject to obtaining the prior consent of the representatives for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in any other circumstances falling within Article 1(4) of the Prospectus Regulation, </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">provided that no such offer of shares shall require the Company or any underwriter to publish a prospectus pursuant to Article 3 of the
Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each person in a Relevant State who
initially acquires any shares or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with the Company and the underwriters that it is a qualified investor within the meaning of the Prospectus Regulation. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">137 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the case of any shares being offered to a financial intermediary as that term is used in
Article 5(1) of the Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the shares acquired by it in the offer have not been acquired on a
<FONT STYLE="white-space:nowrap">non-discretionary</FONT> basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer to the public other than their offer or
resale in a Relevant State to qualified investors, in circumstances in which the prior consent of the representatives has been obtained to each such proposed offer or resale. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company, the underwriters and their affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgements
and agreements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this provision, the expression an &#147;offer to the public&#148; in relation to any shares in any
Relevant State means the communication in any form and by any means of sufficient information on the terms of the offer and any shares to be offered so as to enable an investor to decide to purchase or subscribe for any shares, and the expression
&#147;Prospectus Regulation&#148; means Regulation (EU) 2017/1129. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The above selling restriction is in addition to any other selling
restrictions set out below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the offering, the representatives are not acting for anyone other than the Company and
will not be responsible to anyone other than the Company for providing the protections afforded to their clients nor for providing advice in relation to the offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in the United Kingdom </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In relation to the United Kingdom (&#147;UK&#148;), no shares have been offered or will be offered pursuant to the offering to the public in
the UK prior to the publication of a prospectus in relation to the shares which has been approved by the Financial Conduct Authority in the UK in accordance with the UK Prospectus Regulation and the FSMA, except that offers of shares may be made to
the public in the UK at any time under the following exemptions under the UK Prospectus Regulation and the FSMA: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any legal entity which is a qualified investor as defined under the UK Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to fewer than 150 natural or legal persons (other than qualified investors as defined under the UK Prospectus
Regulation), subject to obtaining the prior consent of the representatives for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">at any time in other circumstances falling within section 86 of the FSMA, </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">provided that no such offer of shares shall require the Company or any underwriter to publish a prospectus pursuant to Section&nbsp;85 of the
FSMA or Article 3 of the UK Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the UK Prospectus Regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each
person in the UK who initially acquires any shares or to whom any offer is made will be deemed to have represented, acknowledged and agreed to and with the Company and the underwriters that it is a qualified investor within the meaning of the UK
Prospectus Regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the case of any shares being offered to a financial intermediary as that term is used in Article 5(1) of the UK
Prospectus Regulation, each such financial intermediary will be deemed to have represented, acknowledged and agreed that the shares acquired by it in the offer have not been acquired on a <FONT STYLE="white-space:nowrap">non-discretionary</FONT>
basis on behalf of, nor have they been acquired with a view to their offer or resale to, persons in circumstances which may give rise to an offer to the public other than their offer or resale in the UK to qualified investors, in circumstances in
which the prior consent of the representatives has been obtained to each such proposed offer or resale. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company, the underwriters and
their affiliates will rely upon the truth and accuracy of the foregoing representations, acknowledgements and agreements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">138 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the purposes of this provision, the expression an &#147;offer to the public&#148; in
relation to any shares in the UK means the communication in any form and by any means of sufficient information on the terms of the offer and any shares to be offered so as to enable an investor to decide to purchase or subscribe for any shares, the
expression &#147;UK Prospectus Regulation&#148; means Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, and the expression &#147;FSMA&#148; means the Financial Services and Markets Act
2000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the offering, the representatives are not acting for anyone other than the Company and will not be responsible
to anyone other than the Company for providing the protections afforded to their clients nor for providing advice in relation to the offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This document is for distribution only to persons who (i)&nbsp;have professional experience in matters relating to investments and who qualify
as investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the &#147;Financial Promotion Order&#148;), (ii) are persons falling within Article 49(2)(a)
to (d) (&#147;high net worth companies, unincorporated associations, etc.&#148;) of the Financial Promotion Order, (iii)&nbsp;are outside the United Kingdom, or (iv)&nbsp;are persons to whom an invitation or inducement to engage in investment
activity (within the meaning of Section&nbsp;21 of the Financial Services and Markets Act 2000, as amended (&#147;FSMA&#148;)) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated
(all such persons together being referred to as &#147;relevant persons&#148;). This document is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to
which this document relates is available only to relevant persons and will be engaged in only with relevant persons. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective
Investors in Switzerland </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange
(&#147;SIX&#148;) or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of
Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering
or marketing material relating to the shares or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Neither this document nor any other offering or marketing material relating to the offering, the Company, or the shares have been or will be
filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of shares will not be supervised by, the Swiss Financial Market Supervisory Authority (&#147;FINMA&#148;), and the offer of
shares has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (&#147;CISA&#148;). The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not
extend to acquirers of shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in the Dubai International Financial Centre </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus relates to an Exempt Offer in accordance with the Offered Securities Rules of the Dubai Financial Services Authority
(&#147;DFSA&#148;). This prospectus is intended for distribution only to persons of a type specified in the Offered Securities Rules of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for
reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus nor taken steps to verify the information set forth herein and has no responsibility for the prospectus. The shares to which this
prospectus relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the shares offered should conduct their own due diligence on the shares. If you do not understand the contents of this prospectus you should
consult an authorized financial advisor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">139 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Australia </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No placement document, prospectus, product disclosure statement or other disclosure document has been lodged with the Australian Securities and
Investments Commission (&#147;ASIC&#148;), in relation to the offering. This prospectus does not constitute a prospectus, product disclosure statement or other disclosure document under the Corporations Act 2001 (the &#147;Corporations Act&#148;),
and does not purport to include the information required for a prospectus, product disclosure statement or other disclosure document under the Corporations Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any offer in Australia of the shares may only be made to persons (the &#147;Exempt Investors&#148;) who are &#147;sophisticated
investors&#148; (within the meaning of section 708(8) of the Corporations Act), &#147;professional investors&#148; (within the meaning of section 708(11) of the Corporations Act) or otherwise pursuant to one or more exemptions contained in section
708 of the Corporations Act so that it is lawful to offer the shares without disclosure to investors under Chapter 6D of the Corporations Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares applied for by Exempt Investors in Australia must not be offered for sale in Australia in the period of 12 months after the date of
allotment under the offering, except in circumstances where disclosure to investors under Chapter 6D of the Corporations Act would not be required pursuant to an exemption under section 708 of the Corporations Act or otherwise or where the offer is
pursuant to a disclosure document which complies with Chapter 6D of the Corporations Act. Any person acquiring shares must observe such Australian <FONT STYLE="white-space:nowrap">on-sale</FONT> restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus contains general information only and does not take account of the investment objectives, financial situation or particular
needs of any particular person. It does not contain any securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether the information in this prospectus is appropriate to their
needs, objectives and circumstances, and, if necessary, seek expert advice on those matters. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Hong Kong
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than
(a)&nbsp;to &#147;professional investors&#148; as defined in the Securities and Futures Ordinance (Cap. 571) of Hong Kong and any rules made under that Ordinance; or (b)&nbsp;in other circumstances which do not result in the document being a
&#147;prospectus&#148; as defined in the Companies Ordinance (Cap. 32) of Hong Kong or which do not constitute an offer to the public within the meaning of that Ordinance. No advertisement, invitation or document relating to the shares has been or
may be issued or has been or may be in the possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if
permitted to do so under the securities laws of Hong Kong) other than with respect to shares which are or are intended to be disposed of only to persons outside Hong Kong or only to &#147;professional investors&#148; as defined in the Securities and
Futures Ordinance and any rules made under that Ordinance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Japan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (Law No.&nbsp;25 of 1948, as
amended) and, accordingly, will not be offered or sold, directly or indirectly, in Japan, or for the benefit of any Japanese Person or to others for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly, in Japan or
to any Japanese Person, except in compliance with all applicable laws, regulations and ministerial guidelines promulgated by relevant Japanese governmental or regulatory authorities in effect at the relevant time. For the purposes of this paragraph,
&#147;Japanese Person&#148; shall mean any person resident in Japan, including any corporation or other entity organized under the laws of Japan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Singapore </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, the shares have not been offered
or sold or caused to be made the subject of an invitation for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">140 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
subscription or purchase and will not be offered or sold or caused to be made the subject of an invitation for subscription or purchase, and this prospectus or any other document or material in
connection with the offer or sale, or invitation for subscription or purchase, of the shares, has not been circulated or distributed, nor will it be circulated or distributed, whether directly or indirectly, to any person in Singapore other than
(i)&nbsp;to an institutional investor (as defined in Section&nbsp;4A of the Securities and Futures Act (Chapter 289) of Singapore, as modified or amended from time to time (the &#147;SFA&#148;)) pursuant to Section&nbsp;274 of the SFA, (ii)&nbsp;to
a relevant person (as defined in Section&nbsp;275(2) of the SFA) pursuant to Section&nbsp;275(1) of the SFA, or any person pursuant to Section&nbsp;275(1A) of the SFA, and in accordance with the conditions specified in Section&nbsp;275 of the SFA,
or (iii)&nbsp;otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Where the
shares are subscribed or purchased under Section&nbsp;275 of the SFA by a relevant person which is: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole
business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each
beneficiary of the trust is an individual who is an accredited investor, </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">securities or securities-based derivatives
contracts (each term as defined in Section&nbsp;2(1) of the SFA) of that corporation or the beneficiaries&#146; rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust
has acquired the shares pursuant to an offer made under Section&nbsp;275 of the SFA except: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to an institutional investor or to a relevant person, or to any person arising from an offer referred to in
Section&nbsp;275(1A) or Section&nbsp;276(4)(i)(B) of the SFA; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where no consideration is or will be given for the transfer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where the transfer is by operation of law; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as specified in Section&nbsp;276(7) of the SFA; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as specified in Regulation 32 of the Securities and Futures (Offers of Investments) (Shares and Debentures)
Regulations of 2005 of Singapore (&#147;Regulation 32&#148;). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Singapore SFA <I>product classification</I>. In
connection with Section&nbsp;309B of the SFA and the Capital Markets Products (the &#147;CMP&#148;) Regulations 2018, unless otherwise specified before an offer of shares, we have determined, and hereby notify all relevant persons (as defined in
Section&nbsp;309A(1) of the SFA), that the shares are &#147;prescribed capital markets products&#148; (as defined in the CMP Regulations 2018) and Excluded Investment Products (as defined in Monetary Authority of Singapore Notice SFA <FONT
STYLE="white-space:nowrap">04-N12:</FONT> Notice on the Sale of Investment Products and Monetary Authority of Singapore Notice <FONT STYLE="white-space:nowrap">FAA-N16:</FONT> Notice on Recommendations on Investment Products). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Notice to Prospective Investors in Canada </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in
National Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> <I>Prospectus Exemptions</I> or subsection 73.3(1) of the <I>Securities Act</I> (Ontario), and are permitted clients, as defined in National Instrument
<FONT STYLE="white-space:nowrap">31-103</FONT> Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus
requirements of applicable securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of Canada may provide a purchaser
with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">141 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser&#146;s province or territory.
The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of these rights or consult with a legal advisor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 (or, in the case of securities issued or guaranteed by the government of a
<FONT STYLE="white-space:nowrap">non-Canadian</FONT> jurisdiction, section 3A.4) of National Instrument <FONT STYLE="white-space:nowrap">33-105</FONT> <I>Underwriting Conflicts</I> (&#147;NI <FONT STYLE="white-space:nowrap">33-105&#148;),</FONT> the
underwriters are not required to comply with the disclosure requirements of NI <FONT STYLE="white-space:nowrap">33-105</FONT> regarding underwriter conflicts of interest in connection with this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">142 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_19"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The validity of the shares of common stock being offered by this prospectus will be passed upon for us by Cooley LLP, Chicago, Illinois. Davis
Polk&nbsp;&amp; Wardwell LLP, Redwood City, California, is acting as counsel to the underwriters in connection with certain legal matters relating to the shares of common stock offered by this prospectus. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_20"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The consolidated financial statements of Ambiq Micro, Inc. as of December 31, 2023, and for the year then ended, have been included herein and
in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">143 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_22"></A>WHERE YOU CAN FIND ADDITIONAL INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-1,</FONT> including exhibits and schedules,
under the Securities Act, with respect to the shares of common stock being offered by this prospectus. This prospectus, which constitutes part of the registration statement, does not contain all of the information in the registration statement and
its exhibits. For further information with respect to us and the common stock offered by this prospectus, we refer you to the registration statement and its exhibits. Statements contained in this prospectus as to the contents of any contract or any
other document referred to are not necessarily complete, and in each instance, we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements is qualified in all respects by
this reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You can read our SEC filings, including the registration statement, over the Internet at the SEC&#146;s website at
www.sec.gov. You may also request a copy of these filings, at no cost, by writing us at 6500 River Place Blvd., Building 7, Suite 200, Austin, Texas 78730. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Upon the closing of this offering, we will be subject to the information reporting requirements of the Exchange Act and we will file reports,
proxy statements and other information with the SEC. These reports, proxy statements and other information will be available at the web site of the SEC referred to above. We also maintain a website at www.ambiq.com, at which, following the
completion of this offering, you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. Information contained on or accessible through our website is not a part
of this prospectus, and the inclusion of our website address in this prospectus is an inactive textual reference only. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">144 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="rom377490_23"></A>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Page</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377490_1">Report of Independent Registered Public Accounting Firm</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-2</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377490_2">Consolidated Balance Sheet</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377490_3">Consolidated Statement of Operations and Comprehensive Loss</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377490_4">Consolidated Statement of Changes in Redeemable Convertible Preferred Stock
 and Stockholders&#146; Deficit</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-5</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377490_5">Consolidated Statement of Cash Flows</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin377490_6">Notes to Consolidated Financial Statement</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g377490g01n54.jpg" ALT="LOGO" STYLE="width:1.00903in;height:0.424167in;">
 </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">KPMG LLP</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">Suite 1900<BR>111 Congress
Avenue<BR>Austin, TX 78701-4091</P></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377490_1"></A>Report of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Stockholders and the Board of Directors </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ambiq Micro,
Inc.: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Opinion on the Consolidated Financial Statements </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have audited the consolidated financial statements and the related notes (collectively, the consolidated financial statements) of Ambiq Micro, Inc. and
subsidiaries (the Company) as listed in the accompanying index. In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December&nbsp;31, 2023, and the results of
its operations and its cash flows for the year then ended, in conformity with U.S. generally accepted accounting principles. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Basis for Opinion
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">These consolidated financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on these
consolidated financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance
with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We conducted our
audit in accordance with the standards of the PCAOB and in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether
the consolidated financial statements are free of material misstatement, whether due to error or fraud. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our audit included performing procedures to
assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the
amounts and disclosures in the consolidated financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated
financial statements. We believe that our audit provides a reasonable basis for our opinion. </P>  <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>/s/KPMG LLP</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We have served as the Company&#146;s auditor since 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Austin, Texas </P>  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February&nbsp;12, 2025 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMBIQ MICRO, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377490_2"></A>CONSOLIDATED BALANCE SHEET </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of December&nbsp;31, 2023 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands, except share amounts) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Assets</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">27,321</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,275</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventories, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,477</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,789</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property, equipment and software, net of accumulated depreciation and amortization
of&nbsp;$11,565</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,983</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT>
assets, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">990</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets, net of accumulated amortization of $5,537</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">72,432</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Liabilities, Redeemable Convertible Preferred Stock and
Stockholders&#146; Deficit</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,703</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">804</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,917</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">219</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrant liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,299</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commitments and contingencies (see Note 9)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock, $0.000001 par value, 325,864,198 shares <BR>authorized,
277,238,979 shares issued and outstanding at December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">320,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; deficit:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.000001 par value; 450,000,000 shares authorized, 9,979,217<BR>shares issued and
outstanding at December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">paid-in-capital</FONT></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,676</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(277,865</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(839</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(261,028</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities, redeemable convertible preferred stock and stockholders&#146;
deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">72,432</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to consolidated
financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMBIQ MICRO, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377490_3"></A>CONSOLIDATED STATEMENT OF OPERATIONS AND COMPREHENSIVE LOSS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the year ended December&nbsp;31, 2023 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46,096</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross profit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">44,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Selling, general, and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">26,743</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">70,763</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(51,322</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss before income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(50,302</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(50,332</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deemed dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,941</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(52,273</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share attributable to common stockholders, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5.38</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used in computing net loss per share attributable to common stockholders,
basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,722,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unaudited pro forma net loss per share attributable to common stock holders, basic and
diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> (0.18 </TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used in computing unaudited pro forma net loss per share attributable to
common stockholders, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">292,732,177</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Currency translation adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(508</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(50,840</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deemed dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,941</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss attributable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(52,781</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:150pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMBIQ MICRO, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377490_4"></A>CONSOLIDATED STATEMENT OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#146; DEFICIT </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands, except share amounts) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Redeemable Convertible<BR>Preferred Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional&nbsp;Paid-</B><br><B><FONT STYLE="white-space:nowrap">In-Capital</FONT></B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated Other<BR>Comprehensive&nbsp;Loss</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Stockholders&#146;</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#8195;Shares&#8195;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&#8195;Amount&#8195;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, December&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">241,828,956</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">288,304</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,332,402</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,836</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(225,592</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(331</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(213,087</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series G preferred stock, net of offering costs of $280</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,972,704</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,258</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">437,319</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">599</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">646,815</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,623</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,623</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deemed dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,941</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,941</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Currency translation adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(508</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(508</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(50,332</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(50,332</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">277,238,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">320,161</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,979,217</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,676</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(277,865</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(839</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(261,028</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:200pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMBIQ MICRO, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377490_5"></A>CONSOLIDATED STATEMENT OF CASH FLOWS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the year ended December&nbsp;31, 2023 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash flows from operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(50,332</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,623</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Amortization of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,176</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in warrant valuations and cancellations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(581</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">839</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <FONT STYLE="white-space:nowrap">non-cash</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,309</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts receivable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,983</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventories</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,162</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,735</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,938</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,721</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other long-term liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(787</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(26,958</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash flows from investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(2,562</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of property, equipment and software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(459</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(3,021</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash flows from financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from exercise of warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">240</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of exchange rate changes on cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(254</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,541</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents at beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25,780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents at end of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">27,321</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Supplemental disclosure of <FONT STYLE="white-space:nowrap">non-cash</FONT> investing and
financing activities:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets in accrued and other long-term liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deemed dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,941</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See accompanying notes to
consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin377490_6"></A>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Description of Business </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ambiq Micro, Inc. (the
Company) is a fabless semiconductor company that has developed technology based on a patented <FONT STYLE="white-space:nowrap">Sub-threshold</FONT> Power Optimized Technology (SPOT<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP>) platform
that significantly reduces the amount of power consumed by integrated circuits. The following subsidiaries were formed by the Company and are wholly owned: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ambiq Micro Singapore Private Ltd.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shenzhen DeKean Electronics Co.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ambiq Micro Asia Ltd.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ambiq Micro Asia Ltd. Taiwan</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ambiq (Shenzhen) Electronics Co., Ltd.</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Global Economic Considerations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The global macroeconomic environment is uncertain, and could be negatively affected by, among other things, increased U.S. disputes with countries who are
existing trade partners, instability in the global capital and credit markets, supply chain weaknesses, and instability in the geopolitical environment in Asia, Europe and the Middle East, and other tensions. Deterioration in economic factors
arising from trade disputes between the United States and China, in particular, could have an adverse impact on our financial results given our customer concentrations in both countries. Such challenges have caused, and may continue to cause,
recession fears, rising interest rates, foreign exchange volatility and inflationary pressures through the imposition of tariffs on sensitive technologies, including semiconductors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Despite the uncertainty of these challenges, the Company believes it has considered all appropriate factors when making financial estimates and will continue
to evaluate the impact of any significant changes resulting from these and other factors affecting the Company&#146;s business performance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity
and Capital Resources </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2023, the Company reported a net loss of $50.3&nbsp;million and had an operating cash
flow deficit of $27.0&nbsp;million. As of December&nbsp;31, 2023, the Company had cash and cash equivalents totaling $27.3&nbsp;million. Since inception, the Company has had negative cash flows and losses from operations which it has funded
primarily through the issuances of common and preferred stock. The Company anticipates incurring additional losses and negative cash flows from operations until such time, if ever, that it can generate significant sales of its products currently in
development and is highly dependent on its ability to find additional sources of funding in the form of debt and equity financing. The Company&#146;s ability to fund its planned operations, research and development, and commercialization of its
products significantly depends on the amount and timing of cash receipts from these funding sources. Adequate additional funding may not be available to the Company on acceptable terms or at all. The failure to raise funds as and when needed and
generate adequate sales could have a negative impact on the Company&#146;s financial condition and ability to satisfy its obligations over the next twelve months. Refer to Note 16 for information concerning funding received subsequent to
December&nbsp;31, 2023 but prior to the issuance of the consolidated financial statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Summary of Significant Accounting Policies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis of Accounting and Consolidation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The accompanying
consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable rules and regulations of the Securities and Exchange Commission (SEC) and include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances
and transactions have been eliminated in consolidation. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Use of Estimates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in
the financial statements and accompanying notes. Estimates are used for, but not limited to, write-down for excess and obsolete inventories, useful lives for property, equipment and software, allowance for sales returns and discounts, allowance for
credit losses, warranties, accrued liabilities, determination of the fair value of stock-based awards, warrants, and deemed dividends, and the realization of tax assets and estimates of tax reserves. These estimates are subjective in nature and
involve judgments that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at fiscal <FONT STYLE="white-space:nowrap">year-end</FONT> and the reported amounts of revenue and expenses during the
reporting period. Actual results could differ from those estimates. In the current macroeconomic environment affected by geopolitical uncertainty, these estimates require increased judgment and carry a higher degree of variability and volatility. As
events continue to evolve and additional information becomes available, these estimates may change materially in future periods. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Unaudited Pro Forma
Information </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Immediately prior to the closing of a qualified initial public offering (IPO), all of the Company&#146;s outstanding redeemable
convertible preferred stock will automatically convert into 283,009,207 shares of common stock as of December 31, 2023. In the accompanying statements of operations and comprehensive loss, unaudited pro forma basic and diluted net loss per share of
common stock has been prepared to give effect to the automatic conversion of all outstanding shares of redeemable convertible preferred stock as if they had been converted at the beginning of the reporting period. The shares of the Company&#146;s
common stock expected to be issued, and the related net proceeds expected to be received, in connection with the planned IPO are excluded from such pro forma information. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash and Cash Equivalents </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company considers all
highly liquid investments acquired with an original maturity of three months or less at the date of purchase to be cash equivalents. Cash equivalents are stated at cost, which approximates fair value, due to the short maturity of these instruments.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Accounts Receivable </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accounts receivable are
recorded at the invoice amount, net of an allowance for expected credit losses. The Company assesses the collectability of outstanding customer invoices, and if deemed necessary maintains an allowance for estimated losses resulting from
uncollectible customer receivables. In estimating this allowance, the Company considers factors such as historical collection experience, a customer&#146;s current creditworthiness, customer concentrations, age of the receivable balance, both
individually and in the aggregate, and general macroeconomic conditions that may affect a customer&#146;s ability to pay. Actual customer collections could differ from the Company&#146;s estimates. For the year ended December&nbsp;31, 2023, the
Company did not record an allowance for expected credit losses as all amounts outstanding were deemed collectible. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Concentration of Risks </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Financial Instruments </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that
potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents and trade accounts receivable. The Company maintains its cash and cash equivalent balances in highly rated financial institutions, which
at times may exceed federally insured limits or be held in foreign jurisdictions. The Company has not experienced any loss relating to cash and cash equivalents in these accounts and believes no significant concentration risk exists with respect to
cash. The Company performs periodic credit evaluations of its customers&#146; financial conditions and generally does not require collateral. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Demand </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There were two customers representing 68%
and 35%, respectively, of total accounts receivable as of December&nbsp;31, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There were three customers representing 32%, 30% and 17%, respectively,
of total net sales for the year ended December&nbsp;31, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The loss of one or more of these customers could have a material adverse impact on the
Company&#146;s results of operations and financial position. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Supply </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our products depend on a sole supplier of wafers and a limited number of third-party manufacturers. The continued and timely supply of input materials and the
availability of manufacturing capacity and packaging and testing services impact our ability to meet customer demand. Supply chain disruptions, shortages of raw material, and manufacturing limitations could limit our ability to meet customer demand
and result in delayed, reduced, or canceled orders. We have established relationships with leading suppliers and partners, and we believe these relationships increase the resiliency of our supply chain for our customers. From time to time, subject
to inventory disruptions, our customers may buy and hold excess inventories. Consequently, we may be subject to resulting fluctuations in the demand for our products. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Fair Value of Financial Instruments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company defines
fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities
required or permitted to be recorded at fair value, the Company considers the principal market or the most advantageous market in which it would transact. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The level of the fair value hierarchy in which the fair value measurement falls is determined by the lowest level input that is significant to the fair value
measurement. The fair value hierarchy is as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level&nbsp;1 applies to assets or liabilities for which there are quoted prices in active markets for identical
assets or liabilities that the Company can access at the measurement date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level&nbsp;2 applies to assets or liabilities for which there are inputs other than quoted prices included in
Level&nbsp;1 that are observable for the asset or liability, either directly or indirectly, such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient
volume or infrequent transactions (less active markets). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Level&nbsp;3 applies to assets or liabilities for which fair value is derived from valuation techniques in which
one or more significant inputs are unobservable, including the Company&#146;s own assumptions. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s financial instruments
consist principally of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and warrants. The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses are considered to
approximate their respective fair values due to the short-term nature of such financial instruments. Cash equivalents, measured at fair value on a recurring basis, are categorized as Level&nbsp;1 based on quoted prices in active markets. On a
recurring basis, the Company measures its liability classified warrant obligations at fair value based on Level&nbsp;3 inputs, which requires a higher degree of judgment (refer to Note 8). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There have been no changes in Level&nbsp;1, Level&nbsp;2, and Level&nbsp;3 and no changes in valuation techniques for these assets or liabilities for the year
ended December&nbsp;31, 2023. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Internal-Use</FONT> Software </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the guidance in ASU <FONT STYLE="white-space:nowrap">2018-15,</FONT> <I>Intangibles&#151;Goodwill and
<FONT STYLE="white-space:nowrap">Other&#151;Internal-Use</FONT> Software <FONT STYLE="white-space:nowrap">(Subtopic&nbsp;350-40),</FONT> </I>we capitalize the implementation costs for cloud computing arrangements, mainly for our inventory management
system and accounting system. These cloud-based computing implementation costs are recorded in prepaid expenses and other current assets on our consolidated balance sheet. The capitalized costs are amortized based on the estimated useful life of the
software arrangement. Capitalized cloud-based computing implementation costs as of December&nbsp;31, 2023 are: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capitalized cloud-based computing implementation costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Capitalized cloud-based computing implementation costs, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Inventories </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Inventories
are stated at the lower of cost or net realizable value. Cost is calculated on a weighted moving average basis. In estimating net realizable value, the Company considers (among other things) the age of its inventories and its product market
acceptance based on known business factors and conditions by comparing forecasted customer unit demand for products over a specific future period, or demand horizon, to quantities on hand at the end of each accounting period. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Property, Equipment and Software, Net </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Property,
equipment and software are carried at cost less accumulated depreciation and amortization. Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the related assets, generally three to five
years. The Company capitalizes costs for the fabrication of mask sets used by foundry partners to manufacture the Company&#146;s product. Major additions and betterments that extend the estimated useful lives of assets are capitalized. Repairs,
maintenance, and minor replacements that do not materially improve or extend the lives of the respective assets are charged to operating expense as incurred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intangible Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Intangible assets represent costs to acquire licensed intellectual property and software tools. The Company accounts for a noncancelable <FONT
STYLE="white-space:nowrap">internal-use</FONT> software license as the acquisition of an intangible asset and the incurrence of a liability to the extent that all or a portion of the software licensing fees are not paid on or before the license
acquisition. The acquired intangibles are subject to amortization on a straight-line basis over the shorter of their estimated useful lives or term of the license arrangement. Costs incurred to renew or extend the term of a recognized intangible
asset are capitalized as part of the intangible and amortized over its revised estimated useful life. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Long-Lived Assets </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Long-lived assets, which consist primarily of property, equipment, software and intangible assets, are reviewed for impairment whenever events or circumstances
indicate their carrying value may not be recoverable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Conditions that would necessitate an impairment assessment include a significant decline in the
observable market value of an asset, a significant change in the extent or manner in which an asset is used, or any other significant adverse change that would indicate that the carrying amount of an asset or group of assets may not be recoverable.
When such events or circumstances arise, an estimate of future undiscounted cash flow produced by the asset, or the appropriate grouping of assets, is compared to the asset&#146;s carrying value to determine if impairment exists. If the asset is
determined to be impaired, the impairment loss is measured based on the excess of its carrying value over its fair value. The Company determines fair value based on discounted cash flows using a discount rate commensurate with the risk inherent in
the Company&#146;s current business model for the specific asset or asset group being valued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No long-lived assets were impaired for the year ended
December&nbsp;31, 2023. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Leases </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective
January&nbsp;1, 2022, the Company adopted Accounting Standards Codification Topic 842 (ASC 842), <I>Leases, </I>using the modified retrospective approach. The Company elected the package of practical expedients permitted under the transition
guidance within the new standard, which among other things, allows the Company to carry forward the historical lease classification. The Company has also elected not to recognize
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> (ROU) assets and lease liabilities that arise from short-term (12 months or less) leases and not to reassess the following for leases as of January&nbsp;1,
2022: (i) whether contracts are or contain leases, (ii)&nbsp;lease classification, and (iii)&nbsp;initial direct costs. The Company does not combine lease components with <FONT STYLE="white-space:nowrap">non-lease</FONT> components and such, the <FONT
STYLE="white-space:nowrap">non-lease</FONT> components are accounted for separately. The classification of the leases as operating or finance leases, along with the initial measurement and recognition of the as ROU asset and lease liability, are
performed at the lease commencement date. The measurement of lease liability is based on the present value of future lease payments over the lease term. When the implicit rate is not readily determinable, the Company uses its incremental borrowing
rate based on the information available at the lease commencement date in determining the present value of future lease payments. The ROU asset is based on the measurement of the lease liability and includes any lease payments made prior to or on
lease commencement and excludes lease incentives and initial direct costs incurred, as applicable. The lease term may include options to extend or terminate the lease when it is reasonably certain the Company will exercise any such options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Rent expense for the Company&#146;s operating leases is recognized on a straight-line basis over the lease term. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redeemable Convertible Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for its redeemable convertible preferred stock as temporary equity in its consolidated balance sheets due to the nature of the terms of
ownership. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Preferred securities that become redeemable upon a contingent event that is not solely within the control of the Company should be classified
outside of permanent equity, as in this case a change in control of the Company. Since it is not probable that the instruments will become redeemable, subsequent adjustment to fair value is not required. As such, the redeemable convertible preferred
stock was recorded at cost as of December&nbsp;31, 2023 and will remain in temporary equity without further adjustment unless it becomes probable that the redemption feature will become applicable. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Revenue Recognition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s revenues consist
of the sale of its products to the Company&#146;s customers recognized on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-in-time</FONT></FONT> basis. The Company&#146;s customers are distributors, large global original
equipment manufacturers and other direct customers who design and manufacture devices for the consumer and industrial markets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Revenues are recognized
when control of the product is transferred to a customer in an amount that reflects the consideration the Company is expected to be entitled to in exchange for those products, in accordance with Topic&nbsp;606 (ASC 606), <I>Revenue from Contracts
with Customers</I>. For direct customers and large global customer contracts, revenue is recognized either when the product is shipped to the customer or upon delivery depending on the prevailing contract terms. For distributor contracts, revenues
are recognized when the product is shipped to the distributor as in these cases the distributor is the contracted customer. Revenues are recognized net of sales credits and allowances for returns and discounts, when applicable. Revenue is recognized
net of any taxes collected from customers, which are subsequently remitted to governmental authorities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Transaction Price </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised goods to the
customer. The transaction price is specified in the standard price list or contract and is confirmed at the time the order for products is placed by the customer and acknowledged by the Company. Certain distributor contracts include variable
consideration, such as limited price protection, return and stock rotation provisions, while direct customer contracts include general right of return provisions. The Company estimates variable consideration using all available information,
including historical experience and current expectations of return and pricing credits and records an allowance to reduce revenue recognized. These estimates take into consideration a range of possible outcomes that are probability-weighted in
accordance with the expected value method in ASC 606 for relevant factors such as current contractual and statutory requirements, specific known market events and trends, industry data, and forecasted customer buying and payment patterns. Overall,
these reserves reflect the Company&#146;s best estimates of the amount of consideration to which it is entitled based on the terms of the respective underlying contracts. The Company recorded a product returns allowance of approximately
$1.4&nbsp;million as of December&nbsp;31, 2023. These allowances are classified as reductions of accounts receivable when the right of offset exists in accordance with ASU <FONT STYLE="white-space:nowrap">2013-1,</FONT> Balance Sheet (Topic 210):<I>
Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities</I>, or as a current liability. As of December&nbsp;31, 2023, the Company has classified $1.4&nbsp;million as reductions of accounts receivable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Performance Obligations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under most of the Company&#146;s contracts, the Company&#146;s single performance obligation is the delivery of promised goods to the customer. The promised
goods are explicitly stated in the customer contract and comprise a single type of good or goods that are substantially the same and are neither capable of being distinct nor separable from the other promised goods in the contract. This performance
obligation is satisfied upon transfer of control of the promised goods to the customer, as defined per the shipping terms within the customer&#146;s contract. While the Company&#146;s customers purchase products on a purchase order basis, the vast
majority of the Company&#146;s master contracts with customers have an original expected term of one year or less with automatic renewal features. As allowed by ASC 606, the Company has not disclosed the value of any unsatisfied performance
obligations related to these contracts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s standard terms and conditions provide for a <FONT STYLE="white-space:nowrap">one-year</FONT>
warranty coverage on all its products by guaranteeing the product will be free from defects and conform to the product&#146;s specifications. Customers may remedy the warranty claim for a replacement of the product or credit. This assurance-type
warranty is not considered a separate performance obligation under ASC 606 and thus no transaction price is allocated to it. The warranty reserve is calculated using historical claim information to project future warranty claims activity. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Contract Balances </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payments are typically due
within 60 to 90 days of invoicing and terms do not include a significant financing component or <FONT STYLE="white-space:nowrap">non-cash</FONT> consideration. There are no contract assets, other than accounts receivable, or contract liabilities
recorded on the consolidated balance sheets. The Company expenses sales commissions when incurred and these costs are recorded within selling, general and administrative expenses on the consolidated statement of operations and comprehensive loss.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Accrued Contract Costs </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s
accrued sales commissions are immaterial as of December&nbsp;31, 2023 and are recorded within accrued liabilities on the accompanying consolidated balance sheets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>End Customer Concentration </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Although the
Company recognizes revenue and directly invoices distributors for sales of its products, the timing and uncertainty of the Company&#146;s revenue and cash flows is most impacted by the ultimate end customers. The following is a summary of net sales
for the year ended December&nbsp;31, 2023 based on the geography of the corporate headquarters of the ultimate end customers (in thousands): </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">China</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,113</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">United States</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,024</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Netherlands</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,458</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rest of the World*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Other countries individually less than 10% </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cost of Sales </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s cost of sales includes the cost of purchasing finished wafers manufactured by independent foundries and costs associated with the assembly,
testing, shipping and handling of products along with allocated costs for salary, stock compensation and related benefits for personnel involved in the manufacturing of our products. Cost of sales also includes depreciation for equipment and
photomasks supporting the manufacturing process, write downs of inventory, software royalties, licensing fees, logistics, quality assurance, warranty, and other costs incurred by the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Segment Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Segment reporting is based on the
&#147;management approach,&#148; following the method that management uses to organize the Company&#146;s reportable segments for which separate financial information is made available to, and evaluated regularly by, the chief operating decision
maker (CODM) in allocating resources and in assessing performance. The CODM is the Company&#146;s Chief Executive Officer (CEO), who makes resource allocation decisions and assesses performance based on financial information presented on a
consolidated basis. The CEO reviews the Company&#146;s consolidated results as one operating segment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock-Based Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company records stock-based compensation expense based upon the grant date fair value for all stock options issued to all persons to the extent such
options vest. That expense is determined under the fair value method using the Black-Scholes option pricing model. The Company recognizes the compensation cost for awards on a straight-line basis over the vesting period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Black-Scholes option pricing model used to compute stock-based compensation expense requires extensive use of accounting judgment and financial estimates.
Items requiring estimation include the fair value of the Company&#146;s common stock, the expected term over which option holders will retain their vested stock options before exercising them, and the estimated volatility of the Company&#146;s
common stock price over the expected term of a stock option. Application of alternative assumptions could result in significantly different stock-based compensation amounts being recorded in the consolidated financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The absence of an active market for the Company&#146;s common stock requires its board of directors, the members of which the Company believes have extensive
business, finance and venture capital experience, to determine the fair value of its common stock for purposes of granting options and for calculating stock-based compensation expense for the periods presented. The Company obtained contemporaneous
third-party valuations to assist the board of directors in determining fair value. These contemporaneous third-party valuations used the methodologies, approaches and assumptions consistent with the American Institute of Certified Public Accountants
Practice Guide, Valuation of Privately Held Company Equity Securities Issued as Compensation. All options granted were intended to be exercisable at a price per share not less than the fair value of the shares underlying those options on their
respective dates of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As there is no public market for its common stock, the Company estimated the volatility of its common stock periodically based
on the volatility of publicly traded stock of comparable companies and consistent with authoritative guidance, as such is deemed more representative of future stock price trends than the Company&#146;s historical volatility. The risk-free interest
rate assumption is based on observed market interest rates appropriate for the term of the Company&#146;s employee options. As allowed by authoritative guidance, the Company has elected to apply the practical expedient in developing its estimate of
expected term for stock options by using the <FONT STYLE="white-space:nowrap">mid-point</FONT> between the vesting date and contractual termination date of the award. The Company has not paid and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
does not anticipate paying cash dividends on its common stock; therefore, the expected dividend yield is assumed to be zero. The Company has elected to recognize forfeitures as they occur, and
therefore has not estimated potential forfeitures of stock grants and adjusted compensation cost for this estimate. All options granted were intended to be exercisable at a price per share not less than the fair value of the shares underlying those
options on their respective dates of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Transactions with <FONT STYLE="white-space:nowrap">non-employees</FONT> in which stock-based payment awards
are granted in exchange for the receipt of goods or services may involve a contemporaneous exchange of the stock-based payment awards for goods or services or may involve an exchange that spans several financial reporting periods. Judgment is
required in determining the period over which to recognize cost, otherwise known as the <FONT STYLE="white-space:nowrap">non-employee&#146;s</FONT> vesting period. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and Development Costs </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Research and development
costs are expensed as incurred. Research and development costs consist primarily of personnel-related expenses, including stock-based compensation, external consulting and services costs, photomasks not directly attributable to a finished product,
equipment tooling and allocations of other costs incurred by the Company. Assets purchased to support the Company&#146;s ongoing research and development activities are capitalized when related to products that have achieved technological
feasibility and have an alternative future use and are amortized over their estimated useful lives. The Company also has hosted software subscriptions, which are stated at cost and amortized as part of research and development expense based on usage
of the asset or on a straight-line basis over the related period of benefit. Research and development costs were $44.0&nbsp;million for the year ended December&nbsp;31, 2023. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Foreign Currency Translation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The functional currency of
the Company&#146;s foreign subsidiaries was determined to be the local currency; therefore, assets and liabilities are translated at the current exchange rate at the balance sheet date and statement of operations items are translated at the average
exchange rate prevailing during the reporting period. Translation adjustments are included in accumulated other comprehensive loss and as a separate component of stockholders&#146; deficit. Transaction gains and losses arising from transactions
denominated in a currency other than the functional currency of the entity involved are included in other income and expense in the accompanying consolidated statement of operations and comprehensive loss. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Income Taxes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company uses the asset and liability
method of accounting for income taxes as set forth in the applicable guidance. Under this method, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and
the tax bases of assets and liabilities. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The
effect of a change in tax rates on deferred tax assets and liabilities will be recognized in the period that includes the enactment date. A valuation allowance is established against the deferred tax assets to reduce their carrying value to an
amount that is more likely than not to be realized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for uncertainty in income taxes based on a
<FONT STYLE="white-space:nowrap">&#147;more-likely-than-not&#148;</FONT> threshold for the recognition and <FONT STYLE="white-space:nowrap">de-recognition</FONT> of tax positions, which includes the accounting for interest and penalties relating to
tax positions. At December&nbsp;31, 2023, the Company has unrecognized tax benefits of $1.0&nbsp;million. The Company recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense. No such interest or
penalties were recognized during the periods presented. The Company had no accruals for interest and penalties at December&nbsp;31, 2023. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Net Loss Per Share </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Basic net loss per share is based on the weighted effect of common stock issued and outstanding and is calculated by dividing net loss adjusted for dividends
declared on preferred stock (whether or not paid), cumulative undeclared dividends, accretion or decretion of mezzanine equity, redemption or induced conversion of preferred stock, amortization of beneficial conversion features and value of the
effect of a downround feature, where applicable, by the weighted average number of shares of common stock outstanding during the period without consideration of the effect of securities that could be converted into shares of common stock. For the
year ended December&nbsp;31, 2023, the Company recorded a deemed dividend of $1.9&nbsp;million as a result of a down round feature in the Company&#146;s Series E, F, and <FONT STYLE="white-space:nowrap">F-1</FONT> preferred stock triggered during
the issuance by the Company of Series G preferred stock (see Note 11). Diluted net loss per share is calculated by adjusting the weighted average number of shares of common stock outstanding for the dilutive effect of additional shares of common
stock that would have been outstanding if potentially dilutive securities had been issued, as determined using the treasury-stock method for stock options and warrants and the <FONT STYLE="white-space:nowrap">if-converted</FONT> method for
redeemable convertible preferred stock. Potential dilutive securities consist of outstanding preferred stock, stock options, and warrants to purchase the Company&#146;s common and preferred stock. Diluted net loss per share excludes potentially
dilutive securities for all periods presented as their effect would be anti-dilutive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accordingly, basic and diluted net loss per share is the same for
the year ended December&nbsp;31, 2023 presented in the accompanying consolidated statements of operations and comprehensive loss. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recently Issued
Accounting Pronouncements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Not Yet Adopted </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2024, the FASB issued ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2024-03,</FONT> <I>Income Statement&#151;Reporting Comprehensive
Income&#151;Expense Disaggregation Disclosures (Subtopic <FONT STYLE="white-space:nowrap">220-40)</FONT></I>, to enhance transparency and comparability in the reporting of expense information for public entities. The update requires public business
entities to disclose disaggregated expense details, such as purchases of inventory, employee compensation, depreciation, and amortization, within each relevant income statement caption. These disclosures must be presented in a tabular format for
both interim and annual reporting periods. Additionally, entities are required to include qualitative descriptions of expense components which are not separately disclosed. Early adoption is permitted. The Company will adopt the updates in this
amendment on January&nbsp;1, 2027 for annual periods and January&nbsp;1, 2028 for interim periods. The Company does not expect a material impact of the disclosure as a result of adoption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In November 2023, the FASB issued ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2023-7,</FONT> <I>Segment Reporting (Topic 280)</I>, which requires disclosure
of incremental segment information on an annual and interim basis for all public entities to enable investors to develop more decision-useful financial analyses. Under the new guidance, public entities must disclose significant segment expenses,
provided regularly to the CODM, that are included in each reported measure of segment profit or loss. Entities must also disclose an other segment items category for each reportable segment, representing differences in various profit and loss
measures, along with descriptions of their composition. Additionally, annual disclosures about a segment&#146;s profit or loss and assets are now required in interim financial reports as well. Entities must disclose the CODM&#146;s title and
position, along with an explanation of how they use reported profit and loss measures. Early adoption is permitted. Topic 280 requires amendments to be applied retrospectively to all prior periods presented in the financial statements. The Company
will adopt the updates in this amendment on January&nbsp;1, 2024 for annual periods and January&nbsp;1, 2025 for interim periods. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Adopted </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In June 2016, the FASB issued ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-13,</FONT> Financial Instruments&#151;<I>Credit Losses (Topic 326)</I>, which
requires that all financial assets measured at amortized cost to be evaluated for current expected credit losses. Under the new guidance, immediate recognition of credit losses expected over the life of a financial instrument is required. The
pronouncement eliminates the incurred credit loss impairment methodology and replaces it with an expected credit loss concept based on historical experience, current conditions, and reasonable and supportable forecasts. Early adoption is permitted.
Topic 326 requires a modified retrospective approach by recording a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. The Company adopted ASC 326 on January&nbsp;1, 2023 and determined that the impact
was immaterial. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Net loss per share </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The table
below sets forth the computation of basic and diluted loss per share for the period presented (in thousands, except share and per share amounts<B>):</B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended<BR>December&nbsp;31,<BR>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Numerator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(50,332</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deemed dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,941</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholder</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(52,273</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Denominator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average shares outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,722,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effect of dilutive shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and Diluted loss per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5.38</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since the Company incurred a net loss for the year ended December&nbsp;31, 2023, the diluted net loss per share
calculation excludes potentially dilutive securities. The following table summarizes the securities that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">277,238,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,143,652</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">290,563</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted stock units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">520,270</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49,307,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">339,501,014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the calculation of unaudited pro forma basic and diluted earnings per share
for the period presented (in thousands, except share and per share amounts<B>):</B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended<BR>December&nbsp;31,<BR>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Numerator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss used to compute pro forma net loss per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(50,332</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deemed dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(1,941</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss attributable to common stockholder used to compute pro forma net loss per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(52,273</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Denominator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average shares outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,722,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unaudited pro forma adjustment to reflect the automatic conversion of all convertible preferred
stock to common stock upon an IPO</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">283,009,207</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unaudited pro forma weighted average number of shares outstanding-basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">292,732,177</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unaudited pro forma net loss per share-basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.18</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Inventories </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
following table represents the components of inventories as of December&nbsp;31, 2023 (in thousands<B>):</B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raw materials</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Work in progress</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,641</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Finished goods</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,908</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total inventories</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">21,477</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recorded inventory valuation allowances of $0.8&nbsp;million during the twelve months ended December&nbsp;31,
2023. The charges were included in cost of sales in the consolidated statements of operations and comprehensive loss. The inventory valuation allowance was primarily due to forecasted sales, which led the Company to believe that certain inventory on
the books may not be utilized and recoverability may be less than the current carrying cost<B>.</B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Changes in the Company&#146;s inventory allowance was
as follows (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowances</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">839</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Write-offs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Property, Equipment and Software </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Property, equipment and software consisted of the following as of December&nbsp;31, 2023 (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Probe cards and photomasks</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Software</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">303</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">589</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixtures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">283</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,548</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Accumulated depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(11,565</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property, equipment and software, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,983</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Depreciation and amortization expense relating to the Company&#146;s property, equipment and software was approximately
$3.3&nbsp;million for the year ended December&nbsp;31, 2023, and are allocated to cost of sales, selling, general and administrative, and research and development costs in the accompanying consolidated statements of operations and comprehensive
loss. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Intangible Assets </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a
summary of the Company&#146;s intangible assets, net (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Term</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intellectual property</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">1-5&nbsp;years</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Software licenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="center">3 years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,124</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(5,537</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2023, the Company purchased and capitalized certain license software tooling costs and
intellectual property licensing agreements of $0.4&nbsp;million to support research and development efforts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Amortization expense relating to the
Company&#146;s intangible assets was approximately $4.4&nbsp;million for the year ended December&nbsp;31, 2023, and was included in research and development expense in the accompanying consolidated statement of operations and comprehensive loss.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table represents the total estimated amortization of intangible assets for the succeeding years (in&nbsp;thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,418</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,139</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total amortization expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Accrued and Other Current Liabilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accrued liabilities and other current liabilities consisted of the following as of December&nbsp;31, 2023 (in&nbsp;thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payroll and related benefits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,035</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,114</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warranty liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">843</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">711</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total accrued liabilities and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">9,703</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Fair Value Measurements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain <FONT STYLE="white-space:nowrap">non-financial</FONT> assets, such as intangible assets and property, equipment and software, are remeasured at fair
value only if an impairment is recognized in the current period. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Instruments Recorded at Fair Value on a Recurring Basis </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s warrant liabilities are remeasured at each reporting period<B>.</B> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Instruments Not Recorded at Fair Value on a Recurring Basis </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Some of the Company&#146;s financial instruments are not measured at fair value on a recurring basis but are recorded at amounts that are approximate fair
value due to their liquid or short-term nature. Such financial assets and financial liabilities include cash and cash equivalents, including money market deposits, accounts receivables, certain other assets, accounts payable, accrued expenses, and
other current liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following summarizes the fair value of our financial instruments as of December&nbsp;31, 2023 (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Quoted&nbsp;Prices<BR>In Active<BR>Markets for<BR>Identical<BR>Assets<BR>Level 1</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Significant<BR>Other<BR>Observable<BR>Inputs<BR>Level 2</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Significant<BR>Unobservable<BR>Inputs<BR>Level 3</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table shows the Company warrant activity for the year ended December&nbsp;31, 2023 (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common<BR>Stock&nbsp;warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Preferred<BR>Stock&nbsp;warrants</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">218</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,103</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(154</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(346</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercises</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(359</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(359</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cancellations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(81</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(81</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">163</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Commitments and Contingencies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contract Manufacturer Commitments </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company relies on a
third-party foundry and contract manufacturer for the manufacturing of its products. Generally, its foundry agreements do not have volume purchase commitments and primarily provide for purchase commitments based on purchase orders. Purchase orders
are placed in advance with consideration of estimates of future demand. These purchase orders can be canceled and rescheduled upon agreement of the Company and the contract manufacturer. As of December&nbsp;31, 2023, the Company had total
manufacturing purchase commitments of $5.2&nbsp;million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Litigation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From time to time, the Company may become involved in various legal actions arising in the ordinary course of business. As of December&nbsp;31, 2023,
management was not aware of any existing, pending, or threatened legal actions that would have a material impact on the financial position, results of operations, or cash flows of the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Leases </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has entered various operating
leases for its worldwide office buildings and research and development facilities and equipment, which are accounted for in accordance with ASC 842. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For
the year ended December&nbsp;31, 2023, the Company recorded approximately $1.2&nbsp;million of operating lease expense, under ASC 842. All the Company&#146;s leases have been classified as operating leases. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Supplemental cash flow information for the year ending December&nbsp;31, 2023 were as follows (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash paid for operating leases included in operating cash flow</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,251</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Supplemental non-cash information related to lease liabilities arising from obtaining <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease assets obtained in exchange for operating lease liabilities arising from lease
modifications</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The aggregate future lease payments of operating lease as of December&nbsp;31, 2023, are as follows (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total future annual minimum lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,072</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(49</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2023, the weighted average remaining lease term for the Company&#146;s operating leases is
1.29&nbsp;years and the weighted average discount rate used to determine the present value of the Company&#146;s operating leases is 6.89%. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. Warrants, Redeemable Convertible Preferred Stock and Stockholders&#146; Deficit </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has one class of authorized
common stock and has authorized for issuance up to 450,000,000 shares of common stock with a par value of $0.000001 per share. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of common
stock are entitled to receive dividends at the discretion of the board of directors, subject to preferences that may apply to shares of preferred stock outstanding at the time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All holders of common stock are entitled to one vote per share on all matters to be voted on by the Company&#146;s stockholders. Upon liquidation, dissolution
or winding up, the holders of common stock are entitled to share equally in all the Company&#146;s assets remaining after payment of all liabilities and the liquidation preferences of any outstanding preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At December&nbsp;31, 2023, the Company has reserved 357,067,090 shares of common stock for the conversion or exercise, as applicable, of the following
securities: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Redeemable convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">277,238,979</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">290,563</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,143,652</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted stock units</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">520,270</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49,307,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total shares</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">339,501,014</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company issued warrants to certain consultants and service providers. The warrants, which were issued on various dates between November 2018 and October
2022, expire between October 2023 and November 2028 and grant the holders the right to purchase shares of common stock at exercise prices ranging from $0.55 to $1.11. At the time of issuance, the Company valued these warrants using the Black-Scholes
option pricing model using the following assumptions: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">1.47%&nbsp;&#150;&nbsp;4.70%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected life</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">10&nbsp;years</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">0%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">35.14%&nbsp;&#150;&nbsp;65.00%</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value per share of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">$0.29&nbsp;&#150;&nbsp;$2.59</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company determined that the common stock warrants issued in November 2018 had characteristics of a liability. As a result,
the warrants have been recorded within long-term liabilities and were valued at $0.1&nbsp;million as of December&nbsp;31, 2023. The warrant liabilities are remeasured at fair value at each reporting period. Refer to Note 8 for more information. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redeemable Convertible Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ending December&nbsp;31, 2023, the Company issued 34,972,704 shares of Series G preferred stock with an original issuance price of $0.90 per
share for cash proceeds of $31.6&nbsp;million. The Company had issuance costs of approximately $0.3&nbsp;million associated with this transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All
classes of preferred stock have a par value of $0.000001 per share. The Company&#146;s preferred stock is recorded in the temporary equity section of the Company&#146;s consolidated balance sheet. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">See table below for a roll forward of the total preferred stock from December&nbsp;31, 2022 to
December&nbsp;31, 2023 which details total redeemable convertible preferred stock presented in the consolidated statements of changes in redeemable convertible preferred stock and stockholders&#146; deficit (in thousands, except share amounts): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7.5pt" ALIGN="center">


<TR>

<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series Seed<BR>Redeemable<BR>convertible<BR>preferred&nbsp;stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series A<BR>Redeemable<BR>convertible<BR>preferred&nbsp;stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series B<BR>Redeemable<BR>convertible<BR>preferred&nbsp;stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series C<BR>Redeemable<BR>convertible<BR>preferred&nbsp;stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series D<BR>Redeemable<BR>convertible<BR>preferred&nbsp;stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series E<BR>Redeemable<BR>convertible<BR>preferred&nbsp;stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series F<BR>Redeemable<BR>convertible<BR>preferred&nbsp;stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series <FONT STYLE="white-space:nowrap">F-1</FONT><BR>Redeemable<BR>convertible<BR>preferred&nbsp;stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series G<BR>Redeemable<BR>convertible<BR>preferred&nbsp;stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7.5pt; font-family:Times New Roman">Balance at <BR>December&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,045,368</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,255,614</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18,456,996</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,228</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">42,890,840</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,908</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39,656,811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">33,411</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29,019,153</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29,738</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">74,840,147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">132,975</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">23,664,027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49,392</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7.5pt; font-family:Times New Roman">lssuance of Series G Preferred stock, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34,972,704</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7.5pt; font-family:Times New Roman">Exercise of warrants</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">437,319</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">599</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7.5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7.5pt; font-family:Times New Roman">Balance at December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5,045,368</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>2,473</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>8,255,614</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>5,179</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>18,894,315</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>10,827</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>42,890,840</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>24,908</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>39,656,811</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>33,411</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>29,019,153</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>29,738</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>74,840,147</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>132,975</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>23,664,027</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>49,392</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>34,972,704</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B>31,258</B></TD>
<TD NOWRAP VALIGN="bottom"><B>&nbsp;</B></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A general summary of the rights with respect to the preferred stock is provided below. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dividends </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of preferred stock, in
preference to the holders of common stock, shall be entitled to receive on a pari passu basis, out of funds that are legally available, cash dividends at the rate of 8% of the applicable original issue price per annum on each outstanding share of
preferred stock. All original issue prices are subject to adjustment for any stock dividends, combinations, splits, recapitalizations and similar events. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dividends are <FONT STYLE="white-space:nowrap">non-cumulative,</FONT> and the Company has no obligation to pay dividends until declared by the Company&#146;s
board of directors. Through December&nbsp;31, 2023, no dividends have been declared by the Company&#146;s board of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Liquidation
Preference </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon any liquidation, dissolution, or winding up of the Company, whether voluntary or involuntary, before any distribution or payment
shall be made to the holders of any common stock, the holders of preferred stock shall be entitled to be paid on a pari passu basis out of the assets of the Company legally available for distribution (or the consideration received by the Company or
its stockholders in an acquisition) for each share of preferred stock held by them, an amount per share of preferred stock equal to the original issue price for such share of preferred stock plus all declared and unpaid dividends on such share of
preferred stock for an aggregate liquidation value of approximately (in millions): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series Seed</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series D</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">34.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series E</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">F-1</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">130.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series F</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series G</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">63.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">347.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The liquidation preferences above represent the cumulative closings of the Series G funding round as of December&nbsp;31,
2023. The funding round continued in multiple closings until August&nbsp;31, 2024. Refer to Note 16&nbsp;for more information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If upon liquidation, the
assets of the Company are insufficient to make payment in full to all holders of preferred stock, then such assets shall be distributed among the holders of preferred stock at the time outstanding, ratably in proportion to the full amounts to which
they would otherwise be respectively entitled. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Conversion </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each share of preferred stock shall be convertible at the option of the holder, at any time, into fully paid and nonassessable shares of common stock. The
number of shares of common stock to which a holder of preferred </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stock shall be entitled upon conversion shall be the product obtained by multiplying the applicable &#147;Series Preferred Conversion Rate&#148;, by the number of shares of such preferred stock
being converted, as defined in the Company&#146;s latest amended and restated certificate of incorporation. The Series Preferred Conversion Rate is the quotient obtained by dividing the Original Issue Price of such series of Series Preferred by the
applicable &#147;Series Preferred Conversion Price&#148;. The Series Preferred Conversion Price is generally the Original Issuance Price for all series of Series Seed, A, B, C, D and G preferred stock, subject to certain adjustments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At December&nbsp;31, 2023, the preferred stock Original Issuance Prices were $0.50 per share for Series Seed preferred stock, $0.55 per share for Series A and
Series B preferred stock, $0.59 per share for Series C preferred stock, $0.88 per share for Series D preferred stock, $1.03 per share for Series E preferred stock, $1.83 per share for Series F preferred stock, $2.09 per share for Series <FONT
STYLE="white-space:nowrap">F-1</FONT> preferred stock and $0.90 for Series G preferred stock. The issuance of the Series G Preferred Stock triggered adjustments to the Series Preferred Conversion Price for Series E through Series <FONT
STYLE="white-space:nowrap">F-1,</FONT> such that at December&nbsp;31, 2023, the Series Preferred Conversion Prices were $1.02 per share for Series E Preferred Stock, $1.74 per share for Series F preferred stock and $1.97 for Series <FONT
STYLE="white-space:nowrap">F-1</FONT> preferred stock. These conversion prices are subject to adjustment in accordance with the Company&#146;s latest amended and restated certificate of incorporation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Voting </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The holders of preferred stock shall vote
together with the holders of common stock and not as a separate class and may act by written consent in the same manner as the holders of common stock. Each holder of preferred stock shall be entitled to the number of votes equal to the number of
shares of common stock into which such shares of preferred stock could be converted immediately after the close of business on the record date fixed for such meeting or the effective date of such written consent and shall have voting rights and
powers equal to the voting rights and powers of the holders of common stock and shall be entitled to notice of any stockholders&#146; meeting in accordance with the bylaws of the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Redemption </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company&#146;s preferred stock is
not generally redeemable except in situations set forth in the certificate of incorporation, including when more than fifty percent of the Company&#146;s voting power is transferred, a triggering event is created that is outside the control of the
Company, and a change in control of Company ownership. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock Warrants </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with the issuance of promissory notes later converted by the Company to various series of preferred stock, the Company issued warrants to the
convertible promissory note holders. The warrants, which were issued on various dates between February 2012 and February 2017, expire between February 2022 and November 2026 and grant the holders the right to purchase in the aggregate the following
shares of preferred stock: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Exercise&nbsp;Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A Preferred</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">797,351</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B Preferred</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">733,047</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C Preferred</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">290,563</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company determined that these preferred stock warrants had characteristics of a liability. As a result,
the warrants have been recorded within long-term liabilities and were valued at $0.1&nbsp;million at December&nbsp;31, 2023. The warrant liabilities are remeasured at fair value at each reporting period. Refer to Note 8 for more information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the time of issuance, the Company has valued these warrants using the Black-Scholes option pricing model using the following assumptions: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">1.74%&nbsp;&#150;&nbsp;2.37%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected life</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">10 years</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">0%</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">33.00%&nbsp;&#150;&nbsp;59.00%</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value per share of preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">$0.55&nbsp;&#150;&nbsp;$0.59</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ending December&nbsp;31, 2023, certain holders of our preferred stock warrants exercised 437,319 shares at an
exercise price of $0.55. Cash proceeds of approximately $0.2&nbsp;million were received in connection with these exercises. The Company had minimal issuance costs associated with these transactions. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Stock Option Plan and Stock-Based Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In
October 2010, the Company&#146;s board of directors and its stockholders adopted the 2010 Equity Incentive Plan (the 2010 Plan) under which the Company may grant incentive stock options (ISOs), nonqualified stock options, restricted stock awards,
restricted stock unit awards (RSUs), and stock appreciation rights of common stock to employees, <FONT STYLE="white-space:nowrap">non-employee</FONT> members of the Company&#146;s board of directors and consultants who provide services to the
Company. In 2019, the Company increased the number of shares issuable under the 2010 Plan to 40,837,342. In October 2020, the Company&#146;s board of directors and its stockholders adopted the 2020 Equity Incentive Plan (the 2020 Plan) as the
successor to the 2010 Plan (collectively, the Plans) and increased the number of shares issuable under the 2020 Plan to 49,056,404. In 2023, the Company increased the number of shares issuable under the 2020 Plan to 64,800,980. The maximum term of
options granted under the Plans is ten years from the date of grant. Options outstanding under the Plans generally vest over four years, with 25% vesting on the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary and equal monthly vesting
installments thereafter. The fair values of the associated common stock underlying the option, rate of exercisability and expiration dates of the options granted are determined by the board of directors at the time of grant. RSUs granted under the
Plans are generally subject to service-based and performance-based vesting condition. The Company currently uses authorized and unissued shares to satisfy stock award exercises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the activity in total shares of common stock available for issuance under the 2020 Plan: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares<BR>Available&nbsp;for<BR>Grant</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, December&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,313,590</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Shares added</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,170,507</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(478,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">789,751</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance, December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,795,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table summarizes the effects of stock-based compensation on research and development, and
sales, general and administrative expense granted under the Plans (in thousands, except per share amounts) for the year ended December&nbsp;31, 2023: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cost of sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sales, general and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,623</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The fair value for the Company&#146;s options was estimated at the date of grant using a Black-Scholes option pricing model
with the following weighted-average assumptions: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="31%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;ended&nbsp;December&nbsp;31,<BR>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3.74</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected life of the options</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.01&nbsp;years</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52.74</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value per share of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.09</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Additional information regarding outstanding options that are vesting, expected to vest, or exercisable as of
December&nbsp;31, 2023 is as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of<BR>Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR>Price&nbsp;Per<BR>Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR>Exercise<BR>Price</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR>Remaining<BR>Contractual<BR>Life (Years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options outstanding at December&nbsp;31, 2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">50,675,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.27</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">228,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.09</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(646,815</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.43</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(948,835</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.49</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.97</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options outstanding at December&nbsp;31, 2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49,307,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested and expected to vest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">49,092,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.03</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercisable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,462,116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">0.46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The weighted-average fair value of options granted during the year ended December&nbsp;31, 2023 was $0.59 per share. The
aggregate intrinsic value of options exercised during the year ended December&nbsp;31, 2023 was $0.5&nbsp;million. Intrinsic value represents the difference between the market value of the Company&#146;s common stock at the time of exercise and the
strike price of the stock option. The total unrecognized stock-based compensation expense related to unvested stock options and subject to recognition in future periods was approximately $4.1&nbsp;million as of December&nbsp;31, 2023. As of
December&nbsp;31, 2023 the Company anticipates this expense to be recognized over a weighted-average period of approximately 1.9 years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2023, the Company received $0.3&nbsp;million from the exercise of
stock options granted under the Plans and granted 250,000 RSUs to a <FONT STYLE="white-space:nowrap">non-employee</FONT> director which vest upon satisfaction of a service-based condition and performance condition based on a liquidity event. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Income Taxes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The income tax amount for the year
ended December&nbsp;31, 2023 differs from the amount that would be expected after applying the statutory U.S. federal income tax rate primarily due to an increase in the valuation allowance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all the deferred tax
assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Due to the uncertainty of the
Company&#146;s ability to realize the benefit of the deferred tax assets, the net deferred tax assets are fully offset by a valuation balance at December&nbsp;31, 2023. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Provision for Income Taxes </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Loss before provision
for income taxes, includes the components for the year ended December&nbsp;31, 2023 as follows (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Domestic</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(45,548)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4,754</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss before provision for income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(50,302</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Deferred Tax Assets </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The components of the deferred tax assets and liabilities at December&nbsp;31, 2023 are as follows (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="84%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Deferred tax assets:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating loss carryforwards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">31,513</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciable assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">14,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Inventory allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,926</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued liabilities and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Uniform capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sales return allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">284</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Warrants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">606</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55,423</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(55,423</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&#8194;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2023, the Company had net operating loss carryforwards (NOL) of approximately
$139.4&nbsp;million. For federal tax reporting purposes, NOL carryforwards of $51.6&nbsp;million will expire in fiscal years 2032 through 2037 if not utilized prior to that time. The remaining $87.8&nbsp;million carries forward indefinitely. As of
December&nbsp;31, 2023, the Company had $13.4&nbsp;million of foreign NOL carryforwards. The foreign NOL will begin to expire after 2026 if not utilized. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Utilization of NOL carryforwards may be subject to substantial annual limitation due to the &#147;change in ownership&#148; provisions of the Internal Revenue
Code. The annual limitation may result in the expiration of NOL and other tax attributes before utilization. The NOL carryforwards are subject to Internal Revenue Service adjustments until the statute closes on the year the NOL is utilized. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Uncertain Tax Position </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company recognizes the
tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities. At December&nbsp;31, 2023, the Company has unrecognized tax benefits of
$1.0&nbsp;million. Additionally, the Company does not expect any unrecognized tax benefits to change significantly over the next twelve months. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Effective Tax Rate </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the year ended
December&nbsp;31, 2023, the income tax provision related to continuing operations differs from the amounts computed by applying the statutory income tax rate of 21% to <FONT STYLE="white-space:nowrap">pre-tax</FONT> loss as follows (in thousands):
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. Federal benefit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(10,563</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Permanent items</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">156</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign tax differential</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(108</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,549</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has established a valuation allowance equal to the net deferred tax assets due to uncertainties regarding the
realization of the deferred tax assets based on the Company&#146;s lack of earnings history. The valuation allowance increased by approximately $10.5&nbsp;million during the year ended December&nbsp;31, 2023, primarily due to net losses from
operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company provides for U.S. income taxes on the earnings of its foreign subsidiaries to the extent required by the Tax Cuts and Jobs Act
(TCJA). However, the Company does not provide for withholding taxes on any portion of the undistributed earnings of its foreign subsidiaries because it intends to permanently reinvest those earnings indefinitely outside the United States. At the
present time it is not practicable to estimate the amount of income or withholding taxes that might be payable if these earnings were repatriated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Company files foreign and U.S. federal and various state income tax returns. For U.S. federal and state income tax purposes, the statute of limitations currently remains open for the years ending December&nbsp;31, 2019 to present. In addition, prior
year NOL carryforwards, including those originated from 2010, that may be utilized in future years, may be subject to examination. The Company is not currently under examination by income tax authorities in any jurisdiction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Ambiq Micro, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to the Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>As of and for the year ended December&nbsp;31, 2023 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Related Party Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company defines related parties as any party that controls or can significantly influence the management or operating policies of the Company to the extent
that the Company may be prevented from fully pursuing its own interests, such as directors, executive officers and stockholders, including a greater than 10% beneficial owner of the Company&#146;s capital stock and their affiliates or immediate
family members. The Company did not have any related party transactions in the year ended December&nbsp;31, 2023. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. Segment and Geographic
Information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following is a summary of net sales for the year ended December&nbsp;31, 2023 based on the country to which the products were shipped,
which may be different from the geographic locations of the ultimate end customers as a significant number of the products produced by customers in these countries are then sold outside those regions: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">China</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57,692</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rest of the World*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,845</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Other countries individually less than 10% </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following illustrates property, equipment and software, net, and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets, net by geographic locations based on physical location (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2023</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">North America</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Taiwan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">China</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">774</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rest of the World*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,973</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Other countries individually less than 10% </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. Subsequent Events </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company performed a review
of events subsequent to the balance sheet date through the date the consolidated financial statements are available to be issued on February 12, 2025 as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company issued an additional 64,257,179 shares of Series G preferred stock in multiple closings for additional cash proceeds of $58.1&nbsp;million.
Additionally, the Board of Directors approved issuance of 6,690,069 warrants to purchase common stock to a related party at an exercise price of $0.45 per share. The warrants are exercisable on the earlier of (i)&nbsp;June&nbsp;1, 2028, (ii)
immediately prior to the consummation of a qualified initial public offering or (iii)&nbsp;immediately prior to the consummation of an asset transfer or acquisition as defined in the Company&#146;s charter. The warrants expire after June&nbsp;1,
2034. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:60pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>&#8195;&#8195;&#8195;&nbsp;Shares </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMBIQ MICRO, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMMON STOCK </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g377490g61t49.jpg" ALT="LOGO" STYLE="width:3.13786in;height:0.930593in;">
 </P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:16pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:18pt">
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-size:16pt"><B>BofA Securities</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>UBS Investment Bank</B></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;13. Other Expenses of Issuance and Distribution. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth all costs and expenses, other than underwriting discounts and commissions, payable by Ambiq Micro, Inc. or the
Registrant, in connection with the sale of the common stock being registered. All amounts shown are estimates except for the Securities and Exchange Commission (the SEC), registration fee, the FINRA filing fee and the&#8195;&#8195;&#8195;listing
fee. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINRA filing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">listing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing and engraving expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer agent and registrar fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#8195;&#8195;&#8195;*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To be provided by amendment. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;14. Indemnification of Directors and Officers. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Registrant is incorporated under the laws of the State of Delaware. Section&nbsp;145 of the Delaware General Corporation Law (the DGCL),
provides that a Delaware corporation may indemnify any persons who were, are, or are threatened to be made, parties to any threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, administrative or investigative (other
than an action by or in the right of such corporation), by reason of the fact that such person is or was an officer, director, employee, or agent of such corporation, or is or was serving at the request of such corporation as an officer, director,
employee, or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys&#146; fees), judgments, fines, and amounts paid in settlement actually and reasonably incurred by such person in connection with such
action, suit, or proceeding, provided that such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the corporation&#146;s best interests and, with respect to any criminal action or proceeding, had no
reasonable cause to believe that his or her conduct was illegal. A Delaware corporation may indemnify any persons who were, are, or are threatened to be made, a party to any threatened, pending, or completed action or suit by or in the right of the
corporation by reason of the fact that such person is or was a director, officer, employee, or agent of such corporation, or is or was serving at the request of such corporation as a director, officer, employee, or agent of another corporation or
enterprise. The indemnity may include expenses (including attorneys&#146; fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action or suit provided such person acted in good faith and in a
manner he or she reasonably believed to be in or not opposed to the corporation&#146;s best interests, except that no indemnification is permitted without judicial approval if the officer or director is adjudged to be liable to the corporation.
Where an officer or director is successful on the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him or her against the expenses (including attorneys&#146; fees) actually and reasonably incurred.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Registrant&#146;s amended and restated certificate of incorporation provides for the indemnification of its directors to the fullest
extent permitted under the DGCL. The Registrant&#146;s amended and restated bylaws provide for the indemnification of its directors and officers to the fullest extent permitted under the DGCL. Each of the Registrant&#146;s amended and restated
certificate of incorporation and amended and restated bylaws will become effective upon the closing of this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;102(b)(7) of the DGCL permits a corporation to provide in its certificate of
incorporation that a director of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duties as a director, except for liability for any: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transaction from which the director derives an improper personal benefit; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unlawful payment of dividends or redemption of shares; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">breach of a director&#146;s duty of loyalty to the corporation or its stockholders. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Registrant&#146;s amended and restated certificate of incorporation includes such a provision. Under the Registrant&#146;s amended and
restated bylaws, expenses incurred by any director or officers in defending any such action, suit, or proceeding in advance of its final disposition shall be paid by the Registrant upon delivery to it of an undertaking, by or on behalf of such
director or officer, to repay all amounts so advanced if it shall ultimately be determined that such director or officer is not entitled to be indemnified by the Registrant, as long as such undertaking remains required by the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;174 of the DGCL provides, among other things, that a director who willfully or negligently approves of an unlawful payment of
dividends or an unlawful stock purchase or redemption, may be held liable for such actions. A director who was either absent when the unlawful actions were approved or dissented at the time may avoid liability by causing his or her dissent to such
actions to be entered in the books containing minutes of the meetings of the board of directors at the time such action occurred or immediately after such absent director receives notice of the unlawful acts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As permitted by the DGCL, the Registrant has entered into indemnity agreements with each of its directors and officers that require the
Registrant, among other things, to indemnify its directors and officers against certain liabilities which may arise by reason of their status or service as directors or officers to the fullest extent not prohibited by law. These indemnification
agreements may be sufficiently broad to permit indemnification of the Registrant&#146;s officers and directors for liabilities, including reimbursement of expenses incurred, arising under the Securities Act. Under these agreements, the Registrant is
not required to provide indemnification for certain matters. The indemnification agreements also set forth certain procedures that will apply in the event of a claim for indemnification thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is at present no pending litigation or proceeding involving any of the Registrant&#146;s directors or executive officers as to which
indemnification is required or permitted, and the Registrant is not aware of any threatened litigation or proceeding that may result in a claim for indemnification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Registrant intends to enter into an insurance policy that covers its officers and directors with respect to certain liabilities, including
liabilities arising under the Securities Act or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Registrant plans to enter into an underwriting agreement which provides
that the underwriters are obligated, under some circumstances, to indemnify the Registrant&#146;s directors, officers, and controlling persons against specified liabilities, including liabilities under the Securities Act. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;15. Recent Sales of Unregistered Securities. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Set forth below is information regarding unregistered securities issued by us since January&nbsp;1, 2022. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Plan-Related Issuances </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We have granted to certain of our directors, employees and consultants options to purchase 51,739,579 shares of
our common stock with per share exercise prices ranging from $0.10 to $0.33 under the 2010 Plan. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We have granted to certain of our directors, employees and consultants options to purchase 41,549,913 shares of
our common stock with per share exercise prices ranging from $0.38 to $1.20 under the 2020 Plan. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We have issued to certain of our directors 3,186,934 shares of common stock having fair market values ranging
from $0.38 to $1.20 per share. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We have issued to certain of our directors, employees and consultants an aggregate of 8,308,280 shares of our
common stock at per share purchase prices ranging from $0.10 to $0.33 pursuant to exercises of options under the 2010 Plan for an aggregate purchase price of $1,644,087.94. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">We have issued to certain of our directors, employees and consultants an aggregate of 1,569,986 shares of our
common stock at per share purchase prices ranging from $0.45 to $1.20 pursuant to exercises of options under the 2020 Plan for an aggregate purchase price of $949,480.33. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Issuances of Capital Stock </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In multiple closings held between February 2022 and March 2022, we issued and sold an aggregate of 23,664,027
shares of our Series <FONT STYLE="white-space:nowrap">F-1</FONT> redeemable convertible preferred stock at a purchase price of $2.091505 per share for an aggregate purchase price of approximately $49.5&nbsp;million. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On multiple dates between February 2022 and July 2022, we issued an aggregate of 776,307 shares of our Series A
redeemable convertible preferred stock upon the exercise of warrants at a purchase price of $0.55 per share for an aggregate purchase price of approximately $427,000. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On multiple dates between February 2022 and June 2023, we issued an aggregate of 637,113 shares of our Series B
redeemable convertible preferred stock upon the exercise of warrants at a purchase price of $0.55 per share for an aggregate purchase price of approximately $350,412. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In multiple closings held between August 2023 and July 2024, we issued and sold an aggregate of 99,229,883
shares of our Series G redeemable convertible preferred stock at a purchase price of $0.904179 per share for an aggregate purchase price of approximately $89.7&nbsp;million. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On June&nbsp;1, 2024, we issued a warrant to purchase up to 6,690,069 shares of common stock at an exercise
price of $0.45 per share. Such warrant is exercisable until June&nbsp;1, 2034. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On October&nbsp;19, 2022, we issued a warrant to purchase up to 100,000 shares of common stock at an exercise
price of $1.11 per share. Such warrant is exercisable until October&nbsp;18, 2032. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offers, sales and issuances of
the securities described in paragraphs (1)&nbsp;through (3) were deemed to be exempt from registration under Rule 701 promulgated under the Securities Act as transactions under compensatory benefit plans and contracts relating to compensation, or
under Section&nbsp;4(a)(2) of the Securities Act as a transaction by an issuer not involving a public offering. The recipients of such securities were our directors, employees or bona fide consultants and received the securities under our equity
incentive plans. Appropriate legends were affixed to the securities issued in these transactions. Each of the recipients of securities in these transactions had adequate access, through employment, business or other relationships, to information
about us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offers, sales and issuances of the securities described in paragraphs (4)&nbsp;through (9) were deemed to be exempt under
Section&nbsp;4(a)(2) of the Securities Act or Rule 506 of Regulation D under the Securities Act as a transaction by an issuer not involving a public offering. The recipients of securities in each of these transactions acquired the securities for
investment only and not with a view to or for sale in connection with any distribution thereof and appropriate legends were affixed to the securities issued in these transactions. Each of the recipients of securities in these transactions was an
accredited investor within the meaning of Rule 501 of Regulation D under the Securities Act and had adequate access, through employment, business or other relationships, to information about us. No underwriters were involved in these transactions.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;16. Exhibits and Financial Statement Schedules. </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(a)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Exhibits. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The list of exhibits is set forth under &#147;Exhibit Index&#148; at the end of this registration statement and is incorporated herein by
reference. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(b)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Financial Statement Schedules. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No financial statement schedules are provided because the information called for is not required or is shown either in the financial statements
or the notes thereto. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&#8201;17. Undertakings. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers, and controlling persons of
the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In
the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer, or controlling person of the Registrant in the successful defense of any action, suit,
or proceeding) is asserted by such director, officer, or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to
a court of appropriate jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned Registrant hereby undertakes that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of
this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4)&nbsp;or 497(h) under the Securities Act shall be deemed to be part of this registration statement
as of the time it was declared effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) For the purpose of determining any liability under the Securities Act, each post-effective
amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="89%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit<BR>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;1.1&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Underwriting Agreement.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;3.1&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Amended and Restated Certificate of Incorporation, as amended and as currently in effect.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;3.2&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Amended and Restated Certificate of Incorporation, to be effective upon the closing of this offering.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;3.3&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Bylaws, as amended and as currently in effect.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;3.4&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Amended and Restated Bylaws, to be effective upon the closing of this offering.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;4.1&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Common Stock Certificate of the Registrant.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&#8199;5.1&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Opinion of Cooley LLP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1 &#134;+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Form of Indemnification Agreement.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.2 &#134;+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Policy.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.3 &#134;+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ambiq Micro, Inc. 2010 Equity Incentive Plan, as amended.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.4 &#134;+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Forms of Incentive Stock Option Award Notice, Incentive Stock Option Award Agreement, Exercise Notice and Investment Representation Statement under the 2010 Equity Incentive Plan.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.5 &#134;+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ambiq Micro, Inc. 2020 Equity Incentive Plan, as amended.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.6 &#134;+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Forms of Incentive Stock Option Award Notice, Incentive Stock Option Award Agreement, Exercise Notice and Investment Representation Statement under the 2020 Equity Incentive Plan.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.7 &#134;+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ambiq Micro, Inc. 2025 Equity Incentive Plan.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.8 &#134;+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Forms of Incentive Stock Option Award Notice, Incentive Stock Option Award Agreement, Exercise Notice and Investment Representation Statement under the 2025 Equity Incentive Plan.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.9 &#134;+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Ambiq Micro, Inc. 2025 Employee Stock Purchase Plan.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.10&#134;+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer of Employment, dated September&nbsp;25, 2015, between Sean Chen and the Company.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.11&#134;+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer of Employment, dated November&nbsp;2, 2015, between Fumihide Esaka and the Company.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.13&#134;+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Offer of Employment, dated September&nbsp;9, 2022, between Scott Goodwin and the Company.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.14&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">TSMC Master Technology License Agreement, dated as of January&nbsp;27, 2011, by and between the Company and Taiwan Semiconductor Manufacturing Co., Ltd.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.15&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Lease, dated November&nbsp;11, 2016, by and between the Company and G&amp;I VII River Place LP. and Confirmation of Lease Term, dated March&nbsp;31, 2017, by and between the Company and G&amp;I VII River Place LP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.16&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">First Amendment to Lease, dated September&nbsp;6, 2019, by and between the Company and G&amp;I VII River Place LP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.17&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Second Amendment to Lease, dated December&nbsp;11, 2020, by and between the Company and G&amp;I River Place LP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>21.1&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Subsidiaries of the Registrant.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of KPMG LLP, an Independent Registered Public Accounting Firm.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Cooley LLP (included in Exhibit 5.1).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Power of Attorney (see signature page hereto)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>107&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Filing Fee Exhibit</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To be filed by amendment. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">+</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Indicates management contract or compensatory plan. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left" style="font-size:10pt;font-weight:bold"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereunto duly authorized, in the City of Austin, State of Texas, on&#8195;&#8195;&#8195;&#8195;, 2025. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>AMBIQ MICRO, INC.</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fumihide Esaka</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWER OF ATTORNEY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Fumihide Esaka and Scott Hanson, Ph.D.,
and each of them, as his or her true and lawful <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, each with the full power of substitution, for him or her and in his or her name, place, or
stead, in any and all capacities, to sign any and all amendments to this registration statement (including post-effective amendments), and to sign any registration statement for the same offering covered by this registration statement that is to be
effective upon filing pursuant to Rule 462(b) promulgated under the Securities Act, and all post- effective amendments thereto, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and
necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorneys-in-fact</FONT></FONT> and agents, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons
in the capacities and on the dates indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Title</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fumihide Esaka</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief&nbsp;Executive&nbsp;Officer&nbsp;and&nbsp;Director<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"><I>(Principal Executive Officer)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">&#8195;&#8195;&#8195;,&nbsp;2025</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scott Goodwin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer (<I>Principal<BR>Financial and Accounting Officer</I>)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">&#8195;&#8195;&#8195;&#8195;,&nbsp;2025</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Scott
Hanson, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">&#8195;&#8195;&#8195;&#8195;,&nbsp;2025</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Wen
Hsieh, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">&#8195;&#8195;&#8195;&#8195;,&nbsp;2025</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Ker
Zhang, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">&#8195;&#8195;&#8195;&#8195;,&nbsp;2025</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Joseph
Tautges</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">&#8195;&#8195;&#8195;&#8195;,&nbsp;2025</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Timothy
Chen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">&#8195;&#8195;&#8195;&#8195;,&nbsp;2025</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-6 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g377490g01n54.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377490g01n54.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M!@0%!@4$!@8%!@<'!@@*$ H*"0D*% X/#! 7%!@8%Q06%AH=)1\:&R,<%A8@
M+" C)B<I*BD9'RTP+2@P)2@I*/_; $,!!P<'"@@*$PH*$R@:%AHH*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*/_
M !$( '\!+P,!(@ "$0$#$0'_Q  <   " @,! 0              " 0% @,&
M 0?_Q !0$  ! P$"!@D0" (* P     !  (#! 41!@@2&"$Q$T%15G&4L=/C
M%"(R,S524U1A<G-UD9.ALP<5-#95@9+!(T(D)C=#8H.BP]+Q1$6"_\0 &@$
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M7-M67=P@R95J6>Y;?2_LK+ZOIO!_ZBL^HX=BV/(ZR_*NO.M/U^C[5SDCB/\
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M1R7[6D*'];'P(_4M=1:)FA='L8;E;=Z<MUM#(R@\QV&!2APP.)!;K"<K%?\
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*'2 -'6A"ELS_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g377490g57z26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377490g57z26.jpg
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M)T&</4+0  @D
M
M
M
M
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MF4QN<N].!#L^E:>UUS*J*XW>=S45-BIK7R,7*8WM7<,,,\^[(8IY?#WYZ'0
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M\&5S]M7>O:Z3.4>ID6@ !!(
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M$YFPK?5CH,YBI>>6G9X4D:3X^$D:JK<^K)E*/4R+0  @D
M                        B7A)'6BN2#;698'HS8^-M;*XQZ\D32+:AFE;
M.VN25*I*2))4ESM[>PF=K._.<\2=<JA:2W550UJ.=#$^1$7@JHBK_L1].5[[
MK8+;<)6-9)54T<SFMX-5S47"=IDSYO[5,67.:YT-@4ERR_E9'^JL_><7:4ER
MR_E9'^JL_><=+D7ZGP9PO\G^A\4<( #UY\X
M           !;G(?_=]U_P!5G[%*C+<Y#_[ONO\ JL_8IS.5_I)>'J=W_&_]
M0AX^C+, !XT^F'F2]_WS7_K$G[RD(FWO^^:_]8D_>4A'T*S^1'QJU_<EWL
MN8P                                   #T5H+\C[3_ *"&^-#H+\C[
M3_H(;X\!>/WI][]3[!<OIK/_ &KT.3Y5/R'N'MB_B-*#+\Y5/R'N'MB_B-*#
M/2\A_3OO?HCPW^5_61_VKU8 !VCS
M     +@Y$?[HN7^NW]TI\N#D1_NBY?Z[?W3E\L?2R\/4[W^-?7Q[GZ%D'Q/_
M &$G^5?V'V?$_P#82?Y5_8>/6I]*>AY: !]$/BX
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MM50S$:VK M#"M)$L4&/@,5FQA/9T$DJ]2ZT  ()
M                  ,-<L+:*H6JQX.D;EDRF?@X7/W9,-E=1OL]"ZUHU*!8
M&+3[**B<WLILX1=_#!DN-.M7;ZJF1VRLT3H]K&<914S]Y@T_0+:K%;K>Z1)7
M4M/' KT3".V6HF<?47RP:YU*9X],J$\I+EE_*R/]59^\XNTI+EE_*R/]59^\
MXZ?(OU/@S@?Y/]#XHX0 'KSYP
M "W.0_\ N^Z_ZK/V*5&6YR'_ -WW7_59^Q3F<K_22\/4[O\ C?\ J$/'T99@
M /&GTP\R7O\ OFO_ %B3]Y2$3;W_ 'S7_K$G[RD(^A6?R(^-6O[DN]@ %S&
M                                   >BM!?D?:?]!#?&AT%^1]I_P!!
M#?'@+Q^]/O?J?8+E]-9_[5Z')\JGY#W#VQ?Q&E!E^<JGY#W#VQ?Q&E!GI>0_
MIWWOT1X;_*_K(_[5ZL  [1Y@
M%P<B/]T7+_7;^Z4^7!R(_P!T7+_7;^Z<OECZ67AZG>_QKZ^/<_0L@^)_["3_
M "K^P^SXG_L)/\J_L/'K4^E/0\M  ^B'Q<
M          %V<C'Y*3?K3_W6E)EV<C'Y*3?K3_W6G)Y9^F?>CT7^,?7>#.\-
M7JK\F;O^J2_N*;0U>JOR9N_ZI+^XIY2Q_<CWH^@WG]F?<_0\U@ ^@GQP
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MF-=M(B^TRF*DC?%3L9+,L\B)OD5$17?4FXRE&9%H  02
M                       1+PDBVBN2#;698'[&Q\;:V5QC'3DB:1;4,TK9
MVUR2I5I21)*DV=O;V$SM9WYSG.2=<JA:2W550UJ.=#$Z1$7@JHBK_L1].U[[
MK8+;<)6-8^JIHYG-;P:KFHN$[3)GS>F53%ESFN=#8%)<LOY61_JK/WG%VE)<
MLOY61_JK/WG'2Y%^I\&<+_)_H?%'"  ]>?.
M            6YR'_P!WW7_59^Q2HRW.0_\ N^Z_ZK/V*<SE?Z27AZG=_P ;
M_P!0AX^C+, !XT^F'F2]_P!\U_ZQ)^\I")M[_OFO_6)/WE(1]"L_D1\:M?W)
M=[  +F,                                    ]%:"_(^T_Z"&^-#H+
M\C[3_H(;X\!>/WI][]3[!<OIK/\ VKT.3Y5/R'N'MB_B-*#+\Y5/R'N'MB_B
M-*#/2\A_3OO?HCPW^5_61_VKU8 !VCS
M        +@Y$?[HN7^NW]TI\N#D1_NBY?Z[?W3E\L?2R\/4[W^-?7Q[GZ%D'
MQ/\ V$G^5?V'V?$_]A)_E7]AX]:GTIZ'EH 'T0^+@
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M9\D_20\?5GS'_(O]1M/#_P!4  =(X@
M     !W?(U^5LGZJ_P#>:7:4ER-?E;)^JO\ WFEVGD.6OJ?!'T?_ !?Z'Q8.
M>TO<ZJONFHX:J1'1T==S,*(U$V6<VQV-W'>J\3H35V>YTM?676&EA=')1U',
M3.<U$VW[*.RF%W[E3B<V'RRRK^,SO3^:.=/SD;0 &,R   'X_:V';&-K&[/#
M)I__ (A]%I[9#;R)F-R*Y6HJ+\)%QCUG/>+Z?_F.N]Z9W%X&.=3<VOP9;?!X
M F*79_JTPJ;O8N\E&*E?+)3L?/#S,JI\*/:1VS]:<3*5>I=:  $$@
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MUSJ4SQZ94)Y27++^5D?ZJS]YQ=I27++^5D?ZJS]YQT^1?J?!G _R?Z'Q1P@
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M)LX1^TN5QC&R<N5L[6%K5P=:9&2VN]I8-*T5*JJ[@ #(80   7!R(_W1<O\
M7;^Z4^7!R(_W1<O]=O[IR^6/I9>'J=[_ !KZ^/<_0L@^)_["3_*O[#[/B?\
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M1.HI;?+)M0-<US)(U;G*IP7ZCABW)L)0NT8S5&J^ICY;M86M]M)V;K%TT[D
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M43X4B-V=I?9T&4C6SP;P"'P%VW3;/P';2NRGM7>I)*/4NM  ""0
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M8G2(B].$5<?<1].U[KK8;=<)&)&^JIXYE8U<HU7-1<?>9,^;TRJ8LN<USH;
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MH<GRJ?D/</;%_$:4&7YRJ?D/</;%_$:4&>EY#^G?>_1'AO\ *_K(_P"U>K
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M[_3,U )MTME5;'Q)5,1&S,22*1KD<V1J]**A",D9*2JC#.$H/#)48 !8J
M      #[B_M&>U#X/N+^T9[4()6IZE;\5/8 WXJ>P'SL^T(JWER_L[-[9?\
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M3%2I,VG8E2]CYD3X3F-V45?4AE*,R+0  @D                  83T(,
M#">A!A/0@  /AT4;F/:YC5:_XR*FYWM/L &.GIX:9FQ3PQQ,X[+&HU/N,F$]
M" "HI0(F. 5$7B@  1$3@@PGH0  <   8:[F4HJCPO'@_-NYW.?BX7/#U9,-
ME6C6ST*VK9\7\PSP?9SCF]E-G&=_#'$R7&G6KM]53(Y&K-$Z-'*F<914S]Y@
MT]0.M5BMUO?(DCJ6GC@5Z)A';+43./J+Y8-<ZF//'IE34GE)<LOY61_JK/WG
M%VE)<LOY61_JK/WG'3Y%^I\&<'_)_H?%'"  ]>?.
M                 6YR'_W?=?\ 59^Q2HRW.0_^[[K_ *K/V*<SE?Z27AZG
M=_QO_4(>/HRS  >-/IAYDO?]\U_ZQ)^\I")M[_OFO_6)/WE(1]"L_D1\:M?W
M)=[  +F,   _3\                                /16@OR/M/^@AOC
M0Z"_(^T_Z"&^/ 7C]Z?>_4^P7+Z:S_VKT.3Y5/R'N'MB_B-*#+\Y5/R'N'MB
M_B-*#/2\A_3OO?HCPW^5_61_VKU8 !VCS
M          +@Y$?[HN7^NW]TI\N#D1_NBY?Z[?W3E\L?2R\/4[W^-?7Q[GZ%
MD'Q/_82?Y5_8?9\3_P!A)_E7]AX]:GTIZ'EH 'T0^+@   _3\
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MBOVU<G^;I)!AH7MDI8W,@?3M5-T3VHU6^I40S%7J66@ !!(
M                         !$O'.>**[F-OGN8?L;'QMK97&,=.2)I!*A-
M*V=*[G?"O XN=Y[.WM["9VL[\YXY)UQJ%I+?55+6HY88G2(B].$5<?<1]/5[
MKK8;=<'L2-]53QS*Q%RC5<U%Q]YDSYO3*IBRYS7.AL"DN67\K(_U5G[SB[2D
MN67\K(_U5G[SCI<B_4^#.%_D_P!#XHX0 'KSYP
M              "W.0_^[[K_ *K/V*5&6YR'_P!WW7_59^Q3F<K_ $DO#U.[
M_C?^H0\?1EF  \:?3#S)>_[YK_UB3]Y2$3;W_?-?^L2?O*0CZ%9_(CXU:_N2
M[V  7,8                                   !Z*T%^1]I_T$-\:'07
MY'VG_00WQX"\?O3[WZGV"Y?36?\ M7H<GRJ?D/</;%_$:4&7YRJ?D/</;%_$
M:4&>EY#^G?>_1'AO\K^LC_M7JP #M'F
M        7!R(_P!T7+_7;^Z4^7!R(_W1<O\ 7;^Z<OECZ67AZG>_QKZ^/<_0
ML@^)_P"PD_RK^P^SXG_L)/\ *O[#QZU/I3T/+0 /HA\7
M                    !=G(Q^2DWZT_]UI29=G(Q^2DWZT_]UIR>6?IGWH]
M%_C'UW@SO#5ZJ_)F[_JDO[BFT-7JK\F;O^J2_N*>4L?W(]Z/H-Y_9GW/T/-8
M /H)\<                                    !]Q?VC/:A\'W%_:,]J
M$$K4]2M^*GL ;\5/8#YV?:$5;RY?V=F]LO\ ["J2UN7+^SLWME_]A5)[/DGZ
M2'CZL^8_Y%_J-IX?^J  .D<0
M[OD:_*V3]5?^\TNTI+D:_*V3]5?^\TNT\ARU]3X(^C_XO]#XL'/Z8NE57W34
M4%2]KHZ*MYB%$:B8;S;787T[U4Z U=GN5)75EUAI871R4=1S,[E:B;;]EJY3
M''<J<3FP^667_&9WI_-'.GYR-H #&9   #YEV>:?SGQ-E=KV''YTA_WR?:R]
MYV+U5&.5&[2HF41.DT_C2X]15/VT?>9+-O\ KH8K1)Z^E3:4G/\ @[/"^:Y_
M'P^:SLY]6=YE,%"UK*2)L<[ZAB)NE>[:5WK54XF<H]3(M  ""0
M                            ##7<SX%4>%X\'YMW.Y^3A<\/5DPV7P/Q
M/0^*MGP#F&>#[.<<WLILXSOX8XF2XTZU=OJJ9'(U9HG1HY>C**F?O,&GJ!UJ
ML5NM[Y$D=2T\<"O1,(Y6M1,X^HOE@USJ8\\>F5-2>4ERR_E9'^JL_><7:4ER
MR_E9'^JL_><=/D7ZGP9P?\G^A\4<( #UY\X
M           !;G(?_=]U_P!5G[%*C+<Y#_[ONO\ JL_8IS.5_I)>'J=W_&_]
M0AX^C+, !XT^F'F2]_WS7_K$G[RD(FWO^^:_]8D_>4A'T*S^1'QJU_<EWL
MN8P                                   #T5H+\C[3_ *"&^-#H+\C[
M3_H(;X\!>/WI][]3[!<OIK/_ &KT.3Y5/R'N'MB_B-*#+\Y5/R'N'MB_B-*#
M/2\A_3OO?HCPW^5_61_VKU8 !VCS
M     +@Y$?[HN7^NW]TI\N#D1_NBY?Z[?W3E\L?2R\/4[W^-?7Q[GZ%D'Q/_
M &$G^5?V'V?$_P#82?Y5_8>/6I]*>AY: !]$/BX
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MU9L*U/\ +T$@Q4JS.IV+5-8R;'PFL55:B^I5,I1ZF1:  $$@
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M?88Y-J:=,J:\#?@ QF0
M
M
M
M                                                    &KLUJI[?
M5W6HIYG2.KJGGY4545&.V4;A,?Y4XD^:1R1RI!L/J&LVFQN=C*[\9]"*J<33
MZ+M$]HLRMKWM?<:J5]75N;P65ZY5$]2;D^HR1R@W7P,4LYI4[<^PWH ,9E
M /F1$6-R.<K4PN7(N,>LYOP6W?\ ,=7[^ATDF$C<KFJY,+EJ)G/JP<WX5:_^
M7:O_ ,N_D9+.O48K2G6=#2/EDIV.J8DAF5/A,1VTC5]O293%2LDCIV,GFYZ5
M$^%)LHW:^I.!E*,R+0  @D
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M/=)(_'I<Y54VX!$I2FZR=66C",%ABJ(  J6   /Q^UL.V,;6-V>&33[>H?\
MN+7]K)^$W#TRQR;2MRGQDZ/6:#Q:O_,-;]I'W%X4ZS'.O4;:U^"^+X/ ,>"[
M/]7C/#Z]Y*,5+))+3L?-"L,BIOC5R*K?K3<92KU+K0  @D
M
M
M
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M=G9X>G<2;[J>S6&:**[U\=+)*W:8CT5<IPSN0GF;2J6%U?V(Y^SHY8E1?<W
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MH  02
M
M
M                                                   #G-3NN=5<
M;7;+8L]/#-)S]761MW1QL5%V$7AM.7">S)>$<;I4I.>"-:5%PEO];?6TENC9
M;[;3N8^:LF:CW5'!=B-N=R="N7ZC;55IMU76,JZNAIIZF-NPR62)'.:F<X15
M3<302[1Y4R(5FL\6=>T_&M1K4:U$1J;D1$X'Z 8S(
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MO'W&WFV.:?SGQ-E=KV=)QO\ \'?]VS[.7N,EFF]/2IBM&EKZT.NHI.=I8WK
M^#*?V;T1%;ZEP9C%2I,E.Q*I8W3X^$L:*C<^I%,I1F1:  $$@
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MJ+]#^Q_F/.IJ+]#^Q_F<&!L=AN(;=>-]G>>=347Z']C_ #'G4U%^A_8_S.#
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MP#T8
M                  !5?*5JR]Z8U7&R@F8ZCJ:1KT9+'M-8]KG(N.'%,'->
M=347Z']C_,W/+S7)X5:*#FUSL23[>?6B8P54>DN=WLK2PC*<%4\K?KS:V5XE
M&$W0[SSJ:B_0_L?YCSJ:B_0_L?YG!@VMCL-Q&IMUXWV=YYU-1?H?V/\ ,>=3
M47Z']C_,X,#8[#<0VZ\;[+FY-M;W;4.H'T=P\'YE('2)S<>RN45J>GUEGE$\
MB7Y82_JC_P!YI>QP.4;.-G;88*BH>DY+M)VMABFZNH !H'1      /QZJC'*
MU-IR)N3.,FG\8W?J)WO<9N'HJL<C5V7*FY<9PIIO +WUU%[HG>7C3K_/X*3K
MU5\OR;*WI&VCB2"=U1&B?!E<_;5WKVNDD&"@<Q])$Z*!U.Q4W1.9L*WU8Z#.
M5>I9:  $$@                                          HGEM_+"/
M]49^\\O8HGEM_+"/]49^\\Z7)7[_ (,Y?+'T_BC@  >E/*
M
M
M                                            OWD:H6T>B(7L>KUJ
MII)W(OYJYV<?^G[R@B]>0^FFI]&2.F8K6S5DLD:JOQF[DSVHIS.5?V->M'5Y
M&^HTZF6  #S9ZH
M                             J#EYAI?"+1-MIX9LR,V-K?L91<X]O25
M26CR\T4OC.T5V6\SS4D.,[]K*+V%7'JN3OIXY_VIX_E/ZJ>79Z  &Z:   !W
M_(E^6$OZH_\ >:7L43R)?EA+^J/_ 'FE['FN5?W_  1ZKD?Z?Q8 !S3J@
M  'S+L\T_G%PS97:7.-QR.-*?/\ _P";D[SKWKACE1JN5$SA.DT?C2J_Y?J^
MV/O,EG7J]:&*T2Z_2IN*7GO!V>%)&D^/A<VJJW/JSO,IAHHTBI8V).^H1$_M
M7N15=ZU5#,4>ID6@ !!(
M  *)Y;?RPC_5&?O/+V*)Y;?RPC_5&?O/.ER5^_X,Y?+'T_BC@  >E/*
M
M
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MC:VD3/85D6KR\UR>%6B@YM<[$D^WGUHF,%5'JN3_ *>.7]J>.Y2^JGG_ &@
M!NFB   =_P B7Y82_JC_ -YI>Q1/(E^6$OZH_P#>:7L>:Y5_?\$>JY'^G\6
M <TZH     !^/VMAVPJ([&Y5X9-/S-_^>6_W=WXC;R[/-OVG;+<+E<XPGIR<
MOS5C_P"8)?\ S)?Q&2']R,=I_<Z'16Y85HH5I8EA@Q\&-6;&RG^7H)!BI73/
MIV.J8VQS*GPFM=M(B^TRE'J76@ !!(
M            *)Y;?RPC_5&?O/+V*)Y;?RPC_5&?O/.ER5^_X,Y?+'T_BC@
M >E/*                                              $B@HYJ^JC
MIZ9BOE>N$1#N'6.Q::B:Z^3NJZQ43-/%A=E?7G'K[##:6T;-TU?89[&[RM4Y
M:)=;*_!W?E+I=?@KIN)&?*1OPOWC([3MFU%#)+IZI6&J:U5\%EQE<>A$1?5V
MF/:</SQ:1E5TQ_MS4GV?]G  S5=-+25#X)V*R1BX5%,)LIUS1J--.C  )(
M                    +6L^B[/+9Z;GX'S3U#'N\+:K]F+"XWX79Z>GT&CG
MT9:8YY&>4=,FRY4QAN[?_G-2-]LFVL\OL;TN3K:*3RS^_N<*#I-6:92Q14LT
M=6VJAJ&HYCVM1$Z?0J^@VD6AZ9M!35-=>8J59T56M>UO0JITN3T&1WFS45*N
M3,2N=JY.-,U]T<."R;'HJSOGDD?<H[DR)JN6GBW.?N7<FR[/0:?E!L=#:EHI
M[?$ZG94,1RT[U=M,Z=^TN?5]12-[LYSYM5+SN-K"S=I*E.\XX &T:8
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M7X-X!#X FS2[/]6F%3=[%WDHJ]2ZT  ()
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MW-_:B>E#A#N=&_D3J;_1=_[3AC8N[E649.M'^#4O2C2$HJE5^0 #9-0
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M<DHZRU[B+G;-0DYYJ*R^S."D>LDCGNWJY<J?(!OG,
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M<I0Y?W(U/33:(A;2L1KXII&3*C<;3\YSZ]RMW^HYG*O[&G6=;D;ZC7J?X.W
M!YL]2
M                    4OR\U$WCJT4^VO@_,22;/1M;2)GL*R+6Y>:YOA-H
MH-A=K9DGV\[L91,%4GJN3_IXY?VIX_E+ZF>?9Z  &Z:   !W_(E^6$OZH_\
M>:7L43R)?EA+^J/_ 'FE['FN5?W_  1ZKD?Z?Q8 !S3J@     'Y(B+&Y%<K
M4POPD7&/6<[X%2_\QUOO3.XZ&7"1OVF[3<+E,9RGL.7\(L?4$W_ER]QDLZ]1
MBM*=9TM*^62G8^HBYF54^%'M([9^M.)E,5*R6.G8RHFYZ5$^%)L[.TOLZ#*4
M9D6@ !!(                                          *)Y;?RPC_5
M&?O/+V*)Y;?RPC_5&?O/.ER5^_X,Y?+'T_BC@  >E/*
M                          VNG+'4WVO2FI=V[+G+P:F[?]YJCN]+*L/)
MY?IHUV9%EYO:3T*S@8;>;A"L==.)L7:SC:3I+15? Z"_V>T5]!0451>XXI:1
MKFN^ [>JX]7J-'Y'6+_F*/\ Z'?A.!555<JN\)E51$RJF&%VG!45H_(V)WRS
MFZRLUQ9WWD=8O^8H_P#H=^$>1UB_YBC_ .AWX3FY-+WB.C\)?13)%C/Q5SCT
MFE7**(V<I?+:UX"=K"'S6-.);=GLUII[-76REO4<LM5L[/P'<455]'K*UO\
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MCJ;>]ZT]4Q'(QZ*BMZ>G?Z.@ZD+Q9.2LH,XUI=;;"[::IZD_1OY$ZF_T7?\
MM.%.ZT;^1.IO]%W_ +3A18?/:=_X(O'[=GW?E@ &R:@
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M6CJ\C?4:=3+  !YL]4
M                                 5!R\P4WA%HGVT\,V9&;&UOV,HN<
M>WI*I+1Y>:*7QG:*[+>9YJ2'&=^UE%["KCU7)WT\<_[4\?RG]5/+L]  #=-
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MGEM_+"/]49^\\Z7)7[_@SE\L?3^*.  !Z4\H
M                  #NM.?X:7W]83^&IPIW6G/\-+[^L)_#4UKU\J[UZFW<
M_G?<_0X4VFF9((KY2OJ\<RBNVL_Y5Q]^#5@SR6)-&M"6"2EV%K4U/>(]7R55
M3*SQ7MJJN5R;"LSN]16EV="^XSNIDQ$J_![#K:VLF=R;0(M1(J^%M:J;:\.;
M7=[#AS5NL&FY/NX&]?;1-**Z\\_OU [G5_Y$Z=_R-_=4X8[G5_Y$Z=_R-_=4
MO;_/#O\ P8KO^W:=WY1PP -DU                  #JN2U,Z[M:>N3^$\V
M%ZT'?ZFZ5$L5%ECG(J+SC=^[VFAT1<X;/JBAKJK:YF)7[6SC.]CDZ53TG:U5
MRTO45$DKKC<FJ]<X1(L)]YS[>5I"VQ074NJO6SJW6-E:6&"T?7VTZD8:*TZZ
MH[<M%#'(D.%1%Y_>B+G./A>LUJZ0UBJJJI4Y7>O_ &A/Q&S\,TMUG<_^F'O,
MM')IJKJ8X(;E<^<D793+8N\PJTM(U=%_]7[FP[*RE18G_P#9>Q^Z6LNJ;362
M35--43M<S91%G:N%SZW&F72&L57.S4>\)^(WUUCT[:ZZ6DJKE<N>C7#L)%C[
MS(REL#[0^Y)<KCX,UZ1KNBSE45?9^:I56TT\=%G3_P 7[EW80:YNKRK_ .2]
MC36_3FMJ"I;- V=7)T.J$POM^$8[WI;5]YJ&S5],Y[FIAJ<ZBHB>K+E]).\,
MTMUG<_\ IA[QX9I;K.Y_],/>7YRT3Q4S_P!K]RCLK%QP.3I_N7L?=JT_<;'H
MK427*#FN<A=L_"1<\/0OJ*P++N%^L=+INY4=OJ:R>6J8K4YU&83_ *5]16AL
MW3&\4I];[NHT;]@6",'DEW]8 !N&@                  ?<,3YI&QQ-<][
MEPB-3*J6-9VU&E*"%EQ>E2RJPKZ#&7-:J91<;U3>F.'0:_2#;;;*!*][4K+G
M*[9@IU9N;T95514Z47HX'2^#R4M2G.-;7ZBK$VN;EPK(&KO5$SE-RHY.*'-O
M-MB>"F7K[)=IV+G=\"QUS]/=OL.<NMJEL53'>],2NJ+=E%RSX6SC>J.X_)SO
M.CIHW7NC9J"PLYBX1_V\/YLJ)NPF=WYJ\$Z33RW.DTE7I;&3>'TDC=FJC>B[
M+55=ZM145/BX]/%3!?\ 55+3RT%'IIRPT<,FV]S<L5^51V%W)E$7:0QN-I:4
MHJ_?M7W,JG966+$Z?;L?:C;7'3%!>HH[M4JZU?"5*EDK=E%<G'&UCBJ]!/M5
MRHI+!>:.S0;%#3P+B;I>[+>GV*G21M6T%RU#<;?3TTKHZ&2G9-)LNPU%5NTJ
MJF4SP.;U-?*:UT3[#8,<PW=-4(BM=(O!4X)Z&^DI"$K:*C6KUIU)?<O.<;"4
MITHNWK;^WY.( !V3SX                     -MI2[I8K[3W!8>>2)'HK-
MK9SM-5O'"^DU(*RBIQ<7HRT)N$E*.J+#GI+-J6RU]1::1]-7T_\ 6;&WM;29
M1/DI\K[CYEI?*304$U.NW7V[;21O2K,O<J[_ &IPR2=,0I;]"UEQLS$GN+W<
MW*Y4_LVX8JIG<O''2O$YO2E+J&%SKG9()'QQK\-4?AJHBY5%3**J;CG)92I*
MF%Y5?D=:3SCBC7$LZ+@^\VU/J.TW6WT]'J>E>V6E3#)F.5%=ZE1&JO0G21+S
M=%U"ZBLUCHUCHH5PQ$7*N7&%55PG0G2;&74^GJERK>K$K:Q/CK31,1%7U[2J
M9(-2<^UU'HNS,AED3#I',:V3'J5KD"3B\2@UWO)?<.2FL+FGW+XG]B1J!BON
M%FTM;*J39@5&3/C<K=ZJO;\;TF&X7BRZ8K*RDM] ^6L9$L7A#I>*N9O7&SZ5
M])SUJCO5BU53[=.Y;@YZ)S;W95^]-VY?9TDGE-H:2DO:.IO@5$S4?/"FY(W;
M+5W;NG*KQ4F-E''&S;JFJY=;ZVQ*VDK.5K%4::6?4NI(Y.>19IY)7<7N5R_6
MN3& =+0Y#=0  0               "^.1.MEJ]%;$J-Q354D+-E/S=SM_KRY
M2AR_N1J:EET1"E*Q&OCFD9,J-QM29SGU[E;O.9RK^QIUG6Y&^HUZG^#MP >;
M/4@
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M5XJC5541?6;&1B21N8Y7(CDPNRY6K]2IO0U+Q;<[-M:5;XFY=K'F;-1>J27
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MZ25RN>Y<JJ](C9VDYJ5I3+L$K6QA!QLJU?;3\'P #:-,
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M)&-1KWIE%<B8PF<^KT'( &.SLXV:I%&6UMIVKK-U  ,AB
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M>4$7KR'T\T&C)'3L<ULM9+)'E>+=R93ZT4YG*O[&O6CJ\C?4:=3+  !YL]4
M
M              5!R\P4WA%HGVT\,V9&;&UOV,HN<>WI*I+0Y>:*7QI:*WX/
M,\S)#QW[647LP5>>JY.^GCG_ &IX_E/ZJ>79Z  &Z:   !W_ ")?EA+^J/\
MWFE[%$\B7Y82_JC_ -YI>QYKE7]_P1ZKD?Z?Q8 !S3J@     'X]%5CD:[9<
MJ;EQG!I_%UWZ\7W1AMYMCFG\Y\397:]G2<;MZ-_[YGVDO>9+--_]5,5HTM?6
MAUU$])*6-S8'TZ*G]D]J-5OJ5$,QBI.?\'9X7S2SX^'S6=G/JSO,I1ZF1:
M$$@                                          HGEM_+"/]49^\\O
M8HGEM_+"/]49^\\Z7)7[_@SE\L?3^*.  !Z4\H
M
M
M                                   "^.1.MEJ]%;$J-1*:JDA9LI^;
MN=O]>7*4.7?R(W2CGT]/;8&(RKI)%DF1&HFWMJJH[/2N['U(<WE15L-.M'4Y
M'E2\:ZIEC  \T>K
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M"L$2I\&-6;"M_P##T$@J]2RT  ()
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MRTKGVZ=0L[DIN'Q?-6F79KUE2 VE=>ZNOM<='6R+-S<O.,D?O<B*F%15XJG
MU9MQ;>J-*22?PL  L5       !UW)GI^DO\ ?ECKID2*G9SRP[*YE1%3=G@B
M95,]/^V.TM%9P<Y:(R65E*UFH1U9R(-]9]/>.=0>*[?7T[W.:KF2JU[6+A,J
MF]N?N,K=)5+K3=Z]M33JRV3.AF9\+:547&6[L8(=M!.C?9YEE86DE5++/RU.
M<!UE'HFIJ;/;[HMPH8:*KDYO;F<K.;7*IORGI3&[TG1Z7H&1:-UA12U5/(RG
M?L-J,JYB>ER815QNZ#'.]0BJQSSIYT,MG<YR=)955?*I6 .@O>F*BW4-OKJ>
M:.MH:[X,,L2*GPODJBIE%X]A,DT/6MJYZ!E1#)=8*=*F2E:BYV=VY'<%=O3=
MZ^)?G[.E:F/9K6M*?UG)@LG1-F6\:*J8K#6MI+XRHVY5VE:]\>-S=I-Z-Z?:
MF\CVV2Z4VL-/V^\4SJ>LBJ%;*_91/"&.5,*Y4W/X*F=_08MJ5912S7$RJZ.D
M9-Y2IG3+7U*^!>:0/DUU?8KM Q=.MIVKFH8B1-=LL^*J\%^-P.;;;:/3N@:J
M^4+&OK:R964TTC<K#&KU1%;G@NRF<\=_J,<;\I45,W2GC[&67)[C5XLE6OA[
ME8 L7DVV=4RW&S7U75<;H%FBED7:DA<CD15:Y=Z?&3=PW&TT!7U=;R@5M%6N
M18*>&2)L&$V&[#FM1<>GU^LO:7IPQ+#\JKJ4L[FK3 \64G33_DJ8'1W^^5;Y
M;Q;:B19H'5*K'M[UC5KUX+Z,;L>PYPV82<E5JAJ3BHNB=0 "Y0       V6F
MTHUOUO2YX\"Y]G.[7#9ST^KTEC:FM%^LUUDND+O&EB5ZR<PW#VQ1KPPS@FRG
M!S?1G<:]K>%9R4.M^'@;-C=G:P<UHNS/Q[BIP6IIMU7)R1W"6DYV2MCJ-B%S
M$5TB)M,W)T]*DZYZ?H+U/I:DKF107F5B/KFQ(C7JQ&9=M(G!55$3ZU]!A=]4
M9-26C:X*M3.K@Y13B\VD^+I0IT':ZZO%3;M45%%:'K0T5$J1QPP?!:JHB95R
M?G*JYXY-_K-K+5IRBO\ 9HHZ.:[11,GYI$1&JK=O+4Z%7"HN#)M+^&L?FTS]
M3'LJ^.DOEUR],^TJL%KZOKJJDY.M-UE-.^.JE5BR2M7X3_@*N]>GZS3Z-U0L
M=^K+A6M9X-,Z))HU1-ANTJ-5Z)T;]Y$;S*4'-1TKU_>G83*ZPC:*S<M:=7:J
M]IP .\USIR.WZXD5S-FVSHM8NSN1&)E7M3UY143_ #(;?E5F<[2FFY&(V+PF
M-'RMC391R[#5X)T;U"O2DX**^;R#N;BK1R?R^95@.MM^AJVJFHJ:6HAIZNMI
MUJ:>-[7*CFHF<*Y$PBXWXWD:RZ1J[I1W2=M334ZVU52=DRJF,9Z414_-4R[1
M9YNNG_1AV:UR6'7_ +.;!T=[TI4VZ&U305$-;!<L) ^)%;EV[=AR(J<4)4NA
MZQD=V:VIA=66R-LM1!LN3X*M5V6N5,+N11M%G2M?[IZC9K6K6'3VKZ') Z6D
MTE/)06VJJZJ*E2Y2I#2M<U7*Y>&T['!N<>GCP$FCZQNH9K0RHIY):>-9:B5$
M>C(6IO55RU%7=C@BYR@Y^SS5=!L]I1.FOY.:!T4>E9YI+0L%3$^ENCUC@G5J
MHB/1<*UR<47/M,UZT=-9Z>X/K+E0)/2*Q/!VR?UDB.QO1..-_P!R^K+G[.M*
MY_\ -/4;/:4<J9+VKZ'+@ S&          '4\F-WIK'JZ.JK9W0TTL3H)'9P
MU,JBHKO4BI]63E@4M+-6D'!Z,R65H[*:G'5'K&FGBJ:>.>GD;+#(U'L>Q<HY
M%X*BF0H3DQULW3+9J&YNJ);:]=J)&_"YA=^<)QPOHSN]&\MS36K[)J-$;:ZY
MCY\;3J=_P)6^G+5W_6F4/+WFY6EA)Y5CVGKKK?K*\16=)=AOP :9N@
M
M   U]^O-!8;<^NNM0D%.U4;M*BJJJJ[D1$WJOL-'JG7]CT[.ZEJ9GU%<U4VJ
M:G;M/;G?ER[D3=A=ZE-:_P!3.U7>(ZC8DBI*=NS#"YV41<KEZIPVEW=AOW2X
M3MI)R5(]OL<V^<HV=A%J#3EV>YJK_6LN=^N-PC8L:54SI4:Y5541>'W8( !Z
M>*44DCRDI.3<GU@ $E0  #O^1+\L)?U1_P"\TO8HGD2_+"7]4?\ O-+V/-<J
M_O\ @CU7(_T_BP #FG5      /F79YI^VN&87*YQA#D^:TUUL[W]WXCK9%PQ
MR[*NPGQ4Z?4:#QC_ /Z[6_91]YDLZ]1BM$NOT-W2K,M.Q:IL;9L?"2-55J+Z
ME4RF&CC6*FC8Z9TZM3'..QEWK7!F*,R+0  @D
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M6JR2-Z.141B)T>PYL&S"P49XZ]5/R:D[PYP=G3*M?*@ !G-<
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MEDIV.J8DBF5/A,1VTC5]O292KU+K0  @D
M               %$\MOY81_JC/WGE[%$\MOY81_JC/WGG2Y*_?\&<OECZ?Q
M1P  /2GE
M
M
M
M                                   #O^1+\L)?U1_[S2]BB>1+\L)?
MU1_[S2]CS7*O[_@CU7(_T_BP #FG5      /F3"1NVFJY,+EJ)G/JP<WX3;/
M^7*O_P O0Z5^UL.V,;6-V>&33[>H?^ZM?VDG<7@8Y_W(VE+')%3L9/,L\B)\
M*16HW:^I-QE(MK\%\ A\ QX+L_U>,\/KWDHJ]2ZT  ()
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M"0
M
M
M
M
M                            #\>JHQRM1%=C<BKC*FG\+OG5=+[W_P#V
MFX>BJQR-=LJJ81?0:?Q7<^OJC["/N+QIU_DI.O57R_)L+;X.E##X')SE/L_
M?MJ[*>U>)),-'(LM-&]T+H%5/[-V,M]6XS%7J66@ !!(
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M\A 84,<NTF^,I?DL[%[QXRE^2SL7O(0&%#'+M-I15;YYE8]K43&=Q.-3:O\
MB5_RJ;8Q35&9[-MK,  J7      /F;8YI_.?$V5VO9TG&[&C?^Y9]E+W'9O5
M48Y6IM.1-R9QDT_C&[]1_P#S;#)9MK3UH8K1)Z^E3:4J3)3L2J=&Z?'PEC14
M:J^I%,I@M[8VT<38)G3Q(GP9'/VU=_XNDSE'J9%H  02
M                          #4W7_B4_RI_N;8U-U_XE/\J?[E[/4QVORD
M, &8U@
M
M
M
M                                "9:O^)7_ "J;8U-J_P")7_*IMC#/
M4V;+Y0 "AD      /QZ*K'(U=ERIN7&<*:;P"]==Q^YM[S<2[/-/YQ<,V5VE
MSC<<A_\ "?SU/>I.\R6:_M*F*T:_KH=50.8^DB=% ZG8J;HG,V%;ZL=!G,5+
MS_@[/"TC2?'P^:5=G/JSO,I1ZF1:  $$@
M               U-U_XE/\ *G^YMC4W7_B4_P J?[E[/4QVORD, &8U@
M
M
M
M
M                       "9:O^)7_*IMC4VK_B5_RJ;8PSU-FR^4  H9
M    #\>JHQRHU7*B9PG2:7QI5]0UG_5'^(W3]I6.V%1'8W*OI-/S%^^?4'N[
MOQ%XTZRDZ]7X-G1,2.EC8V=]0B)_:O<CE=ZU5-QF(]N6%U%"M+$L,&/@QJS8
MV4_R]!(*O4LM  ""0                                          :
MFZ_\2G^5/]S;&INO_$I_E3_<O9ZF.U^4A@ S&L
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M2TK6.M5&MS;&VO6%BU#8_BI)A-I$]6<DLL5  !
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M?JNEK74&*2NBBKW;--+)&FQ)N5<Y15QN1=RX4<S/L'/0[3H@ 8S(
M          3+5_Q*_P"53;&IM7_$K_E4VQAGJ;-E\H !0R      'S+LK&_:
M=LMPN5SC">TY;P>Q]?3?^8KWG4R+B-RJU7(B+\%$SGU'/^&TW_+E;[JSO,EG
M7J,5I3K-[2NF=3L6I8R.94^$UCMI$7U*93%21OBIV,DF=.]J861R(BN[-QE*
M,R+0  @D                                          &INO\ Q*?Y
M4_W-L:FZ_P#$I_E3_<O9ZF.U^4A@ S&L
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M.LC%DT  24
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M/EDIV/J(>9E5/A1[2.V5]J<3*5>I=:  $$@
M                 U-U_P")3_*G^YMC4W7_ (E/\J?[E[/4QVORD, &8U@
M
M
M
M
M                         "9:O^)7_*IMC4VK_B5_RJ;8PSU-FR^4  H9
M      #YDPD;]INTW"Y3&<I[#F?"++U!-_Y:O<=._:V';"(KL;D7ADT_/7_Y
MG;OMW_A,D/[F8[3^Y5-I2LECIV,J)>>E1/A2;.SM?5T&4BVOP;P"'P!VU2[/
M]6N57=[5WDHH]2ZT  ()
M  !J;K_Q*?Y4_P!S;&INO_$I_E3_ '+V>ICM?E(8 ,QK
M
M
M
M
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M>+YOH]HQ(8)=A$!+\7S?1[1XOF^CVC$A@EV$0$OQ?-]'M'B^;Z/:,2&"781
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M>+YOH]HQ(8)=A$!+\7S?1[1XOF^CVC$A@EV$0$OQ?-]'M'B^;Z/:,2&"781
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MAHGI)2QO; ^G14_LGM1JM]2HAF*O4LM  ""0
M
M
M
M
M
M  #YEV.:?SGQ-E=KV=)QV='?+C_ZY3LGJJ,<K4VE1-R>DT_C.Z=13>\1]YD@
MW_70Q6B3U]*FTI>?\'9X4L:SX^'S>=G/JSO,I@H&L921-BG=4,1-TKG[:N]>
M>DSE'J9%H  02                                          "#57B
MVTDRPU=QHX)4WJR6=K7)]2J3CRIRX_XG7CV0_P %ANW&ZJ]6C@W3*II7^]NZ
M6:FE7.AZ8\H;+UO;O>6=X\H;+UO;O>6=YXL!U>@X[_D<CIV>XN)[3\H;+UO;
MO>6=X\H;+UO;O>6=YXL Z#CO^0Z=GN+B>T_*&R];V[WEG>/*&R];V[WEG>>+
M .@X[_D.G9[BXGM/RALO6]N]Y9WCRALO6]N]Y9WGBP#H.._Y#IV>XN)[3\H;
M+UO;O>6=X\H;+UO;O>6=YXL Z#CO^0Z=GN+B>T_*&R];V[WEG>/*&R];V[WE
MG>>+ .@X[_D.G9[BXGM/RALO6]N]Y9WCRALO6]N]Y9WGBP#H.._Y#IV>XN)[
M3\H;+UO;O>6=X\H;+UO;O>6=YXL Z#CO^0Z=GN+B>T_*&R];V[WEG>/*&R];
MV[WEG>>+ .@X[_D.G9[BXGM/RALO6]N]Y9WCRALO6]N]Y9WGBP#H.._Y#IV>
MXN)[3\H;+UO;O>6=X\H;+UO;O>6=YXL Z#CO^0Z=GN+B>T_*&R];V[WEG>/*
M&R];V[WEG>>+ .@X[_D.G9[BXGM/RALO6]N]Y9WCRALO6]N]Y9WGBP#H.._Y
M#IV>XN)[3\H;+UO;O>6=X\H;+UO;O>6=YXL Z#CO^0Z=GN+B>T_*&R];V[WE
MG>/*&R];V[WEG>>+ .@X[_D.G9[BXGM/RALO6]N]Y9WCRALO6]N]Y9WGBP#H
M.._Y#IV>XN)[3\H;+UO;O>6=X\H;+UO;O>6=YXL Z#CO^0Z=GN+B>T_*&R];
MV[WEG>/*&R];V[WEG>>+ .@X[_D.G9[BXGM/RALO6]N]Y9WCRALO6]N]Y9WG
MBP#H.._Y#IV>XN)[3\H;+UO;O>6=X\H;+UO;O>6=YXL Z#CO^0Z=GN+B>T_*
M&R];V[WEG>/*&R];V[WEG>>+ .@X[_D.G9[BXGM/RALO6]N]Y9WCRALO6]N]
MY9WGBP#H.._Y#IV>XN)[3\H;+UO;O>6=X\H;+UO;O>6=YXL Z#CO^0Z=GN+B
M>T_*&R];V[WEG>/*&R];V[WEG>>+ .@X[_D.G9[BXGM/RALO6]N]Y9WCRALO
M6]N]Y9WGBP#H.._Y#IV>XN)[3\H;+UO;O>6=X\H;+UO;O>6=YXL Z#CO^0Z=
MGN+B>T_*&R];V[WEG>/*&R];V[WEG>>+ .@X[_D.G9[BXGM/RALO6]N]Y9WC
MRALO6]N]Y9WGBP#H.._Y#IV>XN)[3\H;+UO;O>6=X\H;+UO;O>6=YXL Z#CO
M^0Z=GN+B>T_*&R];V[WEG>/*&R];V[WEG>>+ .@X[_D.G9[BXGM/RALO6]N]
MY9WCRALO6]N]Y9WGBP#H.._Y#IV>XN)[3\H;+UO;O>6=X\H;+UO;O>6=YXL
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MY9WCRALO6]N]Y9WGBP#H.._Y#IV>XN)[3\H;+UO;O>6=X\H;+UO;O>6=YXL
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M")4^#&YFPK?5L]!(,5*LRT[%JFQMFQ\)(U56Y]63*4>ID6@ !!(
M                                 /*G+C_B=>/9#_!8>JSRIRX_XG7C
MV0_P6'7Y%_??=^4<;EOZ==_X9P@ /4'E@
M
M
M
M                                                           #
MNN0__$RT>R7^$\]6'E/D/_Q,M'LE_A//5AYCEK]]=WY9ZGD/Z=]_X0 !QSL@
M     'X]<,<NRKL)P3I]1H?&3O\ EZM^SC_$;Y^UL.V,;6-V>&33[&H/^_M?
MV3_Q%X4ZS'.O4;.CC6*EC8L[YU:F.<>J*KO6N#,1K8M.M!"M%'S=/L_ ;L*W
M">Q>!)*O4NM  ""0                                          >5
M.7'_ !.O'LA_@L/59Y4Y<?\ $Z\>R'^"PZ_(O[[[ORCC<M_3KO\ PSA  >H/
M+             [^WZ!EJN2VMU(B.\*9-SD;/3 W*/7'M7/L;ZSC;+0.N=TI
MZ-KD8DCOAR+PC8F]SE]2-15^HNWDIOU _4MRM+KI1U-ON+$CI:1K)45B,;LH
MWX3$3?&F_?O5/6:-]MIV<:V?5F^[^^AO7&QA:2I:=>2[^W^]I1='25%;,D-'
M3S5$JIG8B8KW8]B$SQ!>.;J)/%5?S=/_ &SO!WXCW9^%NW;M^\[*S6*337+3
M06QVUL0U[>:<OYT:[VKV+^TL*GNE=_\ :(J*'PF5:-8-A8=I=A&\PC^'#XW2
M5M;XXOX%58<1:QN2DOC;3Q83S]2TT]74,@I(99YWKAL<3%<YWL1-ZF6NM]9;
M9VQW&BGIWK\)&3QN8KD^O"X+MTG;[?02<J51;T8VHI4GB@5O&)FS(N&^C>G_
M *4-&^F@JOZ/$<]7A9Z6L7P9SN*9EPJ)ZL*[=ZO4-MK*B654N*J-AI"K>=&^
M#H:WE.TW:+%8M)W"V47-27"%9IV.E>YKEV8W8WKE$^$O!3XY8],6K3DUE\34
M[H&U=.Z61%D<_*[O2OK-SRU_D7H']37^'$;7E9IJ>LU9H&FKL>"S(R.7/!6J
M]B*AKV-M-<TVV_GKX5-FVL8/G5%)?)3[5*:\373P#P[Q;6>!8VN?YAW-X].U
MC&" >B'O=_\ :&BIDW4R6_F>;Q\'8YI5V<<,9Z"C]94M/1:MO--0X2EAK)61
MHG!&H]41$]G W+M>G;/"UJD^)I7FZJQCB3T;7 ZV^:8CTSI&QW-;.RZ>'PI/
M45,SI.;AVD16L1&.;C<O%<Y7@8M/V_3=VU5INDIJ%[J2X,5M5#+.Y7PR;3_B
MN:J;L(W&47=ZS<Z1Y1KCHR*"R:AI/#[6L,<D>/CLBD:CD1,[G-P[@OLR;^OL
MECI>4/1%[TXC8J6[2.DYEJ;+4PU%VD;^;\;"IPRAJ2M;2%8VE<ZM-/)Y-^!N
M1LK.=)6=,G%--9K-+QJ0)=(:7EY3:C2*VN6&)84?#515+]MKN;VURCE5%3CT
M&HT]R5^%:MO=)<:QS+/:'_UM0Q,.D14VD1.A%V=Z\<?6;/E-U=4:7Y2KG+:K
M?0)<%AC9X9*U[Y&HL;>"*[93L-OR,W1]\T=JRBEF6:[SOEG<KE^%)SD:-1>U
M%]F4,3M+>%ASJ>34?OGULRJSN]I;NQ:S3EIEDM$5E;*W35;J.*DGL38+3/*D
M+965$O/QHJX1ZJKE:J]*ILF[UCI:V:"?507*C\:RU$C74#WROC1(L+M[2-5,
MN1=E/KSZC@+332U-WHZ:%JK-).R-K<;]I7(A;W])>X4\UQLM!&YKJBG9++(B
M?FH_91J?^E5[#<M,4;>%G%NC3KF^HT[+#*[VEI)*J:IDNO5?DC:TTYIRP:$L
M5]I[)'+45_-<Y&^IFV6[<:O7&'9XH5IJ=]KDNG.6.!U/1/BC<D+I%>L;U:FV
MW:7>OPLEN<K7^#6D/_XW\!Q1PN%9PQR;;JUK]R.4*0G@BDE1/3[%L\GFE[%>
MN3V^7BX6QKZVW)+L*V:1K7[$2/3:3:]/HP0.1G3]GU9>Z^BN]N8Z..!9V.CE
MD:K5VD3'QN&_VG5<C4G-<DVKI%8R1&>$.V'IEKL0)N7U&'^C]=6U^I[A&VVV
M^DV:-7;=-&K7+\-NY<N7<:EK:VBC;T;R>6>AN6-E9N5A5+-9Y:E4:@I6+J6N
MHK71;#8ZB2&*&+;>YR-<J)Q555<(1;C:+C;$C6Y6^KI$DWLY^%S-KV93>6+H
M3QBO*/J1ELM])5\XM3'-)5.5K((UD7+LIO\ 5A-ZFVO45)_]GZ-M)*^IAAK<
M1RRLV57^M<BJB97";UQOX*;CO3A*,*5K1<?[XFFKHK2,IUI2KX?WP*H=8[LV
M6&-UKKFR3KLQ-6G>BR+Z&IC?]1B@M=?/<'4,%#525K55KJ=D3ED14XHK<9W%
MU:WOU?8.3'0U5:IN8JUABQ,C45R-2)%5N_H7=GV$+0E5-6<F^O+^^3;O50LB
M2S-1$<C=A%W8X?&=P]'J*J^3YOG'%4K3QK3@6=RL^<YM2=:5\*5XFDK-)VZ+
MDAEO51;9*2]PU"0/VGR)C^L1N]CEW*J*<#+8[M$QCI;77,:]R-:KJ=Z(Y5X(
MF[>JEJ/J)JG^CE(ZHE?*YM4C&J]<JC4E3"&?3/,:TY'9:"OJ.;GL4[95E5=[
M84RN?^A7M3_*ACL[Q.SC*4LUC:[D7M+M"UE&,<G@3[V5'+9;I#-%#+;*UDLJ
MJD;'0/1SU3CA,;S'3VVNJ:M])3T53+5,RCH61.<]N..6HF4+OU=74VHM$V+7
M#59#56S;:Z/:RO.\&)Z\2(QWL53BM"-JZC0FJ(IJ6FCL[U:^JN,B*Z1BIA48
MQJ?'=G&$541%7>N\S0O<I6;DU1IT??6GC^3#.YQC:*"=4U5=U*^'X.&J;5<*
M6N;1U-#50UCL;,$D+FO7/##53*F5+%=UJ5ITM=>M0C.=6+P=^UL?*QC.-W$M
MGE<2-UAY/)H]I56)J->_XZMV8E3*^DF\N&K+OIS5U$RRU/@JR4*+(Y&-=MHK
MWHB+E%X854]&5*POEI:8%&*K*ODR\[E9V>-RDZ1IYHI.WVRNN3W,MU%4U3V)
MER01.>J>W"$:2-\4CHY6.9(U=ES7)A47T*A<%514E)R%V2JC\):R2M\(J9*5
M$VE?F1J*[/0BHU/;@X7E'OU+J74/C6CH)*))X6[:/5%YQR*J*],>Q$]J*9[&
M\.UFTEDFUP]S!;7>-E!-O-I/C['+@ VC4
M
M
M                                                         .ZY
M#_\ $RT>R7^$\]6'E/D/_P 3+1[)?X3SU8>8Y:_?7=^6>IY#^G??^$  <<[(
M     !\R(BQN1SE:F%RY%QCUY.:\&M?_ #%5_P#F7\SI9,)&Y5:KDPN6HF<^
MHYOPJW?\N5?N"&2SKU&*TIUG0TKY7T['5$212JGPF-=M(B^WI,IBI8Y(J=C)
MIEGD1-\BM1NU]2;C*49D6@ !!(
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M14&\D  9"@
M
M
M                                 !W7(?\ XF6CV2_PGGJP\I\A_P#B
M9:/9+_">>K#S'+7[Z[ORSU/(?T[[_P (  XYV0     #\?M;#MC&UC=GADTN
MWJ+_ +JU?]<G<;J1,L<FTK<I\9.CUF@\ 9_S%6_;1_A+PH8YUZC;6OP7Q?!X
M!CP79_J\9X?7O)1BI7R24['SPK#(J?"C5R.V?K0RE7J76@ !!(
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M*1K9X/X!#X$_G*?9^ [:5V4]J[U))1ZF1:  $$@
M                     \J<N/\ B=>/9#_!8>JSRIRX_P")UX]D/\%AU^1?
MWWW?E'&Y;^G7?^&<( #U!Y8   &2#\XQF2#\X(K+0R@ DQ@
M
M
M                                PR_&^HS&&7XWU M'4^  09#[A^,O
ML,QAA^,OL,Q*,<M0  5
M                               ,<W!#$99N"&(@R1T  !8   [KD/\
M\3+1[)?X3SU8>4^0_P#Q,M'LE_A//5AYCEK]]=WY9ZGD/Z=]_P"$  <<[(
M   !^/158Y$=LJJ814Z#3>*[AU]4_8Q]QN)=GFG\Y\397:]AQ_\ \(_]PGV,
MO<9+-/\ JJ8K1I:^M#K*-ZR4T;UA= JI_9NQEO9N,QBI4F2G8E4Z-TV/A+&B
MHU5]2*92C,BT  ()                                          !Y
M4Y<?\3KQ[(?X+#U6>5.7'_$Z\>R'^"PZ_(O[[[ORCC<M_3KO_#.$ !Z@\L
M #)!^<8S)!^<$5EH90 28P
M
M
M       89?C?49C#+\;Z@6CJ?  (,A]P_&7V&8PP_&7V&8E&.6H  *@
M
M      &.;@AB,LW!#$09(Z   L   =UR'_XF6CV2_P )YZL/*?(?_B9:/9+_
M  GGJP\QRU^^N[\L]3R'].^_\(  XYV0     #\>JHQRM3:<B;DSC)IO&-XZ
MB_\ FV=QN7HJL<C5V7*FY<9P:?P"\]=,]S;WEXTZ_P _@I.O57R_)L;>V)M%
M$VGF=/$B?!D<_;5WKVNDD&"A<Q])$Z.!].Q4W1/9LJWU*G09RKU++0  @D
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M6AE !)C
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ME)7P\]!,QBLRF[BB\.*=ID5XLY3P)Y^QC=VM8PYQK+7B<P #,8
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M?_B9:/9+_">>K#RGR'_XF6CV2_PGGJP\QRU^^N[\L]3R'].^_P#"  ..=D
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M3V&ZP)/$E<VGD:Y7-VV.<B(Y%145,HJ*AI6=[4ISB^K-?=?]F]:7-QA"2_\
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M3[236:SI3QS12(,U8Z-]7,Z&-L42O56L8JJC4SN1%7>J>TPFZC18
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M9FO5CMF/<J(OT5W^HK,&2-T4;3G*];?%4,<KXY67-TZDN#J  ;9I
M          'W%&LLK(VJU%<N$5SD:GUJNY#KKI<?$59;:2W);*MM"UCX:IDF
MWF5<.>[*.W8=N3/0U#C@8YV>-JNADA:8$Z:EM<K\]JU+;K1>*"OM_C5L38ZJ
MF;4LVD14SZ<+LN54^OU#E)KZ"MY.-,T5'<:&>KH61I/%'4,5S<187=G?OW;B
MI0:T+FH*"Q?*ZHVYWYS<WA^=)/PZP #=-          &&7XWU&8PR_&^H%HZ
MGP "#(?</QE]AF,,/QE]AF)1CEJ  "H            /UN$<FTBJF=Z(N#\
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M9:/9+_">>K#RGR'_ .)EH]DO\)YZL/,<M?OKN_+/4\A_3OO_  @ #CG9
M  /Q^TK';"HCL;E7TFG\&OO6%#[LOXC;R[/-OVG;+<+E<XPGM.7YJQ=?3?\
MF*]YDA_<JF.T_N=#HK<L+J*):6%88<?!C5FQLI_EZ"08J5TSJ=BU+&,F5/A-
M8[:1%]2F4H]2ZT  ()
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ME*?;0S:AN<EYOE=<94PZIE=(C?DIG<GU)A/J-< 9XQ44DC7E)R;D]6  20
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M0E:)VOR]?]\_ K21CHWN9(U6O:JHJ*F%1?09WT%8RD;5/I*AM*[A,L:HQ?\
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MDJ]2ZT  ()                                          !Y4Y<?\
M$Z\>R'^"P]5GE3EQ_P 3KQ[(?X+#K\B_OON_*.-RW].N_P##.$ !Z@\L   #
M)!^<8S)!^<$5EH90 28P
M
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M\*-';6ROMZ3*8J5DL=.QD\W/2HGPI-E&[7U)P,I1F1:  $$@
M                              \J<N/^)UX]D/\ !8>JSRIRX_XG7CV0
M_P %AU^1?WWW?E'&Y;^G7?\ AG"  ]0>6   !D@_.,9D@_."*RT,H ),8
M
M
M                                          ,,OQOJ,QAE^-]0+1U/
M@ $&0^X?C+[#,88?C+[#,2C'+4  %0
M                                         #'-P0Q&6;@AB(,D=
M6   .ZY#_P#$RT>R7^$\]6'E/D/_ ,3+1[)?X3SU8>8Y:_?7=^6>IY#^G??^
M$  <<[(     !^/VMAVPB*[&[/#)I^=U!\UMOVS_ ,)N'IECD1RMRG%.CUFC
M\6S_ /,%7_\ T_PEX4ZS'.O4;2V>#> 0^ *BTNS_ %:HJKN]J[R28J21\M.Q
M\L*P/5-\:JBJWZTW&4J]2ZT  ()
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MS$ ,*,O.IZQSJ>LQ #"C+SJ>L<ZGK,0 PHR\ZGK'.IZS$ ,*,O.IZQSJ>LQ
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M^)UX]D/\%AZK/*G+C_B=>/9#_!8=?D7]]]WY1QN6_IUW_AG"  ]0>6
M
M
M
M
M                     .ZY#_\ $RT>R7^$\]6'E/D/_P 3+1[)?X3SU8>8
MY:_?7=^6>IY#^G??^$  <<[(     !^/158Y&NV7*FY<9P:?Q;=NO9/=8^XV
M\VQS3^<^)LKM>SI.-QH[TL_ZI3)9K^TJ8K1I:^M#KJ*1):6-Z0/IT5/[)Z(B
MM]2HAF,5+S_@[/"UC6?'PUC14;GU9WF4H]3(M  ""0
M                        >5.7'_$Z\>R'^"P]5GE3EQ_Q.O'LA_@L.OR+
M^^^[\HXW+?TZ[_PSA  >H/+
M
M
M
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M L7S-:O^;4OO#1YFM7_-J7WAHVV[[ZXC8KQN/@5T"Q?,UJ_YM2^\-'F:U?\
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MJTC;/CX:1JJMSZLF4PT;.;IHV+.^?"?VCU15=ZUQN,Q1F1:  $$@
M
M
M
M
M
M                  'X_:V';&-K&[/#)I^;U!\YMGV+_P 1MY$18WHYRM3"
MY<BXQZ\G,>"VG_F2K_\ ,OYF2']R,=I_<Z'06Q8%H85HX^:I\? 9L*S">Q>!
M),5*Z5].QU3&V*94^$QKMI$7V])E*/4NM  ""0
M
M
M
M
M
M    #YD5$C<JM5R87+43.?4<[X70?\N5GN+3HW[6P[8QM8W9X9--M:B_[NT_
M]4G<7@8Y_P!R-K2QR14[&33+/(B;Y%:B*[ZDW&4BVOP;P"'P#_A<89QX9]>\
ME%7J76@ !!(
M
M
M
M
M                                     !^2)F-R*Y6Y1?A)T>LY_P
MB_YBK?>&=QOYE:D3U>U7-V5RB)G*>PY3G-.]2R?^7N[C)9UZC%:4ZSJ('RO=
M,DL21M:_#%1V=MN$W^KIW&4Q2PJ^:%Z2R,2-556-5,/RF-XI:B.IBYR+:V=I
M6_":K5RBX7<OL*&1=AE !!(
M
M
M
M
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MGBI]_P $'QW+Y+177FF<Z]&+L97&]Z-_W)]76N@NM!2HQJMJ><VG+Q391%W
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MPJI7&Z>!F\-=X\\!V&['@W/[73G:V<&&DN;YJ>Z2+&U%I)I(VHGYR-:BY7M
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',H *EC__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g377490g61t49.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377490g61t49.jpg
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M*"@H*"@H*"@H*"C_P  1" $7 ZT# 2(  A$! Q$!_\0 '  !  (# 0$!
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MO"(B (B( B(@"(B (B( B(@"(B (B( B(@"(B (B( B(@"(B (B( B(@"(B
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MFM8A$1:C,(B( B(@"(B (B( B(@"(B (B( B(@"(B (B( B(@"+XXAK2YQ
M&9)X*&=)&F2&A=+;L)NCJ*D9M?6D:T;#\@?"/7N[5NIHG?+=@C"=D8+61(^+
ML86;"E+SUWJPR1PSC@9XTLG8W[SD.M0+C/3)>[R9(+/G:J([,XSG,X=;^'T<
MNTJ-Z^MJ;A5RU5=/)45,IS?)(XN<X]JQU?8^SJZN,N+*^S)E/@N"/U+(^61T
MDKW/>XYN<XYDGI)7Y6WL6&KS?GZMGMM35#/(O8SQ!VN.P=Y4A6;09?ZH-=<Z
MNCH&G>T$RO'<-GG4JS(JJ[\DC5&N<^2(F16)M^@:S1@>R%UKZAW_ "@R(><.
M]*WE/H:P?$ 'T=3-UR5+QZN2BRVI0N6K]C:L6QE6D5K_ .*/!6KE[#G_ +J;
M_,L2HT,X/E&4=+50]<=2X^MFL5M6GH_]]SW\)/Z%6T5A[AH%M$@/L?=JZ \.
M>:R4>8-7'WG0;B&D#G6VIHJ]HW-#C$\]SMGVENAM"B?S:>IA+'L7D10BVU\P
MY>+%)JW>VU5+MR#I&'5/8[<>XK4J7&2DM4S2TUP81$60"(B Z#"N,KYA>8.M
M%=(R+/-U._QHG=K3L[QD>M3O@;3':;T8Z6]M;:ZX[ ]SLX7GJ=\'L/E5:$42
M_#JO[RX]3;7=*OER+U-(<T%I!!V@CBBJGH]TG7;";V4TSG5UISR-/([;&.EC
MN'9N]*LIA7$MLQ1;6UMHJ!+'N>P['QGH<.!_\"H,G#LQWQXKJ6%5T;.7,W"(
MBB&X(B( B(@"(B (B( B(@"(B (B( B(@"(B (B( B(@"(B (B( B(@"(B (
MB( B(@"(B (B( B(@"(B (B( B(@"(B CO3[[VU;\]#ZX565:;3[[VU;\]#Z
MX565T6RO!?J5N7W_ &"(BLR,%9/DV?F/7?X@_P#9QJMBLGR;/S'KO\0?^SC5
M=M/P'ZHD8OB$KHB+FRS"(B (B( B(@"(B ^.<&M+G$!H&9)X*I>E7&<V+L12
MNCD<+73.,=+'P(XO/6[T9!6.TGUDE!H_OT\)(?X,Y@(WC6\7/SJGBNMDTIZV
MOT(67-\(A$179!"L'R?L;2W"!^';G*7ST[->DD<=KHQO9W<.K/H5?%TNC2LD
MH,?6&:(D$U;(CEQ:\ZI'D<5%RZ5=4T_8VTS<)IEQ41%RA;!$1 $1$ 1$0!$1
M $1$ 1$0!$1 $1$ 1$0!$1 %XUM5!14DM35S,AIXFE[Y'G)K0.)*^U51#24T
MM14RLB@B:7OD><@UHWDE5?TLZ19\65KZ&WO?%9(7>(W<9R/ANZN@??NE8N++
M(EHN7FS5;:JUKYF7I4TI5.)));;97R4UF!U7.'BOJ>L]#?D^7H$7KWH*.IN%
M9%2T,$D]3*[59'&W-SCV*P&CG0W2V]L5?BIK*NLV.;2#;%'^E\<]6[M5]*RG
M"KW?_K*]1G?+4BC!6CN_8L+9*.G\'H2=M7/FUGT>+N[RA3GA+1!AVR!DM=&;
MK5C:7U(_)@]4>[RYJ16M9%&&M#61L&0 V  +A,4:5L,V$OB;5&X53=G-4F3P
M#UNSU?.3U*ILR\C*>[6M%]/Y)D::ZEK([N*-D,;8XF-CC:,FM:,@!U!?I5RO
MNG2]51<VST-+0QG<Z3.9_GR'F7$W+2!BJXDFIOU< =[89.:'D9D%[#9=TN,F
MD>2RX+EQ+AH"#N(5'ZBXUM02:BLJ92>+Y7.])7B)Y0<Q*\'J<5O6R'_?^G_I
MA^,^A>9%2BCQ!>*(@T=VKX"-W-U#V^@KI[3I7Q?;BT>RGA48^!51MDS[_;>=
M:Y;)L7=DF9+,CYHM@B@[#VGF)Q;'B"U.CZ9J-V8^H[\2I6PWBNR8DBU[-<8:
MAP&;HL]61O:T[5!MQ;:>_$WPMA/DS<311S1.CF8V2-PR<UXS!'6%'>+-$&'+
MV'RT,1M56=H?3#\F3UQ[O)DI'1:Z[9U/6#T,I0C+A)%1\::.+]A0OEJJ?PF@
M&ZJI\W, ^4-[>_9UKC5>ES0YI:X M(R(.XJ)-(>ARANS9:[#0CH:_P!L:?=#
M*>KXA[-G4-ZN<;:BE\-W#ZD*W%TXP*XHLJZVZLM-?+17*GDIJJ(Y/CD&1'XC
MK6*K=--:HA\@B(O0%ML,8AN.&KI'7VBH,4S=CF[VR-^*X<0M2BQE%26CY!-K
MBBW6CK'EOQG;]:$B"XQ-'/TKCM;\IO2WKX<5V"I#9KI66:Y05]MG?!50NUF/
M;Z#T@]"M5HQQW28SM>9U(+I !X13Y_;;TM/FW=!//9V"Z?CAW?L65%^_\,N9
MVB(BK22$1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$
M1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0$=Z??>VK?GH?7"JRK3:??>VK?GH?7
M"JRNBV5X+]2MR^_[!$169&"LGR;/S'KO\0?^SC5;%9/DV?F/7?X@_P#9QJNV
MGX#]42,7Q"5T1%S99A$1 $1$ 1$0!$1 :?&-K-ZPK=K<SW2HIGL9G\?+Q?/D
MJ7R,='(YDC2U[26N:1D01P5Z% NFK1I4.K9\08>@=-'*=>KIHQFYKN+VCB#O
M(Z=O9:[,R8UR=<O,B95;DMY>1!Z(1D<BBZ KPNVT,V>2[Z0;6&M)BI'^%2NX
M-#-H\KM4=ZY6T6NMO%?%16RFDJ:F0Y-9&,SVGH'65:?15@:/!EF<)RR6Z5.3
MJB5NX9;F-ZAYSW*#G9,::VO-F_'J<Y:^2.W1$7,%H$1$ 1$0!$1 $1$ 1$0!
M$1 $1$ 1$0!$1 $117IUQP;#:?8:VRZMSK6>.YIVPQ'83VNV@=YZ%MIJE=-0
MCYF,YJ$=YG"Z<-(1O%7)8;/-_-D#LIY&'W=X.[]$'RG;P"C3#]EKL076&W6J
M S5,IV ;FCBXG@!TKQM%MJ[O<J>@MT+IJJ=P8QC>)^X<25;'1M@BCP99Q%'J
MRW"8 U-1EM<?BCH:/]5?6VUX%2A#G_O%E?"$LB>\^1Y:., 6_!M""P-J+I(W
M*:J(V_HMZ&^GCU?<>:0[/A"(QU#_  JXD9LI(B-;J+C\$=NWH!7&:5M+3;:Z
M:T87D;)6C-DU8-K8CQ:SI=U[AV[J^U$TM1/)-42/EFD<7/>]Q+G$[R2=ZB8^
M#/(?:WOF;;+XUK<K.MQII$OV*WO95U)IZ$G920$M9E\KB[O\RX]$5U"N-:W8
M+1$*4G)ZL(B+,\"(B (B( O2FGEIIV34TKX9F'-KXW%KFGI!&Y>:+P$OX%TT
MW"W.CI<3L=7TF[PAH F8.O@_S'K*GRQWBWWVWQUMIJHZFF?N>P[CT$;P>HJD
MBWF$<4W3"MR;66F<LSRYR)VV.4=#A]^\*LRMFPL^*O@_T)562X\)<47.1<GH
M^QQ;L96[G*4B&NB Y^E<?&9UCI;U^5=8J"<)5R<9+1EA&2DM4<MC[!%LQC;C
M%6,$59&#S%4P>/&>@]+>KT*JV+,.7#"]WDM]UBU)&[6/&UDK>#FGB%=)<YCO
M"5!B^ROHJYH9,W-T%0!XT3^D=(Z1Q\BG86<Z'NRXQ^QHOH5BU7,IPBV6([)6
MX>O%1;;G%S=1"<NIPX.:>(*UJZ1-26J*QK3@PB(O0%L,/WFML%VI[C;)3%4P
MNS!X.'%I'$'B%KT7C2:T83TXHN/@+%='B^PQ5])DR8>)409YF)_$=G$'H71J
MGNCK%U3@_$$=;%K/I9,HZF$'W1F?I&\?ZE6ZMU;3W&@IZRBE;+33L$D;V[B"
MN8S<7\//AW7R+2BWM(\>9D(B*$;PB(@"(B (B( B(@"(L&NO%LM^?A]QHZ;+
M^VF:STE>I-\$-=#.1<S-C["D1(=B"VG+XLX=Z%\BQ_A24Y-Q!;A^E,&^E9]C
M9_:_\&._'J=.BU]#>[5<"!07.BJ2>$,[7^@K8+!IK@S)/7D$1%X B(@"(B (
MB( B(@"(B (B( BQ*JYT%(<JNNI8#T2RM;Z2OQ37BVU3]6FN-',[HCG:X^8K
MW=>FNAYJC.1$7AZ$1$ 1$0!%@UEYME$XMK+C14[APEG:P^<KRI\06:H=JT]W
MM\KNAE2QQ\Q66Y+GH>:HV:(TAP!:00=Q"+$]"(B (B(".]/OO;5OST/KA595
MIM/OO;5OST/KA5971;*\%^I6Y??]@B(K,C!63Y-GYCUW^(/_ &<:K8K)\FS\
MQZ[_ !!_[.-5VT_ ?JB1B^(2NB(N;+,(L6MN-#0_TVLIJ?YZ5K/25CTU_L]4
M\,IKM;YGGX,=0QQ\Q62BVM=#S5&R1!M&Q%B>A$1 $1$ 1$0'*XBT?89Q!*Z:
MX6N+PAVTS0DQ/)Z26Y9]^:T$.A;",<H>^&LE;\1]0<O, ?.I)1;HY-L5I&3T
M]3!U0;U:-98</VJP4YAL]!!2,/MN;;XSNUV\]Y6S1%J;<GJS))+@@B(O#T(B
M( B(@"(B (B( B(@"(B (B( B(@"(B UN([Q36"R5ETKG904S"\C/:X\&CK)
MR'>J<8@N]7?[U57*N<7U-2_6(&X=#1U 9 =BE?E&8I-3<:?#M*_\C2Y35.1W
MR$>*WN!S^EU+!T!8+%XNSK[<(]:AH7Y0M<-DDV_/L;L/:1UJ]PX1Q:'?/F_]
M7^2!<W;9V<21="V FX9M0N5RB'LQ5L!(<-L$9VAG:=Y\G#;SFFS24ZE,V'L/
MSY3[65E2P[6=,;3T])X;M^>73:9\=_P6M H+=(/9BL:=0C?"S<7]O =YX*KS
MG%[BYQ+G$YDDYDE>8>/+(F\B[V/;K%7'LX'Q%EVBV5EWN$-#;:>2HJI3DR-@
MVGKZAUE6%T?:'+?:61UF)!'<*_8X0;X8CV?#/;LZN*L,C*KQUK+GT(U=4K'P
M(5PK@7$&)R'6NWO-.3D:B7Q(A]([^[-2G8] D0:U]]O#W.XQ4;,@/INSS^J%
M.#&-8QK&-#6M&0 &0 6CO&,,/6=SF7*\T4,C=\?.!SQ]$9GS*FGM&^UZ5K3T
MXLFQQJX+61SE#H?P=3- DM\M2X?"FJ'Y_9("SCHPP<6ZOL%!E^F_/UEA3:7\
M&1NR%SDDZV4TF7G:O>CTK8-JG!K;PV-Q_M89&#REN2TO\9S>]^IFNQY+0PZ_
M0W@^J:1%1U%(3\*&H<<OK9A<5?M LC6N?8;N'GA#5LR^VW_*ILM=VMUUBYRV
M5U+5L&\P2M?EVY'8LU8QS<BM]Y^YZZ*Y>13'$V$KWAJ74O-OF@83DV4#6C=V
M.&SNWK1J\U33PU4#X*F*.:%XR?'(T.:X=!!4+:1-"\,S):_"($4P\9U"YWBN
M_0)W'J.SL5IC;4C-[MO!]?(BV8KCQCQ("1>E53S4M1)3U,3X9XW%KXWMR<TC
M>""O-6I$"(B]!G6.[UMCN<%PM<[H*J$YM<WCT@CB#T*U^C?&M)C.S<_$&PU\
M.3:FGS]H>D=+3P\BJ$MSA#$5;A:^T]SM[O'8<I(R?%E8=[3U'S'(J%F8BR(\
M.\N1NHN=;^A=%%K,-7NCQ#9:6YVY^M!.W/([V'BT]8.Q;-<PTXO1EHGKQ1P.
ME[ [,6V,S4C&B\4C2Z!VXR#C&>WAT'M*JH]CHWN8]I:]IR((R(/0KTJN?*"P
M>+9=67^@CRI*YVK4!HV,FWY_2&WM!Z5;[,RM'V,O8AY57#?1$*(BO2"$1$ 4
MU<GO&9IJLX:N$OY"<E]&YQ]J_>6=AWCKSZ5"J]*:>6FJ(IZ=[HYHG!['M.1:
MX',$+1D4J^MP9G7-URWD7F1<UHZQ-'BO"M)<06BHRYNH8/@RC?W'81U$+I5R
M<X.$G&7-%O%J2U01$6)Z$1$ 1%BW5U0RUUCJ+(U387F+/X^J=7SY+U+5Z T&
M*\>X>PQK,N5>QU4W_P!-!^4E[P-W?DHDQ%IVN$Y='8+=#21[A+4'G']N0R \
MZAR>62>:26=[I)9'%SWN.9<3O)*_"Z.G9M-?&7%E9/*G+EP.AO.-<27DN]D+
MS62,=OC;)S;/JMR'F7/$DDDDDGB413XPC!:16AH;;YA$19'@!R.8WK?67&.(
M;*YOL;>*R)C=T9D+V?5=F/,M"BQE&,EI):A-KD3CA#3G*'LI\4T;7,.SPJE&
M1'6YG'NR[%-MIN=%=Z"*MME3'4TL@S;)&<QV=1ZBJ0KJ='^-+A@ZZB>D<9*.
M0@5%*3XL@Z>IPX'[E5Y6S836]5P?3R)=64UPGR+@HL&Q7:DOEIIKC;I1+2U#
M=9IXCI!Z"#L(6<J%IIZ,L$]>*"(B\! NF;2)?[1BV6TV:K\"IZ>-A<YL;7.D
M<YNMGF0<AD0-BX5FE7&C!LOC^^"(^EJVG*$BYO2)*[^TIHG^8C[E&JZ?%HJ=
M,6XKET*NVR:F^)W+M+.-#_[T1V4T/^5>/\:&,N<#_9V?,<.;CR\FKDN,12/P
M]*^1?X1K[2?5EK]#V,I\88>EDN#6"X4DG-2E@R#P1FUV7#/;LZEW;B&M)<0
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M+C&E-/4AE->86YR0@^+(/CLZND<%29>SY4?''C'[$ZG(5G!\SOD1%7$D(B(
MM?B"Z0V2R5URJ3^2I8G2$?&R&P=I.0[UL%#G*1OO@MBH;-"_*2LDYZ4 _P!6
MS<#VN(/T5NQZNVL4.IA9/<BY$'0QU^*\3A@_*W"XU.T\-9QVGJ \P"M@T6W
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MR3W-W8J,2^Z/[2KSR>YN[%1B7W1_:5;['^?V_<AYGD?E$179""D+0)[Y=O\
MFIOV;E'JD+0)[Y=O^:F_9N4?*\&?HS.KOKU+4(B+DBX.1TM7(VK1[>IVNU9'
MP\PWISD(9Z"2JAJR'*2K.9P=0TK3D:BL:3UM:UQ])"K>NBV5#2ERZLK<MZST
M"(BLR,%8[DU4?-81N%41XT]86Y](:QOWN*KBK7:#*7P;1I:R1DZ8RRGOD<!Y
M@%6[4EI1IU9)Q%K,[Q$1<X605*\74(MF*;O1 9-@JY8VCY(<<O-DKJ*INFRF
M\%TEWD 9-D,<HZ]:-I/GS5MLB6EDH_0B9B^%,X=$17Y7A27R>[B:/2#'3DY-
MK:>2'+K UQZI\JC1=%HYJ_ <=V&?/("LC:3U.=JGS$K3D0WZI1^AG6]V:9<A
M$1<@7!"7*=E(M]@AX.EF>>X-'WE9?)F8!AJ[OXNJPWR,'XK%Y3L9-ML,G!LT
MK?*&_@LODS.!PQ=F\16 ^5C?P5N__P ]>O[D-?F/]Z$#XEE,^([K*3F9*N5W
ME>5/')F _@Q=CQ-8!]AJ@*] B\UX.\5$@^T5._)DE!L=[BXMJ6.\K<ON4W:"
M_P"L_8T8WBD;Z<*@U&DN[[=D7-1CNC;]^:D'DQ4@%%?JPCQGR11 ]@<3ZP48
M:6=;^,:_ZXR/A'FR&7F4M\F9P.&;NT>V%8">PL'X%:\KX<))=$95<;W[DQ(B
M+GRQ.?QOBJAPA97W"X:SR3J10L]M*_H'1NVG@HRP]IVAJ;HV&]VQM)1R.R$\
M,A>8^MPRVCK'D7[Y3-OJ9;79J^,.=2T\DD<N6YI>&ZI/U2/)TJOZN\+"IMIW
MI<6_T(-]\X3T1>>"6.>&.:![9(I&AS'M.8<#N(/0OVJZ:$](_L/-'8;Y-_-L
MCLJ>9Y]P<?@D_$/F/5NL6-HS"K,G'ECSW9>Q*JL5D=4$1%'-A!_*=I0:6PU8
M'C-?+$3T@AI'H*@56%Y33@,/V9GPC5.([F?ZJO2Z;9KUQU[_ '*O)\1A6 Y,
M=076J^TV>R.:*0#])KA^Z%7]3OR7P>;Q&[AG3C]HO=HK_KR]ON,;Q$3FH-Y3
MT(YG#TV6T.G9G]0_<IR4(\IUX%%A]F>TR3'R!GXJEV?^8C[_ &9-R/#9 :(B
MZ@JPB(@)OY,,N57B"'/8YD+\NPO'WJ>U7WDQY^S-\^+X/'G]8JP2YC:/YB7M
M]BTQO#04/\IB$.PK:IN+*W4^LQQ_=4P**>4GE_ 2CSW^R,>7_3E6O">E\?4R
MO\-E:T1%U94A$1 $1$!;[1-)SNCFPN/"G#?(2/N76+CM#HRT:V+/^R=Z[EV*
MX^_Q9>K^Y<5]Q!$1:C,+XXAK2YQ :!F2>"^J'.4#C1UNH6X=MTI;4U3->J>T
M[61'<WM=MSZAUK=13*^:A$PLFH1WF<MI>THRW>:>S8>F,=L:2R:H8<C4'B >
M#/3V*(41=333"F.Y J9S<WJPB(MQB$778+T>W[%F4M!3B&BSR-54$MC[N+NX
M*5+7H$MS& W6\5<S^(IV-C'GUE%MS*:GI*7$VPIG/BD5]16$Q%H-M#+34RV:
MMKF5L<9>QL[FO8\@9Y')H(SZ57M949->0FX>1C95*OO!$12# *=^2^?R>)!T
M&G/[100ISY+Y\?$@Z13']JH.T?R\O;[HW8WB(G=$1<P6I7CE,C_:*SGCX([U
MRH<4R<IG\X;/^JN]<J&UU.!^7B5-_B,(B*8:@KNV096:@!WBGC'V0J1*\%J&
MK;*,=$+!]D*FVORA[DW#YLRD1%1DXY32O[W5_P#U8^D*H"M_I7][J_\ ZL?2
M%4!7^R/"EZE?E]Y!$16Q$"GODPC^28A/RX!YGJ!%/O)A'\WX@/3+"/,]0=H_
MEY>WW-^-XB)M1$7,%H%332#^?6(?U^;UW*Y:IMI$ &/,0@?W^;URK?9'?EZ$
M/,[J.>1$5\0 I.Y.QRT@GKHY1YVJ,5)7)[.6D2(=--*/,%&R_ GZ&RGOHM B
M(N3+<CO3[[VU;\]#ZX565:;3[[VU;\]#ZX565T6RO!?J5N7W_8(B*S(P5C.3
M0W+"=T=TUI'_ -;?Q5<U9#DU#_8RX'IKW?LV*OVGX#]B1B^(2TB(N:+,*'.4
MS2Z^';159>Y53H\_TF$_N*8U%7*/J&1X&IH7 %\M:S5ZLFO)/W=ZE8+:OCH:
MK_#96I$1=65(1$0%OM$[B[1U8"?[L!Y"0NL7)Z)VZNCJP _W8'RDE=8N/O\
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M_ J7^[0?],)X%2_W:#_IA9"+W5GFAC^!4O\ =H/^F%^HZ6GC>'QP1,<-Q:P
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M $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$
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M1+57TQ7+$+)*2U[',A/BR3C]UO7O/#I4@:.M$-OL)BKKZ8[A<QDYK,LX83U
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M5-=DLUOL=$VDM-)%2T[?@QC+,]).\GK*ST51?E67OXV3*ZHU]U!$11S8$1$
M1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$
M1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$
M 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!
M$1 $1$!J;EAFQW,DW"SV^H<?A24[2[RY9KEJ[1#@^KJ'3>Q\D!=O9#,YK>X<
M$1;87V0[LFC!PC+FC%.A;".?N-8/_P!@_@OR="F$L_:5W_<?Z(BS_%W_ -[/
M.QAT,NU:(<(V^H=*:*6K)&0;4RE[6]PR\^:["V62UVIH;;+=1T@_Y,+6'S!$
M6$[K+.])LRC",>2-@B(M1D$1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1
M$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1
M $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$ 1$0!$1 $1$
01$0!$1 $1$ 1$0!$1 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g377490g90w94.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377490g90w94.jpg
M_]C_X  02D9)1@ ! 0$ Q0#%  #_[1WZ4&AO=&]S:&]P(#,N,  X0DE-! 0
M     " < 5H  QLE1QP"   "   < E  #$%L:7-H82!,86MR83A"24T$)0
M    $&]:J?1&070!% DVXCZC3JTX0DE-!#H      .4    0     0
M"W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T
M26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT
M97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0
M '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P     0    !"
M;'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P
M   "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#
M<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O
M;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;
M16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $       !2
M1T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B0&_@
M        0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M      !";&0@56YT1B-2;'0               !2<VQT56YT1B-0>&Q :*SM
M8         IV96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P
M  !09U!#     $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L
M=                %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N
M4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R
M;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M  MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ #%9VP  0 " ,5G
M;  !  (X0DE-!"8       X             /X   #A"24T$#0      !
M %HX0DE-!!D       0    >.$))30/S       )           ! #A"24TG
M$       "@ !          (X0DE- _4      $@ +V9F  $ ;&9F  8
M  $ +V9F  $ H9F:  8       $ ,@    $ 6@    8       $ -0    $
M+0    8       $X0DE- _@      '   /__________________________
M__\#Z     #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M.$))300(       0     0   D    )      #A"24T$1       $     (
M  )    "0      X0DE-!!X       0     .$))300:      -!    !@
M           "<@  !#     & &< .  Y &X .  Y     0
M           !              0P   "<@                     !
M                     !     !        ;G5L;     (    &8F]U;F1S
M3V)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F
M=&QO;F<          $)T;VUL;VYG   "<@    !29VAT;&]N9P  !#     &
M<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC
M94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T
M   ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T
M   *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"
M=&]M;&]N9P   G(     4F=H=&QO;F<   0P     W5R;%1%6%0    !
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M3001       ! 0 X0DE-!!0       0    $.$))300,     !-^     0
M )\   !=   !X   KF   !-B !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O
M8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,
M# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4
M#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,
M# P,# P,# S_P  1" != )\# 2(  A$! Q$!_]T !  *_\0!/P   04! 0$!
M 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&
M!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q
M0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$
MP]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G
M]Q$  @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A<2(3!3*!D12AL4(CP5+1
M\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C
M\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!
M  (1 Q$ /P#TL^@V@Y666[8WN=9]%K3KMA\;=O\ 4]_YZKGJ?U?/.1C:\^YG
M?=_Y-ZCU;_Q/7Q_W'_AY+B#RKG+\N,L9$R(HUHT><YR6"<8QB)6.+5[D]4Z
M9G(QC,S[F=]T_P#GRS_MQ+]J= Y^T8W^<SS_ /)+B:6"RUE9>*P\@%YX'\H_
M11OL+N!DXQ[Z6CO_ &5*>3QC><FN/B6:0L8XGH]A^U.@?]R,;_.9Y?\ D4AU
M3H B,C&$1'N9VVQ_Y[K_ ,Q<<W"+FR,G'$;I#K-I]KBS3V^[?MWL4_V>2Z&9
M6,6GAQL#=)V^YL.V.UW;$/NF+]^2?](9_P#-1^W_ -">N'4_J^(C(QM./<SM
MM_\ (,2_:?U?X^T8WWL^"X9).^XP_?DL_P!*Y/W(_B]Z_,Z,VIEUEM JNW>F
M\[=KHW-?M/YW\X__ #T,]4Z 9G(QC,S[F=]T_P#GRS_/7,9W_(72/C=^4K-3
M8<G&0),I;R'^++A7Y/B62,@!".L82Z_IPC/_ +I[G]J= Y^TXW^<SXI?M3H
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M+@TUZ $ ;&:_0]J?[?( =B8S@T^T&O0"2_8 '?0W.6K^U_JQ_P"51_[:I_\
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M #G5?AC_ /NRMSZW&?J=F&9FAFLS^<SONL_\^6+#_P 6'\YU7X8__NRK</\
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MSW;/<M))0@QK6-_5=KW<YW6"V0<'+)&A J![3RU^U,>M .#3A90+R6LFN 2
MY\<_R$W_ #=Z7N<\L<;'F2\O=,DRZ-=C?4^C9[?>M"JMM53*FR6UM#1/, ;4
MXG'T!/X('$UL/J#LJPL.+?0 W=OM;M;,_0&JYCZJ_P#BU^L7]8?]4Y=FN,^J
MH/\ ST^L7]8?]4Y/QD<&:A7H'_3BB6\//_N9/3,R;G=7MQI/HLH8X"!&\N=N
M,_2^CM7G?^,"/^<[YF/0IF.8FQ>F-QJ6Y#\D-_2V -<Z3PWZ/M^BO,_\8'_B
MF?\ ^%Z?RVJ3DR#ET_<6YOD^KSKMD^S<!_*()G^R&H=W\T_^J?R*:A=_-/\
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MZL(!W^JPW:-GV-;)&Z#_ #CM/[/L_P"FCJ@6=2222"G_V3A"24T$(0
M5P    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !0
M00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  (  R #  ,@ T     0 X
M0DE-!"(      4I-30 J    "  ( 1(  P    $  0   1H !0    $   !N
M 1L !0    $   !V 2@  P    $  @   3$  @   !\   !^ 3(  @   !0
M  "= 3L  @    T   "QAVD !     $   #     [    ,4    !    Q0
M  %!9&]B92!0:&]T;W-H;W @,C4N-" H5VEN9&]W<RD ,C R-3HP,CHP." Q
M,3HP-3HT,@!!;&ES:&$@3&%K<F$      Z !  ,    !__\  * "  0    !
M   $,* #  0    !   "<@         & 0,  P    $ !@   1H !0    $
M  $Z 1L !0    $   %" 2@  P    $  @   @$ !     $   %* @( !
M  $              $@    !    2     $X0DE- _T       @
M /_A 5)%>&EF  !-30 J    "  ( 1(  P    $  0   1H !0    $   !N
M 1L !0    $   !V 2@  P    $  @   3$  @   !\   !^ 3(  @   !0
M  "= 3L  @    T   "QAVD !     $   #     [    ,4    !    Q0
M  %!9&]B92!0:&]T;W-H;W @,C4N-" H5VEN9&]W<RD ,C R-3HP,CHP." Q
M,3HP-3HT,@!!;&ES:&$@3&%K<F$      Z !  ,    !__\  * "  0    !
M   $,* #  0    !   "<@         & 0,  P    $ !@   1H !0    $
M  $Z 1L !0    $   %" 2@  P    $  @   @$ !     $   %* @( !
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M*"@H*"@H*/_  !$( [<&70,!(@ "$0$#$0'_Q  <  $  @(# 0
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M1K=B.MFB>4Y034JJ>Z*701AE\VRNJK5M),.H1V4W#]+C2B._!O?$:BN2V_\
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MUF6I3XF')2!-SZ*FK#C*B-5/\3?6:-\LZ5/]VJ1TC?\ /+0!%.LH*V5/K_\
M1*&9WNT8K#$>KS%)AQ,0RL&5J"K\Z%!6[43_ !.Y]Y@L85#&LK4&LPO2)&=E
M-7-\=Z(J+ERQ&\^XW(&,:B4LV5=/(EQNK7*UE*QI.=,0VS.'*4R"J_.<V(VZ
M)TQ9$57I">L-$6(C5U47>NX^@34J*=K12Z",<OG<K2;K&D]LU&;+8<I3X"/<
MD-SHC;JV^2K^&Y#.8-G\934[%;BJDR,E+(R['P'HJJ[++*([GW&W@RE74HVR
M)>_^2%3:=\S,/BJ8K4M2GQ,-RD";GT5-6'&5$:J?XF^LT?Y9TJ?[M4CI&_YY
M: (IUE!6RI]?_HE#,[W:,7AF/5IBDPHF()6#*U!?IPH*W:G_ '.]9@,7U#&T
MK449ABCR$Y)ZN<2.]$=?+EB-Y]QN8,8U%&6;*GZ>1+C=6N5M)5?2:^:A-F\.
MTID!5^>YL1MT3IE+&C*](,182(Z(C5U478J[C[!-2HIV_2ET$8Y?.Y6DU6-)
M[9F*V7PY27P4>J,<L1MU;?)?]-R&>P;/XPFIJ*W%5*DI* C%5CH#T55==+)E
M$=SFV@RE74HVR)>_^2%3:=\S,-BR8K<M2G1,-2<"<GKI:'&5$;:^>US=W.:1
M\LZ5/]VJ1TC?\\M $4ZR@K94^O\ ]$H9G>[1C\/Q:C'I,")6Y>%+U!47A84)
M;M;FMK9KNMO-;Q=4<;RM21F&:-(3DEJ_Z2.]$=?RQ&^HW0&,:BC+-E3]/(EQ
MNK7*YI56TDQ*A 94</4N%**Y$BO9$:JM;RI^&7U%AQUB) B+!:CHJ-56(NQ5
MMD?8%2HIN^5+H(QR^=RLYFL:4&S$5(&&Z2Z"CE1CEB-NK;Y+_IN0V+!<]BV;
MBQTQ92Y.1AHW\&LNY%UERVV>[G-J!G*LI1MD2]_\D*FT[YF87%LQ7):ENB8:
MDY><GKI:''5$;:Z7VN;NOO-)^6=*G^[5(Z1O^>6@"*=905LJ?7_Z)0S.]VCH
M4&+4(U)EXE:@0Y>H.1>%A0UNUJW6ULUW6WFLXMJ..):IZF&:-(3DEJ_Z2.]$
M=?RQ&^HW4&,:BC+-E3]/(EQNK7*[I%6TD1:C+LJ>'Z7!DU>B18C(B*YK=ZI^
M&7U&_P TZ*V6BNEFH^,C55C5V*NXY034J*;3RI=!&.7SN5G'K&E!(\1(.&Z2
MZ$CE1BK$;=4OE_KC8\%SN+)M\PF+*9)R+6I^"67<BZRY;;/=SFT@RE64HVR)
M>_\ DA4[.^9F!QA-8@E9!C\+R,M.S:N^<R.Y$1$RY7-Y]YIORSI4_P!VJ1TC
M?\XM "%905LJ?6_^1*%W>[.C0HL_&I4O$K$"'+S[D7A8<-;M:MUM;-=UMYJF
M*:ECR7JKX>':)3YN01OS8D9Z(Y5NO_-;NMN-Y!A"HHR<LJ9+C=6N5W1JKI'B
MU.795</TR!).>B18D.(BN:V^:I^&7U&_S;HS9:*Z68U\=&KJ-=L53E!,ZBFT
M\J701AE6^Y6#JSI31RZN&J0K;Y+PC?\ .-GP7.XJFUF.RRF2<BC?]%\7<BZW
MAL]W.;0#*==25LB7O_DA4VG?,S 8QFL0RLC#=A:0EIV:5WSV1W(B(F7*]O/O
M-.^6=*G^[5(Z1O\ GEH 0K*"ME3ZW_R)4VW>[.E1(D]&I<O$J\&' GG(O"PX
M:W:U;KLS7=;>:EB>IX]EZK$AX>HE.FI!$^;$C/1'*MU_YK=UMQO0,(5%&3EE
M3)<;JURO:+5=(T6J2S*M0*9 D7/1(L2'$:KFMOFJ?A5W<RF^3CHS)6*Z58U\
M=&_,:[8J^@Y@)U%-IY4N@C'*K7N5@M9TIW6V&J1;=^$;_G&T8+G,53:3'993
M921U;<%\7<BZWAL]QLX,YUE)6R)>_P#DB--IWS,U_&4UB*5DX3L*R$M.S*N^
M>V.Y$1$\KV^LT]*SI4OGAJD=(W_.+0 A64%;*GUO_D2IW=[LZ='B3L6FP'U2
M"R#.JGX2'#6[6K==F:[K;S4,35/'TO5HD/#]#ITU()]")&>B.7-?^:WFW&]@
MPA449.65,EQNK7-!P]5-(4>K0(=<H5-EI!7)PD2$]%<U+[OPJ^HWB=='9*Q7
M2C&OCHGS&NV*OG0Y@)U%-WRI=!&-E:]RK_EG2I_NU2.D;_G&VX+F\2S<"97%
ME.E9&*U6\$DNY%1R9WO9[N;DVFQ@SG64E;(ETO\ Y(C3L[W9KV,IO$<K*0G8
M5I\K.S"NL]L=R(B)Y7M-12LZ4[I?#5(M^\;_ )Q9X$*R@K9$^M_\B5.[O=G6
MICYJ)3Y=]0ALA3;F(L5C-C7;T3-?6:9B2IX_@5:+#H-#ITS()]"+%>B.7-?^
M:WFW&^ PA447?*GU)E&ZM<T'#E4T@QZM!AUVA4V6IZK^$BPHB*Y$YOPJ^HW>
M?=,,DXKI-C8DPB?,:[8J^=#G G44W?*ET$8V5KE7_+.E3_=JD=(W_/-NP9-X
MDFY:8=BNGRLE&14X)LNY%1R9WO9[N;SFQ SG64U;(ETO_DB--IWNS7,93>)9
M6!"7"M.E9V*JIKI'<B(B9\KV\QJ;:SI3UDOAJD6OG^$;_G%G@0K**MD3ZW_R
M)4VW?,SKTY\S$D)=\_#;"FW,18K&;&NMFB9KZS1Z]5-(D&JQX=&H--F)!%_!
M1(D1$<Y.?\*GJ+ !A"HH-O*GU)E&ZM<T/#=3T@1ZM!AUZATZ6IZ_Z2+">BN3
MP?A7>HW&K1)R%3H[Z9"9&G$;^"AO6S7+SYIZSM@3J*4D\J0C&RM<J_Y9TJ?[
MM4CI&_YYM^#)O$<U*QG8KI\K)1T5.#; <BHJ9WO9[N8V$&<ZRFK9$NE_\D1I
MV=[MFLXTG,42C("X4ILI/.5?PB3#D353/9=[>8U9E9TIJY-;#5(1M\_PC?\
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M'%+2\&5A)"EH4.##38V&U&HGD0Y0#7+0
M
M
M
M                                  #7<3X/I.(N#=.2[6QV.1R1H::K
MU\J64S4"'!I\A#AJ_5@0(:-UGNV(B6S53L&-Q'285;H\S(1GN8V,U6H]JV5J
MVV^DL4W*T9/8894KR2VF18YKVHYBHK5V*A)5&CVO3F':P[">(G+K(JK*QES1
M4M>U_P#$6N95J+I2L]WD*<U-7  *3,
M               &#Q7AJ4Q++0($\^*D.#$1Z-8J(CLT6RY9[#[QC66X?PW.
MU);*L%J:J+O57(U/2J'#@2HS]6PS)SU58QDQ'8D3YJ616JB*BV\I;",X1TL=
MFVQA)QD\C,W*P(<M+0H$%NK"A,1C4Y$1+(<@!49@
M
M
M
M                                                &*JV'Z;5IR5F
MI^69%C2ZW8JHB\N7I,J"NJ57JA):4)^D5685\M-,X261RJC6-17JEKK:ZY%T
M(2JI[?I17*2@^I8H *2P
M     T/2Y3ZE5:93Y&FRL68A1IAOQC42Z-8BHMU\QNE-E62-.E92']"!"9";
MX&I;^ASJYJ.1JJEUW7)+)5&X*'DC!02DY<0 "LS
M
M
M
M                                                !H6/<)U"JXAH
M]3H[X,.- <J1G1'*EV99)9%YS?3IU>J25'D7SE3F&2\LQ41T1U[(JK9-A;1G
M*$KPWF$XJ2M([B;,]H.*4F84Y*09F6>D2!&8V)#>FQS52Z+YCE*MQF
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M?W=3J$0)O(\)*;#:-% !-@N $Y1Y1L  Y1OS"A  GI"J2I&X$@<J*!OY@0/
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ML]IYI-E-VTN+;$L'Q5OM/-)3;<];@O AT/G_ &G]U4Z@A"0;1HC8BCP C/>
M3ZPOA 3, ;B$WV)VA !89W&X7 &P;0N9'+< G8@3G'@";,P!8)M5!?,<P 3>
M 0B7 )3?R BUCE@P(T=52!"?$5-J,:J^H;B4F]B./;<(<T:4F(+5=&EXT-.5
M[%1#A\(33W!IIV8]8MD1;(G8F6P$#PD;B<Q_0 !5(Y2?* .4@D ! 1RW)1=O
M(  FQ2#[8QT1R-AM5SUR1K4NJ@(^4LFT)M6QR1I>- 5$CP7PE78CVJESC79M
M"=R;-;Q;/G'K V(""$Y"1M0 (6"9!-_(<TG*QIR.V#+0W1(CMC6ANRNR4KNR
MWG#RC>9FJX:JU*E4F9^5X*"JZJ.X1KL_ BWW&%W\YC"<9J\7=&52G.F\LTT_
M4E,U";QLV#.ZW,C (-PL-X '+RB^2V&0 WD$A0"-W,$RN+$@6 MGM V@#<H\
M(38  !NV!,D &T+S#<+  <I"H2FSF  M9 1X,P"=P0(-V0 W<A.9  &X(+W&
M]  ,AN(3*X!<FB?M6=XP_P!2&Y&FZ)^U9WC#_4AN1Y'&>//J?0>S?M:?1 J+
M2]VR2WBC?;>6Z5%I>[9);Q1OMO-CLO[C\,U.W/M'U1H_.,AZ"-QZ8\23NVA"
M"?" $ "9IF !;D(4FP!&T;MI.Q%(R!!.\C>2/,"0@\@'+=0",N0<MB;"X!&W
M(FRVR&S</6 1;G)3PC/RA ""1L"* $";^4A%Y";[@!8@E/"-P!'/<DBY** @
MNP;K#>  B!$ \H)'D()0<H("><;+A!?< 1X22+YC=R@$IF$O<>7(C+.P SSY
M!L)0( 0B;24YQO\  .4 C.Q(1;A !O&PA24  3>-VP;=X 39F$WV(Y24 %K)
MRD'TA%L@+!"-]B2.6UP"=HWA,KA%2P "["+*J+F2 -V8MM"H/" +K;,"_(-P
M)";;"XY1L0$$7R)OM"6WCU $*2@R1!N (W[03YR+> $$CR@77R DA-Y-L@ #
MT#A3M9I/BL+V4,H8O"G:S2O%87LH90\95^N75GTG#^%'H@ "LM   !K.D:@3
M6)L*S%,D8D&''B/8Y'1E5&_-<BKL15]!LQT*[6)&A4Y\_58_ 2K%1KGZCG65
M5LF3453.FY1FG#>8R2<6GN(PY(Q*9AZER$=S'1I65A0'N8JJU7-8C55+[LC(
M'#(S<&>DI>;E7Z\O,0VQ8;K*FLUR71;+FF2G,8R;;;9*W;  ""0
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M5NMRV6Q=V>XQE4AYW?L:_:RG.%*K>\<J7Y.CN06R!%\^8Z9Q"5\(1,MH(O<
MD)SD<H]8!.X!-X\  ]0M?(6R%\@ B!!_4( -UR"4R\ 0 )S#=SC80B@$IX2-
MFPE @!Z!PIVLTKQ6%[*&4,7A3M9I/BL+V4,H>,J_7+JSZ30\*/1  %9:
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M\)'@)5+$<IZ8\23N&X!+H 1FJ#F)VD)S $C<+D)MS "D^L96"[  B!0FP<J
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M0Z'S_M+[NIU)O=%%\KBUAN-HT2";9Y#<H0 *N80  )FH";-XW@(;"-FTG)5
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M@9>4 A,MY/E!"6\H!("!.8 !$"D6S )(0FVT ! EQM4(H  VC*X OR#<!L0
MN/1/VK+XP_U(;D:;HF[5G>,/]33<CR.,\>?4^@]F_:T^B!46E_MDEO%&^V\M
MTJ+2_P!LDMXHWVWFQV7]Q^&:G;OVCZHT?*PV[!8> ],>)&X(%  !&^Q*6 1'
MH)3>02 -F\$;R;YY $;R4";  -Q"^$FVWG&S: -W@()N-J@ $$@ )D03N (M
MRD@)<!#U$)<> GE4 (+9 ;  +YC?L"@#RD( FW( GF&[G N /"/ ,PNP !"
M@%R=BA-X15N-X W #< $RWYD  !-I*( FW( A-J\I-^91O(3>!N";24(L2 @
MGA&Q".4G=S@$$J-@V[P @(2Z$[MH"9!*KD$7, #EY!>Z C< 2NS(9ANP@ G<
M.8A.920"$R)(3,E $$7: @1,P F\G<18@ E-]P@"  ;AM10G, $\(&_D&W8
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M!*^D>H@E  $MF+9C< .46"^ 9@$$WY!8;@ ""4W@$$WMD$R&P!!+;M@\ W
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M4(@V  A-A.T)R   C;< >DGE"<@Y0 $V*$";%N -VP;B+D@$;MI*;%";PG,
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M@O<;@ B9!"+D@!-BY#9<<MB%7,"Y)";[A=Z$ID 0@W9DH0 @E]Y)"6NHSMD
MB1ZPF:D66X!*7'* F=^4 )R#>HY0E@!L(\*$V\P "6V!-F8L+[K@#80G+<G9
MM  2]K(!M&X )X1;D&X>H (N68V"UQR@ )D$ "";U&_F&V]PF_, #U#:B@
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M )W#8F6P7"^@ (@&[F(V $I87"BWG ";^4;E'K  0CU$D(N8!.ZPV!$R'+R
M!5LF0\(W*0EP"=]AZAF "$Y%)V>$>4A/" 3F$(38I/* 1:RDCGN$S  S06VD
M)D 2@79F-W@ !">DD#/.X 2V9&6=B<\^0@ D7\PY+  <M@FT7Y!Y0"%)0"X
M39F-B<P1=H (2]B=@RL/ !8)F02@ "*-Q!/* /(,B!NR )LMU"#;< #RA @3
M:H!&XG(  ;=@1<ALV  )L'A0>$)L (7E):/ /* !L"#EN -]P@0;@"+7N2F8
M0;-@ WD;\QO4E$S4 N/1/VK.\8?ZD-R--T3]JR^,/]2&Y'D<9X\^I]![-^UI
M]$"HM+Z?_DDMXHWVWENE1:7^V26\4;[;S8[*^X_#-/MW[1]4:-D2@7,)L/3'
MBAS(-V8"; !NR&>X>$)L4 <HMYP$L -PN,QL3E "HHWCRC;F /2-Q&PG( (F
M04)S! !MR%L]H(O=0"4&\6W$( 3F!OY0@ V(1RDH1?D! 3E)(0( 3>R"WG(W
MDIX021G<E1M4)M 1)"7WA=BWVA-@ W$!%L2 ,[#G'@%P"-MQN)3:1O!!*;!R
MBXY;Y@D@G<1OR)39F -@W#> +A+C+RC?D%V6 ";\PG*!G8 *-I"Y$@ ;1NVD
M(H!-DS(38I/+O&X A$R)1 JV !&\9*2G..4 DBU[A"$ &=Q?:@&X $C<0ELP
M#Z(6]T(3>2!O"BV03-%(3>@ 2PW!4520!NY@!Z@ F\)O 0 7MX1M0;E" 'H'
M"G:S2?%87LH90Q>%.UFD^*PO90RAXRK]<NK/I.'\*/1  %9:   #7<?X>B8G
MPU'I<&.R7?$>QR1'M5435=?8;$8[$%:DJ!3(E0J<1T.58J-<YK5<MU6R9(9T
MW)33AO,9)--/<?= D74NA4V0>](CI66AP%>B61RM:C;^@[QP4^;@S\A+3DJY
M70)B$V-#54M=KDNBV\"G.8RNV[[R5:VP  @D               U'"_;97?V
MU]HVXU'"_;97?VU]HVXVL7XGX7\&AV;X+ZR_E@ &J;X
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MOW&H8;]N/LC5NP'#_<C^F?UA< X?[D?TS^LVD#6J_._<:AAOVX^R-6[ </\
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MJ%O-?W973DWFOQ  *"P
M
M
M
M                            &LZ1J_-8:PK,5.0AP(D>&]C4;&15;\YR
M(NQ47TFS&DZ8Y*:G\"3DO(2T>9CNB0E2'!AJ]RHCTODF9;02=6*ENN85&U!M
M&S8<G8E3P]2Y^.UC8TU*PH[T8BHU'.8BK:]\KJ9 Q&#H,27PC0X,>&^%&AR,
M!CV/:K7-<D-J*BHNQ44RYA-)2=C*.Y  &)(              !J.%^VRN_M+
M[2FW&HX7[;*[^VOM&W&UB_$_"_@T.S?!?67\L  U3?
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MGI\S']15>1?)?_9)1>^LETS>L=DE%[ZR73-ZR@$2X5<AW/3YF/ZAJ\B^2_\
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M3-ZQV247OK)=,WK* V7"CN>GS,?U%5Y%\E_]DE%[ZR73-ZQV247OK)=,WK*
M(OR[1W/3YF/ZBJ\B^3TG BPX\%D6"]KX3VHYKFK='(NQ4/LQ>%.UFD^*PO90
MRAP9QRR<>!ZJG+/!2?F@ #$S    !HFFV(^%H^G70GN8Y(L+-JV7Z:&=*&DF
MH<3&<LL7+@;V##8)<KL&T%SE57+(2ZJJ[5_!M,R1)96T2G=7  ,20
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MTQR@ "  $) ( !(  (  "     ;P$   Y0 @   Y0"0-P0!,@0  02  2
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M3;C4<+]ME=_;7VC;C:Q?B?A?P:'9W@OK+^6  :IO@
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MZ#< 1;,^CY)38 @$WA+WV!=H M=+CF"KD0G, 3O5!;;RA".4 G>O,-P7:,P
M-V8L-RW &ZP1.4)L(V@%[X [4*;^POM*9\P& >U"F_L+[2F?/'8CQ9]7_)]&
MPGV]/HOX!1_PD/QJ@_L1O6PO H_X2'XU0?V(WK87]G?<1_/\$XGPV4R #TIR
M@    "0  0   0  22 @!!   )  )  !    "  D@  @D  $! $ ) )(
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M'1P/VEX?_A\O_+:9HXI27A2<K!EI9B0X$%C8<-B;&M1+(GF.4QF\TFR8JRL
M 8D@              &H87[;*[^VOM*;>:CA?MLKO[:^T;<;6+\3\+^#0[.\
M%]9?RP #5-\                     U:H8I64T@TS#? *Y)R76/PM_HV2(
MMO\ ^OTFTE8U]CET]X;<C5U4I[[K;+Z,P6<7UH**A;S7]V5TVVY7X@ %!8
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MVE]HVXU'"_;97?VU]HVXVL7XGX7\&AV;X+ZR_E@ &J;X
M    !\+"A+&;$6&Q8J)9'*B:R)X?.?97-<J$W#TW8>D63$1LI%D7/?"1?FN7
M5CYJGD3S%C%E2FX*-WO5S",LU_0  K,P     "H-+G;-!\5;[3S24WF[:7%_
M_)H/BK?:>:0>MP7V\.A\_P"T_NZG4GP #:;1HD;"0FT)F B$0D>4<P"'J(]!
M.[E(N 2FP!!:P W#P9D(I*[-@!M6C/MH@_LKZT+*J,5*FM5I,:SG)"X1G@NM
MO2TK71GVT0?V5_H;95)U*=I)E7.=^#C04:[RJ]$])QL9!SQ#MO4;K\'I.S:J
MIX19MSE9]&K&K8!I#IC%&K%;=DH]=?F<E[>E"SY:?2=94]3Z$)=1/)=%]1U'
MR4'#\M6J@CDO,(L3_J^<J>E3&X BK'PU-Q7;8CWN7RN<IK8FIK"=7R5DOY9N
M8*EJC6'\WF;_ (1I>#<,_+T[&B1WZDI"<NLJ;57D])M3:9@N-..IT.&U)JZL
MUD>_Z27Y^8Y=%3X?R3/L2SG\.Y5;O5+(=2/B&ARD^]CL.QTF(;[71C=M_"7U
M:E6I6E%7V;K.WN:F'I4:.'A.2C^K?F3?X7 QDOA*!)8RA2,ZU)B3BHYS+N5+
MHBIMM;E,Q5:'A*D5%?CZ(QKT^; UWV39G>]_3O/N#76UC&%,:DK'EG06O54B
MVSOJVM9>8US2QVPM_83U(90=6K5C"<FKQVVZD5%A\/AYU*45)*6RZ]#9*U@N
M@P8;)Y'K*R;,XB(Y514\MUY#Y9AS#5;I4Q$HT+@XK$6ST>Y;*B7WJIV<;]H[
M?(8[1-^3*C_YN*8RJZ!U<[O%V-F4*&M*@J:M)7>ST\N!J^$\,/K%8CR\9VK!
MEW*D1S>5%M;T*;>ZFX*A3B2,2&Q9G)+\(_;YSFT;18?QNN0D5.%^,*OA36<5
MU4I";2M18*PGK%5^2VY=AM7EB*THN;BDENV'/2AA,/"<::DY-WNK[GN,KC#"
MWR'/RZPG+$DXSD1%7;>^PW*9PCAV#(2LW,PTEH36HZ*NNY=?).?U<I\Z3'HR
ME4^$YR)$6,W(X-)7:K(^!/\ ZE"K5:T:2S-7;6PVGAZ.'E7:@FHI-)G6H]&P
MW4\21X4E!AQY)L-%1&O?9%MRWN:[%PZD]C*9ID@U(,%BHNU5U6V3EOO4RFB+
M\K3/["?U,OAE\-ND:KH]41[H2(G_ &%LJDZ-2:3;M'S_ )*:=&EB:-*3BEFF
M[VV;-NPF8HV#Z5&AR,\Q'S3D3YSGO1<\L[+;<8#%V#X<E,2L:F/196:>C&HJ
MK\U55$3R9FS8EJ](D*J^'/T*+'C+\[A4:U4<EUSV\QB\18B^4Z5+2-/ILU+Q
M'O9P"OU43)45+9Y;BNA*NI1DF[/?=JQ;BH89QG!J*:W633Z/9YG-.4+#>&Z?
M+NK,M$FHT1$NK7*F>_8J9&+Q;ANFLI252B1$9"LBK"5RKE>V5[F:CXBB2DG!
MD\749RW1$:K;.:J)E=?G*=+&&&J=%H?RQ2&I!8B(NHB:J*E[;+7O<FC.<9Q=
M23VO?OB_\&.(I4YTYJE!62W6M)>OJ5NF6\E%'*.6YVCS83.Y&XG8E@MLP!?(
M)L() 'A'*+@ C,)X20 "!DBY$V! \I!*;0"2]< =J%-_87VE-@,!@#M0IO["
M^TIGSQV(\6?5_P GT;!_;T^B_@%'_"0_&J#^Q&];"\"C_A(?C=!_8C>MA?V=
M]Q'\_P $XGPV4R$ /2G* )( "  D  $  ;@@ /0N@WM&C_MK[2GGH]$:!WI#
MP9$<J71(B^TXT.T?!_*+\+XAYZ<Q^LOS7>8](X?RT/Y][U_EFNKI;PTB_D*;
M_P"SK-XFJE J^CR;G92"Z# C2;G-8ZUT167W&MBZM2:BI0MM+J,(QO:5]AYP
MPOABI8EG'0*9"1VK;7>Y;-9?E-OG]#F(924?&AQY&9<U+\%!>_67SM1/2;QH
MZ8VB:)YZI2J?^I6%%BJY-JJW6L:5HNQ?6(V-Y:!-3D:8@S3G,<U[KHF2K?T%
M\J]:;FZ=K1^2N-."45+>RNEDYAL[\3="<DSK:G![[\A84EH=Q!,2K(L28D)9
MSDOP49[D<G-DU4,]I#F)/#FEBF52+#_!<'KQ41-ZZZ7]/H-@Q91&8VF)"JX>
MKT%CH5EAMB.5&WR6Z):]\B*F+FU%K]*:WVO^!&DMJ>UKR*<J>"ZK3*]+4J=;
M#A1)AR-A155>#=SWM>WD+\@X05NC]*,K9%9[@=3A]7YM]:][VOZ"KM+$[B6%
M)RU-K\M+< Q[7PIJ#===4:J;UYUW&_2L1W$HC]9=?XKM_P"LJQ,ZDX4Y76_R
M_G_1G248RDK>106(*3&H=6F*?,Q(42+!=JN="55:O@NB%C?!Z[8)W]TG]2J7
M.5SE5RW5=JEK_!Z[8)W]TG]3=Q=UAY7X%%'Q$=321C"O4[&M2EY*HOA08;F:
MC48U43YC5WISEC88GGXOT:QG5I&QHFJYKWN2VLJ+=%RV>0Z>*N+[Y?FEKDS!
M94+MX5KH+G*BZJ6S1J[K&!QGI&HTIAUU&PDQ.#<W51[&JUK$O=;(MEOUG/MI
MH0C3@TU;;:QL?0Y.4MG T7"> :GB>G3,Y3X\JQD!51617.1SE1-UD4Y:WHXK
M-&H#ZM/OEF0FJC5A:SM?P[+>DL70+$6!A2J16HBN8YSD1=F27-*@XCJV)<<2
MU.J,]%=3XE08QTOK?,5$B6M9>8VU6JNK)*V6)3D@H)^;.##FBRO5N1;--66E
M(3TNWXPYR:R7W613'XOP#6<+P^%G6PHTM9+QX"JK455M;-$7D\Y8^G.N3U';
M2Y"FS$26AN9K*L-;71+I;_SD,EHXJ4?$^C6I,J[ECK"=$A:SLU<C6-<BKY5*
MEB:R@JSME;W&>B@VZ:WHH_#>'ZAB*>25ID'7?^DY<D:G*IND[H;Q#+2;XT./
M(S+VI?@83W:Z\R7:B>DWC1++,I6 JO.P%O&:Z*J+^RQ%0KS"ND:?I6(XL[4X
M\S-2D36UH".V76^5UW9ECK5JDY*E:T?DQ4*<4L_F:2R1F7SWQ-L%RS.MJ\'O
MN6#(Z&\0S,JV-$CR$LYW^JC/?K)YFJGI-ET=3TABC2=4:Q+2SX34E]=K8MKH
MY-5M\N:YLF,*#6ZE7FS,EB.6D8$-$1L!8JM7)56ZI;G,*V+FIJ"_3LN[[?P9
M4Z*<7+>4)B3#E1P]4%DZC!U7JJHQS<VO2^U#:Z+HEKU3D(<TZ+)R;8B(YK9A
M[D<J;ER:I8^E&/+0,/T>>FX\&9FI"8@O=P;T76^<U76WYZI&)I62TB4.3B4:
MM0X#X5EX-ZJUNM9=J*E[ILR(URI*$7NXNUQH8J36_P!"G<7X(JV%D8^H,AQ)
M=RZJ1H*JK56RK;-$7<IRX.P%6,4P7QY%(,&6:NKPT=51M[7MDBKO3SF[8^?B
MNB832F5*')SM-<U(?QN&KE5%NJIM7FY#,8!K5,K^ DP\D^LC/MA\$OZ*JB(B
MZU[*EELJ&;Q-14<RL]N]<.-C%4HY[/V-!Q!HLKU&DGS6M*SD)B*Y_P 6<Y5:
MB)=56Z(:C1J3.5B?9)T^"L6.[]%-V=OZETR5&Q=@VBS7R3&D*M)K=ZLUG*K&
MI=57:B;%&@:6;'C5RJ1X;6S;XME1/T=97*J>= L7*-*4VU*V[_:&A3DH[KFK
M<2^($E^$^-T[6M?@]=^MX/HF@U"CSM.JGQ">@K F=9&ZKN=;7-J;CJN)C!)G
MXY&5G#:O JY=6VRUO2;]ITDX+HE"G4;:,L755>5-9EO6IE&M6IU(PJV>8APA
M*+E#R-,?HBKZ?$EAQI**V:1'78YUH:99NNWGW7V*:EBO#\SAJL1J;.Q(,2-#
M1JJZ$JJW-J+O1.4O72?7YZA8(I[J;%6#%C0V-X1JJCF_-39YSS[4ZC.52;?-
M5"8B3,PZVM$B+=5LEO4B&6$J5:JSSM85HPALCO.H #>* ">4A"  @!( "#<0
M0 @W@$@]HRGXI!_8;ZCQ<>T93\5@_L-]1Q^UMT/S_8W<%_['* #BF^57IB_*
M5/\ W+O:*^1"P=,653I_[EWM%>[CU?9_V\?^\SP7:WWE3_O)!,R4R(WDFX<Y
M#EL%V ( 1<V[1<Y$Q2RZVO"<GJ-2VY'=HT\^F5*7FX:76$]'6Y41;V]!57@Z
ME.4%YHOPM14JT:CW)FR:4X;FXD5SOHO8BIYD-<I=)GJHL1*?+/F%8EW(VV7G
M+0GY6BXUE8,=)O@H\-++94:J<RW0^I6)1,$TZ,QDRL:8B9\KG;K71+6WG-IX
MQTZ2I1B\ZV6L=FMV=&K7E7G-*F]M[HQ.BZCNEJE/1)Z#J3,"S4:[:V]T4P]8
MQ?58.(XZPYE4@PHJM2'JMM9%MR<Q]X-Q0V5Q%-1YU=2#.OUGKFNJN=O6;+-X
M2H]0J*U))]4A1'<(K4<U$7R6(FXTZ\I8A732MLN31C.MA8PPDK--WVV?HSXT
MH2D&/09>>5B),:[6ZR<FJY;&1QG4)FFX52+)Q.#B_-36LBV^<G*:KI(Q)+SK
M(5.D'Z\*&Y'.>B*F:(Y+>E#-Z0XT)^$6M9$8YUVY(Y%7Z2%$:4DJ,9KS?ML-
MN=>+EB94GNBMJX[3M8"JLW.X<FXTY$X:)"UE151$W+R> UK">(ZG-8K2#'F5
M?!>]6ZBM:B6UD3D,GHXC0V86J#7Q&-54=9%<B;G&JX,>UN,(3G*C6\(N:K_Q
M(71I0S5_TFO+$5,F&_4]N_;Z^9LV)6-;I&IJM:B*YMU7ER4[&DZM3]-C2D.1
MCK":Y%5UFHM_.AUL2Q8;M(5,>V(Q6HW-R+EL4ZFER)#B34GP;VN^:OT5N8T8
M*52BI*_Z3/$5'"CB'!V>9;OP;8^IS*8&^/:Z+,\!?75$VZNVQA=&-:GZE,S<
M.>F%C(C=9+M1++=.1.<[$6-"XN-3A&:_Q>VKK)?Z)A-$<1D*>G.$B-:BP\M9
M;;T*U2CH*KMMN6RKSUJ@LVQK;M.[@QC8>/*JUJ(C43)$-8QIVWQ?WO\ ]U,Q
M1:M+T['TX^8>UL&*[45^U$RRV<YGJ_AND3=0^58]1X*'='.1KD7])5V65=Y>
MJBHUE*>YQ1JNB\1AG"FU>,W?;Y'7TC=I]/\ !#]2&2KT],4_ \*/*1.#BHQ$
M1UD6VWE,;I*C2[\,2C96*R)#16ZMESM;+(Y<61H3L!0V-BL5VJW)')?>:T(Y
MH4TU_P"S-RI+)4K.+_\ 1'SHSJ\[4X$XR?CK&1J*J71$Y.1#'8%8UF.*DUB(
MC4>Y$1-WTB-$L6'#;/:[VLNB_26W(,%18;,<5-SGM:U7NLJKDOTBZK%1E745
MLLC7H3<X8:4G=YF=ZF2<.9TES[XB(J0H:.1%Y?FF,Q_B2I26(XLM)3#H,. C
M;(C6K>[47>G.?$S6H=(TAS$T]UX#D1CE;GDJ)GZ#.U;#M(Q--_*<*H:G"HFM
M9R)L2V].8++3J1J5E>.5>5]H>>M2G2P\K3SMO;9VVFMXLQ5(UZ5E$@RL9)N$
M]%N]$1JY[,E,^Z7Q+6*1!:U9.F06M16HYRHJMMEN4Q&*YG#\A-R4"F2T!8D.
M(CHL1K-B7_L;+B&4D<74Z4B2]09"A0D5RHJVVVW*FZPFXPC#+&T=NUJ]OQZB
MG&52=7-/-*RV1=K_ )]#L3<K,0L"3D&HQH4S&9 ?^$9FFQ;;D.AHOCQ(M FU
MB/<[5B*B779D=N% D9?!<[3Y"<;'U841EW.1%5V=TW;S":*ZC+0Y:;D(\5K(
MKGJYM\KI9$VE&5RH5+<>']C9S*.*HW=OTVWW^?,U2CQHD?%4)8T1SU1ZIFM[
M;3=-(,LR<Q)0H$3Z#XMG)RI=MS!3M(EZ-BR32!,I%9$57*JN1;;>0R.D^=;
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M[:%E*&DFH<3&<LL7+@;ZBW2Z9H#"X'[2\/\ \/E_Y;3-&,EE;1*=U<  Q)
M             -1POVV5W]M?:-N-1POVV5W]M?:-N-K%^)^%_!H=F^"^LOY8
M !JF^                     :35L-STSI6HU?A-9\0E91T&(JN2^LJ14V;
M?TVF[&.CUJ0@5N7I$6.UL_,,6)#A72[FIK9_]KO,9$LJ2E)1S>2V=#"*2O8
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M36<V[E\'D/K%UJQ1)"KPEUHJ(D&,B;E6Z]1FJ3_[;$H=)AHB1(MX\=-][?\
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ML1J1%5&7365-MC-XCP\^E0)2<@Q6S$A-L1T**WEMFBY;46Z>0P)86$/_ 'C
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MNQK42R(GD.4QD\TFR8JRL  8D@
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M*ELKY_I*5]X"-Y7/"QG%Q;WNY;3QTZ<E)+<K?[_N;?@^H06R^(7SDQ"AQ)B
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MSW$^@A$"<AL&J>@L*=K-)\5A>RAE#%X5[6:5XK"]E#*'BZOURZL^E8?PH]$
M 5EH   -5TG5N<P]A"9J--<QLS#?#:U7MUDLKD1<C:C2],%/FZG@:;EJ?+19
MF8=$AJD.$U7.5$>BKDA=ATG5BI;KF%2^1V-BPQ.1:AANDSLRJ+'F92%&B*B6
M36<Q%6R>%3)&)P? BRV$Z) F(;H<:%(P&/8Y+*UR0T145.6YEBN=LSL91W*X
M !B2                                          ?"LAK%1RM9PB)D
MMLS[*XKD_-0]-^'I)DQ$;*1)%SGPD=\URZL?-4\B>8L<LJ4W!1?%7,(RS7]
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MVEX?_A\O_+:9HQDLK:)3NK@ &)(
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M@ ( 2  A   )   ( 0 @D  D     D@$;@@'*2 $W@$   D  $       $D
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M1M[;KV.Z=6E3L.I4R3GI='M@S4%D=B/2SD:YJ*E^>RG:,97N[[R5:VP  @D
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M=]Q'\_P3B?#93( /2G*     )  !!  !))) !   )     !       &\(
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M8U+(UJ)9$3R'(8R>:39,596  ,20
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MR\Q#=#CPI*!#B,<EE:Y(:(J+Y3+%<[9G8RCN5P #$D
M                        ^5U.$2^KK[N4^BMZY/34/3CAZ39,16RL21<Y
M\%'KJ.75CYJFS<GF+(+*E/(HOBKF$99K^@ !69@
M
M
M
M                                                ^8L6'"8KXKVL
M8GZ3ELA]&A:<?S=SO[V%[:%E*&DFH<68SEEBY&^,<U[4<Q4<U4NBHMT5"3"X
M'[2\/_P^7_EM,T8R65M$IW5P #$D
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M84U!9'8UZ)K(US45$6V_,[1C*]W?>2K6V  $$@
M                   %7X@_/]AK^'O]F8+0,3,X?D)C$<K7(L-RU"6AK"AO
MULD:NLFS_K<98NJU%-12\E;^3"$7&]_-@ %)F      >1M*_;W6_&GFHFWZ5
M^WNM^-/-0/84/#CT1QY?4P0A(+3$   $$@  @D !  !R@@D ;B/ 2 ""0  0
M2   $ &XC<  "4        "$ D $$@ ! -P!!(    !!* ( ""2 "0-P  (
M!*   @$@ $$@ )O    ( )  !!)!( ()         ( )!!( ()   (  )
M   ( )W$$H !RD$@ (      02  A!(    (&X$@$$@  A"0 !N! !(!" !"
M2"0 -Q&XD $$@    @D$ $D$A  0"4  ()38 ""0  0A( !!*@$$@ $$H
M  -Q!( (!(0  (  !RD $D(2    !N()( !( !!( !!)!* !"6_23PGR2WZ2
M 'J+0)VA-\:B?T+%*ZT"=H3?&HG]"Q3R6+\:?4ZM'PT  :Y:   #0M./YNYW
M]["]M#?3@G9.6GI=T">EH,S <J*L.,Q'M6VS)<BRC/1S4WY,QG'-%Q,9@?M+
MP_\ P^7_ );3-'Q A0X$&'!@0V0X4-J,8QB(C6M1+(B(FQ#[,9/-)LE*RL
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M"_M.<&%#P)1W,AL:JHVZM:B;FE"0H42*MH4-[UY&HJE.'KZ:&>UC*I#)+*?
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MG(LI,M:KEEXR-Y58MC*YB<(0@E"0""0 ""0    0 3R@    @D(      G,
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M9<S&#Z73M'6DB#(S%8A3CIF L)SE8D)(3E5BHB_.7:E^0E1ITU>A+]5MV_\
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M=LSL2""2XQ   !!( !!( !"$@ (02  ""=P   !!(  0)L   ()  ! !(0
MA "0 .4@D  !     @   W@ !   0"0 $"   A"0  @W           @$@ (
M    $ !!(0          <P  &P  $("2  "4        !!.X ;@" "0
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M "4!!(!!)  )()0   6  ()   0 (0"0 $! !.X$> D $$BP !!(    (!(
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M4_!:YL*:@LCL:_:B.:CD1>?,[1C*]W?>2K6V  $$@
M                      %7X@_/]AK^'O\ 9F"T#%3% I\QB&5K<6$JU&6A
MK"AQ-9;(U=;*W_6[SF5+JM134;>2M_)A"+C>_FP "DS      /(^E?M[K?C3
MS4#;]*_;W6_&GFH(>PH>''HCCR^IA  6F(()  !!( "$$H "$)  ! 0 D@E
M@  ( !(0@ $@@ $@@ G>   0  2 $  ("  G< @ "      ($  ()(0 D;@@
M    ()()  ( !(()     (N2 02  !M  (0D(0 2""0 $! !(   "$ $C<"$
M ) "  $$@     @ DC:20 20A( ()  (!) !* !  @  (  !* #< "   2
M 0  2 @ !!( !!( "! B  @D  @D    $ D@ D @ D ( 0"4(W $@  @D$ $
M@6 !!(( )      ()  (W$@ $$H0@!)!(  !" $@(  -P0)O ()     (/IN
MU/"02SZ2>$ ]0Z!.T)OC43^A8I76@3M";XU$_H6*>2Q?C3ZG5H^&@ #7+0
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M[J&9<19G3!W/DN?[BFNB=U#Y,G^X9KHG=0S+B+,Z9)VTID_W%-=$[J'R9/\
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MF0 >3.L
M                         4U\)C\AT7QE_LGGT]!?"9_(=%\9?[)Y]/3=
MF_;K\_R<W$^(P""3?-<]+?!S[0HWCT3V6%HE7?!S[0HWCT3V6%HGD\9X\^IU
M:/AH  UBT                     IWX2_:[2/&G>PIYZ/0OPE^UVD>-.]A
M3SR>F[,^W7Y.;B?$9)!(-\UR"0$ ()   ! !(! !)  !*<X()0 @D  @G>"
M 2   !N ()   ;])/""6_23P@'J'0)VA-\:B?T+%*ZT"=H3?&HG]"Q3R6+\:
M?4ZM'PT  :Y:   #@G9R6D9=8\[,09> U418D9Z,:E]F:Y'.:%IQ_-W._O87
MMH648:2:@_-F,Y98N7 WJ#%AQX,.+ B,B0HC4<Q[%NUR+FBHJ;4/LPN!^TO#
M_P##Y?\ EM,T8R6631*=U<  Q)
M        -1J6%IF;TDTG$C(T%):3EG0'0U5==55(J73*W^L3?N-N,--8CD9;
M%$G0(KW)/S4)8T-NJME:B.7;:WZ#MYF2RHYM1S<-G0PBDKV  *S,      \C
MZ5NWNM^-/-0Y3;]*_;W6_&G&H'L*'A1Z(X\OJ80;0-Q:8@$$@ ](_!L[1I_^
M(O\ Y4(\W'I'X-G:-/?Q%_\ *A'.[3\!]4;&%\0M8 'FSI
M        U?2C^;VO^*O-H-7TH_F]K_BKRVAXD>J,9_2SR  #V!QR"V_@U]N=
M1_A[OYD,J4MGX-?;G4?X>[^9#-7&^!/H6T/$1Z. !Y0ZH
M      -:TF=H&(/$XGJ-E-:TF?F_Q!XG$]191\2/5&,_I9X] ![$XX+.^#MV
M_N\3B>MI6)9WP=NW]WB<3UM-;&>!/H64?K1Z9 !Y,ZP
M
M!37PF/R'1?&7^R>?-QZ#^$Q^0Z-XR_V3SZ>F[-^W7Y_DYF)\1D$D$F^4'I;X
M.?:#&\>B>RPM$J[X.?:%&\>B>RPM$\GC/'GU.K1\-  &L6@
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M.C%6ZM1S4=;TG<,97N[[R5:VP  @D
M           J_$'Y_L-?P]_LS!:!C)B@T^8K\M6HL"]1EH:PH<767YK5ULK;
M/TW><R9=5J*:BEY*W\F$(N-[^;  *3,      \CZ5^WNM^-.-0W&WZ5NWRM^
M-/-0/84/#CT1QY?4P""=Q:8@$$\H!!Z2^#9VC3W\1?\ RH1YN/2'P;.T:?\
MXB_^5".=VGX#ZHV,+XA:X /-G2        5;)==@ !@)+%M*G:S,TR6C*^/+
M7X1R6U&VO=+WW64QDEI(H$Y7EI,.+%281_!H]S6I#<Z]K(M_Z%JH5'_ZF&DA
MQ-R !49@      U?2C^;VO\ BKC:#5]*/YO:_P"*O+:'B1ZHQG]+/(!!(/8'
M'"%L_!K[<ZC_  ]W\R&5,6S\&OMSJ/\ #W?S(9JXWP)]"VAXB/1P /*'5
M                  !K6DS\W^(/$XGJ-E-:TF?F_P 0>)Q/464?$CU1C/Z6
M>/4 ![$XX+.^#OV_N\3B>MI6)9WP=OS@.\3B>MIK8SP)]"VC]:/3( /)G5
M
M                *:^$Q^0Z+XR_V3SZ>@OA,_D.C>,O]D\^IS'INS?MU^?Y
M.9B?$9  -\H/2_P<^T*-X]$]EA:)5WP<^T*-X]$]EA:)Y/&>//J=6C]"  -8
MM                     *=^$OVNTCQMWL*>>CT+\)?M=I'C3O84\]'INS?
MMU^3FXGQ&0202;YK@$  D    ( 0"0  @ !"$@ #<   02  020 2   ""0
M2WZ2>$@-^DGA /46@3M";XU$_H6*5UH$[0F^-1/Z%BGDL7XT^IU:/AH  URT
M   &A:<?S>3O[V%[:&^G%-2T";@K"FH,*/"7-61&(YJ^12RE/1S4^#,9QS1<
M3%8'[2\/_P /E_Y;3-'S"ALA0F0X3&LAL1&M:U+(U$V(B;D/HQD\TFR4K*P
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M36QG@3Z%M'ZT>F0 >3.J
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MRZ+JN:Q$5+IDN:;C*%<[9G8RCN5P #$D
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M[=O[O$XGK:5B6=\';M_=XG$];36QG@3Z%M'ZT>F0 >3.J
M
M   4U\)C\AT7QE_LGGT]!?"8_(=%\9?[)Y\/3=F_;K\_R<W$^(R0 ;YKGI;X
M.?:%&\>B>RPM$J[X.?:%&\>B>RPM$\GC/'GU.K1^A  &L6@     '#.S4&2E
M(TS,O1D&$Q7N<JVLB)<J^8TNQ(DW&91<-S52EH:VX9D1R7\B,7UFQ:86QW8#
MGTEE<CD5JNM]6^?H/O1W-4.)A:1;(.E45D)O"HBHKD=;._EN;E&$(TM)..;;
M8UYRDYY(NQ\8%T@2.*8CI5T%TE4&M5SI=[];)%1,E5$NN:;C="F*O%D)G3%1
MEP^L)=5J?&%@+=M[K>]O^DN<QQ-.,&G%635[<#*C-R33VV  -4N      *=^
M$OVNTCQI?84\]'H7X2_:[2/&G>PIYZ/3=F?;K\G-Q/B, @E#?-< @D
M  @ $@$( 2 +  @$@!  @! 3>"4 &X      -^DGA!+?I)X0#U#H$[0F^-1/
MZ%BE=:!.T)OC43^A8IY+%^-/J=6CX:  -<M   !P3T[*T^6=,3\S EH#51%B
M1HB,:BKLS7(YS0M./YO)W]["]M"RC#234'YLQG++%R-Z@1H<Q AQH$1D6#$:
MCV/8Y'-<U4NBHJ;45#[,+@?M+P__  ^7_EM,T8R6631*=U<  Q)
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M.FRLMKI$X*&UFNGZ5DM<[1RGO-U;@ ""0   :UI,_-_B#Q.)ZC936M)GYO\
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MC<Q\5^+\,_@+WX.^5_ < HTYT[YI7N)R4K65B2"07F !!( ()( ) ( )0$
MD@D@ D!   WZ2>$@EGTD\(!ZBT"=H3?&HG]"Q2NM G:$WQJ)_0L4\EB_&GU.
MK1\-  &N6@   PV+L/P,34.+3)N+%@PHCFN5\.VLFJM]YF3!XTQ"S"] C52)
M+NF&PW-;P;7:JKK+;;8SIYLZR;_(QE;*\VXR-(D64RDR4A"<Y\.5@,@-<[:J
M-:C45>?([9TZ+/)5*/(5!L-8;9J!#CHQ5OJZS4=:_E.X8RO=WWDJUM@ !!(
M                                        !5^(/S_8:_A[_9F"T#&Q
MZ'3X]=EJS%E]:HR\-84*+K.^:U=;*U[?INW;S)%U6HIJ*7DK?R80BXWOYL
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M)E8ZHGT79JRUE4U7355YR<Q) @S%-BR\.3BO;!B.1UHZ73-+IS)LOM,CB/\
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M!]-VH02W:@!ZAT"=H3?&HG]"Q2NM G:$WQJ)_0L4\EB_&GU.K1\-  &N6@
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M//1Z;LS[=?DYF)\1@ &^4   $ $@    @D $9! 2 ""0 02     !N()0 (
M   0 2&[4\();])/" >H= G:$WQJ)_0L4KK0)VA-\:B?T+%/)8OQI]3JT?#0
M !KEH   -.TMU.<I&"9N<ILP^7F6Q(:-B,VHBN1%-Q-2TIT:>KV#9J0I<%(T
MT^)#<UBO1MT1R*N:JB%V'MI8YMUS"I?([&8PE,19O"M&F9F(L2/&DH,2(]=K
MG*Q%5?.94QF%I2-(89I$G--U)B7DX,*(VZ+9S6(BI=,ES0R97.V9V,H[E<
MQ)                                          /A8L-(J0E>U(BI=&
MWS4^RLJ_$>FGK#<-'N2&L@]5;?)?FS&XLTMJ4\BB^*N80EFOZ  %1F
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M2SR " >P..26U\&OMSJ/\/=_,AE2[BV?@U]N=1_A[OYD,U<;X$^A;0\1'HX
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MB6^>R*NJO)FTWS"45T;#5->[:L!B>@IK_KHPJ/?N]BRG^FI*"W&6 !I&P
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MF%P/VEX?_A\O_+:9HQDLLFB4[JX !B2
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MW]WB<3UM*Q+.^#M^<!_B<3UM-;&>!/H64?K1Z9 !Y,ZP
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M=GLV-6]LRRS"O)1IQI)[MK_)-)-RE-^8 !J%X
M   !37PF?R'1O&7^R>?3T%\)C\AT7QE_LGGT]-V;]NOS_)S,3XC%B"4!OE!Z
M6^#GVA1O'HGLL+1*N^#GVA1O'HGLL+1/)XSQY]3JT?#0 !K%H   ..9A<-+1
M85[:[5;?PH<@&X%:X>T146GQ6QY]\2=B?I0XFJL._@U;EAR,G+2$NV!)P608
M+4LC&)9$.<%M2O4J_6[F$*<8?2@ "HS         *=^$OVNTCQIWL*>>MQZ%
M^$QVNTCQIWL*>>D/3=F?;K\G-Q/B, @DWS7!!(  ! !(\H !!.Q"  2""0
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MK&[&I9#Z -$V       :OI1_-[7_ !5YM!J^E'\WM?\ %7EM#Q(]48S^EGD
M 'L#CA"V?@U]N=1_A[OYD,J8MGX-?;G4?X>[^9#-7&^!/H6T/$1Z. !Y0ZH
M     -6QK@BF8KAM6<18<RQ+,C,O=$\%TOM-I!G"<J;S1=F8RBI*S-8P7@NF
M84@O22:KYB(B)$C.O=UN:ZVW[#$R.C219B6+6*C-QIV(L=8\.%$NC8:ZUT1,
M\[9>8WT&>L5+MYMK,=%"R5MP1$1$1$LB;@ 4E@      -:TF?F_Q!XG$]1LI
MK6DS\W^(/$XGJ+*/B1ZHQG]+/'H&X(>Q.."SO@[]O[O$XGK:5@6?\';\X#O$
MXGK::V,\"?0LH_6CTR #R9U@
M                                         "FOA,_D.B^,O]D\^GH+
MX3/Y#HOC+_9//IZ;LW[=?G^3FXGQ&02 ;YKGI;X.?:%&\>B>RPM$J[X.7:%&
M\>B>RPM$\GC/'GU.K1^A  &L6@                    %._"7[7:1XT[V%
M//)Z&^$OVNTCQIWL*>>MYZ;LS[=?DYN)\1@@D&^:Y!(0  $$@$$@ $ $H -P
M! !( 0 @DA"0 0"0 @(L2 02  $ ( )#=J>$$MVH >H= G:$WQJ)_0L4KK0)
MVA-\:B?T+%/)8OQI]3JT?#0 !KEH   -"TX_F\G?WL+VT-](<UKDLY$5.14+
M*4]'-3X&,XYHN/$PV!^TO#_\/E_Y;3-!$1$1$2R)N!C)YFV2E96  ,20
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MC/ GT+*/UH],@ \F=8
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MV$KVI$<ET;?-?_+'V5C7WN33WAMB.756GO54OE]&8+.+:E/(HOBKF$)9K^@
M!49@     'D?2OV]UOQIQJ"&WZ5NWNM^-/-00]A0\./1''E]3() +3$   'I
M#X-G:-/_ ,1B?RH1YO/2'P;.T:>_B+_Y4(YW:?@/JC8POB%K@ \V=(
M               &KZ4?S>U_Q5QM!J^E'\WM?\5<6T/$CU1C/Z6>0-Q )/8'
M'!;7P:^W*H_P]W\R&5*6U\&OMRJ/\/=_,AFKC? GT+:'UH]&@ \H=4
M               &M:3/S?X@\3B>HV4UK29^;_$'B<3U%E'Q(]48S^EGCU
M>Q..06?\';\X#O$XGK:5@6?\';\X#O$XGK::V,\"?0MH_6CTR #R9U0
M
M            "FOA,_D.B^,O]D\^GH+X3'Y#HOC+_9//IZ;LW[=?G^3F8GQ&
M 02;Y0>EO@Y]H4;QZ)[+"T2KO@Y]H4;QZ)[+"T3R>,\>?4ZM'Z$  :Q:
M                 4[\)CM=I'C3O84\]'H7X2_:[2/&E]A3STAZ;LS[=?DY
MF)\1D(2 ;Y0""0G,     .4( $!!(   !"! 2 02+   !  "$)  ()  0;B
M"0SZ2>$$LVIX0#U#H$[0F^-1/Z%BE=:!.T)OC43^A8IY+%^-/J=6CX:  -<M
M   !UJE4)2F2CIJH3,*6EVJB+$BNU6HJY)F=DT+3C^;N=_>PO;0LHP52I&#\
MV8SEEBV;S+1X4S+PH\O$;$@Q6(]CVK='-5+HJ+R*AR&%P/VEX?\ X?+_ ,MI
MFC&2RR:)3NK@ &)(                                         !J]
M0PK\;Q_3,2_&D;\3EU@<!J?2ND1+WO\ \ST&T&"F\32<KBV2P]$:_P".3<%8
MS%1,K(CU_P#HIG2RHYM1S<-G0QBH[;  %9D      >1]*W;W6_&GFH&WZ5^W
MNM^-/-//84/"CT1QY?4R1N" M,2 3N  -QP9I%K6$:9%D*4V46!$C+'58T-7
M+K*UK=J*F5FH:<083IQJ++-71E&3B[HM#CNQ5]G3>@=[PX[L5?9TWH'>\5@"
MG4Z'(C+33XEG\=V*OLZ;T#O>''=BK[.F] [WBL -3H<B)TT^)9_'=BK[.F]
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MKK-1UK[[7VG=,97N[[R5:VP  @D
M         J_$'Y_L-?P]_LS!:!THM*DHM4@U*)+,=/06:D.,OTFMSR3_ !+Y
MSNEU6HIJ*7DK?R80CEOZL  I,P     #R/I7[>ZWXT\U V_2MV]UOQIYJ!["
MAX<>B./+ZF-P(0E"TQ    () ()! !(( !(W  !   !M()      \(!!(( !
M*   @D $ $H ""0 0A(  0!  $ " $$[@0 2@  (!(  %B "2"2 "4   ()"
M $ D  @D $$H  02  .4!  02   "  2  $V   )L&XC<2  0 "0$" $(2"
M"0  02-P ()()     &XA "2-Q*!  !8 $("2 "4 0@ D  #P@;@@! )  38
M 0@!(   "  !  ""0  02  02$     &\  @G<     0"0 ""0""0  ""0""
M0$ ()"  $$@ @D(   -P  0  !   0 "4!!( 0 (    0?34S3PD!OTD\(!Z
MBT"=H3?&HG]"Q2NM G:$WQJ)_0L4\EB_&GU.K1\-  &N6@   T+3C^;N=_>P
MO;0WT*E]I92GHYJ? QG'-%QXF%P/VEX?_A\O_+:9H QD\S;)2LK  &)(
M                                     !H]6Q%/2VEBBT&&L/XA-2CH
MT1%1=;61(RY9V_0;N-X*]K5)GHVFB@5.'+172$&2=#B1T:NHUUHV2KL_2;YR
MPB^NHI0R\/[LKIW_ %7X@ %!8      >1]*_;W6_&GFH(;?I7[>ZWXTXU ]A
M0\./1''E]3()()W%IB!N  "$(  3N()    !!*$  D ( ""2 "0   @
M      0  $"Y(0  $( 2@"!  @"   $ $@  $<I(  N"$ !(0   ;@ @ 0 $
M$CE  0( "-Y.X$ $D  $@  $)Z0 "0  !8   #E !!(      0  $ $@;@
M$  ()W$ $@$ $@!     02 ""4  !!) !(! !)!( (0$D;@"0  !L      (
M)  ( !*    $ $A     "/  2    $ W"P " (  02@ &X  @$@ ( 0 2
M$  "   7( W $@A"4  "  $$A     0A(  ;])/""6_23P@'J'0)VA-\:B?T
M+%*ZT"=H3?&HG]"Q3R6+\:?4ZM'PT  :Y:   #3-+U1FZ7@>;FJ=,1):8;$A
MHD2&MG(BO1%-S-6TET*;Q'A*9IU.X/XQ$>QR<([5;9'(JYEM!I58N6ZYA4OD
M=C)X0CQ9K"=%F)B(Z)'BR4")$>Y;JYRPT557RF6,=AF2BT[#E*D9C5X:6E(4
M%^JMTUFL1%MY4,B83MF=C*.Y7  ,20
M           #C=&AMC-A*]J1')=&[U3_ ,0Y"L*^J\?F&DNMOD]^7_3,%GEM
M2GD47Q5S"$LU_0  J,P     #R/I6[>ZWXT\U W'2HQSL=UO52__ *IQJ7 1
M/J^D]A0\./1''E]3.,')P,3ZOI(X")]7TEIC<^ <B08GU1P$3ZOI .,')P,3
MZOI"0(GU?2 <1*')P,3ZOI' 1/J^D X@<O 1/J^D<#$^KZ0#C(.7@8GU?2.!
MB?5](!Q$G(D")]4<!$^KZ0#B).3@(GU?2. B?5](!Q@Y. B?5](X&)]7T@'&
M0<O Q/J^DA($3ZOI /@')P,3ZOI' Q/J^D XP?? Q/JD\#$^KZ0#B).3@(GU
M?2.!B?5]) N<80^T@Q/J^DG@8GU20<8.3@(GU0D&)]7T@'&#DX")]7TC@8GU
M?2 <8.3@(GU?2.!B?5](!QH#D2#$^KZ1P,2WT?2 <0W'+P,3ZOI' 1/J^D X
MT(.7@(GU?2. B?5](!QH#DX")]7TC@(GU?2 <1)R<#$^KZ1P,3ZOI .,@Y>!
MB?5](X")]7T@'&0<J0(GU?2.!B?5](%SC!R<!$^KZ1P$3ZOI .,)L.3@7_5]
M(X&)]7/P@'&.4Y. B?5])' Q/J^D ^ <G Q/J^D<#$^KZ0#C(V'+P,3/YOI'
M Q/J^D@'$2<G Q/J^D<!$^KZ20<8.1(,3ZOI' 1/J^D XP<G Q/J^D<!$^KZ
M0#C0@Y>!B?5](X&)]7T@'&#DX&)G\WTD<#$^J <9)R<#$^KZ1P$3ZOI .(DY
M. B?5](X&)]7T@'&0ARI B?5](2#$^KZ0#B).3@(GU?2.!B?5](%SB).3@8G
MU?2. B?5](!Q@Y$@Q/J^D<#$^J <8.3@8GU?2.!B?5](!Q@Y.!B?5](X")]7
MTD XB>4Y.!B?5](X&)]7TD@XD!R<#$^J3P,3ZOI .,@Y4@Q/J^D)!B?5](!Q
MA#DX&)]7TC@8GU0#CW Y.!B?5](X&)]7T@'&/"<B08GU?2. B?5]) ./<#[X
M&)]7TD\#$^KZ20<0.7@(GU?2. B?5](!QH#[X&)]7TD\#$^KZ0#B).3@8GU?
M2. B?5]((.,'(D")]7TC@8GU?2"3C(.3@8GU24@Q/J^D XPAR<#$^KZ1P,3Z
MOI .,'(D")]7TC@8GU?20#C!R<#$^KZ1P,3ZOI)!Q@Y. B?5](X&)]7T@'&#
MDX")]7TC@(GU?2 <8.3@8GU?21P$3ZOI /@A#E2#$^KZ1P,3ZOI .,'(D")]
M7TC@(GU?2 <>X')P,3ZOI' Q/J^D XP<G 1/J^D<#$3]'T@'$2AR<#$^KZ1P
M$3ZOI N<8.3@8GU?2$@1/J^D XP<G 1/J^D<#$^KZ0#C0CE.7@8GU?2$@Q/J
M^D@'$2AR<#$^KZ1P$3ZOI)!Q$G)P$3ZOI' 1/J^D XQN.3@(GU?2. B?5](!
MQ$G)P,3ZOI' 1/J^D XB3DX&)]7TC@8GU?2 <9!R\#$^KZ1P,3ZOI .,A#EX
M&)]7TC@(GU?2 <2$G(D&)]7TC@(GU?2 <9+?I)X3ZX&)]7TDI!B(J?-](!Z>
MT"=H3?&HG]"Q2NM G:$WQJ)_0L4\EB_&GU.K1\-  &N6@   ZM3J,G2Y-TU4
M9B'+2S51%B1%LB*JV0[1H6G'\W<[^]A>VA91@JE2,'YLQG++%RX&\RL>%-2T
M*8EHC8D"*Q(D-[5NCFJET5/(<AA<#]I>'_X?+_RVF:,9++)HF+NK@ &)(
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MX*7]U9U#L.PWW@I?W5G49X#2SYF,D>!@>P[#?>"E_=6=0[#L-]X*7]U9U&>
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MV:CHL)L16_554O8YS!WOM)6[8  02
M           8+&M>=AN@1ZFV L9L%6ZS>97(WEYSOT*H,JM&DI^'DDQ!9%MR
M:S46WI(KU/95*/-R45-9L:&K43GVIZ40T70[&J$C"J% J,M%8DA%<V'&<U;/
M^<J9+LM\TV(PC*BVMZ?P5.3C42\F62 #7+0
M
M
M
M                                            5/I3A1JUC/#]'A,=
M:$JQU7<J715]DM6-%AP(3HD:(R'#;M<];(GE)AO9%8U\-S7L5+HYJW12ZA5T
M4L]KE=2&=9;DL8V&QK&)9K4LB<B$@%)8
M                 #XB/AP(3XD1S8<-J*YSE6R(F]5/LXYJ!#F9:+ C-UH4
M5JL<G*BI925Z@XJ=4)6HR_#R,>''A75NM#<BI=%MN.R4TUTUHPQ2J/<^+AN>
MB9?\E;WW[+77?G8N*!%9'@LBPEUF/2Z+S%U:CH[2B[Q>YE=.IFNGO1]@ H+
M
M
M
M
M    0BHJJB+FFT JS2S6(M4G93"M(>KYB8>CIA(:WLU+K9>38BED4>092Z7*
MR,)RN9+PVPT<NU;):YC:7A2F4ZN356@PE=.S&U[W*Y6Y(F5URV&>-BK5BX1I
MPW+^2J$&I.4MX !KEH
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ME8<Y$FX<O";,Q$1'Q4:FLY$V74[!E*LE#1P5N/%D*F\V:3  -<M
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M8RHF2(FSR &,*LX.\79DN$9*S1S8<T=T'#U5AU"FPYALS#14:KXJN3-%1<O
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M4VG?D^GRDK^X@M9ZD.Z 8MM[62DEN  ()
5                        /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g377490g91n91.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377490g91n91.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_[1CD4&AO=&]S:&]P(#,N,  X0DE-! 0
M      \< 5H  QLE1QP"   "    .$))300E       0S<_Z?:C'O@D%<':N
MKP7#3CA"24T$.@      Y0   !     !       +<')I;G1/=71P=70    %
M     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /
M<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4     0
M    #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T
M '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT
M:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $
M !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R
M8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;
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M(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP
M#F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P
M       -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N
M9P      .$))30/M       0 & 2\0 !  ( 8!+Q  $  CA"24T$)@
M#@             _@   .$))300-       $    6CA"24T$&0      !
M !XX0DE- _,       D           $ .$))32<0       *  $
M CA"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M     0 R     0!:    !@       0 U     0 M    !@       3A"24T#
M^       <   _____________________________P/H     /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H   X0DE-! @      !     !
M   "0    D      .$))301$       0     @   D    )      #A"24T$
M'@      !      X0DE-!!H      T$    &              #Y   "#0
M  8 9P Y #$ ;@ Y #$    !                          $
M     @T   #Y                      $
M$     $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C
M=#$    $     %1O<"!L;VYG          !,969T;&]N9P          0G1O
M;6QO;F<   #Y     %)G:'1L;VYG   "#0    9S;&EC97-6;$QS     4]B
M:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G
M<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X
M   -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E
M $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @
M;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG    ^0    !2
M9VAT;&]N9P   @T    #=7)L5$585     $       !N=6QL5$585     $
M      !-<V=E5$585     $       9A;'1486=415A4     0      #F-E
M;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO
M<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )
M=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=
M  MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N
M90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P
M   ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG
M   X0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$
M%       !     ,X0DE-! P     #I     !    H    $P   '@  ".@
M#G0 &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D@     '_VP"$  P(
M" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,
M$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( $P
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M &4 ( !0 &@ ;P!T &\ <P!H &\ <    !0 00!D &\ 8@!E "  4 !H &\
M= !O ', : !O '  (  R #  ,@ T     0 X0DE-!"(      3)-30 J
M"  ' 1(  P    $  0   1H !0    $   !B 1L !0    $   !J 2@  P
M  $  @   3$  @   !\   !R 3(  @   !0   "1AVD !     $   "H
MU    &     !    8     %!9&]B92!0:&]T;W-H;W @,C4N-" H5VEN9&]W
M<RD ,C R-3HP,CHP." Q,#HT.#HR,P       Z !  ,    !__\  * "  0
M   !   "#: #  0    !    ^0         & 0,  P    $ !@   1H !0
M  $   $B 1L !0    $   $J 2@  P    $  @   @$ !     $   $R @(
M!     $              $@    !    2     $X0DE- _T       @
M     /_A 3I%>&EF  !-30 J    "  ' 1(  P    $  0   1H !0    $
M  !B 1L !0    $   !J 2@  P    $  @   3$  @   !\   !R 3(  @
M !0   "1AVD !     $   "H    U    &     !    8     %!9&]B92!0
M:&]T;W-H;W @,C4N-" H5VEN9&]W<RD ,C R-3HP,CHP." Q,#HT.#HR,P
M     Z !  ,    !__\  * "  0    !   "#: #  0    !    ^0
M   & 0,  P    $ !@   1H !0    $   $B 1L !0    $   $J 2@  P
M  $  @   @$ !     $   $R @( !     $              $@    !
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M\?_:  P# 0 "$0,1 #\ VI
M
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M*RZ4[:6OGIV23P-7*1O5J*YJ<UZ*9,Z:66G?$U*62)\:-3;V;D5,=W0[@
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MU3#4.69TF^+..:)R_42<
M
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M9PL1K<KU7"? A[
M
M                             "/<0JJ6CT1J&6G<^.5ENJ7LD8Y6N8Y(
MG*BHJ=%*&X;\.=1:XT?0Z@=Q%O\ 0K5+(G8-DD>C=DCF=>U3.=N>G>!LT"B_
M<,U#_"EJ'^<_SA[AFH?X4M0_SG^<!>@*+]PW4'\*6H?YS_.'N&Z@_A2U#_.?
MYP%Z HKW#-0_PIZA_G/\XY]PS4/\*6H?YS_. O0%%^X9J'^%+4/\Y_G#W#-0
M_P *6H?YS_. O0%%^X9J'^%+4/\ .?YP]PS4/\*6H?YS_. O0%%^X9J'^%+4
M/\Y_G#W#-0_PI:A_G/\ . O0%%^X;J#^%+4/\Y_G#W#-0_PI:A_G/\X"] 47
M[AFH/X4M0_SG^</<-U!_"EJ'^<_S@+T!1?N&:@_A2U#_ #G^</<-U!_"EJ'^
M<_S@+T!1?N&:A_A2U#_.?YP]PS4/\*6H?YS_ #@+T!17N&:A_A2U#_.?YQS[
MAFH?X4M0_P Y_G 7H"B_<,U!_"EJ'^<_SA[AFH?X4M0_SG^<!>@*+3@9J#^%
M+4/\Y_G#W#-0?PI:A_G/\X"] 47[AFH?X4M0_P Y_G#W#=0?PI:A_G/\X"]
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MP(I-[;+1S4,+K<Z!U&K$6)8<;-O=C'+!TU=MM;W^45=%1.>B8[22%JJB?"J
M51:^,]%%>:6V7B9_E-54,IXDCI^2N5R-7*Y\50L;5FHX+';'U+W.3:]K?0W=
M36[75*R_\4K"FF:%D\=NO"MK'T,:.2'[^S"OVIYOHNZ^"FTKK=334_8UD$-2
MS.526-'(OR*!4-;Q;EM4K9;I*U*7]T79!E=B=>_K@L_1FHJ35.G:*[V]SW4]
M2USF*]FU<(Y6]/A0J?CX^S14#K71TUO6XUE'+'3Q1L8DCWKR1&HB95<^!+^
M5KJK9PNL,5?%-3U+(I$?!*Q6N9F5Z\T7U?T@6%(](XW/=Z*=2JJOBU1?=5<[
M+33/\HH7JUZ.@Y)A43KW]2T:QJNII&M1554Z(:R66BN-FXS:PN%9I^:IHZAS
MFQOFB5&+Y[5RBJBHO10+ITWK!]TO5-1N>BI+NY=GCHU5Z_(3@@.F=6Z>JKM3
MT;H;507217+#"CV)*YJ-55<U,(N.3OF4GK51S4<U45%3**@'(
M
M
M
M        (MQ/S]P6H\?HRJ_JG$;]C7_N;L7\:H_KY"2<3_Q"U'_TRJ_JG$;]
MC7_N;L7\:H_KY +-
M      $8UUI"@UA:GT%U@2>G<]KU:LCF<V].;>9QI'0MBTK#ML]&L#G(S?\
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M@
M
M
M                     $6XG)_[A:C_ .F57]4XC?L:_P#<W8OXU1_7R$EX
MG?B%J3_IE5_5.(U[&O\ W-V+^-4?U\@%F@
M                             '52TT-+&K*=B,:JY5$\3M
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M5RKX]QGS*YQ">*,X2D &;(
M
M                                        $6XGKC06H_\ IE5_5.(W
M[&O_ '-V+^-4?U\A).)WXA:C_P"F57]4XC?L:_\ <W8OXU1_7R 6:
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MT,=9WMONJ)O:I>WS#N3\GDF$7TL"LWT[XSU(F:RNL'S&BI&U%ZHB(?1T5D
M
M
M                $6XG_B%J/_IE5_5.(W[&O_<W8OXU1_7R$DXG?B%J/_IE
M5_5.(W[&O_<W8OXU1_7R 6:
M     (AQ,_%RM^+O-=S8CB9^+E;\7>:[]YR]Y\ZKK?,)T Z IM(!\(0   "
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MJ(DL:/3"]>ITT5HMM#+VE#;Z.FDQMW0PM8N/#*(>T#$=T8  2D
M
M
M        $6XG)G06H^?_ )95?U3B-^QK_P!S=B_C5']?(23B?^(6H_\ IE5_
M5.(W[&O_ '-V+^-4?U\@%F@
M    "(\2<+I^L1RX1:=^5\#7_L8/?V_.A?G%#\7:WXN\UT.EM?AVAN:<>I&9
M<G>:EJZF(E[^Q@]_;\Z#L8/?V_.AX 6?P7:?I4^=J>7O[&#W]OSH<I!!^<-^
M=#'@?@NT_3_DYVIY>]88/?V_.@2&#W]OSH> #\%VOZ?\G.OY>_L8,_N[?G0)
M#![^WYT/ !^"[3]/^3G:GE[^Q@]_;\Z'U&R)CT<RIVN3HJ+A3' G\%VGZ?\
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M,1PI>:/$R*OE$?+*?OC9DU8TM^'*'XQ%^TAM.4=YL]+:S$:48RZ6PO:\6XI
M 4G0
M
M
M        1;B?^(6H_P#IE5_5.(W[&O\ W-V+^-4?U\A).)WXA:C_ .F57]4X
MC?L:_P#<W8OXU1_7R 6:
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MZDJ(57"31K_W(?3Y8XUP^1C5]:H@Q)E]@^&31/7#)&.7U.13[(
M
M
M                                   !%N)_XA:C_P"F57]4XC?L:_\
M<W8OXU1_7R$EXG?B%J3_ *95?U3B->QK_P!S=B_C5']?(!9H
M                              AW$_\ %RM^+O-<S8OBA^+E;\7>:Z'H
M/AGTG%WWU  '24@    @ (   /1;Z5U;5QT\:X<]<)RR1VZCZM]OJKA(YE'%
MVCDQE-R)UZ=5.R\VFMLU9Y+<X%@J-J/V;D=R7IS150N?2>F::S6NFJJM:7?-
M$U55T:-7*<^:J8SB>VUW"QUERAFHGU;4C8U$<UTF-Z)R7KT52C7><6KPQ'3L
MM>FF*<4]U.@]UDHY*VZ4D3(W/8Z9C'*C=R(BNQS+VM^AK:V!K):6@?(F<YIV
MY-VONJ:'S,-+0MJ_*U[!Z;G&D5RJXVHB-9*]J(B81,.4RNBX:6>[2-KNP[+L
M55.VQC.4\>\W3;%>)IB,SA@07Q#8].2O:R-EG<]W1$9&JJ<:@TC:Z>VI,RFH
M&9SA4A:G<I3C?TSB869VEL9A1  +ZJ      "=    &6TO\ ARA^,Q?M(;':
MLMS[G:O)XV*]W:-=A%1.F?$UPTM^'*'XQ%^TAM0<;XG::7I:'2V%8O6]943I
M>[):K1JVDD>UKW]HQ&N:JJJHUZ=4(]=K/+]RM%>UC=MJIEC1^Y-JXWIR3K^0
M>S4EFN45]G2GIJI8:BH>K^SB=M5%=WXZ]2P&V5]1PUM%$^!=\<[GJQT:\O.D
M[OE+-M2NEB\3\TQG]E:M)U,UF/EB<?NBFKKR^\UU!298YSX$B1&M5%ZKXF6U
MI3NI>'^G('(J.8Y45%7/<I&-%VBX2ZPMLE=2U2PQU"(O;1.QMY^*="Q>+U%+
M+9[=%14[WHR9?-B8J[4V^"&N]JTU=/2KV[_Y9UI:VGJ:D]^W^$<H/]R]]^,)
M^U$8SAYIFFO232W#MFMI86SQ+&Y$ROKY+RY&;HJ*J;P?O=.M-.D[IT5L?9KN
M5-T?1.O<ID>%%%41TU3'402PJ^E:S[XQ6\_E,;:G!IZDUG^+_P!,J4XK:<3'
MM_[0O4-PI*W4ZTUXF[*W.C17OC:NY%1,IW+WX[CR]M9K5>;2_3=4^H5U0U9N
MU1?-PYNW&43UF:U19)+1JY:J6WON5*R)$6)D"N:Y514\%3D96UWRTR5=)#]P
M*QO<]C.U6E:FU<HF[T.[J;>9$5B:1,QCS#"-/,S%IQ.?NB^OJQU?<ZFIDV[G
MJST4PG)J)_823B=>6,BLE&CV^23TZMG=M7<U/-Z?_BF*XB6^HGO-4ZBMT[85
M5FUL<*X3S$ST3Q,]Q*L;YV66KAI5D92TZK)"R)55_H\N7P&/%3.EG[_X*Q;&
MI_7_ +0.]4VEZ>Q4LMGKIYKJZ1$FB>CMK68=S3+4[T;W]Y,-1W>Z7[3-?4S1
M0K0Q(C)9&)MV\T7HJY[T[CHMM[ME-110U&@7S2M3#I%I6Y=S];"4U^H:.AH)
MJ9FDY9*:1-TD+(4VOY]Z;<+T0QO>V8_+F8GWF&=:1B?S8B8]HE$-+VK0\U/1
MR/N=7[9HUKGQHCMJ/\/0Z9]9W<2(VSZSION@5:>@\E:DDD?5.;\=,KUQW&)J
MVON=RBDME@J+6UDR2+L@5N6Y]'DB$YU1J6C2M;'6Z0FN+EC1>T="C\)E>7-J
M_#\HMQ5U(M&9S$^\=/Z%8K:DUG$8Q[3U.'EGTH^6:33U=55,T:1NF1^41J\\
M=6IWY+&*?X86ZMJ+]=ZJ"&>U4RS,E2%S',1S%>Y49W)R3E\I<!SM[&-3'%E?
MVDYIG&  %-:
M
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M@
M
M                   BW$_\0M1_],JOZIQ&_8U_[F[%_&J/Z^0DG$]/_<+4
M?_3*K^J<1OV-?^YNQ?QJC^OD LT
M         0WBA^+E;\7>:Z&Q?%#\7*WXN\UT/0?#/I.+OOJ  .DI     @
M2"'=15,M'51U$"HV5BY:JIDZ00E<'#;6E?54]SCN4R/;3P(L&R-J87SNOCT0
M@%[UC>;W324]PGC?%)C<B1-;T7*=/6A@&/<S.QSFYZX7&3Y-%-MITO-XCNVV
MU[VK%9D)#8M8WBQT[(+=/''&S.$=$UW5<KU(\#=:E;QBT9:ZVFLYB65MNH+A
M;JQ]522M;,Z7ME56(OG9SD[K]JBZ7V-67*9DC5>C_-C1O-$QW?"80$<NN>+'
M4XK8QGHD]=KJ^UUKGM]14QNI9F[7M2)J*J?#CU$8.$.133K2,5C!:]K?-.0
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M#$[,<4;%Z9:U$,Z;^:TX9C,^6NVQBU\YZ>'U&BMC:U>J(B'T <]?
M
M
M          !&.)35?H;4+&]76VI1/JG$=]CG"Z#A#9(W^DCJC^O>6/,Q)8GQ
MJJHCVJU<>LZZ.G;2T[86*JM;GFO7KD#N
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MJ)ZC?J[C&UBN<S/WZM.GH9W$SC$1]NC+  Y3I
M
M
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MO*'FG^TQ?M(;4&E.C+S4NU);6JD>'5<*+R7]^GK-UCD_$K\<UE>V>E.E%HD
M!RUT
M
M
M   '553MIXG/?G"(O1"O8]<5$NO*&@CD3VKD@<Z1JQINW(CUY+\C0+'!\PR-
MEB9(S.UR93)CKO>Z.U(JU:R)C'HMSU R8.NGF;44\4T>=DC4>W/@J9,5>M24
M%G54K%E145&^8S/-4R!F08>TZBH;I_LBRKYR-\YN.9F  /B:5L,3I'YVMZX(
MY5:VM--4K!*Z?>CMO*/EGYP),#HHJJ.L@[6'.S..:8.\
M                   *ZXW?BA<?BDIJ ;?\;OQ0N/Q24U .KL_D:+]P %MB
M  (          $@ "  !(           0  @  SFBOQGM7QR']M#>@T7T3^,
M]K^.0?MH;T'/W_\ "STN\@ .>W
M
M
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M7&[\4+C\4E-0#;_C=^*%Q^*2FH"'5V?R--^X "VP !D !D       (
M     0        ! .X )9S1/XS6KXY!^VAO0:,:)_&>U?'(?VT-YSG[_ /A9
MZ7>0 '/;@
M
M
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M88*NX0U%-4,DD^]/;A,*W&?UEF@                9
M   "NN-WXH7'XI*:@&W_ !N_%"X_%)34 ZNS^1IOW $!;8     (  $P!
M0                  G0    !G-$_C/:_CD/[:&]!HOHK\9[7\<A_;0WH.?
MOOX6>EWD !SVX
M
M                                                           =
M4U3! N)IHXUQGSW(AU>V-#^>4WUK?M(S ]0/+[8T/YY3?6M^T>V-%^>4WUK?
MM&8,O4#R^V-%^>4WUK?M'MC1?GE-]:W[1F#+U \OMC1?GE-]:W[1[8T/YY3?
M6M^T9@R]0/+[8T/YY3?6M^T>V-%^>4WUK?M&8,O4#R^V-%^>4WUK?M'MC0_G
ME-]:W[1F#+U \OMC1?GE-]:W[1[8T7YY3?6M^T9@R]0/+[8T7YY3?6M^T>V-
M%^>4WUK?M&8,O4#R^V-#^>4WUK?M'MC1?GE-]:W[1F#+U \OMC1?GE-]:W[1
M[8T7YY3?6M^T9@R]0/+[8T/YY3?6M^T>V-%^>4WUK?M&8,O4#R^V-%^>4WUK
M?M'MC1?GE-]:W[1F#+U \OMC0_GE-]:W[1[8T7YY3?6M^T9@R]0/+[8T7YY3
M?6M^T>V-#^>4WUK?M&8,O4#R^V-%^>4WUK?M'MC0_GE-]:W[1F#+U Z8:NFF
M7$-1#(J?O7HIW$C"7Z_T5MECI9JAC*J=%[)CFJN[GZB/6ZX+27NJKZA6,BF9
ML:Y47"KR^7N,)KUDL.M+%42PR5,,>Y7)M7&,],DQM-5:;E V.>EI8U:BNV2.
M;E.>.A2FTWOC.,-.9M+.U];%14;ZB=Z,C:B*KE151,K@C<VJ)MROIT@?!G*.
M5J]/'J>#BQ6O@L%5%"]S=T3%16KC_P 1#(:+HJ:IT3;99X(WROILN>YN55>9
MLM:UKS2L]F4S,VQ#,V&]4=ZI5GHIV3,W*S+45.:?#\)DU7"94@&@(4M]1'1Q
MX2-5<_#4PF<>'R$_7FF#9HWF]<RRI.8ZH]>M0>1SNAIW1.E3"[7-7H>&W:TI
M)*R&DK*B".HFD;'&Q&.\Y57&/G)'-;:&2599J:%TB\E<YJ9*BOD,4NO+%Y!
MU&1UK4>L291/OK>N.AIU;7TYB<L+3:O5=**BIE.@/F)JL8C57*IWGT6VT
M    !77&[\4+C\4E-0#;_C=^*%Q^*2FH!U=G\C3?N  ML            GK
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MJR@K[FU'[ZF+;O<U79QU5<)R0U6THI7,]V46F93( &AF
M
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MK2.GV93;4K$3,]WQO4YWJ>R*SW*9B/AMU9(Q4RBM@<J*GS'354%72MS54M1
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M:]8E1V'(BYV^GT,.'4X^*:Y8XMQ9F%@(J*F4!UTT:PPM8KU>J?E+WG87(;@
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M7$JNB8Y>JHBGT$3"83D@*#>
M
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M"0
M
M                                      !3_&_\(4_Q7^\XJ(MSC?\
MA&G^*_WG%1GI]C]"KS^Y^M8 !;:         G_#S3]#>J!R5-,R2=9G-1SG.
M1,(U%QR^4@ 153HJH:]2DWKB)PSI:*SF8RO^RZ)BL]2M5'%3M8CFR>8]RKAJ
MY[S&ZOKZ._7U]E[*1SUC;+]\3#>7K1<D#U??8+CIC3='!*QTE'"K)$;G*+M:
MG/YE(?E<]5R4M+:WM/,U+=5G4UJUC@I'1M)06Q*6RQP4",B>ZG:Q5RN,[<(0
M74FA9*B1U;6-II*B1R-<_>[*X3"=W@A2NYW[Y?G&YW[Y?G&GLKZ=IM%^_P!O
M]FIN::E<37^_^EPZ=T9:JFTU\M111/DB=AKE>[ER^$BENNM/I+5ES1&2,B5J
M1M;$B.QT7O4A.Y4[U^<XZEBNA.;<=LQ+3.K$1'#&)A=EFXAT5RNM/2QMK.TD
M7"*^-J)T5>YQEN(U_AM5FH73),OE37M;L:B]R=<KZS7U.70Y557JJJ:9V%..
M+1VAMC=VX9K/NX !?5  X Y       !8?!W\(S?\Z#^EQ?10W!W\(S_\Z#^E
MQ?)Y[XE]5V=A], !SEX                  %=<;OQ0N/Q24U -O^-WXH7'
MXI*:@'5V?R--^X "VP        7[P*US145(ENJ65;EIZ=4\UC=OIYY+G/>2
MS6_"^@U);JB6S4=+!7I&D44L\CTVJCL]V>Y5[BJ-%\,X-166EK(ZJJ[>5BO>
MR-&X;YRIWEG\-]"SZ4J89JI:EL4<SI7.EQR16HWN*&KPUM-J6Q+..O26O>JM
M,UNF:U]+<)*=\C)'1JL+E5,IUZHA(^#UXKV:IH+8RH<E ]97.BPF%7LW+G.,
M]40SOL@+Y0W.YQTU%41RRTU3*DC6HN6].OS';P.T5/734FH8VSJR.26+EC;Z
M"I\/Y1OF^=+-F,1UZ,K[*#_9='?\B?\ HB)G['>%OW#6V7";MTR9_P#J..>,
MNAI]445D6)LZK00RH[L]O>C.N?XIY.#U51V*HI]-35")6PLDD6)_IHBKN[N7
M12K,Q;0Q'M_MGVLI+3:JWB[1*G5+PG]:6][(U-VB:>1>;UKX\K_V2'GM?"B:
MAUQ2WERU?91UR52JNW:B;]WPX.SC'76_44L^GHJIJU%-4,G<UB+N1$8O7/+\
MM#9-HOJ5FOLCM$Y:Y&?T78*K4%V;#1/A8Z';*[M7*B*FY$Y81>?,LR_<&:6W
M2,9!65LCG1H]$<C.N5]7J+CX?:<2P::HNP6269:9(U:]$Y=_<;-3<UBN:HBO
M7##\8;BZP\.[O3TKG15CDBD8]B(J(BS,1>OJ1>XU-J)I*B>2:9VZ61RO>[Q5
M5RJE_P#$;0=TU)5-NE935$#H86P[(U;M5-ZKGG_&*%NE(M#<JND=G=!*^)<]
M?-54_L)VT1%<1.91:<R\P +*        0SFBOQGM7QR']M#:[C/^)O\ _)C_
M *'&J.B?QGM?QR']M#:WC/\ B;__ "8_Z%*>Y^I1E7M93_"K1]EU#I[6-3<J
M".HK*;=Y/(][D[-5:]<\E\40R?!*MGL_$:ZV:615H*:@58X6(BHUROB=G*\_
MRG?.1KAU<M616O4U!IK3[+E3UCEBGD5V%BRCD3'-.Y54M7@SHBKL]6Z_7>*>
MEN=73/@FI7[5:S[XW&%3GS1B+\IAK6B.+BG^A2)Z.Q_'+3+(YWK27?$*JCOO
M,?=X??"26[B%::^STURA@K4@G;O:CF-1R)ZTW>KQ-?>%E RHXAT-2Y[D=%<%
M1&]R]26>R6<_L[<U6[(TK%PJ=_FF-]#3B\4A-;VF,RDO_M":3_,KU]1'_F%D
M6/45)>;+%<Z5D[:>2G2I1LC41VU4SC"*J9^4AE\I*%.%EYC9/F!7MW28YHN]
MG_H4_HN6:-VHHX6;X&TSD8_/5O/"F$:-+UF:],,IO,3$+9O''+3-IK5I:FDN
M[I$:CLLAC5.?PR(2JT:XMETL=PNM/#5MIJ*F\JD:]C4<K-JNPB(Y4SAJ]Y ?
M8WT]&[2%+,^;-7V\R)$J=QT<?+M#4T]!%:WLGE@2H;,UN4VKAJ(B_,I'*K-^
M7$?\IFTQ&7OD]D%I-CE:M%>LI_\ (C_S"PDU10K8:N[]G4>34T7;/;M3>J8S
MR3.,_*4#8:_75?H*BMELTG'4VYKW/CJ4=YSEWN5?RO%53Y#.</M#7Y-$ZOH[
MS;ZBCJJQJ)!'EJJ_S79QS]:&5]'3C[=?*(M9(JCC]I6"9T3Z*\JYJX7$$>/Z
MPEM_XA6FQV^:LJX*UT434<Y(V-5<9QRRY"GXM3:OX96:FIJC3,"VZ%?)HJFH
M=S>JY?\ DKUY+\Q-^)]FFU&]EYTVQ]PJJ.'LF0QX1KW;LX7..YV2)TJ1:/'G
M)Q3C[O38N-NF[S5I3TM)=FORB9DAC1.:X[GJ9[7'$2T:-E[.ZP5TCNS;)_H[
M&NY.<K4ZN3O0KK3G$6]VZ%]HU%9:2WI3Q=@QRJJN<].6%PJ\S 6!&U'&ZRI6
MN[+_ $21,=>6R4GD5S,S'2/OW./V6#9^.FF+K<J6AIJ2[MFJ)60L5\,:-1SG
M(B9Q(O+F2G66O+7I)KG7*&LD1NW/8,:[TNG5R%=^R*AIT^XY>TVJR=ZQX3TU
M^]X_L(#KY\C]#/69NUW;MY?**:-+Q%O9$WF)PN*S\:-.76LBIJ:ENK9)'HQ%
M?%&B97X'J?&HN-FF[#=Y[=64EV?/#M5RQ0QJWFU')C+T[E/5H&R1S</UIVN=
MFLH(6JJ(F4S'W?.5]51:KX?ZHJZJTZ?2X6]8T@CGJ%1$<KD:Y>BIS16JAC%-
M.UIB/\IS:.ZY-%:NH-7T4]5;(JF..%Z,<D[6M7*IGEA5)$1'AOJS[K+;53K'
M#&^"1(WMBSA%QE47)+BO>.&TQC#96<QD !@D
M
M                                                      %(>R N
M4=#<Z9LC'N5:/=YO\=Q2GW2T_O$OZBUO9,_A:D^(_P!]QK^=W:ZMJZ58A0U-
MOIWO,RE/W24_O,OZA]TM/[Q+^HBP+'.NP]+I^$J^Z6G]XE_4/NEI_>)?U$5
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M'#")\.M*.TG;:FG>Z!\D\B2.=$BHBKC"JN26 &NUIM.93$8C$  (2
M
M
M           #7OV3/X7I/B/]]QK^; >R93_6U)\1_ON-?SM;?Z55:?FD[P ;
M@   !                   3H        $   (6[['C\,5/QBF_:<;3FK'L
M>/PO4_&*;]IQM.<K>?.W:?8 !4;                   5UQN_%"X_%)34
MV_XW?BA<?BDIJ =79_(TW[@ +;        @         (    (
M   &<T3^,]K^.0_MH;T&C&B?QGM7QR']M#><Y^__ (6>EWD !SVX
M
M
M                                     :]^R9_"U)\1_ON-?S8#V3.?
M;:D^(_WW&OYVMO\ 2JK3\T@0 W    0            "
M(  +=]CQ^&*GXQ3?M.-IS5CV._*\5/QBF_:<;3G*WGSMNGV  5&P
M          %=<;OQ0N/Q24U -O\ C=^*%Q^*2FH!U=G\C3?N( "VP     0
M )            "          .\   !G-%?C/:OCD'[:&]!HQHG\9[7\<A_;
M0WG.?O\ ^%GI=Y  <]N
M
M
M    &O?LF/PM2_$?[[C7\V ]DS^%J3XC_?<:_G:V_P!*JM/S2  W   '>
M0 (#/Z.TS6:DND-+30S/9(KDW1HBX5&JI@"_/8V-I<QJZ%5J_*9=LF>B=DG+
MK\)KU;\%)F$Q&92[3>AZ*VZ8K*"KB8M34T?DZ+)$W>U^U4RGKRIK_JW2%39M
M3NLU(R:HF2)LN'-1'85"^.*E'JZE6>X6F]04U/"LT^Q6(KMK4RB<V+SY%,:2
MO=PO^N&UUWJ75-6L#F+(K4;R1.281$0KZ$VZWSEE;PF%OX))/;:.IGJJV)\T
M+)'-[-OFJJ(JI^LCG$7AS%I*Q15\=543*^H;#MD8B)S:Y<\OXIL3?J2[U6G*
M!+)71TDOD6-STSYRL3:O1>AKYQ2I]74ML;!J:]P5]*V=F(XV(F'JURHOHIW9
M^<C1U+WMUDF(A6)(M%:>;J*NJ('RR1I%'ORQ$7/-$[R.F0L]XK[-,^6V5"P2
M/;L<J-1<IG..:%RV<=&*XDX(0+_YA6?5M/!?N#;;91]NVJK')M<[SHVXY)D\
M7#G7FJ[SK2UVZIO#Y(9Y%:YKHF(B^:J]S<]Q9W&K4[K!8K7#*LKI9DDB>Z-&
MX54:GC\)3FVK6\5F>[+$8RU; !=8@          M[V._X7J?C%-^TXVF-6?8
M\?A>I^,4W[3C:8Y6\^=MT^P "HV                   KKC=^*%Q^*2FH!
MM_QN_%"X_%)#4 ZNS^1IOW  6VL0 !(           &  P .X        ( $
M 2     ,YHG\9[7\<A_;0WH-%]$_C-:OCD'[:&]!S]__  L]+O( #GMP
M
M
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M?8\?ABI^,4W[3C:<U9]CQ^%ZGXQ3?M.-ICE;SYVW3[  *C8
M     "NN-WXH7'XI(:@&W_&[\4+C\4E-0#J[/Y&F_< !;8          "  !
M(   !P0.0 2  " #("0  !@#O"  !+.:*_&>U?'(?VT-Z#1?17XSVKXY!^VA
MO0<_?_PL]+O( #GMP
M
M
M  U[]DS^%J3XC_?<:_FP'LF5_P!;4GQ'^^XU_.SM_I0KS\T@ -Z  !   D
M   9>[7^LNEMMU#5)%V%"S9%L;A<81.?/GT0Q !$1CL " D
M     !;WL=_PO4_&*;]IQM,:L^QX_"]3\8IOVG&TQRMY\[;I]@ %1L
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MQR']M#>@T=T533IJ:UJL,N$JX?R5_?H;Q'/W_P#"V:,YR  Y[<
M
M
M                                   ->O9,_A>D^(_WW% &P'LF?PM2
M?$?[[C7\[6W^E56GYI  ;@  !            0   $ '> D
M6[['?\,5/QBF_:<;3FK/L>/PO4_&*;]IQM,<K>?.VZ?8 !4;
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M-MC431J_Z^H>7_ZF']LV[*&[[PZ_PR9FM@ %-TP
M
M
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MQLB<O=SFZSHVBT9@ !4;@                  0?BU^*]?\6D-8.:_ ;/\
M%K\5Z_XM(:P)X'1VGR.'\1^HY3IS"IX''><EI0<(N0O( (/R1T0Y1 H!J9^
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M*B)CQ54/9HNY7&[6"*KO-&VCK'.<CH6HJ(B(N$7FJ]QCP3$<3.-2LVX([LX
M#%L
M
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MJP9GARU:[6L-RI4[2A=$]J2].:-QT7GU)U*UM7+';ZFIIZG!*Y  478
M
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M  AD
M
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MARIUPG@9,C'#3\3*#X9/ZQQ)RO>,6F(7=*TVI$SX  8M@
M
M
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M22AT]2T\[',D8K\M<F%3+E7^TS(!6F<SE?K7AB*Q[  (9
M
M
M                 *5X^?[?!\4_ON*3^ NSCY_MT'Q3^^XI-.AU=O\ 3AYW
M>?6L(J]XP.X(IN51,G&#D!(@[E'0*!QW'/<.0 XP<] .[F$..HP%3P.4\%"7
M!RGJ 0!T.%YG(0 @4)T"@.[D$.$Y(<IW@.IQR^8Y[AR 90(IQ@YZ!#A0.\8
MY.$0Y0!*SN!WX3J/^=!_2XV(-=N!R_ZSJ/\ GP?TN-B3F[KYW=^'_2  5EX
M                 $'XM?BO7_%I#6%39[BU^*]?\6D-8?A.CM/D</XC]0"#
M)QGD6G/%4(O08R@1 ER[H$Z!!TR 3D<=5" (,8.>\8Y#UA)C&1U7U#(3H \1
MW8 P!PG4YQE5!QG '/4XZ=#E$\ G> 7KD#J$ X0YP#E.8(<'"=%.5.$$ B8"
M)XG/J  XQR.3A$Y=0,YHU?\ 7U"G_P"YA_;0V[-1-'8]OJ'XS#^VAMV4-WWA
MU_AGRV  4W4
M
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M&RIIWLDB?G#F.1R+A<=4^ ]
M
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M5L;'H:W,;T19?ZQQ+#%:6M7M+8Z>@219>RW>>K=N<N5>GRF5
M
M
M
M
M
M
M
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MNY$P?1\0QI$S:U55/6?8
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MM=NYMY[E=RY@;(T%6VLA=(QKFHCMN%/2>6W44=!"Z*%SW-5V[SE3.>7V'J
M
M
M
M              Y<-5? H7CEK^ICO#=(VN>:WU592QU#+@R;#8\/<JICUI'C
MKWE\O:CV.:O14PI6VKN"VE-57-E?=4K^W9$D*=E/M3:BJJ<L?\2@8SA/;[-9
M:*.LJ:F@JKK7QQ.J*C<U))9>:JYW/*JJN4C?LHZ'RK2D];!&LCEFA;YC=R]5
M[T)';_8]:)H*^FJX&W/MJ>5LK-U3E-S5RF?-\4+'J]/455:?:Z7M?)]^_D["
MY^$""TFJ:.FX/QQI+$M3#8D:D23-WJ]*?T<=<YY8,7P*F?4V:FOM1&^):B.6
M/LY.3DQ+CK_VGJAX Z.9>?;)6W+REM1Y0W_24QNW;NFWIDL>.Q4<=JBM[>T\
MGB<KF^=SRJJO7Y5 UKN&KZGB/JV"+R]]LM-/.M'5T<\R.94MW+E5Z)C'(OO1
M/M-:K7!;K6M$B4[%3$#VXQN5>B?"0JH]CKH:>>2:1MTWR.5[L57>JY_>F<T=
MP;TMI*MGJK0E=VLT?9.[6?<F,HOAZ@)+7U=HJJED=SAI=SFXW3O:F&Y7Q[LY
M-?\ CC/!;[U9?N11E/))7.2H=0JB[VY;C=M[NI<VM>%]AU8KI+FE6LG9)"G9
M3;4VHY7>'BJGAT=P:TQI:62>VMKDEE1N_M)]R>:N4[@)MIQ\[[=FI>]\F]>;
M^N#)@                                                 "B>./$
M6>AN\>D[<^:CJKA1LE97LF1&PKVC^[X(_'O+V*VU?P7TKJRY15UV2O[>.%(&
M]E/M3:CG+TQXN4##\*;?9K-0,KJVJM]7=*Z*-:BH5[4DE>F55SE5<JN5,9[)
M:@2KT5=JV&/M'HV!J;6[E_=6]Z?"9.G]CKH>">.:-MTWQN1[<U7>BY_>EFU%
MBHY[1);9.T\FD<CEP[GE%1>OR 0*RZGHZ7@[1Q=K%Y3!86-[+MFH]7)3HFW'
M7.4Q@PW V22MM='?JB-\/:)*Q8Y$\Y,.5O7Y#WLX!:.6\ON3VW+RCRCRA/\
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MS/L
M
M
M
M
M
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M+*VLW1L5)$3;C&47_B\.H%R AO"6^5>H-'QUU?.Z>=9GL5[FHU<(O+DG(F0
M   "GWZIOU9Q8L-+07!8[%)%BIIGL9E[_OG/.%7N9WIT N  B/$*@U976>JC
MT;<J>AKW(SL9)L8;AR*[.6.ZMRG0"7 \-@BKH;';HKO,R>Y,IHVU4K/1?*C4
M1[DY)R5V5Z)\![@    %/ZXU1?X[Z^BLMP6G[*J1KT<QBHK/!,HH%P
M   %4<.-57C4=V9(ZM<^ACF?%)'(QK554;E,83UIW@6N           !5*:D
MOE7K&X4%)7*R"FJE8K',;C9OQA%QD"U@        "K^*O$NFT[<4TU1NK(;]
M4P,J8)F1,=$UFYV4557.<,=^2O5 +0!KTMJXV7&E6Z6[5MLCM\[.WA8]&H]L
M:IE$5.Q7GCUDPX47W4+:R.QZQN"5]WVOE=+$QJ1JS\E,HUO/Y +5      1&
MLX@6FDUI;=,2Q5BW&OC[6)S8V]FB>?U7=E/07N\"7
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MR5L4SXW;'/[G*G)>B]Y'N&UOU=065L6M[E37"XI*]5D@QC9RVIR8WU]P$P
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M=KD3DO,J+@KKS4&I>)%?;[I<I*BWLH'3,B=$QN'HZ-,Y1,_E.[^\"^@
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M)S5JXZ_*!L&#ST-7'6TZ30HY&*JIYR84]
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M(-.Z9ME/3.EG\OW4JMI7-=M168\[GTYGK]CO;FVS04L#&-8BULCL-3">BS[
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MYX807&GT=21WJF=2UJ/DWQ+U1-ZX[U[L$J//#60R,15>UB_O7.1%/0BY3*=
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M/WM._O4EE+34=NI\4[(H(4:G1<)A.AWQ2QRM1T4C'M7HK5R!]@
M  .FLIVU5-)!(KD:],*K>I3U^]CKI6]7FLN55<KXR>JE65[8Y8D:BKX9C5<?
M*7. *TT#P;L&B;K35]KK;I-- KU:VHDC<U=S5:N=K$[E,_K?0EMUA<;#67*H
MK(I;-4^50)3N:B/=EJX?EJY3S$Z8[R6  5AKG@KI_6533S7.NNL+H5>K4IY(
MT1=RHJYRQ? L\ 5C:>"^G[79H;;!775T$3E<USY(U<N55>>&8[_ A_&NB@U'
MQ+TG8G/?Y-60.B>Z/S7IYSEY*J8[O OX\$UEM<]PIZZ:VT<E;3_N-0^%JR1_
MQ78RGR 4W3^QJTKVL=1+<KZV9'(Y6I-#C*+_ ,LMNIT]2U%EJ+8^2=()W(YS
MD5-R85%Y<L?DIW&8 &%L.G*2RQRLI99WI(Q&+VBHO)/@1/$QD6@[;'KJ+5;:
MBL6X1P+3I&KF]EMPJ9QMSGGXDM  AG$3AU:M>4'DEVJ:Z"/M6RYIGL:N6HJ)
MZ35Y<R9@"K=%\$=/:1KHJJW5UVEDCF9.B3R1JFYO1.3$Y$F70EM75-??O**S
MRNL8C)&;F[$1$:G)-N?R4[R6  B81$\"GM5>Q^TQJ745PO-=<;U'4ULJRR,A
MEB1B*O@BQJN/E+A %?\ #_A59=#OB=:JNXS+%(^1/*7L=S<W:OHL3N/+Q X.
M6'7%3#/=:VZ0OB?)(U*:2-J*KU15SN8O@A90 K"S<%M/VFSMMM/775T#7*Y'
M/DC5V57/<Q$_43.]::I+OIN:RU$L[:66D=1J^-41Z,<S:JHJHJ9QZOD,X *R
MX<<%]/Z!U Z[VBNNL]2Z!T&VJDC<S:Y455PUC5SYJ=XU[P8L&MJNFJ+I776%
M].US&I3R1M145<\]S%+- %6Z%X(Z=T9=)J^V5UVFEEB[%S:B2-6HFY'<MK$Y
M^:AG.(?#>TZZ3%VJ:Z#[TD/^C/8WDCE=^4U>>5)L *ETIP&TUIFIFGH;A>)'
MRM1JI-+$J)A<\L1H699K9#::1:>G?(YBN5^7JBKE?@1/ ]P Q]\M,%YMU11U
M+Y&131/A<L:HBHCDPN,HO,J*X>QMTE75+IY;G?6N5$3#9H<<O_I%V@"(Z*T=
M:M 6ZM2AJ:N2"3:^1U2K7*W:BIRVM3Q*QXKLI^)URGTM9I'55312QUSF1?>G
M(U(]N5=(FU4S*G).?-/67U+&R6-T<K&O8Y,*UR914/!16*TT-PEKZ*V45/72
ML[.2HB@:V1[>7)7(F53S4Y>I .K3-FBLEN;3PNE=E&J[M%151<(G<GJ,J]J.
M8YJ]%3!R (AHWA_;-*.:ZWU%;*K7N>G;N:O-6[5Z-0ELL:2Q/C=E$>U6KCUG
MT (G0:#MM%>?;.*HK%GV+'M<YNW'T<_K/O16B+=I&LO53;IZN5]UG\HF2=S5
M1KLN7#<-3"><O7/<2D 0^OX?VNMU35W^6HK4JZF-L;V->W8B(C4Y)MS^2G>9
M+4&EJ.^0MBJY:AC6Q=DBQN:BX^5%YF> $9GT9;YM/T-G=/5)34BJK'(YN]<Y
MZKMQW^!75S]CAI.XSMEFN=]:Y&[<,FBQC*KWQ^LNL 1C2&B[?I:U,H*">JEA
M93I3HZ9S5=M3OY-3F?-CT1;K/<XJZFGJWRQYPDCFJWFBIW-3Q)2 *\XA\);'
MKIU.MVK+E!V#WR-\FD8W*OQG.YB^!5=[X>V33]5)IRV5E?,L.'HDSFJ_SDW+
ME48B=YLN>&>SVR>K=53V^DDJ7)A9GPM5ZITZXR!4>N:];XW3UDLFVJADB\DJ
ME5%:^/.QJ85V$SU[E3D6;H:T+8=*T%L<CT6G:Y,/<BKS>J]4Y=Y[8K):X9FR
MQ6VC9*U=S7M@:BHOBBX,@!CM16B"_62KM=6^5D%2S8]T2HCD3.>645.[P,9I
MO1U!8*)U+1S54D;H5@S*YJKM\>34YDD $2X?:"MFAK=)1VJHK)HGSNG5:ES7
M+N5K6X\UJ<L-0^[KH>W7.ZQ5\\]6V:.;MT:QS4;NRBXYMZ<B5 ")<0=!6S7-
MKEH+K45D,4BL574SFM=YJY3TFJ1C1? [3ND;BRMMU?=Y96RQS(D\D:IEBY3I
M&G+F6H (C?- VR\WN:Z5-16,GE:UJMC<U&X1$3O:J]WB2NGB;!3QPL55;&U&
M(J]<(F#[ $6XB:'MVN[33V^[3U<$,$Z3M=3.:URN1KFX7<U>6'*5[<O8X:3N
M$S))KG?6N:W:FR:+IS_^7ZRZP!B=+V&FTYIJALE%)-)2T<*0L?*J*]4\55$1
M,_(5SJ[@)IK5%U2OK[A>8YDC2+;#+$C<(JKWQKSYEN "O;9PGLEOCMC(:RY.
M2@1B1[WL\[;C&[S/4G3!CM?\#].ZWU+->[K7W:&JE8QCF4TD;6(C4PF$<Q5_
M66F ('PVX7V;A_%5QV>KN$Z5,C)'^5/8["MSC&UC?$^.('"JRZX=*ZZU=QA6
M21DB^3/8WFUNU/28O<3\ 4]I3V/VF--:BM]YH;C>I*FBE26-DTL2L54\42-%
MQ\I..(FA[=KRT4]NNT]7!##.D[74SFM<KD:YN%W-7EARDI %.VSV/>E[?3K#
M#<;TYJN5V7RQ9[O_ )?J+/T_9:>QVZGHJ5\KXH(FPM614551J83.$3F9, "F
M;]['?2MZNE57U5RO;):B9\[FQRQ(U'/<KE1,QKRYES "&</>'=JT-1QTUJJ:
MZ9C-^%J7L<OG+E?1:AW_ '"6WVZI+GY16=O32=HQNYNU5SGGYN?UDL $8XA:
M*M^NK-!;;M/5PP0U#:EKJ9S6N5R-<W"[FJF,/7N\"0TE,RF8YK%<J*N>9W
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M9RJ*F>7@=6B-'4&C[536^VS54L-/&L375#FJY45V[GAJ$D
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MVS6V.3MFPK(]$1_/GE%S^4O?WD@ 'GH:."AIV04D?9Q,:C6MRJX1$PG4]
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ML,
M
M
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M/?N3L>PQTYYSA/@ D
M
M
M                     ,3J>T27NU.HXJZ:A<KVN[:'TDQW=4/)I72E%IYL
M_8-BDDF5KG2=BUKE5,\U5.J\R0@
M
M
M
K                                                      /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g377490g92n92.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g377490g92n92.jpg
M_]C_X  02D9)1@ ! 0$ 7P!?  #_[1?"4&AO=&]S:&]P(#,N,  X0DE-! 0
M      \< 5H  QLE1QP"   "    .$))300E       0S<_Z?:C'O@D%<':N
MKP7#3CA"24T$.@      Y0   !     !       +<')I;G1/=71P=70    %
M     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /
M<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4     0
M    #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T
M '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT
M:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $
M !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R
M8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;
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M(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP
M#F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P
M       -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N
M9P      .$))30/M       0 %_AL  !  ( 7^&P  $  CA"24T$)@
M#@             _@   .$))300-       $    6CA"24T$&0      !
M !XX0DE- _,       D           $ .$))32<0       *  $
M CA"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M     0 R     0!:    !@       0 U     0 M    !@       3A"24T#
M^       <   _____________________________P/H     /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H   X0DE-! @      !     !
M   "0    D      .$))301$       0     @   D    )      #A"24T$
M'@      !      X0DE-!!H      T$    &              $)   "+P
M  8 9P Y #( ;@ Y #(    !                          $
M     B\   $)                      $
M$     $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C
M=#$    $     %1O<"!L;VYG          !,969T;&]N9P          0G1O
M;6QO;F<   $)     %)G:'1L;VYG   "+P    9S;&EC97-6;$QS     4]B
M:F,    !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G
M<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X
M   -875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E
M $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @
M;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   !"0    !2
M9VAT;&]N9P   B\    #=7)L5$585     $       !N=6QL5$585     $
M      !-<V=E5$585     $       9A;'1486=415A4     0      #F-E
M;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO
M<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )
M=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=
M  MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N
M90    ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P
M   ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG
M   X0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$
M%       !     ,X0DE-! P     #6T    !    H    $P   '@  ".@
M#5$ &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D@     '_VP"$  P(
M" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.#@X4$0P,# P,
M$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,#/_  !$( $P
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M24I))))2E5MZEB56OJ<7E]9 >&5V/ ) ?M+JF/;NV.:Y6E4POZ3G_P#AAO\
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M+06$U[@""6R-?Y//YR+;6YVX,QO2G;R08@N.GT?YS_OBQ:_K#U#V%M=6[3:
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MQ\6QN%B7-LJK)MLD/CTV0ZV&N_=V>U28"09=5V/<NZUU&Z6EFYVDB).A,?\
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M '     4 $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P "  ,@ P #(
M-     $ .$))300B      $R34T *@    @ !P$2  ,    !  $   $:  4
M   !    8@$;  4    !    :@$H  ,    !  (   $Q  (    ?    <@$R
M  (    4    D8=I  0    !    J    -0   !@     0   &     !061O
M8F4@4&AO=&]S:&]P(#(U+C0@*%=I;F1O=W,I #(P,C4Z,#(Z,#@@,3 Z-#DZ
M,3D       .@ 0 #     ?__  "@ @ $     0   B^@ P $     0   0D
M        !@$#  ,    !  8   $:  4    !   !(@$;  4    !   !*@$H
M  ,    !  (   (!  0    !   !,@("  0    !              !(
M 0   $@    !.$))30/]       (          #_X0$Z17AI9@  34T *@
M  @ !P$2  ,    !  $   $:  4    !    8@$;  4    !    :@$H  ,
M   !  (   $Q  (    ?    <@$R  (    4    D8=I  0    !    J
M -0   !@     0   &     !061O8F4@4&AO=&]S:&]P(#(U+C0@*%=I;F1O
M=W,I #(P,C4Z,#(Z,#@@,3 Z-#DZ,3D       .@ 0 #     ?__  "@ @ $
M     0   B^@ P $     0   0D         !@$#  ,    !  8   $:  4
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M#@\,$!<4&!@7%!86&ATE'QH;(QP6%B L(",F)RDJ*1D?+3 M*# E*"DH_]L
M0P$'!P<*" H3"@H3*!H6&B@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H_\  $0@#/0;5 P$B  (1 0,1 ?_$ !T
M 0 " @,! 0             &!P0% 0,( @G_Q !>$  ! P,!!0(&"@X) P0
M 0T  0(#! 41!@<2(3%!$U$4(C)A<9$(%1<C,T*!D['1%C0W4E-5<G22E*&R
MP>$8-394<W6STM,D8H(E0^+P)B>#HL+#\3A$159C9(3_Q  : 0$  P$! 0
M             0,$ @4&_\0 ,Q$!  (! @4!!@4$ P$!      $"$0-1!!(3
M(3%!!10R4I&Q%2)A<:$S@='P(T+!X?'_V@ , P$  A$#$0 _ /5(
M
M
M
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M:J[Z>^JF?_T2\P
M
M
M
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M6@Z31E@HJ:;P>MNT+9&RW%(-R25'2*Y$7BJ\$5J<_BDT
M
M
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MRZ\R7FLL]XLUQC_]%N-OJXU54_Z2=DB93GY*FS
M
M             !1.T+;S/I*ZMHV6"*J17R-WW52L\EV.6ZH%[ \R1^R@G=ST
MS3I__P!R_P"PWMO]D1%4X[:V4,.5QQKT_P!H%_ KK3VUBP7)C5K+G9Z-59O8
M?<(^"YQCBJ$XMMVMUS8K[;<*2L8CMU74\S9$1>>."KQ S0
M
M
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MV@       PKC=J"VM:ZOJX:=KG;C5D=C+NX#-
M                                                    @>H]DNCM
M15/A%VM+IYD5SD=X5*SBY<KP:Y.I/ !4DNP'0JJO9V7'IK9_]QH[A['JQ/:Y
M*&@IXUQPWJR?GZU+W 'B;;)LGJ=!VF&YN\#2FGJDIV-AFD>Y,L<[BCD3AXJ]
M2U?8DK65NF;C4OE8L4=P<UR*F%^"9YO.9OLQ?N=VG_-6?Z,IU>PW_L%>?\S7
M_2C OP
M
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MG-C?K+6*KI]IT=H;''J::BH6*J1M7LWJJO[N"KTR6C#-',S>B<CFYQD#[
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MMM;5Z6<+!!@V6C\!I%B3>XO5WC+Z#.+ZS,QF8PSVB(F8B<@ .G(
M                 *(]F+]SNT_YJS_1E.OV'']@[S_F:_Z49V>S%^YW:?\
M-6?Z,IU>PW_L%>?\S7_2C OP
M
M                                                     (/MO^Y3
MJ3\W3]]I."#[;_N4ZD_-T_?:!T;$/N?6/\S83\@&Q#[GUC_,V$_
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MTS*=&X8Y&JJJN?3Z2W2XN+7K.IG$?[W5:O!36EHT\9G_ 'LL( 'N/
M  41[,7[G=I_S5G^C*=?L./[!WG_ #-?]*,[/9B_<[M/^:L_T93J]AO_ &"O
M/^9K_I1@7X
M
M                                       $'VW_ '*=2?FZ?OM)P0?;
M?]RG4GYNG[Z =&Q#[GUC_,V?Q)^5_L0^Y]9/S-A8
M                                   /AL4;9'/;&Q'NYN1$RORGV
M                         Z):*EEE[66F@?+RWW1HJ^LYFI*>=C6SP12-
M:F$1[$5$3S9.X'/+79US6W=4--!#$D4,,<<2+E&-:B)ZCX@HJ6G55@IH(E5<
MJK(T;E?D,@#EC8YK;L6>W4,\BR3T=-*]>;GQ-<J_*J"&VT,+VOAHJ:-[5RCF
MQ-14_890')7.<)ZEL8RQIZ"CJ%S44E/*N<Y?&COI0^6VN@:W#:&E1.Y(F_49
M8')6>^"-2T1C+HEHJ69D;)J:&1D?D-=&BHWT=Q]+2P+#V*P1+%G.XK$W?4=H
M'+&R.:V[#9:[>R1LC*&E:]J[R.2%J*B]Z+@[*BBI:E56HI8)57J^-'?29 ')
M7&,)ZELYRPVVJW,7+*"D:O>D+4_@?<EOHY6(R2DIWL1<HUT;51/V&2".G7Q@
MZE]Y0G6-++)=::FIJ.1T#XO&='&JL1<KSPF.B$HL4*T]HI8E;NJQF,8QCY#.
M!5I\/%-2VIGRNU.)G4TZZ>/  #0S           UU]HWUE%(C'JU6QOX(F<Y
M0@MBK:NR0,@=8ZJI5JJN^D:IG/\ XJ66#)K<+U+QJ5MB8_O]VS0XOITG3M7,
M3_;[*^TE::BLN-16S12T2,J&RI')&J;R95<=#-U0M=<KA/;((:J&)BM>E2U'
M*UWBIP3'I[^A- <5X**Z73B?W_5W/'3.KU9K^WZ?Y_NBFI;5N4+9*.G3>CBX
MLBCXO7Y.I&J"FK;@K:>2AJ:9(TW]]\;L+QY<D[RT 1J\!6]^:)Q&R=+VA;3I
MRS&9W  ;WG@       *']F+]SNT_YJS_ $93X]AQ_8*\_P"9K_I1G9[,7[G=
MI_S5G^C*=?L./[!7G_,U_P!*,"^P
M
M                                                         @^V
M_P"Y3J3\W3]]I."#[;_N4ZD_-T_?:!C[$/N?6/\ ,V%@%?[$/N?63\S86
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MW>+Y[^16AV4\3IYXXF81SW(U,\LJ98]J<3/K]FJ?97#1Z?=8WV>,_N\7SO\
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MRITQZ%.]'BZ:MN3$Q/Z^JO6X.^E7GS$QX[>G\-J #6R
M       *']F+]SNT_P":L_T93X]AQ_8.\_YFO^E&??LQ?N=VG_-6?Z,I@>P^
MN$4.D;G2.:]99;BY6JB)CX)GG\P'H<!.(       (SM,NU58M WVZ6^7LJND
MI72Q/W4=NN3KA>"_*4YIE=MFI]/4=\M>J[+'0UD?:1,G@C1Z)E4XHD"IGAWJ
M!Z)!4NQ?5>H+G0)!JVN96W!]4]&211,8U(T8U41=UK>.=[IU+:     5;L@U
M1?=27G5D5TK6S4]NN"P0M[)C%:S>>F/%1,\&IS M(
M==1,V")9'HJM3N/.M?M2U*NT>VVJEN*LH9;NE+)&ZGB\:-9D;NYW<\L\<Y ]
M' %20ZLU!6:SM=+2US&V]:GLZB-\3,O;O8PB[JKR\Z 6V
M
M                               !!]M_W*=2?FZ?OH3@@^V_[E.I/S=/
MWV@=&Q#[GUC_ #-A/R ;$/N?6/\ ,V$_
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M8_VGVLAU"]58JU$[)/%S_P!W/U@6T
M
M               !!]M_W*M2?FZ?OH3@@^V_[E.I/S=/WT Z-B'W/K'^9L)^
M0#8A]SZQ_F;"?@                                        8MQ^UT
M_*0IR3X1_I4N.X_:Z?E(4Y)\(_TJ!\CF$.$ Y" ( & $ (  !RU<*B]QQT.
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MZFH?\!G[J 9H
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MW!;<R=:A)%D9VN]E5QG<QCCW$ET_8Z:QT[X:1\SVNW459515X)A.2(;4
M
M                                            (/MO^Y3J3\W3]]I.
M"#[;_N4ZD_-T_?:!T;$/N?6/\S83\K_8A]SZQ_F;"P
M                       ,:X_ )^44W+\(_P!*ER7'X!/RD*<D^$?Z5 ^!
MZ1D(  1.8 9 3J  Z ?*  'R@ $ !#CO.>1PG4#D!  '10@ ($ 0  @ < ,
M !D !P  ^X?A$+?L?]34/^ SZ$*@A^$0M^Q_U-0_X#/H0#0:BU!7T%S?34D<
M#D1J*F^U<\4])CRW^^4<M&ZX4]+'!.Y%WFIE=WAE>#NY3#U:J-U%(KE1$W&\
M5]!D:FJ(:FEM45/)'-)N*W$;D<K55&HG! )?;:ME;2-GC7+554SC'(R2"25\
MMKT[' K9&2MDXKO*Q<*JJ8<S9Z>%U2E_?*K4WNR29<KYO* L<$'6[S3:?I-U
M\K)=]5<])%RJ9<=%@@N%V=VR7"JB8Q^XK5<Y47AGO\X$_!7ES?6)6RTKKA/
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M^:L_T93K]AO_ &"O7^9K_I1@7X
M
M                                                       $'VW_
M '*=2?FZ?OM)P0?;?]RG4GYNG[Z =&Q#[GUC_,V$_*_V(?<^L?YFPL
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M?\U9_HRGQ[#C^P5Y_P S7_2C OL
M
M                                                        (/MO
M^Y5J3\W3]]I."#[;_N4ZD_-T_?0#'V(?<^LGYFPL K_8A]SZR?F;"P
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MA>'!?Y ;T'#%56-5R854XH<@
M    41[,7[G=IQ^-6?Z,IU>PW_L%>?\ ,U_THSL]F-]SNT_YJS_1E.OV&_\
M8*\_YFO^E&!?@
M
M                                          0?;?\ <IU)^;I^^A."
M#[;_ +E.I/S=/WV@=&Q#[GUC_,V$_*_V(?<^L?YFS^)8
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M;R7T^*<Z'PVX2LA\:F2%=QZ\U\9/Y@30
M /E[VL3QE1/E/HK+;;LQH=>6E];(ZN==;=1S^ PT\C&MEE5N6M=O-7FYK4YI
MS L":XQ1*J+QQW*AH+EKBCH6N<^GF=NIGQ5;]9Y"CV):[5/&T[5)_P#GHO\
M<;RW;!]0R*GAEIKX^/'=GBY ;_V26T2AU5INEM-)1U,,M-7MF<^16JU42.1,
M)A?^Y"4>P^K6PZ2N=(YCE?+<7*CNB>],^HPM.>QRMDZ,6\.O-.[<RJ,GB\K/
M+R%Z%^:9T_2:=I)::A?,]DDG:*LKD5<X1.B)W ;<
M
M
M         (/MO^Y3J3\W3]]"<$'VW_<IU)^;I^^T#'V(?<^L?YFPL K_ &(?
M<^LGYFPL                                         #&N/P"?E%-R
M<9'^E2Y+C\ GY13<OPCO2H'QR/HX]( )U R .#G(X\1T #@$     ,'' #D!
M.(P Z@#H!PIS@(<@< 9"     '4 .@.%_8!R@"!0/N!/?$+?L?\ 4U#_ (#/
MH0J"#X1"W['_ %-0_P" SZ$ ^JFVT55(LE32PRO7@KGM15.IMDMC7(K:"F14
M7*+V:&P 'Q#%'"Q&1,:QB=$3"&))9[=(N9**G<O>K$,X 8=/:Z&F>KJ>DAC<
MJ856L1.!]U5!2U2HM33Q2JB817MSP,D =--24],W=IX8XTQC#4QP.I+;1).V
M9*6%)6\$?NIE#+ &+4V^CJD:E1312HWBF\U%P*:W4=*Y'4U-%$Y.2M:B&4 ,
M*:U4$[MZ:C@>N57+F(HAM-O@?OPT<#'8QEK$0S0!@/LUM>N7T-.J^=B'?2T5
M-2?:T$<7#'B-QP,@                              $7VCU%;3:;62VR
M3QU';,3,.=[''/(\@W/66TB*Z5C6734W9-F>C41TN$3>7&#W,?#XFO3#L@>&
MZ;7^T&%V9[CJ5R8QQ?(2*V;8]04,K'U_M]*QKLN1TB\4^4];5-JIJAN[(C\9
MSP<1ZY[.[%<HWLJF5*M<W=7=EQP]0%4:?]D=;7;E/56BXK*UO%[Y6<5SYST!
M153:J-SV)A$7',\![5;3363:=>K90H]*6GJ6L8CW97&&KQ7Y3WW0T45%&YD"
M.W7+O+E<\0,@
M
M                                         (7MG@EJ-E^HH:>)\LKZ
M=$:QC5<Y?&3DB$T.FLIHZNFD@F15C>F'87 $*V+P34^@[-'41212-I&(K7M5
MJHO<J*3LZ**DBHX&10(J,:FZF5SP.\
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M5IDZG/0W'@--W.]8\"I^YWK'O.GN=2K3@W'@--W.]8\!I^B.]8]YT]SJ5:=
MO$W"45-U1WK'@5-W.]8]YT]SJ5:F#X1"X+'_ %-0_P" SZ$*WBHJ??3".SZ2
MRK4U&VND:WDD343U'=-6M_A=5O%O#OEJ(8OA98V?E.1#X964SW(UE3"YRKA$
M1Z+DBU_ES=GPU/P6ZBKN\^1N*"R43$@GC:_?\5Z9=UYG%=6UK3%8\.8M,SB&
MX!@U5TIZ698I5?OIW)DQF:BH7O1B+)E5QY)9.I2)Q,NN:-VW!J)=0T,4BL<L
MF4_[3-97POI9)T5W9LY\.(C4K/B2+1/JR@:9VHZ!KE15ERG_ &&;2W&"II'5
M,2N[-J[JY3"Y_P#JB-2ENT21:)\2S :I]^HF/5BK)E%QY)K[GJ)&(Y*-RH_A
MC>8<VUJ5C.43>L)*#36B]1U6&2*Y9/%3R<)E3<G=+Q>,PZB8MW@ !TD
M                             '@S;E]V;4?YXW]UI[S/!FW+[LVH_P \
M;^ZT]Y@
M
M                                #0W?5-#:[K;;?41U#IJ^7LHE8UJM
M1<HGC95.'C)RR!O@
M   =-7\%\I6S_+=Z2R*SX+AWE;O\MWI,'&>C/K>CY !B4!R<  <H< A(AR<
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MF*3RS#JL4;$IT5&MSNL7./,;0TUIHKC2N5)YX71Y:B(WN3Y#<E^E\/>,+*>
M %CH                                  '@O;E]V;4?YXW]UI[T/!>W
M+[LVH_SQO[K3WH
M
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M3'3,5JN57)O2-55RO/Q4+I*>V#VNWMEOM;'3,943R0S/?E<N<N^N?6JEP@
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MS;E]V;4?YXW]UI[S/!>W+[LVH_SQO[K3WH
M
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MC_/&_NM/>AX,VY?=EU'^>-_=:>\P
M
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MHC$(YI^)]75OF5,I%)S3@2LP+3;_ &O9*W?1^^J+P;@SSG1I-*]_+FE<1W
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M>SS,D T1&(PMB,  )   >"]N7W9M1_GC?W6GO0\%[<ONRZC_ #QO[K3WH
M
M
M        $4V@ROBHZ=6+A?'^A"L?#JC[]/4A96T;[2IO_/Z$*LZ'RWM6TQKS
MB7UGLBL3P\9C_<LE*ZH^_3U(<^'3_?\ [$,4'F\]MWI\E=F3X=4??IZD'AM1
M]^GJ0QCD<]MT\E=F3X=/]_\ L0X\.G^__8AC'(Y[;G)79D^&U'WZ>I!X=4??
M_L0Q@@Y[;G)79D^'5&?+3U(<>'5''QT]2&.!SVW.2NS(\.J/O_V(<^'3_?\
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M*O,O;FF9  =N0    !TU?P7'O*V?Y;O2635_!?*5L_RW>DP<9YAGUGR #"H
M<G!( (<D#@')P2   R[54I25\4[E5$9GDF>BH=5;*DU7/*G)[U<GRJ=)R3S3
MCE3GMAP=DDSY&,:]<HQ,-X<CK.4ZD9 X "   #E#@= .3@  <H#@@ #DD#@
M#[C\M.\L6U_U;2_X3?H*ZA\M"Q;7_5M+_A-^@V<'YE?H>99(-)=;U)1UCH(Z
M=)51$7RL'3[?53'Q)44"Q,D5,.<Y>7?R-<ZU(G"V=2L=DA!U4DZ5$*2-QA>Y
M<G:6Q.>[OR &JI[C6/WEFH71M1<955Y=_(YFT1Y1,X;4&FIKRZ:MG@6%$2/K
MO<S<BMXOX(M$^ &HN-W=231QI"CM]^YE78P=M5754;E["C=*G1453GJ5[_HC
MFAL@?,3E=$QSF[KE1%5.Y>X^BQT
M    /!>W+[LVH_SQO[K3WH>"]N?W9=1_GC?W6GO0
M
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M=1_GC?W6GO,\&;<ONS:C_/&_NM/>8
M
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MGC?W6GO,
M
M                   (OKS[4@_\_H*W+'U[]J4__G]!7* !YCCO.0"!>0.
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M/+<_P\GY2_2>=QWF&;7\NL (8% !D=  '0<@  0 $  !   .#D @    !T
M  9 #H @! %"<@ 4 #NI?AVGIO2/]EK1^:1?NH>8Z7X=IZ<TC_9:T?FD7[J&
M[@?BE?H>9;8 'I-(
M      /!>W/[LNH_SQO[K3WH>#-N7W9M1_GC?W6GO,
M
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M>W=3-56;[6NWD;G'?G)"+K6NN-:^I>W<5R(F,YY(88 #!PG4YY .@Z#J.:X
M!     ( @ VFG?MYWY"_2A;3/(;Z"I=._;SOR%^E"VF>0WT <@
M          ,"]_::?EI_$\MS_#R?E+])ZDO?VFGY:?Q/+<_P\GY2_2>=QWF&
M;7\PZPG( P*!.H0=X3@       $  ! G4 @  = !@   " (    ( $  =X0
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M\@+7
M                                  $7UY]J4_\ Y_05P6/KS[4@_P#/
MZ"N, .0   ( '(   B<QT"<@ '0    " (@       . .1U4=  0    @  <
M0-GIW[?=^0OTH6VSR&^@J33GV^[\A?I0MMGD-] '(
M # O?VFGY:?Q/+<_P\GY2_2>I+W]II^6G\3RW/GMY/RE^D\[CO,,VOZ.L &!
M0!   0)U'(   " =0    #  Y.!T" ,! @0  <@<*,  $  !.H 0!T 0 =U+
M]L,/3>D?[+6C\TB_=0\R4GP[?E^@]-Z1_LM:/S2+]U#=P/Q2OT/,ML #TFD
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M]J"4E1P9X*V5%X(N,^62+;E#'[0Z#MU>Q)H$K60JQ.6,(BIT7D6G[C&S[_\
MMFE^<D_W 1G9K-<*/26J75K:CP.FMZ+2U<KEQ4,;')[XBKWHC5X=Y ;'0W?:
M5=O:=D]=06=6+,EU@<Y[5>WXG-$ZKUZ%VZ_@I[/H2XT%NC["!UMGIV,;Q1&I
M$K6IQXX1#2>QQM\=/LYI9'L:M1V\R;Z*O+> A>SJSU.CM6Q6YETJKM'45C6/
MDF<J=GNJJ<LKSR:3V0NBI+EJRX7*GNU5+)--"BT#6Y;$B0(F\G'S=WQB8;-Y
M4ONM;S,S/_I]S5B]IP7RW>3CT=3KU%5LN6V._P!HPY704\<OC<&_!P\E3CGQ
MP)5LNV9NTA21N=?JROWY&S[LK,8\5$W?*7AP+,7@F5.NG3=IXD[FHG[".Z\U
M)#IN@@EG2=>W>L;>R:BKG&>.50"N=;7&?4>U6T6*@B6HLM92HDU;$Y7LC>G:
M.PJ<E7Q6^M#6WBC;I>]TD+'^(ZK2%KE3<WD1R=Q%],;.-JM1NW"V:IM$$D3U
M:USY'Y1<?X*IR4UVNK'KS2]VT]4ZWOU'<HJNXL9$E*Y7*U^\BJJYC9PQZ0/0
MVURN9;="UU3(]&-8^)-Y783B]$YFMV04*P4U95[BHVLCAE:[=QO(J.7.>O,T
MOLCI9ZG05SM]/)N/<Z!R;WD\)&KZ>A/M TS:?1=A3"=I[7TZ/5.JI&T#?@
M
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M^TT_+3^)Y;G^'D_*7Z3SN-\PS:[K !@4 0<QR # R$  Y.  "  !T" !D#O
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M:2*^P6M:.=9)6;Z/14PG!5__ %26TTJ3T\<J(J(]J.1%\YS6];>)1$Q/AV
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M,W>GI0EEOI6T5!34D;E<R")L35=S5&IC*^H[P
M
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M/\/)^4OTGJ6]_::?EI_$\M3_  \GY2_2>=QWF&;7\O@<@.A@4 0#   Y X
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M@O;G]V74?YXW]UI[T/!>W+[LVH_SQO[K3WH
M
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M9X,VY?=EU'^>-_=:>\P
M
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MO)+"L5YTW+34$$55;G52LC8C$W=[?5$3'IR7QJVM>:YB,+(M,VF,I)1U,=7
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M0R-KI(V*JJQR\T7Y21EE;1:,PZB<QF  '20
M           !X+VY?=EU'^>-_=:>]#P9MR^[+J/\\;^ZT]Y@
M
M                                                          !7
MFV3^K:+TR?0A19>FV-/_ $VB],GT(46>3Q?]1DU?B !T,JH Z#H 0Y.  0 =
MX !  '48     @P .3@  G4   @   (      2#1']</_P )WTH>E8O@F>A#
MS5H?^N'_ ."[Z4/2L7P3/0AZ?!?#+3H>'T #:O                  !@7O
M[33\M/XGENH^'D_*7Z3U)>_M-/RT_B>6Y_AY/RE^D\[CO,,VOY=?0 =# H
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MAX,VY?=FU'^>-_=:>\P
M
M                              KS;'_5M%Z9/H0HO!>FV/\ JVB],GT(
M46>3Q?\ 49-7X@(!DRJA $Y*.@ = $  )R #J $  #B   !.H3@   '0 $ 0
M  $    ,  !W@ 2#0_\ 7+_\%WTH>E8O@F>A#S5H?^N'_P""[Z4/2L7P3/0A
MZ7!?#+3H>'T #<O                  !@7O[33\M/XGEN?X:3\I?I/4E[^
MTT_+3^)Y;G^'D_*7Z3SN-\PS:_F'6.@!@4 & G, $ 0 <G&0@ (   X@
M0  .H   =  '0  $"  .8Y !S.0!V4OP[3TYI'^RUH_-(OW4/,E)\.WY3TWI
M'^RUH_-(OW4-W _%*_0\RVP /2:0  8MQMU'<H6Q5]-%41M=O(V1N41>6?VJ
M:S[$-/?B:A^:0WH.9K6?,(Q$NJDIH:.FCIZ6)D4$:88QB81J>8[0#I(
M                                     /!>W+[LVH_SQO[K3WH>#-N7
MW9=1Y_OC?W6GO,
M
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MP3/0AYKT/_7#_P#!=]*'I2+X)GH0]+@OAEIT/#Z !N7@
M  P+W]II^6G\3RU4?#R?E+])ZEO?VFGY:?Q/+4Z>_P GY2_2>=QWF&;7]'P
M# H @0Y X'0!     *,@     !    .0. <'( (   '0      [:3X=O_P!Z
M'IS2/]EK1^:1?NH>9*3X=IZ;TC_9:T?FD7[J&[@?BE?H>9;8 'I-(
M                                           /!>W+[LVH_P \;^ZT
M]Z'@O;G]V74?YXW]UI[T
M
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M)\.WY?H/3FD?[+6C\TB_=0W<#\4K]#S+;  ])I
M                            !X,VY?=FU'^>-_=:>\SP9MR^[+J/\\;^
MZT]Y@
M
M               !7FV/^K:+TR?0A19>FV3^K:+TR?0A19Y/%_U&35^( !E5
M      #DX   #:RWN:73L-H6-J0Q2=HC\KE5ROR=35( 3,S/E.7TQ[F+ECE:
MOF7!\@$(  !RUSF<6.5N>Y<!55RY<JJO>IP@ ( .@#H$ P 3D    0   )!H
M?^N'_P""[Z4/2L7P3/0AYJT1_7#_ /"=]*'I6+X)GH0]+@?AEIT/#Z !N7@
M                 P+W]II^6G\3RW/\/)^4OTGJ2]_::?EI_$\MS_#R?E+]
M)YW'>89M?T=8.3@P* =     ! $ =0 H  ( Z!!T #      $Y  $    Y X
M '0  .0';2_;#3TYI'^RUH_-(OW4/,=)\.T].:1_LM:/S2+]U#=P/Q2OT/,M
ML #TFD                                                  '@S;
ME]V;4?YXW]UI[S/!FW+[LVH_SQO[K3WF
M
M                                           %>;8_ZMHO3)]"%%H7
MIMD_JVB],GT(47T/)XO^HR:OQ  ,JH . .0 @! #D <#  !!T  =0@ ! G4
M$Z@( "=0  0#J<@<#T <@     "0:'3_ -8?_@N^E#TK%\$ST(>:]#_UP_\
MP7?2AZ4B^"9Z$/3X+X9:=#Q+Z !M7@                  P+W]II^6G\3R
MU/\ #R?E+])ZEO?VFGY:?Q/+4_PTGY2_2>=QOF&;7]'P$Y &!0(/0 @    @
M'4  .8 !#D#@  #DXP  '0 , Y. " (.H <@$   #DX!R!V4OP[3TYI'^RUH
M_-(OW4/,E+]L,/3>D?[+6C\TB_=0W<#\4K]#S+;  ])I
M                                  !X,VY)_P#EEU'^>-_=:>\SP9MS
M^[+J/\\;^ZT]Y@
M
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MFM9RT:-9B.ZS@5G[JT?XH?\ K'_Q'NK1_BA_ZPG^TUKEF K/W5H_Q0_]8_\
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MD1.^I1/_ -4"T 1G1NKJ;4Z2>#QLC<R-KW-;,CU3/1<(28
M                      !PKD3FJ)Z0.0=3ZF!B9?-&U/.Y$,2:]VJ!%6>Y
MT,:(F55\[$^E0/#FW)/_ ,LNH_SQO[K3WF>!]M%3!5[7M03TLT<T#ZMJMDC<
MCFN3=;R5."GO6*6.5%6)['HG#+5R!]@
M
M                           !Y[VDVVFN&N**.I1RM6XX7"XYO:BGH0@]
M]T''<KW37'PQ['1U*5&XD2+GBBXSGS 9'N<Z?_!5'SRG'N<Z?_!5'SRDQ $/
M]SG3_P""J/GE'N<Z?_!5'SRDP $.]SG3_P""J/GE'N<Z?_!5'SRDQ $.]SG3
M_P""J/GE.?<YT_\ @JCYY28 "'>YSI_\%4?/*<^YSI_\%4?/*3  0[W.=/\
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ML4M"USXI\JUO*5>XV?N<Z?\ P51\\I*+?2I1T[8D=O81$SC')#) A_N<Z?\
MP51\\IQ[G.G_ ,%4?/*3$ 0[W.=/_@JCYY3GW.=/_@JCYY28 "'>YSI_\%4?
M/*<^YSI_\%4?/*3  0_W.=/_ (*H^>4X]SG3_P""J/GE)B (=[G.G_P51\\H
M]SG3_P""J/GE)B (?[G.G_P51\\H]SG3_P""J/GE)@ (?[G.G_P51\\IQ[G.
MG_P51\\I,0!#_<YT_P#@JCYY3CW.=/\ X*H^>4F( A_N<Z?_  51\\H]SG3_
M ."J/GE)@ (?[G.G_P %4?/*/<YT_P#@JCYY28 "'^YSI_\ !5'SRG'N<Z?_
M  51\\I,0!#_ '.=/_@JCYY1[G.G_P %4?/*3  0[W.=/_@JCYY3GW.=/_@J
MCYY28 "'>YSI_P#!5'SRG/N<Z?\ P51\\I, !#_<YT_^"J/GE./<YT_^"J/G
ME)B (?[G.G_P51\\H]SG3_X*H^>4F  A_N<Z?_!5'SRCW.=/_@JCYY28 "'>
MYSI_\%4?/*/<YT_^"J/GE)B (=[G.G_P51\\IS[G.G_P51\\I, !#O<XT_\
M@JCYY1[G.G_P51\\I,0!#_<YT_\ @JCYY1[G.G_P51\\I, !#O<YT_\ @JCY
MY1[G.G_P51\\I,0!#O<YT_\ @JCYY33ZOV?V*GT[62QQ3H]J-QF5?OD+),.\
M4*7*VS4CG[B28\;&<85%Y?(!46P:FCI=0ZABB148QC6IE<\$<I=)$-%Z.9IN
MZW*J95.F\+Z+'N[OC*O?QYDO
M>8-J^T':=HB]]C7SVIM)622NHT9"UZ]DCL)O=RX5#T^8%SLUKNCHW7.VT58Z
M-%1BU$#9%;GGC>1< >-5VQZ[K_$\(H%Z_:[4/E:K7.H?>5?0.[3WODC>9[";
MI33K%RVP6EOHHXT__5,F*QVF%46*UT+%3BBMIV)_ #R?I+81J*YW%]9?8J1U
M/(S?;V53A=[*>;NR>N*&CAHHW,@14:Y=Y<KGB=T<4<34;&QK&IP1&I@^@
M
M
M
M
M
M
M
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M/1D\+)41Z)G#FYXXZF::S35'%0V.@AA<]S&4\3$5R\<(U$0V8
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MDD(9LGL=+9]&6AE*^9R)3(Q.T5%X9ST1"9@
M
M
M
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M?X- J=IG.=SCS):?$$388(XF9W6-1J9YX1,'V
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MI'10LW&K(J*N//A$-@
M
M
M
M
M
M
M
M
M
M
M
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MZKI.RE2)4G5O%53.>"@6(      X5R)S5$.0
M    $-H=?T=7KJ[:791U"5-NC21\RJW<<B[O+CGXZ>H"9    .0 %4[0MM=J
MT5J"HM-7:JZKEA:QRR0*S=7>3/5?.?>@ML]KUC5)!2VJNI7+,R%%F5O-W7@H
M%I@  #0ZQU-3Z7HJ>IJH)9FS3)"B1JB*BX5<\?0;*UU[+A Z6-CF(UV[AWH3
MZP,P     !%-)ZVI-255P@IJ6>)U%4>#O5ZHJ.7*IE,=.!*P !PKD;Y2HGI
MY!USRI#"Z1454;T0@VDMI=#J35-\L=/;ZN":U2K%)+(K=V14>K<MPOF GH
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MVQU$:206^J9)&R1,L:N$\E.GE$^VV7"DM.S6\N<L:.3L7)$CD1SLS,3*)_\
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M5</9U4D"->F^CDWN?0C\>D;W/MHM^J*RE8E)#3NB=*V5O#WM[4\7.>;D+5
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MD<J>,W*<G%C #S58-/[9-)^%PZ<M=O2GJ).T=VTL+ERG!.;^XMS9O-KJ5/\
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M U::9B,2+<<C?%:J\<O<;36VB+M?;O:52E1]';ZU)HU25K51B.3"KQX\$+9
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M)U7(C7*C&YXJB<$^4U6SR^7?4&GDKM0626R5O:N9X)(JJNZF,.XHG,"3
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MY66RAG?NRU;W/5(DPJY7+4 MP$'NFNG4MYFM]-1QU#X9>S?B1<MX\U3!.
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M^VMU)052:FOJM5D<J1[[=S&$7&,<B9:EMU'HC9\Z&&=SHFU"+VDB87+EY<$
MJO1>NMHFK+GJ*AM]_IXYH:I:>E6>FB:V/+GHW.(URG!.>26[0F:CM6RZVMUM
M7TUPN:5V)9J5J(URKVJMPFXSDW"<OK-[L1L+;7'>:AS%_P"KDCE:KD3_ +EX
M>LL2[VV&Z4K8*CR$>C^2+QPJ=?2!4<UIVF4<='6P:AM3;$V)KZBG[-JR/14X
M8S#Z/C(;+94RI?K&\5-9(R222G3*IPRN\WIA.XUU/L!ML-T\-^R6^.7M%?V3
MGMW..>&,<N):VGK1#9+53T,#G2)"U6]H]$WG<57CCT@;( ZJMVY23/5<(UCE
M_8H'FG;3K"'36VR!UQ2HEM\=$QSXH6-5RJK7HF,JG7'4G&C-O&E[S-16NCH;
MRR95BIT66&)&[SE1J<4D5<9\QK=*T<=\VJ6^[.C;44Z1/C5SFHYN4C>G7CU+
M?N]#1T]HKY8:.G8]D#W(K8T1<HU<= *ZVI[0*YERJM):/J):#4\79R^%3PQN
MI^S5J.5..\N<*GQ/E(A77':YI6MME9J75-LJ[6]4FFBI:>-7NB;A7-3,+>*H
MO>GI-OLWIH*O:9X?,_>JGT[FK&J93"-1.OH-SMINE"^JM%F=.Q*FXMD@A9A=
MYSE5J83IU0#/NFN*B39S;[_;I9HGU-2L67Q,5V$61.*<4^*0?1&H-I.OIUKM
M.ZAHJ:V4DG8U,593QM>]RIE%;NQ.X85.J&OVLT4UHV&V:T4R/=6P7/>?&JX<
MC529<\.'QD+TI[;#9+#4>"(B;S4>O!$X\$Z 0:^ZDU+)3QV.TW&.#4="[-=4
MR1,6&5JIP1GBKWM^*G)2+/KMJ^E+U3RZMU/;*VVM8KYHJ2"/><B[S6XS"WD[
M"\TX>HCU+H&CV@;7-40U=WKZ-\;&S*E*Y$XX8W'%.7$LC1>Q"VZ7U117ME\N
MU?)2[^(*IS71NWF.9Q3'3>SZ4 V&K=HL6G]*V*KG\*=57>-6POCB8NZ_"85R
M*J(B9<G+) I*O:_8K3)?K[JJU5%JIW(V6&"GC[5RN5&IA.P:G-R=4X'?K^&"
MX:N9!52+%'35J]FUJ</*3ACY"\JRKH(<P53HD1<*K'-RGT 5GKK:-/8K%I.G
MCEJ&WC45(C::=L,;F-G<V-$<_/)-Z1%X(O7AT(U+)M?T]1^VNH=56FIMR+V:
MQT\$>_O+P1>,#>'RGS/.V\Z\A21K.RH[EB'"93=[7ASY>2G(DOL@]3T-OTA4
M4,$\3[DR>)5IU1>#5XY[N6 .O2VL[[#I/4UQU#7>%24L':TRPPQHK$1KE7AN
MM1>2<\F@M4VUW6E#'?=)ZIM5'9JG*0PUD$:2M5JJQV<0.3BYJJGC+P5/06'9
M=*17+0M;;JE\L,5VHFQO>U$WF(YBHJM_2ZE3W-ERV'2N?9HGW&VM5*:.2M=P
M<LB=HO!JIQ16JG("5;:(==T.B;G6QWJ@2WP4^:B-(VJ]Z[R>3F/T=4(WL7L>
MTFJL-+>Z2_VIENK8%[&-[$[1N'JGC)V2IT7JI/-L]8R6WI;GO1'U=-P9W^-Z
MB4;*Z;P30%F@QC<C<F/_ #<!CWZ@UK-KNW55EN]#3Z693*VKHY&(LLDWOF'-
M7LU7'&/XR>2O#OEU,DK:>-*AR.E1/&<G)5.PX<Y&M5SEPB)E5 J;V2-%-+LW
MO$SG,6E3L$5F?&5>V9YO1U,_8QJRTZQT6RS4M-5M2UT-/1523M1K7YC5B[BM
M<JX\1W%<+Q0FD5[L]QJ6T#*F&>61,I$YBKG''JF.A2>VRRVZS:QTC41U\U)-
M45CY&0Q^*V5R21JC5PG+*XX]X%HZJNUJV:Z-\)BIJAE!#*C&QP>^.17JJ_'=
MW^<K"]0;:J:T5E]@U=96VQL3JMD78,61(L;R-PM/C>QCK\IJMH5.NJKI46JZ
M3RTL#MR15B7*HJ-3'/*$CM/L?+7'X)4_9-?7M1&R=FY[5:O7&,<@)ILJU55W
M/1-KFO\ ,^JNSV/6>9D;6M>J2.1,(F$Y8Z(4]LWV@;0M8T%PHZ6_P-NCI^RI
M9IZ:%K&<,\=V-?/T4M/: R'1.SZWT]*[?9%5)$CY$PJY21W'!SLJLE-I73]S
ME3CF9)=Z1J<.")T K"BVH:PTOJJY6+6EW2OJHFI!&ZCIH=Q)785'9W&+C"]W
MR&[I[CM3TQJNBBUAJ6W5UN6-TLL5)!'O.14>UN%[%B\'(B\^7J,G9_:FW/;I
MK*XU$:/IIH&.C<J(K<IV:<,^A3/VC5"5.VRP69BHZ:IMRO:Q.:X[=?1\50)'
MK75M=;K%8JNAG?$^M1=Y>S8N>"8RBHN.?0ZKOKF?3.SB:_WR2:H?'4I$KJ>)
MBNPJHB<%W4*_V].JNRT50TT674U6K)$1<*B>(G$W&TZGB=JQ;7,]6TBP,D7T
M\>G(#"IYMKMPIY-146J;4S3RM]L&4TD$?;)2JG:(SX!4W]SAY7/KU)+/M2CM
M>S&'4=Q\,E>Z?LE=%#'O+XZHG#*)T)[:*J@MVG[/33RL8V2EB9&CF^6B,:G=
MYT*=U>M/7;6*VVO5K*%(6/1&IPSV;5Y<N8&-7+MH]I:V^T^KK.RVQQ.JFQ+3
MQ]HD>-Y$QV&,X\_REB;'-8U.H-.T%->I9*F^-A?)45"1L9&_$BHF$;CHK?BI
MR-CKRXT5KV?7**25C'K;G]FU47QL,QT*[T$K[;I2WZA:F(ZIKHD5?)\M>6./
MQ (YIK:;K+4\LMHM=X2*[U,G94LT]-"D;%Y^-AB]$7HI)-GVI==4&KKG;=<W
MJFN,4#>S8VE@C:B2;R<<I&Q<8S]1LO8YZ>@L%BO#I,O<^K21'RHBJWQ43@J&
MBTHY]RVRZWB8F\R%'R-5/,]O>!+MKNN*^V7!FE]-5$E'J2MIF5%+4OB8^!B)
M([>WM[>7*MC>GDKS3TI [M)M9HK Y^H-3VNJH[C YC60P,1R-5OC(OO+<<%Z
M*;;3$OMOM=L5;4M3?C@DC1O-%3LY5Z_E&=MVU52TU?INV4;X999JUU-,Q45%
MCRK4X=.H'5LOJJC2.QA\[I$25M<[QHD1W!RM3XQ.-G-YNMQI[I5WBJ;40-1D
ME.UK&M<QBHY51<(G'&.J\BOML=/[3[$:NEIU<LWAD3D:O!<*Y.XF%AJJ/3NR
M6CJZB=&3U%DCF1KTX*Y($7'#SJ!KM.ZQO-SV\76R>&*NGHK>DT5*Z)B.;)B+
M*[R)O<W.^-U-9K?6&JK]?Z2AV>7-EKPY:>;PV&-4=+O81R+NO7'J]!KMF-7[
M9N;J:-&[]3&^'Q?)X.1/3\4VGL:Z:!L6K'MD6=RW+>R],JQ>/! .W0-WUU:]
M7U=!KV]4ERIH:=4W*2%C??%5BM=E(V+C=54^7D5+>[7M'N>TNR^'7^V2WY6(
MVCJ>S:UD;,O5$<B18^^^*O,]7Q5UNGNDU%&^)U=&W>D9N^,B<.N/.A2^RF6*
M^7NGN,3DD2GJG1;R=,-SUX_& E<M_O6@]-4;];5C:^JF9X,U]#&U42;"KO+E
MK/%X=WR%?03[9ZZS3W6CU;:&4L#TB>U]/'OJ[Q>*)V"ICQDZ]YL=M+67"YTM
M/53.BCBN*.;NKS7'(MC7]QHK#HZX5U8Z*GI(NS5[E;XJ9D:U.">=4 ANRS7E
M=?J:]T-RJ)9KI9Z9&U$O91M8^9$<CG,W<917-5>*)Z$(?6Z\UGJ'5[=+Z2O$
M=%<Y(>W9+54\79(U$5797<<N<)W&5L\MS;?1:\OC7.\'NU%)4T[U\E[7)(]%
M3KC#DYFQ]C?0I6:>CO,K/?DFEBWL(O#"=>8';7WS6^E+=[6ZEO--5WV[1+#;
M*BEA8L<,R)A729C;PWGL7R7<$7AT7%T]:=M=2U*BJU?8WT[D5$:D+$7.?-3^
MGJ3_ &DZ'I]94#63U-1!+!%*V-8,957HG>GF0KS9_?+MHO4TN@?!6SVV@IW5
M#*VH<JS/<]6OPN%QCQU3ET0"\*1LS:2%M4YKYT8U)'-Y*['%4^4@&V':##H6
MT4U4]*K,M2D.88V/7R'.^,J=Q84+E?$QZ\%<U%*$U;.MTVEWRVU+&K!3HQ[<
M\>.XSHO#JH"O@VSV"BEO%XU;9I[73-[26*"!BR.:O#"9@1,\4ZH2W9KJ._W>
MGK:NZUS)Z?P-9H6I$QKFN[UPU/I4[MM^HJ"WZ&NUK6HC]MJBD1U/3.1<R)OX
MY\OBKUZ&ETZY;7LJL59)XE16TB1R,7DU5:O+ $,TMM&UMK")MGLEY9!?*E[D
M@J*FFB2)J-3?=G#'?%:Y/)7BJ>DD^S#4^M(=27:VZXO$%Q6&5M/%X-!&U&O1
M[FN7*,8N%PAO?8^V.GT_H-S'IO.;62/[61J;R91J<T(9H"22OV@;1WM;O-I*
MJ:1JIYI9<?0!*]K&N+I379^EM)53Z'4+HV5#*F:&-T",XJY%54<N<)][\I"-
M4-VJT-@GI=3ZEM=92W.F>Q&00L3Q%;AR*O8M5,HY.1OM#.]L]K-/75#463P5
M[-WFF$:O>=FV;55++JK2-HH)(9_"ZE]--P5%CR^-O#IU7U 2W8#1R4&S"V4\
MRL<]LDRJK5RG&5RDAVB53J+1-XJ&*J.C@5R*B(O5.\[]&4*6[3]/3)G#5<O'
MGQ<JD:VWU.]H"]6YBIV]52JC$3FO%.0%+:,VQV#2M_K9[Q276>HDA[)[Z>*-
M<KEJIP5Z=$/0.SW6UMUW:)[C:(:N&"&=:=S:IC6N5R-:[*;KG)C#DZFAV'6:
MGAV66".LHX7U#8Y-Y9(VN<OOK^:DLU(^"UZ<KYHF1P1L;O+N-W4YHF> %4:-
MDBO>UO7=+(USO )4=XWBIY2\L<^74W6J]0ZFOMP]K="W&.W5<T;>Q?61,5C7
M(JN<J^*_FU%3DO'NYF-LXH6,N&K+M$Y7>&TROWNB^4O#J57L:V6T&T#3'MQ<
M+]=**L2H? D=,],;K41<\45<\5 EWV1;2='W^U4VM-0T5?!<*ME-$VBIX^"[
MZ([>58F814<G+).MJNM*VABJ+-IJ>2COS5C>VHDB8Z)&+Q5..]QQ_P!ITZ.V
M0V[1[ZVKCNMQN+WL1R)6*UR,5N5RG#@1#3\<-5[))U1-*YTJT2HL*\6_!)Q
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MPRIJJ=\#)^VBC>CLLXHO3T#:EH*MU3#)-9*VGM]S5&-;4R(JX:B\4X9YH6(
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MTT-/&BHQC8UPF5S][WJ60_35]J]$72T72[1U-?5+B*H5J[K&^+P7AWHOK)H
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MQ;/-KD3-R/:+3M;W=DO^PO8 5WM"OMPL6F&4,56]+O+0.8VK9C"3(W&_A?\
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MX.D4,;&JB,7*Y7BB="$)LDUG9I$BT3JJDLMNQO+ QCES(O!7<6KS1&I\A>X
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M5OM]+14R*D%-$V&-'+E=UJ(B97T(5Y[(:X,MFSB:HD=NM2IB;G&>:J!.5O\
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MVL:0U-7PT=FN,DU1,_LV-=32,R[&>:M[B=@
M
M
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MSCO\X$A
M
M
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MO!5:U$53M
M
M
7                           !_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
